Query 014610
Match_columns 421
No_of_seqs 331 out of 2511
Neff 8.5
Searched_HMMs 46136
Date Fri Mar 29 06:48:54 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/014610.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/014610hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0598 Ribosomal protein S6 k 100.0 3.7E-62 8E-67 458.7 20.8 269 11-280 23-297 (357)
2 KOG0581 Mitogen-activated prot 100.0 2.8E-61 6.1E-66 452.9 23.5 257 13-272 79-343 (364)
3 KOG0615 Serine/threonine prote 100.0 1.3E-61 2.7E-66 458.5 19.5 266 8-274 167-447 (475)
4 KOG0575 Polo-like serine/threo 100.0 1.7E-60 3.6E-65 471.2 24.1 261 8-270 13-275 (592)
5 KOG0201 Serine/threonine prote 100.0 2.5E-61 5.5E-66 460.1 15.4 283 5-288 5-287 (467)
6 KOG0574 STE20-like serine/thre 100.0 3.5E-62 7.6E-67 445.3 5.0 355 6-375 26-406 (502)
7 KOG0616 cAMP-dependent protein 100.0 1.6E-58 3.4E-63 421.1 20.1 263 11-278 42-311 (355)
8 KOG0593 Predicted protein kina 100.0 1.3E-58 2.9E-63 422.5 14.8 257 13-269 2-289 (396)
9 KOG0595 Serine/threonine-prote 100.0 4.2E-57 9E-62 428.2 22.9 263 7-271 4-275 (429)
10 KOG0582 Ste20-like serine/thre 100.0 2.8E-56 6E-61 425.8 25.4 270 11-280 24-309 (516)
11 KOG0592 3-phosphoinositide-dep 100.0 1.4E-56 3.1E-61 436.7 18.9 262 11-274 71-348 (604)
12 KOG0605 NDR and related serine 100.0 3.5E-56 7.5E-61 434.3 21.4 261 11-273 139-454 (550)
13 KOG0694 Serine/threonine prote 100.0 4.2E-56 9.1E-61 444.6 21.3 284 10-297 365-656 (694)
14 KOG0583 Serine/threonine prote 100.0 1.5E-55 3.3E-60 434.6 24.9 259 10-269 14-280 (370)
15 KOG0591 NIMA (never in mitosis 100.0 3.1E-57 6.8E-62 409.8 10.4 248 10-258 16-275 (375)
16 KOG0578 p21-activated serine/t 100.0 3.7E-56 8E-61 437.1 18.3 269 9-280 269-539 (550)
17 KOG0597 Serine-threonine prote 100.0 2.3E-55 4.9E-60 428.8 16.1 254 13-269 2-256 (808)
18 KOG0661 MAPK related serine/th 100.0 1.6E-55 3.6E-60 423.4 13.6 263 9-273 6-300 (538)
19 KOG0588 Serine/threonine prote 100.0 1.2E-54 2.6E-59 431.2 19.9 263 7-271 6-270 (786)
20 KOG0198 MEKK and related serin 100.0 2.7E-54 5.9E-59 411.1 18.8 259 12-271 16-283 (313)
21 KOG0659 Cdk activating kinase 100.0 6.2E-54 1.3E-58 385.8 19.3 257 13-270 2-287 (318)
22 KOG0600 Cdc2-related protein k 100.0 6.6E-54 1.4E-58 415.0 18.3 258 11-269 115-405 (560)
23 KOG0033 Ca2+/calmodulin-depend 100.0 2.4E-55 5.2E-60 390.5 6.5 259 10-270 8-273 (355)
24 KOG0585 Ca2+/calmodulin-depend 100.0 5.5E-53 1.2E-57 405.6 22.4 258 11-270 95-378 (576)
25 KOG0610 Putative serine/threon 100.0 7E-53 1.5E-57 399.6 21.0 261 12-273 76-401 (459)
26 KOG0660 Mitogen-activated prot 100.0 5.9E-53 1.3E-57 395.1 17.2 262 8-270 17-316 (359)
27 cd05571 STKc_PKB Catalytic dom 100.0 1.2E-51 2.6E-56 403.1 23.1 251 19-271 1-258 (323)
28 KOG0579 Ste20-like serine/thre 100.0 3.7E-53 8E-58 416.9 12.0 267 11-278 30-303 (1187)
29 KOG0663 Protein kinase PITSLRE 100.0 3.7E-52 8.1E-57 384.7 17.2 258 13-271 76-368 (419)
30 PTZ00263 protein kinase A cata 100.0 3.9E-51 8.4E-56 400.6 24.4 257 10-271 15-278 (329)
31 cd05612 STKc_PRKX_like Catalyt 100.0 1.9E-51 4.2E-56 395.7 21.5 255 13-272 1-262 (291)
32 cd05585 STKc_YPK1_like Catalyt 100.0 8.8E-51 1.9E-55 395.0 25.6 248 21-270 1-253 (312)
33 KOG0032 Ca2+/calmodulin-depend 100.0 7.4E-51 1.6E-55 401.4 25.1 260 8-270 30-299 (382)
34 cd07871 STKc_PCTAIRE3 Catalyti 100.0 1.6E-50 3.4E-55 388.7 24.7 255 12-267 4-288 (288)
35 KOG0580 Serine/threonine prote 100.0 5.3E-52 1.2E-56 368.4 12.2 255 11-269 20-278 (281)
36 cd05595 STKc_PKB_beta Catalyti 100.0 5.6E-50 1.2E-54 391.4 27.6 251 19-271 1-258 (323)
37 KOG0577 Serine/threonine prote 100.0 6.2E-51 1.4E-55 399.0 20.7 266 9-279 22-293 (948)
38 cd07869 STKc_PFTAIRE1 Catalyti 100.0 1.9E-50 4.1E-55 390.8 23.8 259 12-271 4-295 (303)
39 cd05593 STKc_PKB_gamma Catalyt 100.0 2.5E-50 5.4E-55 394.7 24.0 251 19-271 1-258 (328)
40 PTZ00426 cAMP-dependent protei 100.0 2.2E-50 4.8E-55 397.0 23.6 258 11-273 28-293 (340)
41 KOG0690 Serine/threonine prote 100.0 6.4E-52 1.4E-56 381.6 11.7 271 9-281 164-441 (516)
42 KOG0594 Protein kinase PCTAIRE 100.0 2.6E-50 5.6E-55 378.3 21.2 260 12-272 10-310 (323)
43 cd05589 STKc_PKN Catalytic dom 100.0 7.4E-50 1.6E-54 390.6 25.4 254 15-271 1-264 (324)
44 cd05628 STKc_NDR1 Catalytic do 100.0 6.3E-50 1.4E-54 397.2 25.1 258 13-271 1-300 (363)
45 KOG0589 Serine/threonine prote 100.0 5.5E-51 1.2E-55 398.1 17.2 258 11-269 2-263 (426)
46 cd05626 STKc_LATS2 Catalytic d 100.0 1.6E-49 3.5E-54 396.9 28.1 260 13-273 1-314 (381)
47 cd05592 STKc_nPKC_theta_delta 100.0 1.2E-49 2.5E-54 388.0 26.4 251 19-271 1-255 (316)
48 KOG0599 Phosphorylase kinase g 100.0 2.4E-51 5.1E-56 370.1 13.1 259 10-269 14-288 (411)
49 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 6E-50 1.3E-54 392.6 24.2 255 13-271 1-264 (333)
50 KOG0192 Tyrosine kinase specif 100.0 6.7E-50 1.4E-54 391.5 24.1 249 13-263 41-298 (362)
51 cd05587 STKc_cPKC Catalytic do 100.0 1.9E-49 4.2E-54 387.6 27.4 257 14-272 1-265 (324)
52 cd05599 STKc_NDR_like Catalyti 100.0 5.3E-50 1.2E-54 397.6 23.7 257 13-271 1-303 (364)
53 cd05631 STKc_GRK4 Catalytic do 100.0 1E-49 2.2E-54 382.4 24.9 256 14-271 1-268 (285)
54 KOG0611 Predicted serine/threo 100.0 6.7E-51 1.4E-55 384.0 16.2 256 10-268 50-307 (668)
55 cd05625 STKc_LATS1 Catalytic d 100.0 7.3E-50 1.6E-54 399.4 24.6 259 13-273 1-314 (382)
56 cd05588 STKc_aPKC Catalytic do 100.0 1.3E-49 2.9E-54 389.7 25.8 252 19-271 1-269 (329)
57 cd05598 STKc_LATS Catalytic do 100.0 8.2E-50 1.8E-54 398.1 24.7 257 13-271 1-308 (376)
58 cd05590 STKc_nPKC_eta Catalyti 100.0 1.2E-49 2.6E-54 388.6 25.2 251 19-271 1-260 (320)
59 cd07848 STKc_CDKL5 Catalytic d 100.0 9.2E-50 2E-54 382.3 23.9 254 13-267 1-287 (287)
60 cd06649 PKc_MEK2 Catalytic dom 100.0 5.2E-49 1.1E-53 385.8 29.1 258 12-272 4-309 (331)
61 cd05620 STKc_nPKC_delta Cataly 100.0 2.7E-49 5.9E-54 385.4 25.2 251 19-271 1-255 (316)
62 cd05591 STKc_nPKC_epsilon Cata 100.0 3.3E-49 7.1E-54 385.5 25.6 251 19-271 1-261 (321)
63 cd05584 STKc_p70S6K Catalytic 100.0 2.1E-49 4.6E-54 387.2 24.3 252 18-271 1-263 (323)
64 cd05594 STKc_PKB_alpha Catalyt 100.0 8.1E-50 1.8E-54 390.4 21.3 251 19-271 1-259 (325)
65 cd05616 STKc_cPKC_beta Catalyt 100.0 3.7E-49 8E-54 385.4 25.5 257 14-272 1-265 (323)
66 cd05629 STKc_NDR_like_fungal C 100.0 1.6E-49 3.5E-54 396.2 23.4 257 13-271 1-312 (377)
67 cd05573 STKc_ROCK_NDR_like Cat 100.0 1.7E-49 3.8E-54 391.4 23.1 257 13-271 1-292 (350)
68 cd05614 STKc_MSK2_N N-terminal 100.0 3E-49 6.5E-54 387.4 24.4 257 14-271 1-274 (332)
69 KOG0658 Glycogen synthase kina 100.0 2.6E-50 5.6E-55 378.0 15.4 258 9-273 20-315 (364)
70 cd05619 STKc_nPKC_theta Cataly 100.0 7.9E-49 1.7E-53 382.2 26.3 251 19-271 1-255 (316)
71 cd05570 STKc_PKC Catalytic dom 100.0 7.2E-49 1.6E-53 382.7 25.5 252 19-272 1-260 (318)
72 cd05575 STKc_SGK Catalytic dom 100.0 7.8E-49 1.7E-53 383.2 24.9 251 19-271 1-258 (323)
73 cd07859 STKc_TDY_MAPK_plant Ca 100.0 8.1E-49 1.7E-53 384.5 24.3 257 14-271 1-297 (338)
74 cd05596 STKc_ROCK Catalytic do 100.0 9.4E-49 2E-53 389.8 24.9 261 11-272 41-312 (370)
75 cd05618 STKc_aPKC_iota Catalyt 100.0 7.5E-49 1.6E-53 384.4 23.8 252 19-271 1-269 (329)
76 cd05627 STKc_NDR2 Catalytic do 100.0 4.4E-49 9.4E-54 390.7 22.1 258 13-272 1-301 (360)
77 PLN00034 mitogen-activated pro 100.0 8.6E-49 1.9E-53 387.6 23.2 255 12-270 73-334 (353)
78 cd05617 STKc_aPKC_zeta Catalyt 100.0 2.6E-48 5.7E-53 380.2 26.3 252 19-271 1-267 (327)
79 cd05586 STKc_Sck1_like Catalyt 100.0 3.2E-49 6.9E-54 387.0 19.3 251 21-271 1-260 (330)
80 cd05601 STKc_CRIK Catalytic do 100.0 1.4E-48 3.1E-53 382.2 23.8 258 13-271 1-270 (330)
81 cd05621 STKc_ROCK2 Catalytic d 100.0 1.9E-48 4.1E-53 387.6 24.9 260 11-271 41-311 (370)
82 KOG4717 Serine/threonine prote 100.0 4E-49 8.7E-54 381.2 18.9 258 11-270 16-276 (864)
83 cd07872 STKc_PCTAIRE2 Catalyti 100.0 2.1E-48 4.5E-53 377.5 23.8 258 12-270 5-292 (309)
84 cd05615 STKc_cPKC_alpha Cataly 100.0 2E-48 4.4E-53 380.4 23.7 256 14-271 1-264 (323)
85 cd06650 PKc_MEK1 Catalytic dom 100.0 5.9E-48 1.3E-52 378.7 26.6 258 11-271 3-306 (333)
86 KOG0584 Serine/threonine prote 100.0 1E-49 2.2E-54 395.2 14.1 259 7-270 33-302 (632)
87 cd05582 STKc_RSK_N N-terminal 100.0 8.4E-49 1.8E-53 382.0 20.0 252 18-271 1-261 (318)
88 PTZ00036 glycogen synthase kin 100.0 2.6E-48 5.7E-53 394.8 24.2 255 10-271 63-358 (440)
89 cd05608 STKc_GRK1 Catalytic do 100.0 4.8E-48 1E-52 369.9 24.6 249 21-271 1-264 (280)
90 KOG0667 Dual-specificity tyros 100.0 1.2E-48 2.6E-53 390.7 21.1 255 9-270 182-508 (586)
91 PHA03212 serine/threonine kina 100.0 6.5E-48 1.4E-52 386.2 26.5 250 12-270 91-382 (391)
92 cd05602 STKc_SGK1 Catalytic do 100.0 2E-48 4.4E-53 380.6 21.6 251 19-271 1-258 (325)
93 cd05622 STKc_ROCK1 Catalytic d 100.0 8E-48 1.7E-52 383.2 25.3 261 10-271 40-311 (371)
94 cd05604 STKc_SGK3 Catalytic do 100.0 4.8E-48 1E-52 377.9 23.2 251 19-271 1-258 (325)
95 cd05603 STKc_SGK2 Catalytic do 100.0 4.1E-48 8.8E-53 377.7 22.1 251 19-271 1-258 (321)
96 PTZ00283 serine/threonine prot 100.0 1.2E-47 2.6E-52 395.0 26.7 263 7-270 26-303 (496)
97 cd06609 STKc_MST3_like Catalyt 100.0 2E-47 4.2E-52 363.7 25.9 259 13-273 1-260 (274)
98 cd05597 STKc_DMPK_like Catalyt 100.0 1.2E-47 2.6E-52 376.1 25.0 259 13-271 1-273 (331)
99 PTZ00267 NIMA-related protein 100.0 2.4E-47 5.3E-52 391.8 27.6 257 12-270 66-329 (478)
100 cd07862 STKc_CDK6 Catalytic do 100.0 1.3E-47 2.9E-52 367.8 23.6 252 13-267 1-290 (290)
101 cd07853 STKc_NLK Catalytic dom 100.0 1.5E-47 3.3E-52 381.3 23.9 257 14-271 1-295 (372)
102 cd06640 STKc_MST4 Catalytic do 100.0 6.4E-47 1.4E-51 361.1 27.2 264 12-277 3-266 (277)
103 cd05623 STKc_MRCK_alpha Cataly 100.0 2.5E-47 5.3E-52 374.1 24.9 259 13-271 1-273 (332)
104 cd06611 STKc_SLK_like Catalyti 100.0 3.4E-47 7.5E-52 363.2 25.1 263 11-274 3-272 (280)
105 cd05605 STKc_GRK4_like Catalyt 100.0 3E-47 6.4E-52 365.3 24.5 256 14-271 1-268 (285)
106 cd06625 STKc_MEKK3_like Cataly 100.0 8.2E-47 1.8E-51 356.6 26.2 254 13-267 2-263 (263)
107 cd08529 STKc_FA2-like Catalyti 100.0 1.1E-46 2.4E-51 354.0 26.8 253 14-267 1-256 (256)
108 cd07873 STKc_PCTAIRE1 Catalyti 100.0 3.7E-47 8E-52 367.3 23.8 258 12-270 5-292 (301)
109 cd06644 STKc_STK10_LOK Catalyt 100.0 1.5E-46 3.3E-51 361.2 27.7 267 12-279 11-284 (292)
110 cd07876 STKc_JNK2 Catalytic do 100.0 9E-47 2E-51 373.9 26.5 255 10-269 18-320 (359)
111 cd08223 STKc_Nek4 Catalytic do 100.0 1.6E-46 3.5E-51 353.4 26.7 253 14-267 1-257 (257)
112 cd05624 STKc_MRCK_beta Catalyt 100.0 5E-47 1.1E-51 371.8 24.2 259 13-271 1-273 (331)
113 PF00069 Pkinase: Protein kina 100.0 1.7E-47 3.6E-52 360.2 19.6 253 15-267 1-260 (260)
114 cd05102 PTKc_VEGFR3 Catalytic 100.0 4.9E-47 1.1E-51 372.4 23.6 252 11-263 5-329 (338)
115 cd06642 STKc_STK25-YSK1 Cataly 100.0 2.7E-47 5.9E-52 363.5 20.8 265 12-278 3-267 (277)
116 cd07878 STKc_p38beta_MAPK11 Ca 100.0 3.4E-47 7.4E-52 374.4 21.7 259 7-270 9-304 (343)
117 cd06610 STKc_OSR1_SPAK Catalyt 100.0 1.9E-46 4.2E-51 354.3 26.0 255 13-267 1-267 (267)
118 cd06615 PKc_MEK Catalytic doma 100.0 2.4E-46 5.1E-51 363.1 26.9 255 13-270 1-293 (308)
119 cd06917 STKc_NAK1_like Catalyt 100.0 2.7E-46 5.8E-51 356.2 26.6 258 14-272 2-263 (277)
120 cd06637 STKc_TNIK Catalytic do 100.0 1.4E-46 3E-51 357.0 24.5 257 9-267 2-272 (272)
121 cd06656 STKc_PAK3 Catalytic do 100.0 1.6E-46 3.4E-51 362.5 25.0 263 10-275 16-280 (297)
122 cd07863 STKc_CDK4 Catalytic do 100.0 8.7E-47 1.9E-51 361.6 22.9 251 14-267 1-288 (288)
123 PTZ00284 protein kinase; Provi 100.0 1.1E-46 2.3E-51 386.2 25.1 254 10-270 126-444 (467)
124 cd05580 STKc_PKA Catalytic dom 100.0 2.5E-46 5.3E-51 359.6 26.0 255 13-272 1-262 (290)
125 cd06646 STKc_MAP4K5 Catalytic 100.0 2.1E-46 4.5E-51 355.1 24.9 257 9-266 5-267 (267)
126 cd06645 STKc_MAP4K3 Catalytic 100.0 1.3E-46 2.9E-51 356.4 23.5 254 12-266 8-267 (267)
127 cd07847 STKc_CDKL1_4 Catalytic 100.0 2E-46 4.4E-51 358.3 24.7 255 13-267 1-286 (286)
128 cd06641 STKc_MST3 Catalytic do 100.0 4.3E-46 9.4E-51 355.4 26.7 260 13-274 4-263 (277)
129 cd05630 STKc_GRK6 Catalytic do 100.0 2.2E-46 4.8E-51 359.4 24.8 255 14-270 1-267 (285)
130 cd06654 STKc_PAK1 Catalytic do 100.0 4.9E-46 1.1E-50 358.9 27.2 258 11-271 18-277 (296)
131 cd07874 STKc_JNK3 Catalytic do 100.0 1.7E-46 3.7E-51 371.3 24.3 257 9-270 13-317 (355)
132 cd06628 STKc_MAPKKK_Byr2_like 100.0 3.7E-46 8E-51 353.2 25.4 253 14-267 1-267 (267)
133 cd07861 STKc_CDK1_euk Catalyti 100.0 2.1E-46 4.5E-51 358.2 24.0 253 14-267 1-285 (285)
134 cd06613 STKc_MAP4K3_like Catal 100.0 6.4E-46 1.4E-50 350.1 26.8 254 12-266 2-262 (262)
135 cd07875 STKc_JNK1 Catalytic do 100.0 2.2E-46 4.8E-51 371.8 24.8 257 9-270 20-324 (364)
136 cd06643 STKc_SLK Catalytic dom 100.0 5.6E-46 1.2E-50 355.3 26.3 259 13-272 5-270 (282)
137 cd08227 PK_STRAD_alpha Pseudok 100.0 4.1E-46 8.8E-51 364.5 25.8 256 16-271 1-314 (327)
138 cd08221 STKc_Nek9 Catalytic do 100.0 1E-45 2.3E-50 347.9 27.5 253 14-267 1-256 (256)
139 KOG0612 Rho-associated, coiled 100.0 7.6E-48 1.7E-52 401.0 14.1 260 12-272 74-346 (1317)
140 cd05607 STKc_GRK7 Catalytic do 100.0 2.7E-46 5.9E-51 357.2 23.8 248 21-270 1-260 (277)
141 cd06619 PKc_MKK5 Catalytic dom 100.0 7.5E-46 1.6E-50 354.3 26.6 253 13-272 1-261 (279)
142 cd08219 STKc_Nek3 Catalytic do 100.0 7.7E-46 1.7E-50 348.8 26.0 250 14-264 1-252 (255)
143 cd06655 STKc_PAK2 Catalytic do 100.0 7.9E-46 1.7E-50 357.6 26.2 257 12-271 18-276 (296)
144 KOG0986 G protein-coupled rece 100.0 1.2E-47 2.5E-52 366.8 12.4 264 8-273 180-455 (591)
145 KOG0587 Traf2- and Nck-interac 100.0 3.2E-46 6.8E-51 381.1 23.5 262 8-271 14-289 (953)
146 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 5.3E-46 1.2E-50 356.0 23.8 258 13-272 1-270 (286)
147 cd08218 STKc_Nek1 Catalytic do 100.0 1.1E-45 2.4E-50 347.7 25.5 253 14-267 1-256 (256)
148 PTZ00266 NIMA-related protein 100.0 5.7E-46 1.2E-50 396.8 26.4 265 6-271 6-302 (1021)
149 cd07839 STKc_CDK5 Catalytic do 100.0 1.6E-46 3.5E-51 359.1 19.3 253 14-267 1-284 (284)
150 cd05632 STKc_GRK5 Catalytic do 100.0 1.4E-45 3.1E-50 353.7 25.9 257 14-272 1-269 (285)
151 cd06623 PKc_MAPKK_plant_like C 100.0 2.2E-45 4.7E-50 346.5 26.6 257 13-270 1-262 (264)
152 cd06639 STKc_myosinIIIB Cataly 100.0 2.6E-45 5.7E-50 352.3 27.6 257 10-268 19-291 (291)
153 cd07868 STKc_CDK8 Catalytic do 100.0 6.2E-46 1.3E-50 361.2 23.5 246 18-267 6-317 (317)
154 cd06608 STKc_myosinIII_like Ca 100.0 1.2E-45 2.7E-50 350.1 24.7 256 10-267 3-275 (275)
155 KOG4279 Serine/threonine prote 100.0 3.1E-47 6.8E-52 378.4 14.1 250 20-270 582-838 (1226)
156 cd05048 PTKc_Ror Catalytic Dom 100.0 8.7E-46 1.9E-50 353.8 23.6 252 12-264 4-279 (283)
157 KOG0604 MAP kinase-activated p 100.0 4E-47 8.8E-52 346.7 13.6 252 11-270 59-328 (400)
158 cd06612 STKc_MST1_2 Catalytic 100.0 1.3E-45 2.8E-50 346.7 24.3 252 12-267 2-256 (256)
159 cd06605 PKc_MAPKK Catalytic do 100.0 6E-46 1.3E-50 351.1 22.1 254 13-269 1-262 (265)
160 cd06651 STKc_MEKK3 Catalytic d 100.0 2.8E-45 6.1E-50 347.5 26.4 254 13-268 2-265 (266)
161 cd06632 STKc_MEKK1_plant Catal 100.0 2.2E-45 4.7E-50 345.4 25.3 253 14-267 1-258 (258)
162 cd08217 STKc_Nek2 Catalytic do 100.0 2.4E-45 5.2E-50 345.9 25.5 253 14-267 1-265 (265)
163 cd07870 STKc_PFTAIRE2 Catalyti 100.0 1.8E-45 4E-50 353.4 25.1 256 11-267 3-291 (291)
164 cd06631 STKc_YSK4 Catalytic do 100.0 2E-45 4.4E-50 347.9 25.0 252 14-267 1-265 (265)
165 cd05064 PTKc_EphR_A10 Catalyti 100.0 1.8E-45 3.9E-50 349.2 24.6 251 12-263 4-260 (266)
166 cd06636 STKc_MAP4K4_6 Catalyti 100.0 1.3E-45 2.9E-50 352.5 23.8 256 10-267 13-282 (282)
167 cd06658 STKc_PAK5 Catalytic do 100.0 4.7E-46 1E-50 358.5 20.8 264 8-274 17-282 (292)
168 KOG0696 Serine/threonine prote 100.0 2.8E-47 6E-52 360.2 11.8 261 12-274 348-616 (683)
169 cd05574 STKc_phototropin_like 100.0 2.2E-45 4.8E-50 357.1 25.5 258 13-271 1-296 (316)
170 cd07841 STKc_CDK7 Catalytic do 100.0 1.9E-45 4.2E-50 354.2 24.5 257 14-271 1-289 (298)
171 cd06638 STKc_myosinIIIA Cataly 100.0 3.1E-45 6.8E-50 350.5 25.4 256 10-267 15-286 (286)
172 cd06652 STKc_MEKK2 Catalytic d 100.0 6.3E-45 1.4E-49 344.7 27.3 254 13-268 2-265 (265)
173 PHA03207 serine/threonine kina 100.0 1.6E-45 3.5E-50 369.3 24.5 253 10-270 89-381 (392)
174 KOG0586 Serine/threonine prote 100.0 2.4E-46 5.1E-51 370.9 18.0 260 10-271 53-313 (596)
175 cd08220 STKc_Nek8 Catalytic do 100.0 5.1E-45 1.1E-49 342.7 25.5 252 14-267 1-256 (256)
176 cd07846 STKc_CDKL2_3 Catalytic 100.0 9.3E-46 2E-50 353.9 20.8 255 13-267 1-286 (286)
177 cd06614 STKc_PAK Catalytic dom 100.0 5.3E-45 1.2E-49 349.3 25.9 264 9-275 15-281 (286)
178 PHA02988 hypothetical protein; 100.0 4.7E-45 1E-49 350.1 25.5 240 19-263 26-274 (283)
179 cd06630 STKc_MEKK1 Catalytic d 100.0 4.7E-45 1E-49 345.5 25.2 254 14-268 1-268 (268)
180 cd07832 STKc_CCRK Catalytic do 100.0 3.6E-45 7.8E-50 349.6 24.3 254 14-268 1-286 (286)
181 KOG0197 Tyrosine kinases [Sign 100.0 7.7E-46 1.7E-50 363.2 19.9 246 13-262 206-455 (468)
182 cd06647 STKc_PAK_I Catalytic d 100.0 3.8E-45 8.2E-50 352.2 24.3 262 11-275 17-280 (293)
183 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 3.5E-45 7.5E-50 350.4 23.9 256 12-270 4-272 (284)
184 cd05609 STKc_MAST Catalytic do 100.0 9.3E-45 2E-49 351.2 27.1 258 13-271 1-280 (305)
185 cd07860 STKc_CDK2_3 Catalytic 100.0 2E-45 4.4E-50 351.5 22.1 253 14-267 1-284 (284)
186 PHA03209 serine/threonine kina 100.0 1.9E-45 4.1E-50 364.4 22.6 248 12-269 65-356 (357)
187 cd05633 STKc_GRK3 Catalytic do 100.0 5E-45 1.1E-49 349.0 24.6 251 20-272 1-263 (279)
188 cd05578 STKc_Yank1 Catalytic d 100.0 1.7E-45 3.6E-50 347.1 20.9 252 14-267 1-258 (258)
189 cd07844 STKc_PCTAIRE_like Cata 100.0 5.8E-45 1.3E-49 349.7 24.9 255 12-267 4-291 (291)
190 cd07845 STKc_CDK10 Catalytic d 100.0 4E-45 8.8E-50 354.3 23.9 259 11-270 5-296 (309)
191 cd07836 STKc_Pho85 Catalytic d 100.0 4.2E-45 9.1E-50 349.0 23.5 253 14-267 1-284 (284)
192 cd05572 STKc_cGK_PKG Catalytic 100.0 7.6E-45 1.7E-49 343.4 24.8 248 21-270 1-258 (262)
193 KOG0983 Mitogen-activated prot 100.0 2.6E-46 5.6E-51 337.6 13.9 257 13-271 92-356 (391)
194 cd05096 PTKc_DDR1 Catalytic do 100.0 9.1E-45 2E-49 351.0 25.8 252 11-263 3-300 (304)
195 cd06648 STKc_PAK_II Catalytic 100.0 9.5E-45 2.1E-49 348.0 25.7 258 13-273 19-278 (285)
196 cd06607 STKc_TAO Catalytic dom 100.0 2.3E-44 4.9E-49 348.9 28.1 263 9-276 11-279 (307)
197 cd05049 PTKc_Trk Catalytic dom 100.0 6.3E-45 1.4E-49 347.1 23.3 251 12-263 4-276 (280)
198 cd06626 STKc_MEKK4 Catalytic d 100.0 2E-44 4.4E-49 340.2 26.5 254 14-267 1-264 (264)
199 PHA03211 serine/threonine kina 100.0 5.5E-45 1.2E-49 370.7 24.2 249 12-269 168-460 (461)
200 cd05106 PTKc_CSF-1R Catalytic 100.0 3.7E-45 8E-50 364.5 22.2 251 12-263 37-367 (374)
201 cd06659 STKc_PAK6 Catalytic do 100.0 3.8E-45 8.3E-50 352.9 21.6 259 11-272 19-279 (297)
202 cd05062 PTKc_IGF-1R Catalytic 100.0 1.1E-44 2.4E-49 345.5 24.5 254 10-264 3-274 (277)
203 cd07837 STKc_CdkB_plant Cataly 100.0 6.1E-45 1.3E-49 350.0 22.9 255 13-268 1-295 (295)
204 KOG0662 Cyclin-dependent kinas 100.0 3.7E-46 8.1E-51 318.1 12.7 257 13-270 2-289 (292)
205 cd06617 PKc_MKK3_6 Catalytic d 100.0 2.2E-44 4.8E-49 343.9 26.5 259 13-273 1-270 (283)
206 cd08215 STKc_Nek Catalytic dom 100.0 1.8E-44 3.8E-49 338.3 25.3 253 14-267 1-258 (258)
207 cd08225 STKc_Nek5 Catalytic do 100.0 7.9E-45 1.7E-49 341.6 23.0 253 14-267 1-257 (257)
208 cd05104 PTKc_Kit Catalytic dom 100.0 6E-45 1.3E-49 363.1 23.3 252 12-264 34-370 (375)
209 cd07849 STKc_ERK1_2_like Catal 100.0 7.2E-45 1.6E-49 357.0 23.5 259 11-271 3-299 (336)
210 cd05090 PTKc_Ror1 Catalytic do 100.0 1.4E-44 3.1E-49 345.8 24.9 251 13-264 5-279 (283)
211 cd05606 STKc_beta_ARK Catalyti 100.0 1.7E-44 3.8E-49 344.9 25.1 251 20-273 1-264 (278)
212 cd05061 PTKc_InsR Catalytic do 100.0 2E-44 4.3E-49 346.0 25.5 260 10-270 3-286 (288)
213 cd06627 STKc_Cdc7_like Catalyt 100.0 3.7E-44 8.1E-49 335.9 26.7 253 14-267 1-254 (254)
214 cd07833 STKc_CDKL Catalytic do 100.0 1.1E-44 2.3E-49 346.7 23.5 255 13-267 1-288 (288)
215 cd06624 STKc_ASK Catalytic dom 100.0 2.5E-44 5.4E-49 341.2 25.6 255 12-267 7-268 (268)
216 PLN00009 cyclin-dependent kina 100.0 1.4E-44 3E-49 347.8 24.0 258 13-271 2-291 (294)
217 cd07843 STKc_CDC2L1 Catalytic 100.0 1E-44 2.2E-49 348.5 22.9 254 13-267 5-293 (293)
218 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 6.3E-44 1.4E-48 342.4 28.3 258 13-273 1-275 (287)
219 cd05084 PTKc_Fes Catalytic dom 100.0 2.1E-44 4.6E-49 338.4 24.5 244 19-263 1-248 (252)
220 cd07831 STKc_MOK Catalytic dom 100.0 1.4E-44 2.9E-49 345.0 23.5 250 15-267 1-282 (282)
221 cd06629 STKc_MAPKKK_Bck1_like 100.0 2.2E-44 4.8E-49 342.1 24.8 254 14-267 2-272 (272)
222 cd05036 PTKc_ALK_LTK Catalytic 100.0 1.9E-44 4.1E-49 344.0 24.0 254 10-264 3-274 (277)
223 cd07850 STKc_JNK Catalytic dom 100.0 2.1E-44 4.6E-49 356.1 25.0 261 6-271 9-318 (353)
224 cd07867 STKc_CDC2L6 Catalytic 100.0 2.2E-44 4.8E-49 349.9 24.4 245 19-267 7-317 (317)
225 cd08228 STKc_Nek6 Catalytic do 100.0 5.3E-44 1.2E-48 338.4 26.4 251 13-264 2-261 (267)
226 cd05033 PTKc_EphR Catalytic do 100.0 5.1E-44 1.1E-48 338.7 25.9 252 12-264 3-261 (266)
227 cd07858 STKc_TEY_MAPK_plant Ca 100.0 1E-44 2.3E-49 356.1 21.8 259 11-270 3-297 (337)
228 cd05108 PTKc_EGFR Catalytic do 100.0 2.7E-44 5.8E-49 349.9 24.2 251 12-264 6-264 (316)
229 cd05577 STKc_GRK Catalytic dom 100.0 3E-44 6.5E-49 342.7 23.8 249 21-271 1-261 (277)
230 KOG4236 Serine/threonine prote 100.0 8.3E-46 1.8E-50 359.0 13.0 258 18-278 569-833 (888)
231 KOG0607 MAP kinase-interacting 100.0 1.6E-45 3.5E-50 338.7 14.1 253 18-271 83-368 (463)
232 KOG1989 ARK protein kinase fam 100.0 1.4E-43 3E-48 364.6 29.5 254 9-267 33-310 (738)
233 cd07835 STKc_CDK1_like Catalyt 100.0 1.6E-44 3.4E-49 345.1 21.1 252 15-267 1-283 (283)
234 cd00192 PTKc Catalytic domain 100.0 6.7E-44 1.5E-48 335.2 24.9 245 19-264 1-260 (262)
235 cd06657 STKc_PAK4 Catalytic do 100.0 3.8E-44 8.3E-49 345.2 23.7 259 14-275 21-281 (292)
236 cd05611 STKc_Rim15_like Cataly 100.0 5.9E-44 1.3E-48 337.0 24.5 249 18-271 1-258 (260)
237 cd05122 PKc_STE Catalytic doma 100.0 1.1E-43 2.5E-48 331.2 26.1 250 14-266 1-253 (253)
238 cd06653 STKc_MEKK3_like_1 Cata 100.0 1.4E-43 3E-48 335.6 26.7 253 13-267 2-264 (264)
239 cd05088 PTKc_Tie2 Catalytic do 100.0 4.6E-44 9.9E-49 346.3 23.8 251 12-264 6-276 (303)
240 cd05091 PTKc_Ror2 Catalytic do 100.0 4.2E-44 9.1E-49 342.4 22.9 251 13-264 5-279 (283)
241 cd05032 PTKc_InsR_like Catalyt 100.0 7.8E-44 1.7E-48 339.0 24.6 252 11-263 4-273 (277)
242 cd06616 PKc_MKK4 Catalytic dom 100.0 5.7E-44 1.2E-48 342.3 23.7 257 13-271 4-274 (288)
243 cd05089 PTKc_Tie1 Catalytic do 100.0 8E-44 1.7E-48 343.4 24.8 250 13-264 2-271 (297)
244 cd06606 STKc_MAPKKK Catalytic 100.0 2.3E-43 5E-48 330.5 27.2 253 14-267 1-260 (260)
245 cd05114 PTKc_Tec_Rlk Catalytic 100.0 1.1E-43 2.3E-48 334.6 24.9 247 13-263 4-253 (256)
246 cd05054 PTKc_VEGFR Catalytic d 100.0 4.1E-44 8.9E-49 352.1 22.5 253 11-264 5-329 (337)
247 cd05052 PTKc_Abl Catalytic dom 100.0 1E-43 2.2E-48 336.3 24.3 249 12-263 5-257 (263)
248 KOG4721 Serine/threonine prote 100.0 3.5E-45 7.5E-50 357.4 14.5 240 13-264 124-364 (904)
249 cd05053 PTKc_FGFR Catalytic do 100.0 8.8E-44 1.9E-48 341.8 23.9 255 9-264 8-287 (293)
250 cd05093 PTKc_TrkB Catalytic do 100.0 1.4E-43 2.9E-48 340.2 25.1 250 12-263 4-274 (288)
251 cd08530 STKc_CNK2-like Catalyt 100.0 1.3E-43 2.8E-48 332.9 24.5 251 14-267 1-256 (256)
252 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 3.2E-43 6.9E-48 332.6 27.2 250 13-263 2-260 (267)
253 PF07714 Pkinase_Tyr: Protein 100.0 2.8E-44 6E-49 340.1 19.9 247 16-263 2-257 (259)
254 cd05579 STKc_MAST_like Catalyt 100.0 5.3E-44 1.1E-48 336.7 21.6 249 21-271 1-264 (265)
255 cd05109 PTKc_HER2 Catalytic do 100.0 1.6E-43 3.5E-48 337.8 25.0 251 11-263 5-263 (279)
256 cd07855 STKc_ERK5 Catalytic do 100.0 3.7E-44 8.1E-49 351.7 21.0 259 11-270 3-300 (334)
257 cd08226 PK_STRAD_beta Pseudoki 100.0 1E-43 2.3E-48 347.6 24.1 255 18-272 3-316 (328)
258 cd05148 PTKc_Srm_Brk Catalytic 100.0 5.2E-44 1.1E-48 337.3 21.2 250 11-263 4-256 (261)
259 KOG0614 cGMP-dependent protein 100.0 5.6E-46 1.2E-50 359.1 7.8 264 8-273 415-686 (732)
260 cd05066 PTKc_EphR_A Catalytic 100.0 1.6E-43 3.4E-48 335.7 24.3 251 12-263 3-261 (267)
261 cd07865 STKc_CDK9 Catalytic do 100.0 1E-43 2.3E-48 343.4 23.4 255 12-267 11-310 (310)
262 cd07834 STKc_MAPK Catalytic do 100.0 5.2E-44 1.1E-48 349.6 21.6 257 14-271 1-296 (330)
263 PTZ00024 cyclin-dependent prot 100.0 9.1E-44 2E-48 348.9 22.9 260 10-270 5-319 (335)
264 cd05581 STKc_PDK1 Catalytic do 100.0 4.7E-44 1E-48 340.3 20.3 253 13-267 1-280 (280)
265 cd07842 STKc_CDK8_like Catalyt 100.0 8E-44 1.7E-48 345.4 22.1 253 14-267 1-316 (316)
266 cd05045 PTKc_RET Catalytic dom 100.0 2.1E-43 4.5E-48 339.1 24.6 249 14-263 1-281 (290)
267 cd05098 PTKc_FGFR1 Catalytic d 100.0 1.8E-43 3.9E-48 342.5 24.4 252 12-264 17-295 (307)
268 cd06633 STKc_TAO3 Catalytic do 100.0 4.2E-43 9.1E-48 341.2 27.0 262 10-276 18-285 (313)
269 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.6E-43 3.5E-48 355.1 24.7 251 12-263 36-392 (400)
270 cd07880 STKc_p38gamma_MAPK12 C 100.0 1.4E-43 3.1E-48 349.0 23.8 263 4-271 6-305 (343)
271 cd08229 STKc_Nek7 Catalytic do 100.0 1.7E-43 3.7E-48 334.9 23.4 250 13-263 2-260 (267)
272 KOG4645 MAPKKK (MAP kinase kin 100.0 4.2E-46 9.1E-51 392.4 6.0 261 10-270 1232-1500(1509)
273 cd05116 PTKc_Syk Catalytic dom 100.0 2.4E-43 5.2E-48 332.6 24.2 243 19-263 1-250 (257)
274 KOG0608 Warts/lats-like serine 100.0 3E-44 6.5E-49 354.3 18.7 263 10-274 626-938 (1034)
275 cd05072 PTKc_Lyn Catalytic dom 100.0 2.3E-43 5E-48 333.1 24.1 249 11-263 4-256 (261)
276 PHA03390 pk1 serine/threonine- 100.0 2.1E-43 4.5E-48 335.6 23.8 245 12-269 13-267 (267)
277 PRK13184 pknD serine/threonine 100.0 2.3E-43 5E-48 375.4 26.7 251 13-264 2-285 (932)
278 cd05111 PTK_HER3 Pseudokinase 100.0 3E-43 6.4E-48 336.5 24.9 250 12-263 6-263 (279)
279 cd05060 PTKc_Syk_like Catalyti 100.0 3.9E-43 8.4E-48 331.0 25.1 243 19-263 1-250 (257)
280 cd05051 PTKc_DDR Catalytic dom 100.0 3.6E-43 7.8E-48 337.9 24.9 251 12-263 4-292 (296)
281 cd05113 PTKc_Btk_Bmx Catalytic 100.0 3E-43 6.6E-48 332.0 23.9 248 13-264 4-254 (256)
282 cd07854 STKc_MAPK4_6 Catalytic 100.0 1.3E-43 2.8E-48 349.1 22.3 257 11-270 3-306 (342)
283 cd05075 PTKc_Axl Catalytic dom 100.0 3.7E-43 8.1E-48 333.5 24.1 249 15-264 1-267 (272)
284 cd05063 PTKc_EphR_A2 Catalytic 100.0 5.7E-43 1.2E-47 331.7 25.3 251 12-263 4-262 (268)
285 cd05115 PTKc_Zap-70 Catalytic 100.0 4.9E-43 1.1E-47 331.0 24.6 242 20-263 2-250 (257)
286 cd05068 PTKc_Frk_like Catalyti 100.0 6E-43 1.3E-47 330.5 25.2 249 11-263 4-256 (261)
287 cd07877 STKc_p38alpha_MAPK14 C 100.0 3.7E-43 8.1E-48 346.3 24.7 261 5-270 9-306 (345)
288 cd08216 PK_STRAD Pseudokinase 100.0 5.1E-43 1.1E-47 340.1 25.2 254 19-272 4-303 (314)
289 cd08222 STKc_Nek11 Catalytic d 100.0 1.5E-43 3.2E-48 334.2 20.9 252 14-267 1-260 (260)
290 cd05099 PTKc_FGFR4 Catalytic d 100.0 5.6E-43 1.2E-47 340.3 25.3 254 9-263 8-288 (314)
291 cd05035 PTKc_Axl_like Catalyti 100.0 5.3E-43 1.2E-47 332.1 24.5 249 15-264 1-268 (273)
292 cd05071 PTKc_Src Catalytic dom 100.0 5.5E-43 1.2E-47 331.4 24.5 248 11-263 4-255 (262)
293 cd05050 PTKc_Musk Catalytic do 100.0 3.8E-43 8.3E-48 336.8 23.7 252 11-263 3-284 (288)
294 cd05094 PTKc_TrkC Catalytic do 100.0 5.8E-43 1.2E-47 336.3 24.8 250 12-263 4-277 (291)
295 cd05059 PTKc_Tec_like Catalyti 100.0 4.5E-43 9.7E-48 330.6 23.5 249 12-264 3-254 (256)
296 cd06635 STKc_TAO1 Catalytic do 100.0 1.4E-42 3.1E-47 338.0 27.8 259 10-273 22-286 (317)
297 cd05101 PTKc_FGFR2 Catalytic d 100.0 5.6E-43 1.2E-47 338.5 24.7 255 9-264 11-292 (304)
298 KOG0193 Serine/threonine prote 100.0 2.9E-44 6.3E-49 354.5 15.8 253 7-263 386-648 (678)
299 cd07851 STKc_p38 Catalytic dom 100.0 1.7E-43 3.7E-48 348.4 21.3 261 6-271 8-305 (343)
300 cd05092 PTKc_TrkA Catalytic do 100.0 5.8E-43 1.3E-47 334.5 24.3 250 12-263 4-276 (280)
301 cd07852 STKc_MAPK15 Catalytic 100.0 2.8E-43 6.2E-48 345.7 22.3 260 9-270 3-301 (337)
302 cd05039 PTKc_Csk_like Catalyti 100.0 8.9E-43 1.9E-47 328.1 24.8 244 12-263 5-251 (256)
303 cd07864 STKc_CDK12 Catalytic d 100.0 2.8E-43 6.1E-48 339.6 21.9 258 9-267 3-302 (302)
304 cd05067 PTKc_Lck_Blk Catalytic 100.0 7.2E-43 1.6E-47 329.7 24.2 248 11-263 4-255 (260)
305 cd07840 STKc_CDK9_like Catalyt 100.0 5.4E-43 1.2E-47 334.3 23.5 252 15-267 1-287 (287)
306 KOG0596 Dual specificity; seri 100.0 7.6E-44 1.6E-48 347.9 17.7 259 7-269 355-632 (677)
307 cd05065 PTKc_EphR_B Catalytic 100.0 7.9E-43 1.7E-47 331.1 24.4 250 13-263 4-263 (269)
308 smart00219 TyrKc Tyrosine kina 100.0 9.4E-43 2E-47 327.2 24.6 248 15-263 1-256 (258)
309 cd06634 STKc_TAO2 Catalytic do 100.0 1.1E-42 2.4E-47 337.4 25.7 260 9-273 11-276 (308)
310 KOG0695 Serine/threonine prote 100.0 3.5E-44 7.6E-49 331.7 14.2 262 11-273 248-525 (593)
311 cd05118 STKc_CMGC Catalytic do 100.0 3.2E-43 6.9E-48 335.4 21.2 252 15-267 1-283 (283)
312 cd05613 STKc_MSK1_N N-terminal 100.0 9.6E-43 2.1E-47 334.3 24.6 257 14-271 1-275 (290)
313 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 1.1E-42 2.3E-47 328.5 24.3 248 11-263 4-255 (260)
314 cd07866 STKc_BUR1 Catalytic do 100.0 3.3E-43 7.2E-48 340.1 21.0 255 12-267 7-311 (311)
315 cd05055 PTKc_PDGFR Catalytic d 100.0 1.2E-42 2.6E-47 336.4 24.9 252 11-263 33-296 (302)
316 cd07879 STKc_p38delta_MAPK13 C 100.0 3.6E-43 7.9E-48 345.9 21.5 258 8-271 10-304 (342)
317 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 1.6E-42 3.4E-47 331.6 25.1 249 13-263 3-276 (283)
318 KOG0666 Cyclin C-dependent kin 100.0 2.8E-44 6.1E-49 329.5 12.3 260 11-271 22-344 (438)
319 cd05041 PTKc_Fes_like Catalyti 100.0 2E-42 4.4E-47 324.6 24.9 243 19-263 1-247 (251)
320 cd05100 PTKc_FGFR3 Catalytic d 100.0 1.3E-42 2.8E-47 340.7 24.7 252 12-264 11-289 (334)
321 cd05103 PTKc_VEGFR2 Catalytic 100.0 7.7E-43 1.7E-47 343.8 22.9 253 11-264 5-335 (343)
322 cd05047 PTKc_Tie Catalytic dom 100.0 1.5E-42 3.2E-47 329.8 24.1 243 19-263 1-263 (270)
323 cd05123 STKc_AGC Catalytic dom 100.0 8.1E-43 1.7E-47 326.6 21.8 245 21-267 1-250 (250)
324 cd05082 PTKc_Csk Catalytic dom 100.0 1.9E-42 4.2E-47 326.0 24.5 242 13-263 6-251 (256)
325 cd05085 PTKc_Fer Catalytic dom 100.0 2.7E-42 5.9E-47 323.5 25.3 244 19-264 1-247 (250)
326 cd07857 STKc_MPK1 Catalytic do 100.0 1.1E-42 2.5E-47 340.8 23.7 257 14-271 1-299 (332)
327 cd05043 PTK_Ryk Pseudokinase d 100.0 2E-42 4.3E-47 330.3 24.4 252 11-263 4-271 (280)
328 cd05069 PTKc_Yes Catalytic dom 100.0 2.4E-42 5.3E-47 326.3 24.7 248 11-263 4-255 (260)
329 cd05034 PTKc_Src_like Catalyti 100.0 2.9E-42 6.3E-47 325.4 25.0 249 11-263 4-256 (261)
330 cd05057 PTKc_EGFR_like Catalyt 100.0 3E-42 6.5E-47 329.1 25.4 251 11-263 5-263 (279)
331 cd07830 STKc_MAK_like Catalyti 100.0 1.3E-42 2.7E-47 331.7 22.7 251 15-267 1-283 (283)
332 KOG1187 Serine/threonine prote 100.0 1.6E-42 3.5E-47 341.2 23.9 252 9-263 71-347 (361)
333 cd05095 PTKc_DDR2 Catalytic do 100.0 2.3E-42 4.9E-47 333.0 24.5 252 11-263 3-292 (296)
334 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 1.8E-42 3.8E-47 331.6 23.4 251 13-264 4-279 (284)
335 cd06618 PKc_MKK7 Catalytic dom 100.0 2.8E-42 6E-47 332.4 24.9 260 11-272 13-281 (296)
336 cd07829 STKc_CDK_like Catalyti 100.0 9E-43 2E-47 332.1 21.1 252 15-267 1-282 (282)
337 cd05097 PTKc_DDR_like Catalyti 100.0 1.8E-42 4E-47 333.5 23.4 251 12-263 4-291 (295)
338 cd05610 STKc_MASTL Catalytic d 100.0 2.9E-42 6.4E-47 366.6 27.0 148 12-159 3-152 (669)
339 cd05046 PTK_CCK4 Pseudokinase 100.0 2.6E-42 5.7E-47 328.4 23.8 251 13-264 5-272 (275)
340 PHA03210 serine/threonine kina 100.0 1E-42 2.3E-47 359.1 22.5 260 10-271 145-461 (501)
341 cd05107 PTKc_PDGFR_beta Cataly 100.0 2E-42 4.4E-47 347.1 24.0 253 11-264 35-395 (401)
342 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 2.9E-42 6.3E-47 337.6 24.4 255 11-270 8-294 (328)
343 cd05058 PTKc_Met_Ron Catalytic 100.0 4.4E-42 9.5E-47 324.3 24.6 245 19-264 1-255 (262)
344 cd05056 PTKc_FAK Catalytic dom 100.0 4.9E-42 1.1E-46 325.9 24.8 251 12-264 5-261 (270)
345 cd05040 PTKc_Ack_like Catalyti 100.0 4.7E-42 1E-46 323.2 24.4 243 19-263 1-253 (257)
346 cd05112 PTKc_Itk Catalytic dom 100.0 6.6E-42 1.4E-46 322.0 24.9 249 12-264 3-254 (256)
347 KOG1026 Nerve growth factor re 100.0 2.5E-43 5.4E-48 361.3 16.2 254 8-262 481-756 (774)
348 KOG0194 Protein tyrosine kinas 100.0 7.6E-43 1.6E-47 346.9 19.2 250 13-263 157-415 (474)
349 cd07838 STKc_CDK4_6_like Catal 100.0 6.6E-42 1.4E-46 327.0 24.8 250 15-267 1-287 (287)
350 cd05044 PTKc_c-ros Catalytic d 100.0 4.1E-42 8.9E-47 325.8 22.8 244 19-263 1-265 (269)
351 cd05110 PTKc_HER4 Catalytic do 100.0 5.2E-42 1.1E-46 331.9 23.6 251 12-264 6-264 (303)
352 KOG0603 Ribosomal protein S6 k 100.0 2.3E-43 5E-48 351.4 14.4 245 10-267 319-566 (612)
353 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.6E-42 3.5E-47 327.3 19.1 239 19-264 1-256 (258)
354 cd05073 PTKc_Hck Catalytic dom 100.0 1.8E-41 3.9E-46 320.4 25.9 249 10-263 3-255 (260)
355 cd05583 STKc_MSK_N N-terminal 100.0 6.7E-42 1.4E-46 328.2 22.9 258 14-272 1-274 (288)
356 cd05042 PTKc_Aatyk Catalytic d 100.0 8.7E-42 1.9E-46 324.0 23.4 244 19-263 1-265 (269)
357 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 1.2E-41 2.7E-46 323.1 24.4 244 19-263 1-265 (269)
358 KOG1035 eIF-2alpha kinase GCN2 100.0 6.4E-43 1.4E-47 366.9 16.7 255 11-268 477-875 (1351)
359 KOG2345 Serine/threonine prote 100.0 5.5E-43 1.2E-47 312.3 13.5 252 12-264 20-296 (302)
360 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.4E-41 2.9E-46 322.1 23.8 239 19-264 1-260 (262)
361 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 1E-41 2.2E-46 325.2 22.2 238 20-264 2-272 (274)
362 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 1.3E-41 2.8E-46 320.1 22.5 236 19-263 1-256 (259)
363 cd05083 PTKc_Chk Catalytic dom 100.0 2.1E-41 4.5E-46 318.6 23.1 241 13-263 6-249 (254)
364 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 3.6E-41 7.7E-46 322.3 24.8 249 13-263 4-278 (284)
365 cd08528 STKc_Nek10 Catalytic d 100.0 3E-41 6.5E-46 320.1 23.9 249 14-264 1-266 (269)
366 cd05576 STKc_RPK118_like Catal 100.0 8.3E-42 1.8E-46 318.8 19.5 229 24-267 4-237 (237)
367 KOG1006 Mitogen-activated prot 100.0 1E-43 2.3E-48 319.6 5.3 257 11-269 62-332 (361)
368 KOG1095 Protein tyrosine kinas 100.0 1.3E-41 2.9E-46 359.9 21.7 256 7-263 686-956 (1025)
369 cd05086 PTKc_Aatyk2 Catalytic 100.0 7.9E-41 1.7E-45 317.7 24.5 244 19-263 1-264 (268)
370 PHA02882 putative serine/threo 100.0 1.1E-40 2.3E-45 321.5 25.0 255 5-263 4-291 (294)
371 cd05074 PTKc_Tyro3 Catalytic d 100.0 6.5E-41 1.4E-45 318.3 23.1 249 15-264 1-268 (273)
372 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 6.2E-41 1.3E-45 319.8 22.8 251 12-263 3-278 (284)
373 KOG0196 Tyrosine kinase, EPH ( 100.0 3.6E-43 7.9E-48 354.2 6.4 344 12-358 628-982 (996)
374 KOG0669 Cyclin T-dependent kin 100.0 1.4E-43 2.9E-48 316.7 2.6 260 11-271 15-322 (376)
375 KOG0671 LAMMER dual specificit 100.0 4.4E-42 9.5E-47 323.3 12.0 257 7-270 83-412 (415)
376 KOG4250 TANK binding protein k 100.0 7.9E-42 1.7E-46 343.0 14.6 210 5-215 5-227 (732)
377 KOG0576 Mitogen-activated prot 100.0 2.7E-42 5.9E-47 342.9 6.5 261 9-270 11-277 (829)
378 KOG0668 Casein kinase II, alph 100.0 9.7E-41 2.1E-45 294.7 10.7 251 12-270 37-328 (338)
379 KOG4257 Focal adhesion tyrosin 100.0 1E-39 2.2E-44 322.1 17.2 245 17-263 393-644 (974)
380 KOG1151 Tousled-like protein k 100.0 1.8E-40 3.9E-45 316.4 10.9 260 10-269 460-746 (775)
381 PLN03225 Serine/threonine-prot 100.0 3.7E-39 8.1E-44 335.5 21.5 255 11-271 130-457 (566)
382 smart00220 S_TKc Serine/Threon 100.0 1.2E-38 2.6E-43 295.0 22.3 241 25-267 1-244 (244)
383 KOG1094 Discoidin domain recep 100.0 7.9E-39 1.7E-43 314.0 16.1 258 4-263 529-799 (807)
384 KOG0199 ACK and related non-re 100.0 7.4E-39 1.6E-43 319.4 15.7 255 12-269 109-373 (1039)
385 KOG0670 U4/U6-associated splic 100.0 2E-39 4.3E-44 314.5 10.7 257 7-269 426-751 (752)
386 PLN03224 probable serine/threo 100.0 1.9E-37 4.1E-42 316.0 24.1 258 12-269 144-505 (507)
387 KOG1027 Serine/threonine prote 100.0 6.9E-39 1.5E-43 326.1 10.0 258 15-282 511-785 (903)
388 KOG4278 Protein tyrosine kinas 100.0 1.3E-37 2.7E-42 306.9 18.3 249 12-263 266-518 (1157)
389 KOG0664 Nemo-like MAPK-related 100.0 1.5E-39 3.2E-44 293.8 3.7 257 14-271 54-350 (449)
390 KOG0665 Jun-N-terminal kinase 100.0 4.4E-38 9.6E-43 290.1 10.9 256 7-268 11-314 (369)
391 KOG0984 Mitogen-activated prot 100.0 1.9E-37 4.2E-42 270.0 13.4 221 12-234 45-275 (282)
392 PLN00113 leucine-rich repeat r 100.0 1.3E-36 2.8E-41 337.6 22.8 238 13-264 690-947 (968)
393 KOG1290 Serine/threonine prote 100.0 5E-36 1.1E-40 289.4 20.8 136 7-145 71-222 (590)
394 KOG0200 Fibroblast/platelet-de 100.0 1.6E-35 3.6E-40 310.9 22.1 250 13-263 296-574 (609)
395 KOG1025 Epidermal growth facto 100.0 1.3E-35 2.7E-40 300.8 18.1 249 13-263 696-952 (1177)
396 KOG1167 Serine/threonine prote 100.0 2.2E-36 4.7E-41 288.3 11.0 257 10-272 33-389 (418)
397 cd00180 PKc Catalytic domain o 100.0 1.5E-33 3.3E-38 254.2 23.4 213 21-265 1-215 (215)
398 KOG3653 Transforming growth fa 100.0 6.3E-35 1.4E-39 281.2 14.2 243 13-262 210-497 (534)
399 KOG1152 Signal transduction se 100.0 1.4E-35 3E-40 291.1 9.3 200 13-214 561-771 (772)
400 KOG2052 Activin A type IB rece 100.0 4.5E-34 9.9E-39 273.5 17.3 250 7-263 205-498 (513)
401 smart00221 STYKc Protein kinas 100.0 1.5E-32 3.3E-37 252.0 22.0 214 15-228 1-218 (225)
402 PLN00181 protein SPA1-RELATED; 100.0 7.3E-33 1.6E-37 300.9 9.8 199 67-270 28-271 (793)
403 KOG1024 Receptor-like protein 100.0 1.1E-31 2.4E-36 253.2 14.4 251 12-263 283-550 (563)
404 KOG1345 Serine/threonine kinas 100.0 1.6E-31 3.4E-36 241.7 8.0 252 10-267 21-290 (378)
405 smart00750 KIND kinase non-cat 100.0 2.3E-30 4.9E-35 230.1 13.0 160 96-269 1-170 (176)
406 COG0515 SPS1 Serine/threonine 100.0 8.8E-28 1.9E-32 229.6 23.9 252 15-269 2-280 (384)
407 KOG0590 Checkpoint kinase and 100.0 2.3E-30 4.9E-35 269.4 6.4 257 13-271 317-592 (601)
408 PRK09188 serine/threonine prot 100.0 3E-28 6.4E-33 238.9 17.3 166 10-186 15-195 (365)
409 KOG1164 Casein kinase (serine/ 100.0 2.6E-27 5.6E-32 231.3 19.9 252 10-264 14-293 (322)
410 KOG0603 Ribosomal protein S6 k 100.0 2.1E-29 4.6E-34 251.7 4.9 242 20-273 1-252 (612)
411 KOG1165 Casein kinase (serine/ 99.9 1E-25 2.2E-30 209.3 16.8 246 9-259 24-290 (449)
412 KOG1163 Casein kinase (serine/ 99.9 2.7E-26 5.7E-31 204.8 12.1 244 10-258 12-274 (341)
413 cd05147 RIO1_euk RIO kinase fa 99.9 1E-25 2.3E-30 203.1 12.4 142 17-162 1-168 (190)
414 KOG0606 Microtubule-associated 99.9 3.7E-26 8E-31 238.7 9.8 229 10-277 80-328 (1205)
415 PRK10359 lipopolysaccharide co 99.9 6.4E-25 1.4E-29 201.3 12.4 174 9-206 27-216 (232)
416 cd05145 RIO1_like RIO kinase f 99.9 2.7E-24 5.9E-29 194.1 15.5 143 17-163 1-169 (190)
417 PF14531 Kinase-like: Kinase-l 99.9 4.6E-24 9.9E-29 201.3 13.2 235 12-255 11-288 (288)
418 PRK12274 serine/threonine prot 99.9 1.2E-23 2.6E-28 189.1 15.2 189 15-216 4-211 (218)
419 PRK10345 hypothetical protein; 99.9 8.5E-23 1.8E-27 186.3 15.0 136 16-158 5-156 (210)
420 KOG4158 BRPK/PTEN-induced prot 99.9 2.2E-23 4.9E-28 197.8 10.5 189 69-259 274-505 (598)
421 KOG1240 Protein kinase contain 99.9 1.3E-23 2.7E-28 220.1 2.6 243 14-264 24-291 (1431)
422 smart00090 RIO RIO-like kinase 99.9 4.9E-22 1.1E-26 185.3 12.7 145 13-162 28-199 (237)
423 KOG0195 Integrin-linked kinase 99.9 1E-22 2.2E-27 184.7 6.4 240 14-262 191-440 (448)
424 KOG1166 Mitotic checkpoint ser 99.9 3.5E-21 7.6E-26 205.1 14.4 198 7-210 692-901 (974)
425 KOG0590 Checkpoint kinase and 99.8 4.2E-23 9.2E-28 215.1 -2.5 258 12-269 19-291 (601)
426 PRK14879 serine/threonine prot 99.8 1.8E-20 3.8E-25 171.6 14.3 136 18-160 1-143 (211)
427 KOG1033 eIF-2alpha kinase PEK/ 99.8 9.5E-22 2.1E-26 193.6 4.9 176 84-267 329-515 (516)
428 cd05144 RIO2_C RIO kinase fami 99.8 3.8E-20 8.3E-25 168.1 12.6 139 14-163 16-177 (198)
429 TIGR03724 arch_bud32 Kae1-asso 99.8 4.1E-20 9E-25 167.7 12.3 131 20-160 1-138 (199)
430 PRK09605 bifunctional UGMP fam 99.8 3E-19 6.6E-24 186.0 16.2 137 13-160 333-476 (535)
431 KOG1023 Natriuretic peptide re 99.8 2E-19 4.2E-24 180.2 12.6 199 65-263 1-219 (484)
432 cd05119 RIO RIO kinase family, 99.8 1.3E-18 2.8E-23 156.2 11.8 138 18-163 2-166 (187)
433 PRK01723 3-deoxy-D-manno-octul 99.8 1.2E-17 2.6E-22 156.0 15.1 135 19-160 37-191 (239)
434 cd05120 APH_ChoK_like Aminogly 99.7 4.9E-18 1.1E-22 145.5 10.1 132 17-160 2-138 (155)
435 KOG0601 Cyclin-dependent kinas 99.7 2.9E-18 6.3E-23 172.0 5.8 256 10-268 111-383 (524)
436 KOG0606 Microtubule-associated 99.7 2E-18 4.3E-23 181.3 2.2 268 11-279 802-1107(1205)
437 KOG1243 Protein kinase [Genera 99.6 4.6E-15 1E-19 150.5 15.0 183 15-208 15-199 (690)
438 PRK04750 ubiB putative ubiquin 99.6 4.5E-16 9.7E-21 159.7 5.3 144 12-163 119-316 (537)
439 TIGR01982 UbiB 2-polyprenylphe 99.6 5.7E-15 1.2E-19 149.6 12.2 140 19-163 123-309 (437)
440 KOG1266 Protein kinase [Signal 99.6 3.5E-16 7.5E-21 146.0 1.0 207 62-273 118-340 (458)
441 cd05146 RIO3_euk RIO kinase fa 99.6 5.3E-14 1.1E-18 126.4 13.5 142 18-164 2-177 (197)
442 cd05151 ChoK Choline Kinase (C 99.5 2.1E-14 4.5E-19 126.5 9.5 127 18-159 3-135 (170)
443 KOG0601 Cyclin-dependent kinas 99.5 5.6E-15 1.2E-19 148.5 6.2 252 10-268 262-518 (524)
444 cd05154 ACAD10_11_like Acyl-Co 99.4 2.4E-12 5.3E-17 118.1 9.8 141 18-160 3-206 (223)
445 COG3642 Mn2+-dependent serine/ 99.4 9E-12 2E-16 108.8 12.0 131 19-159 2-139 (204)
446 KOG3087 Serine/threonine prote 99.3 3.1E-11 6.8E-16 105.1 12.8 142 17-160 11-165 (229)
447 KOG3741 Poly(A) ribonuclease s 99.3 9.1E-11 2E-15 116.2 15.9 212 26-264 289-521 (655)
448 PRK15123 lipopolysaccharide co 99.2 4.8E-10 1.1E-14 106.2 17.1 131 27-159 36-193 (268)
449 KOG0576 Mitogen-activated prot 99.1 4.2E-12 9.2E-17 128.3 -2.0 243 12-270 241-490 (829)
450 PF01163 RIO1: RIO1 family; I 99.1 3.3E-10 7.2E-15 101.5 10.3 127 28-162 1-157 (188)
451 KOG2137 Protein kinase [Signal 99.1 1.7E-11 3.7E-16 125.3 2.1 152 118-270 106-271 (700)
452 PF06293 Kdo: Lipopolysacchari 99.0 4.4E-09 9.5E-14 96.1 13.4 106 55-160 55-170 (206)
453 COG4248 Uncharacterized protei 99.0 2.3E-08 5E-13 97.2 16.5 244 9-260 7-292 (637)
454 COG0478 RIO-like serine/threon 99.0 4E-09 8.7E-14 97.6 10.4 137 15-161 93-252 (304)
455 COG0661 AarF Predicted unusual 98.8 2.8E-08 6.1E-13 101.9 11.5 141 19-163 131-317 (517)
456 PRK09902 hypothetical protein; 98.8 9.6E-08 2.1E-12 86.4 13.1 136 22-159 27-178 (216)
457 TIGR02172 Fb_sc_TIGR02172 Fibr 98.7 1.4E-07 3E-12 87.5 12.8 134 18-159 6-181 (226)
458 PF06176 WaaY: Lipopolysacchar 98.7 2.9E-07 6.2E-12 83.7 14.3 137 10-158 28-181 (229)
459 PF01636 APH: Phosphotransfera 98.7 1.6E-07 3.5E-12 86.5 12.4 137 18-159 2-196 (239)
460 KOG1035 eIF-2alpha kinase GCN2 98.6 1.4E-07 3.1E-12 101.8 9.9 206 53-270 224-440 (1351)
461 COG1718 RIO1 Serine/threonine 98.6 5.6E-07 1.2E-11 82.7 11.9 139 20-164 55-219 (268)
462 cd05150 APH Aminoglycoside 3'- 98.5 7.8E-07 1.7E-11 83.2 12.0 134 20-159 5-192 (244)
463 PLN02876 acyl-CoA dehydrogenas 98.4 1.9E-06 4.1E-11 94.6 13.6 145 17-161 42-258 (822)
464 KOG1235 Predicted unusual prot 98.4 1.1E-06 2.4E-11 90.0 10.4 139 19-163 167-357 (538)
465 KOG1826 Ras GTPase activating 98.4 2.1E-08 4.5E-13 110.1 -2.9 212 56-268 1274-1496(2724)
466 COG2112 Predicted Ser/Thr prot 98.3 3.4E-06 7.3E-11 73.7 9.8 130 15-160 24-155 (201)
467 PF13095 FTA2: Kinetochore Sim 98.3 9.5E-06 2.1E-10 73.0 12.0 127 12-158 36-206 (207)
468 PF10707 YrbL-PhoP_reg: PhoP r 98.3 1.7E-05 3.8E-10 71.6 13.6 129 18-154 6-165 (199)
469 cd05155 APH_ChoK_like_1 Unchar 98.3 4.2E-06 9.1E-11 77.9 9.1 74 18-99 2-82 (235)
470 PF12260 PIP49_C: Protein-kina 98.2 5.3E-06 1.1E-10 74.5 8.8 98 60-161 8-112 (188)
471 cd05157 ETNK_euk Ethanolamine 98.1 3.6E-05 7.8E-10 71.4 11.7 75 18-98 3-79 (235)
472 PRK10593 hypothetical protein; 98.1 5.8E-05 1.2E-09 72.9 13.3 92 2-98 2-100 (297)
473 cd05153 HomoserineK_II Homoser 98.1 5.7E-05 1.2E-09 72.7 12.9 149 5-159 5-204 (296)
474 PRK09550 mtnK methylthioribose 98.0 0.00018 4E-09 71.9 14.5 78 18-97 31-117 (401)
475 TIGR02721 ycfN_thiK thiamine k 97.9 3.5E-05 7.5E-10 72.7 8.7 133 20-160 3-175 (256)
476 TIGR00938 thrB_alt homoserine 97.9 0.00018 3.8E-09 69.8 12.5 140 15-159 24-216 (307)
477 PRK05231 homoserine kinase; Pr 97.9 0.00041 8.9E-09 67.5 14.9 137 17-159 26-216 (319)
478 KOG2268 Serine/threonine prote 97.8 2E-05 4.3E-10 75.2 3.6 135 13-158 92-249 (465)
479 cd05156 ChoK_euk Choline Kinas 97.7 0.00021 4.5E-09 69.1 9.9 76 18-99 3-85 (302)
480 KOG1093 Predicted protein kina 97.7 0.00014 3.1E-09 73.2 8.3 168 56-276 27-206 (725)
481 cd05152 MPH2' Macrolide 2'-Pho 97.5 0.00063 1.4E-08 65.0 10.2 31 131-161 186-217 (276)
482 COG3173 Predicted aminoglycosi 97.5 0.00061 1.3E-08 65.9 9.9 147 13-162 25-230 (321)
483 KOG2270 Serine/threonine prote 97.4 0.0014 2.9E-08 63.9 11.0 145 16-164 147-317 (520)
484 TIGR01767 MTRK 5-methylthiorib 97.4 0.0013 2.9E-08 64.6 11.0 75 19-95 1-84 (370)
485 TIGR02906 spore_CotS spore coa 97.2 0.0081 1.8E-07 58.1 13.9 28 130-158 187-214 (313)
486 PLN02236 choline kinase 97.1 0.0036 7.8E-08 61.8 10.8 137 17-159 40-230 (344)
487 PLN02756 S-methyl-5-thioribose 97.1 0.0082 1.8E-07 60.1 13.2 82 17-102 36-128 (418)
488 PRK12396 5-methylribose kinase 97.1 0.0025 5.5E-08 63.4 9.1 76 18-95 34-117 (409)
489 PF03881 Fructosamin_kin: Fruc 97.0 0.0027 5.8E-08 60.9 8.2 84 7-96 9-97 (288)
490 PLN02421 phosphotransferase, a 97.0 0.0039 8.5E-08 61.2 9.3 136 18-159 19-212 (330)
491 TIGR02904 spore_ysxE spore coa 96.9 0.027 5.8E-07 54.7 14.5 29 131-159 197-225 (309)
492 COG5072 ALK1 Serine/threonine 96.3 0.013 2.9E-07 57.1 7.6 72 83-160 298-370 (488)
493 PRK06148 hypothetical protein; 96.3 0.05 1.1E-06 61.3 13.4 137 19-160 31-236 (1013)
494 PTZ00384 choline kinase; Provi 96.1 0.054 1.2E-06 54.2 10.9 78 16-99 53-137 (383)
495 COG2334 Putative homoserine ki 96.0 0.11 2.4E-06 50.8 12.7 134 20-159 33-227 (331)
496 PRK11768 serine/threonine prot 96.0 0.23 5E-06 48.5 14.9 69 26-97 38-113 (325)
497 PF07387 Seadorna_VP7: Seadorn 95.8 0.035 7.5E-07 50.7 7.4 85 56-157 103-189 (308)
498 COG3001 Uncharacterized protei 95.6 0.054 1.2E-06 49.8 7.8 76 18-99 21-99 (286)
499 PF02958 EcKinase: Ecdysteroid 95.6 0.068 1.5E-06 51.2 9.1 72 22-93 2-98 (294)
500 KOG1236 Predicted unusual prot 95.5 0.052 1.1E-06 53.9 7.8 62 85-147 319-381 (565)
No 1
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-62 Score=458.65 Aligned_cols=269 Identities=31% Similarity=0.555 Sum_probs=248.7
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..++|+++++||+|+||+||+++.++|++.||+|++++... .....++..|..||.+++||+||+++..|++++.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 46899999999999999999999999999999999987653 3457899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
|+||+.||+|+..|++.+.++|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||+|+.........
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999776666677
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
.++|||+.|||||++.+. +|+..+|+||||++||||++|.+||...+.......|.....+..+..++.+++++|+++|
T Consensus 183 ~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred ccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHh
Confidence 889999999999999887 5999999999999999999999999999999999999888866777779999999999999
Q ss_pred ccCCCCCc----CHHHHHhChhcccccCChhHHHHh
Q 014610 249 KKVPAERP----SAKELLRHRFIRNARKSPRLLERI 280 (421)
Q Consensus 249 ~~dP~~Rp----t~~elL~hp~~~~~~~~~~~~~~~ 280 (421)
.+||++|. ++.+|.+||||+...+...+...+
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 99999996 789999999999887655444333
No 2
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-61 Score=452.85 Aligned_cols=257 Identities=41% Similarity=0.705 Sum_probs=241.5
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE-EEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK-LWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lV~E 91 (421)
++.+.+..||+|..|+||+|+++.|++.+|+|++.....+...+++.+|+++++.++|||||.+|+.|..+.. ++|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4788899999999999999999999999999999777777788999999999999999999999999999994 999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+||+|.++++..++++|..+..++.++++||.|||+ ++||||||||+||||+..|.|||||||.+..+.+. ..++
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~t 236 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANT 236 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hccc
Confidence 99999999999988999999999999999999999995 89999999999999999999999999999988765 5578
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCC-----CHHHHHhhccCCCCCCCchH-HHHHHHHHH
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-----HPMRVLFIIPRENPPQLDEH-FSRLMKEFV 244 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~~l~~li 244 (421)
++||..|||||.+.+. .|+.++||||||++++||++|+.||... +..+.+..|..+.+|.++.. +|+++++||
T Consensus 237 fvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred ccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 9999999999999987 4999999999999999999999999874 67788889999999999986 999999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
..||++||.+|+|+.|+|+|||+++...
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999999986544
No 3
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-61 Score=458.46 Aligned_cols=266 Identities=31% Similarity=0.475 Sum_probs=234.9
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHH------HHHHHHHHHHHHHcCCCCCeeEEEEEEE
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EIEDIQKEISVLSQCRSPYITEYYGSYL 81 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~ 81 (421)
.+...+.|.+.+.||+|+||.|-+|..+.||+.||||++++.+... ....+.+|++||++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3456788999999999999999999999999999999997665322 3455789999999999999999999999
Q ss_pred eCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC---CCEEEeecccc
Q 014610 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVS 158 (421)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~---g~vkL~DFGla 158 (421)
..+..||||||++||+|.+.+-.++.+.|+..+.+++||+.||.|||++||+||||||+|||++.+ ..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999999876 67999999999
Q ss_pred cccccccccccccccCccccCcccccCcC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHhhccCCCCC---CC
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPRENPP---QL 232 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~ell~g~~pf~~~~~~~-~~~~i~~~~~~---~~ 232 (421)
+... ......+.||||.|+|||++.+.. .+..++|+||+||+||-+|+|.+||.+..... ....|.++... ..
T Consensus 327 K~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 8776 446678999999999999997642 24457899999999999999999998775544 66666666543 44
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCCh
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 274 (421)
+..++.++++||++||..||++|||++|+|+||||+.+....
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 668999999999999999999999999999999999876443
No 4
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.7e-60 Score=471.19 Aligned_cols=261 Identities=31% Similarity=0.576 Sum_probs=242.6
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
.+.-..+|+..+.||+|+|++||.+++..+|+.||+|++++.. .....+.+.+||+|.++|+|||||+++++|++.++
T Consensus 13 ~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 13 EDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 3334468999999999999999999999999999999997643 34567889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+|||+|+|..++|..++++.++++|.+++.+++||+.||.|||+++|||||||.+|+||+++.+|||+|||+|+.+..+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~ 245 (421)
++..+.||||.|.|||++... +++..+||||+||+||-||.|+|||...+-.+.+.+|..... .+|..++.++++||.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIR 250 (592)
T ss_pred cccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHH
Confidence 888999999999999999865 689999999999999999999999999988888888876654 566789999999999
Q ss_pred HHcccCCCCCcCHHHHHhChhcccc
Q 014610 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
++|.+||.+|||+++||.|+||+..
T Consensus 251 ~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHhcCCcccCCCHHHHhcCHhhhCC
Confidence 9999999999999999999999643
No 5
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-61 Score=460.07 Aligned_cols=283 Identities=66% Similarity=1.073 Sum_probs=267.9
Q ss_pred cccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 5 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
..+.......|+.++.||+|+||.||+|++..+++.||||+++++...+..+.+++|+.+|.+++++||.++|+.|..+.
T Consensus 5 ~~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 5 DVLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred hhhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 34556677899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
.+|++||||.||++.++++.+..+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++.++...
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999999887
Q ss_pred cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
..++.+++|||.|||||++.+. .|+.++||||||+++|||++|.+|+...++++.+..|++..||.+...+++.+++||
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred hhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence 7777899999999999999965 699999999999999999999999999999999999999999999999999999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccccCChhHHHHhhcCCCCCC
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPI 288 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~~~~~~~~~ 288 (421)
..||.+||+.||+|.++|+|+|++.+.+...+.+.+.+...+..
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRV 287 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhh
Confidence 99999999999999999999999998888888887777665544
No 6
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-62 Score=445.30 Aligned_cols=355 Identities=39% Similarity=0.689 Sum_probs=288.7
Q ss_pred ccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 6 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
+|.++..+-|.++++||+|+||.||+|+++++|..||||.++.+. +++.+.+|+.||.+++.|+||++|+.|.....
T Consensus 26 sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 26 ALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred hhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 467778889999999999999999999999999999999987654 67899999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
+|||||||..|++.++++ ++++|+|+++..+++..++||+|||...-||||||..|||++.+|.+||+|||+|.++...
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999999999999996 4689999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--chHHHHHHHH
Q 014610 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKE 242 (421)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~ 242 (421)
..++++++|||.|||||++... +|+.++||||||++..||..|++||.+.++++.+..|+..+|+.+ +..+|.++.+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFND 261 (502)
T ss_pred HHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHH
Confidence 8999999999999999999876 599999999999999999999999999999999999998888776 5689999999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcccccCChhHHHHhhcCCCC------CCCCCCCCC----------CccccccccCC
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY------PIQEEPDTP----------INGVRAVGEAS 306 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~ 306 (421)
||++||.++|++|.||.++++|||+++++.-..+...+.+.... +...+.... ...+...+...
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~~~~q~~~~~~~~~~~~~~~~~m~s~~~~~~s~~~~ 341 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKAILGQAPMAASSGNDATLLSEGMSTMIDGGESTLVQ 341 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHHHhccCchhcccCcccchhhhcccccccccccccee
Confidence 99999999999999999999999999987655443333221111 000000000 00111111122
Q ss_pred CceeeccccCcccceeec-------cCCceeecCCCCcCccCCcCCCccccccCCCCccccCCCCCCCCCCccccc
Q 014610 307 GTVKVVRDKRSEETVQVS-------SQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPKRTA 375 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 375 (421)
++++.+-.. ....++. ..+..++|+ .++..+++++++...+.+++ +|+| ++||.|+..
T Consensus 342 ~~~~~~~~~--~~~s~~E~~~~~~~~~~s~~In~-----~~~~~~~~~~~~~~~t~~~~--~PS~--~~~F~q~~~ 406 (502)
T KOG0574|consen 342 HKDNYVTAQ--SLRSQMESLRIGGEIPKSAYINS-----SSKNGNSPRVQPPGHTASAS--DPSK--NQPFAQDGT 406 (502)
T ss_pred ccchhhHHH--HHHHHHHhhhccccccccccccc-----ccccCCCCCcCCCCCCCCcC--Cccc--cCchhhcCC
Confidence 222211000 0000111 113334443 24556678999999999998 9999 999999665
No 7
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-58 Score=421.08 Aligned_cols=263 Identities=29% Similarity=0.542 Sum_probs=241.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..++|+.++.||.|+||.|.+++.+.+|..||+|++++.+. -.++++...|..+|+.+.||+++++++.|.+.+.+||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34689999999999999999999999999999999987663 3457888899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||||++||.|+.++++.+++++..++.++.||+.||+|||+++|++|||||+|||||++|.+||+|||+|+.... ..
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---rT 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---RT 198 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---cE
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987643 45
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
.+.||||.|+|||+++.. +|+.++|+|||||++|||+.|.+||.+.+++..+.+|..... .+|..++.++++||.++|
T Consensus 199 ~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHHHH
Confidence 689999999999999876 599999999999999999999999999999999999987764 667789999999999999
Q ss_pred ccCCCCCc-----CHHHHHhChhcccccCChhHHH
Q 014610 249 KKVPAERP-----SAKELLRHRFIRNARKSPRLLE 278 (421)
Q Consensus 249 ~~dP~~Rp-----t~~elL~hp~~~~~~~~~~~~~ 278 (421)
+.|-.+|. ...+|..||||+.+.+...+.+
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 99999993 6789999999998765554433
No 8
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=1.3e-58 Score=422.52 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=227.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|+.+.++|+|+||+||++++++||+.||||.+--... +...+-..+|+++|++|+|||+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 579999999999999999999999999999999865544 3334556799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
||+..-|.++-+....+++..+..+++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+..+....+.+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 99886666666555679999999999999999999999999999999999999999999999999999998777777889
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC--------------C---------
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------------N--------- 228 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~--------------~--------- 228 (421)
+.|.||.|||++.+...|+..+||||+||++.||++|.+.|.+..+.+.+..|.+. +
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 99999999999999878999999999999999999999999999998887665321 0
Q ss_pred ----CCCC---chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 229 ----PPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 229 ----~~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
+..+ ...++..+.+|+++||..||++|++++|+|.|+||..
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1111 1245678999999999999999999999999999953
No 9
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-57 Score=428.17 Aligned_cols=263 Identities=31% Similarity=0.539 Sum_probs=238.0
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
......++|.+.+.||+|+||+||+|+++.++..||||.+.+.. .....+.+..|+.+|+.++|||||++++++.+++.
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34456689999999999999999999999999999999998776 66677889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC------CCEEEeeccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------GDVKVADFGVSA 159 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~------g~vkL~DFGla~ 159 (421)
+|||||||+||+|.++|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999865 358999999999
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--CCCCchHHH
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFS 237 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s 237 (421)
.+.. .....+.||+|.|||||++... .|+.|+|+||+|+|+|+|++|++||...+..+....+.++. .+.++..++
T Consensus 164 ~L~~-~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 164 FLQP-GSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hCCc-hhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 8864 3455689999999999999766 49999999999999999999999999999988887776543 455566778
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
....+++...|..+|..|.+..+-+.|+++....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8888999999999999999999999999997543
No 10
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-56 Score=425.85 Aligned_cols=270 Identities=44% Similarity=0.811 Sum_probs=243.2
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
-.+.|++.++||.|..++||+|++.-+++.||||++++++....++.+++|+..|+.++||||++++.+|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35799999999999999999999999999999999999998888999999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
.||.+|++.++++.. ..++|..|+.|++++++||.|||.+|.||||||+.||||+.+|.|||+|||++..+.....+.
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999999863 459999999999999999999999999999999999999999999999999987665543322
Q ss_pred ----cccccCccccCccc-ccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC---------ch
Q 014610 169 ----KTFVGTPFWMAPEV-IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---------DE 234 (421)
Q Consensus 169 ----~~~~gt~~y~aPE~-~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------~~ 234 (421)
+++.|||+|||||+ ++...+|+.|+||||||++..||.+|..||....+++++.....+.++.+ ..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK 263 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence 56799999999999 66667899999999999999999999999999999998877766666522 23
Q ss_pred HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCChhHHHHh
Q 014610 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (421)
Q Consensus 235 ~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~ 280 (421)
.++..++.+|..||++||.+||||+++|+|+||+.++....+...+
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~ 309 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKL 309 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhh
Confidence 5678899999999999999999999999999999887655544443
No 11
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-56 Score=436.74 Aligned_cols=262 Identities=29% Similarity=0.535 Sum_probs=236.9
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (421)
...+|.+.+.||.|+|++|++|+++.+++.||||++.+... +..+..+.+|-.+|.+| .||.|++|+.-|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 44789999999999999999999999999999999876542 33456788999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
+|+||+++|+|.++|++.+.|+|..++.++.||+.||+|||++|||||||||+||||++||++||+|||-|+.+.....
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987643211
Q ss_pred ------------cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCch
Q 014610 167 ------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE 234 (421)
Q Consensus 167 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 234 (421)
...+++||..|++||++... ..++.+|+|+||||||.|+.|.+||.+.++.....+|..... .++.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-~fp~ 308 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-EFPE 308 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-cCCC
Confidence 12458999999999999876 478999999999999999999999999999888888876554 5677
Q ss_pred HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCCh
Q 014610 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (421)
Q Consensus 235 ~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 274 (421)
++++.+++||+++|..||.+|+|+.||.+||||..+.+..
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 8899999999999999999999999999999999886544
No 12
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=3.5e-56 Score=434.29 Aligned_cols=261 Identities=31% Similarity=0.548 Sum_probs=233.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..++|+++++||+|+||.||+|+.+.||..||+|++++.. ...++.+++.|..+|...++|+||++|..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4579999999999999999999999999999999998775 45678999999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc----
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---- 164 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~---- 164 (421)
||||++||++..+|.+.+.|+|+.+++++.+++.|++-||+.|+|||||||+|+|||..|++||+|||||..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998543210
Q ss_pred -------------------cc-----c-------------------ccccccCccccCcccccCcCCCCCccccHHHHHH
Q 014610 165 -------------------IS-----R-------------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGIT 201 (421)
Q Consensus 165 -------------------~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvi 201 (421)
.. . ..+.+|||-|||||++.+. +|+..+|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHH
Confidence 00 0 0135799999999999987 49999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHhhccCCCC---CCCchHHHHHHHHHHHHHcccCCCCCc---CHHHHHhChhcccccCC
Q 014610 202 VIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKS 273 (421)
Q Consensus 202 l~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~elL~hp~~~~~~~~ 273 (421)
|||||.|.+||...++.+...+|..+.. .+-...++.+++|||.+||+ ||++|. +++||.+||||+.+.+.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999998876541 11123578999999999999 999997 59999999999988654
No 13
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-56 Score=444.57 Aligned_cols=284 Identities=30% Similarity=0.507 Sum_probs=247.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKL 86 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 86 (421)
....+|+++++||+|+||+|++|..+.+++.||||++++.. ..++++.++.|.+|+.... ||+++.++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999999999999999998876 4567889999999998885 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
|+||||+.||++..+++ .+.+++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++.......
T Consensus 445 ~fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99999999999655544 48899999999999999999999999999999999999999999999999999987776666
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
..+++||||.|||||++.+.. |+.++|+|||||+|||||.|..||.+.+..+....|....+ .+|..+|.++.+++++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMRR 601 (694)
T ss_pred ccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHHH
Confidence 788999999999999999875 99999999999999999999999999999999999987764 5677899999999999
Q ss_pred HcccCCCCCcC-----HHHHHhChhcccccCChhHHHHhhcCCCCCCCCCCCCCCc
Q 014610 247 CLKKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297 (421)
Q Consensus 247 ~L~~dP~~Rpt-----~~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (421)
+|.++|++|+. +.+|.+||||+.+.+.. +..+.-++|..+....+.+..|
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~-L~~r~i~PPf~P~i~~~~D~sn 656 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD-LLNRRIKPPFVPTIKGPEDVSN 656 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccCCHHH-HhhccCCCCCCcccCChhhhcc
Confidence 99999999985 58899999999987443 4333333444333333333333
No 14
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-55 Score=434.65 Aligned_cols=259 Identities=32% Similarity=0.511 Sum_probs=235.0
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC----HHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~----~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 84 (421)
...++|++.+.||+|+||+|+.|.+..+|+.||||+++.... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456799999999999999999999999999999998876421 134567889999999999 999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeeccccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTR 163 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGla~~~~~ 163 (421)
.+|+|||||.||+|.+++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999998999999999999999999999999999999999999999999 9999999999987754
Q ss_pred ccccccccccCccccCcccccCcCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHH-HHHHH
Q 014610 164 TISRRKTFVGTPFWMAPEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF-SRLMK 241 (421)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-s~~l~ 241 (421)
......+.||||.|+|||++.+...| +.++||||+||+||.|++|..||.+.+...+...|.... ..++..+ |.+++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEAR 252 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHH
Confidence 44566789999999999999887525 588999999999999999999999998888888876554 3556666 99999
Q ss_pred HHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
+||.+||..||.+|+|+.+++.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999986
No 15
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.1e-57 Score=409.80 Aligned_cols=248 Identities=36% Similarity=0.579 Sum_probs=227.5
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEE-EEEeCCE-E
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYG-SYLHQTK-L 86 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~-~ 86 (421)
....+|+++++||+|+||+||++++..+|..||.|.+.... +....+.+..|+.+|++|+|||||++++ .|..++. +
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34467999999999999999999999999999999987554 4556788999999999999999999999 5555444 8
Q ss_pred EEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCcEEEccCCCEEEeecccc
Q 014610 87 WIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHN--EG--KIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~--~~--iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
+||||||++|+|..+|+. ++.++|..+|+++.||+.||.+||+ .+ |+||||||.||+|+.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999964 4679999999999999999999999 45 999999999999999999999999999
Q ss_pred cccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCc-hHHH
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFS 237 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s 237 (421)
+.+........+++|||.||+||.+.+. +|+.++||||+||++|||+.-++||.+.+-.....+|..+..+.++ ..+|
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence 9998877777889999999999999886 5999999999999999999999999999999999999999888888 7899
Q ss_pred HHHHHHHHHHcccCCCCCcCH
Q 014610 238 RLMKEFVSLCLKKVPAERPSA 258 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~ 258 (421)
..+..+|..|+..||+.||+.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc
Confidence 999999999999999999986
No 16
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-56 Score=437.05 Aligned_cols=269 Identities=42% Similarity=0.754 Sum_probs=246.6
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
......|+....||+|+.|.||.|....+++.||||.+++..-. ..+-+..|+.+|+.++|+|||++++.|..++.+|+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 44567899999999999999999999999999999999876533 34668899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||||++||+|.+++.. ..++|.+++.|.+++|.||+|||.+||+|||||.+|||++.+|.+||+||||+..+.....++
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 9999999999999976 669999999999999999999999999999999999999999999999999999998888888
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--chHHHHHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVSL 246 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~li~~ 246 (421)
.+.+|||+|||||++... .|+.++||||||++++||+.|.+||-..++...+..|.....+.+ +..+|.++++||.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 999999999999999876 599999999999999999999999999999999999887776665 56899999999999
Q ss_pred HcccCCCCCcCHHHHHhChhcccccCChhHHHHh
Q 014610 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~ 280 (421)
||+.|+++|++|.|||+||||+.+.....+...+
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi 539 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKMAKPESSLNPLI 539 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHH
Confidence 9999999999999999999998776655554443
No 17
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=2.3e-55 Score=428.82 Aligned_cols=254 Identities=32% Similarity=0.577 Sum_probs=236.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|.+.+.||+|+||.||||+.+.|.+.||||.+++.. .+.++.++.+|++|++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999999999999999998765 56678999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
||.| +|+.++...+.++|+.++.++.|++.||.|||+++|+|||+||.|||+..+|.+||||||+|+.+..........
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 9976 999999999999999999999999999999999999999999999999999999999999999877655555667
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
.|||.|||||++.+. +|+..+|+||||||+|||+.|++||...........|..+... .+...+..+.+|+..+|.+|
T Consensus 161 kGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-PPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred cCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-CcccccHHHHHHHHHHhhcC
Confidence 899999999999876 5999999999999999999999999999888888888776654 44578999999999999999
Q ss_pred CCCCcCHHHHHhChhccc
Q 014610 252 PAERPSAKELLRHRFIRN 269 (421)
Q Consensus 252 P~~Rpt~~elL~hp~~~~ 269 (421)
|.+|.|..+++.|||.+.
T Consensus 239 P~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred hhhcccHHHHhcChHHhh
Confidence 999999999999999974
No 18
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-55 Score=423.41 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=229.1
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCC-EE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT-KL 86 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~~ 86 (421)
....++|.+++.||.|+||.||+|..+++|..||||.++.....-+.-.-.||+..|++|+ |||||++.+++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4456899999999999999999999999999999999866543333334468999999998 999999999999988 99
Q ss_pred EEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
|+|||||+ .+|.++++. ++.|++..++.|++||++||+|+|.+|+.||||||+|||+.....+||+|||+|+.....
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence 99999995 599999975 468999999999999999999999999999999999999998889999999999876543
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC--CC---------------
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--EN--------------- 228 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~--~~--------------- 228 (421)
...+.++.|+||+|||++.....|+.++|||++|||++|+++-++.|.+.+..+.+.+|.. +.
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 4556789999999999999888899999999999999999999999999999888876632 00
Q ss_pred ----CC--------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 229 ----PP--------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 229 ----~~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
.+ .+...++.++.++|.+||.+||.+||||.|+|+||||+.....
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 01 1122367889999999999999999999999999999876544
No 19
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.2e-54 Score=431.21 Aligned_cols=263 Identities=25% Similarity=0.441 Sum_probs=241.2
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
.+...-+-|++.+.||.|+.|.|.+|.+..||+.+|||++.+.. .......+.+||-||+.+.||||+++|++|.++.
T Consensus 6 ~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 6 SHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 34556688999999999999999999999999999999997763 3445678999999999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
++|+|+||++||.|++++.+.++++|.+++.+++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|.....
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
.....+.||+|-|.|||++.+..+.+.++||||+|||||.||+|++||.+.|....+.++.++.. .++..++.++++||
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLL 243 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHH
Confidence 34556889999999999999988667899999999999999999999999998888888877764 67889999999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhccccc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+||..||++|+|.+||++|||+....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999997543
No 20
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-54 Score=411.09 Aligned_cols=259 Identities=42% Similarity=0.717 Sum_probs=224.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC--EEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--KLWII 89 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV 89 (421)
..++...+.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|++++|||||+++|...... .++|+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 456889999999999999999999999999999987774443 678999999999999999999999755544 69999
Q ss_pred EecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeeccccccccc---c
Q 014610 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTR---T 164 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~~~~~---~ 164 (421)
|||+++|+|.+++++.+ +++|..++.+.+||++||+|||++|||||||||+||||+. +|.+||+|||++..... .
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999999866 8999999999999999999999999999999999999999 69999999999886653 1
Q ss_pred cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHhhccCC-CCCCCchHHHHHHHH
Q 014610 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRE-NPPQLDEHFSRLMKE 242 (421)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~-~~~~~~~~~i~~~-~~~~~~~~~s~~l~~ 242 (421)
........|||.|||||++........++|||||||++.||+||.+||.. .........+... ..|.++..++.++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 12234678999999999998532233589999999999999999999998 4555555555433 345788889999999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
||.+||.++|++||||.++|.|||.+...
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999997643
No 21
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=6.2e-54 Score=385.80 Aligned_cols=257 Identities=29% Similarity=0.461 Sum_probs=228.4
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHH-HHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.+|..++.||+|.||.||+|++.+||+.||||.+...+..+ ......+||+.|+.++||||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 58999999999999999999999999999999998765432 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|++ .+|..+++.. ..++..++..|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..+......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 995 5999999864 57999999999999999999999999999999999999999999999999999998877666666
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC---C-------------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---N------------------- 228 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~---~------------------- 228 (421)
.+-|.||.|||++.+...|+..+||||.|||+.||+.|.+-|.+.++.+++..|.+. +
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 689999999999999999999999999999999999999999999988877655321 0
Q ss_pred -C-CC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 229 -P-PQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 229 -~-~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
| +. +-...+.++.+|+.+||..||.+|+|+.|+|+|+||+..
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 0 00 112346778999999999999999999999999999864
No 22
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=6.6e-54 Score=415.04 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=225.5
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 87 (421)
..+.|+.+++||+|+||.||+|++..||+.||+|.+..+.. +....-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34689999999999999999999999999999999987763 34456678999999999999999999988876 6899
Q ss_pred EEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||+|||+. ||.-++.. .-.|++.++..+++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+.+.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999965 99999876 35899999999999999999999999999999999999999999999999999997755433
Q ss_pred c-ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---CC---------CC---
Q 014610 167 R-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---EN---------PP--- 230 (421)
Q Consensus 167 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~~---------~~--- 230 (421)
. .+..+-|.||.|||++.+...|+.++|+||+||||.||+.|++.|.+.+..+++..|.+ .. .+
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 3 55678899999999999999999999999999999999999999999998887766521 00 00
Q ss_pred ------CC-------chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 231 ------QL-------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 231 ------~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
.+ ...++..+.+|+..||+.||.+|.||.++|+++||..
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 00 1135677889999999999999999999999999953
No 23
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-55 Score=390.51 Aligned_cols=259 Identities=25% Similarity=0.462 Sum_probs=231.6
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
-..+.|++.++||+|.|+.||++.+..||+.+|+|+++..+ .....+.+.+|++|.+.|+|||||++++.+......||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45678999999999999999999999999999999987654 33357889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC---CCEEEeeccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~---g~vkL~DFGla~~~~~~~ 165 (421)
|+|+++|++|..-|-..--++|..+-.+++||++||.|||.+||||||+||+|+|+... .-+||+|||+|..+. ..
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 99999999998766554678999999999999999999999999999999999999543 469999999998877 44
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC---CCCCchHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKE 242 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~ 242 (421)
.....+.|||.|||||++... +|+..+|||+.||+||.||.|.+||++.+..+.+..|..+. ++..+..+++++++
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred cccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 445568999999999999865 59999999999999999999999999999988888887654 34456789999999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
||++||..||.+|+|+.|+|+|||+++-
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999753
No 24
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-53 Score=405.58 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=222.2
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-------------HHHHHHHHHHHHHHcCCCCCeeEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------DEIEDIQKEISVLSQCRSPYITEYY 77 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-------------~~~~~~~~E~~il~~l~hpnIv~l~ 77 (421)
..++|++++.||+|.||+|-+|++..+++.||||++++.... ...+.+++||.||++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357899999999999999999999999999999999654311 1246899999999999999999999
Q ss_pred EEEEeC--CEEEEEEecCCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEee
Q 014610 78 GSYLHQ--TKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (421)
Q Consensus 78 ~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~D 154 (421)
++..+. +.+|||+|||..|.+.+.-.. ++ +++.+++.|++.++.||+|||.+|||||||||+|+||+++|+|||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 998874 579999999999988766443 45 99999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-----ccccccccccCccccCcccccCc---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC
Q 014610 155 FGVSAQLTR-----TISRRKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR 226 (421)
Q Consensus 155 FGla~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~ 226 (421)
||.+..... ........+|||.|+|||++.+. ...+.+.||||+||+||.|+.|+.||.+....+...+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 999876522 11222346899999999998763 2245678999999999999999999999999999998876
Q ss_pred CCCCCCch--HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 227 ENPPQLDE--HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 227 ~~~~~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
... .++. .+.+.+++||++||++||++|++..+|..|||....
T Consensus 334 ~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred Ccc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 543 3332 478999999999999999999999999999999754
No 25
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7e-53 Score=399.56 Aligned_cols=261 Identities=31% Similarity=0.471 Sum_probs=231.8
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
..+|++++.||.|.-|+||+|..+.++..+|+|++++.. ....+.+++.|-+||+.++||.++.||..|+..+..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 368999999999999999999999999999999998765 345577888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccc----
Q 014610 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR---- 163 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~---- 163 (421)
||||.||+|+.++++ ++.+++..++.|+.+++.||+|||-.|||+|||||+||||-++|++.|+||.++..+..
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999999976 46799999999999999999999999999999999999999999999999999743210
Q ss_pred -----------------------------c-----------------------cccccccccCccccCcccccCcCCCCC
Q 014610 164 -----------------------------T-----------------------ISRRKTFVGTPFWMAPEVIQNSEGYNE 191 (421)
Q Consensus 164 -----------------------------~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 191 (421)
. ..+.++++||-.|+|||++.+. +.+.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgs 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGS 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCc
Confidence 0 0112346899999999999886 5899
Q ss_pred ccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCc-hHHHHHHHHHHHHHcccCCCCCcC----HHHHHhChh
Q 014610 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPS----AKELLRHRF 266 (421)
Q Consensus 192 ~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt----~~elL~hp~ 266 (421)
++|||+|||++||||.|..||.+.+..+.+..|....+.... ..++..++|||+++|.+||.+|+. |+||.+|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 999999999999999999999999999999888766543221 267899999999999999999998 999999999
Q ss_pred cccccCC
Q 014610 267 IRNARKS 273 (421)
Q Consensus 267 ~~~~~~~ 273 (421)
|+.+++.
T Consensus 395 F~gVnWa 401 (459)
T KOG0610|consen 395 FEGVNWA 401 (459)
T ss_pred ccCCChh
Confidence 9988765
No 26
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.9e-53 Score=395.15 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=226.1
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEec-cCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe----
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-LEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH---- 82 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~-~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 82 (421)
.-.+..+|..++.||+|+||.|+.|.++.+|+.||||.+. .-......++..+|+++|+.++|+||+.+++++..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3445678888999999999999999999999999999885 23345567889999999999999999999999876
Q ss_pred -CCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 83 -QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
-+.+|+|+|+| +.+|..+++.++.++++.+..+++||+.||+|+|+.+|+||||||+|+|++.+..+||||||+|+..
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 35699999999 6799999999888999999999999999999999999999999999999999999999999999877
Q ss_pred ccc--cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC------------
Q 014610 162 TRT--ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------ 227 (421)
Q Consensus 162 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------ 227 (421)
... .+..+.++.|.||.|||++.....|+.++||||+||||.||++|++.|.+.+....+..|..-
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 532 233456789999999999998888999999999999999999999999988765555433210
Q ss_pred ---------------CCCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 228 ---------------NPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 228 ---------------~~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+.. +..+.++.+.+|+.+||..||.+|+|++|+|+|||+...
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 0101 122567889999999999999999999999999999754
No 27
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=1.2e-51 Score=403.10 Aligned_cols=251 Identities=30% Similarity=0.516 Sum_probs=221.9
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999987543 2334567789999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcc
Q 014610 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (421)
Q Consensus 97 ~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~ 176 (421)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999988889999999999999999999999999999999999999999999999999998754333333445789999
Q ss_pred ccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCc
Q 014610 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (421)
Q Consensus 177 y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 256 (421)
|+|||++.+. .++.++|||||||++|||++|..||...+.......+.... ..++..++.++.+||.+||.+||++||
T Consensus 161 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred ccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999776 48999999999999999999999998887766655554433 345567889999999999999999999
Q ss_pred -----CHHHHHhChhccccc
Q 014610 257 -----SAKELLRHRFIRNAR 271 (421)
Q Consensus 257 -----t~~elL~hp~~~~~~ 271 (421)
++.++++||||....
T Consensus 239 ~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 239 GGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 899999999998764
No 28
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-53 Score=416.91 Aligned_cols=267 Identities=45% Similarity=0.813 Sum_probs=243.7
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..+.+.|+..||-|+||+||+|.+++++-..|.|+|... ....++.+.-||.||..|+||+||++++.|...+.+||+.
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 346788999999999999999999999999999998644 4567888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 91 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|||.||-...++-. +.+|++.+|..+.+|+|.||.|||+++|||||||..|||++-+|.++|+|||++........++.
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99999999887754 57899999999999999999999999999999999999999999999999999988877777888
Q ss_pred ccccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--chHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEF 243 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~l 243 (421)
+++|||+|||||++.. ..+|++++||||||++|.||..+.+|....+++.++.+|.+..||.+ +.+|+..+.||
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 9999999999999753 24699999999999999999999999999999999999998888876 56899999999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhcccccCChhHHH
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~ 278 (421)
+++||.+||..||+++|||+|||+.++.....+.+
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ire 303 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRE 303 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhCcccccCCcchHHHH
Confidence 99999999999999999999999998765544433
No 29
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=3.7e-52 Score=384.72 Aligned_cols=258 Identities=26% Similarity=0.474 Sum_probs=225.4
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHH-HHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWII 89 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV 89 (421)
+.|+.+..|++|+||.||+|+++.|++.||+|.++.++.... --.-.+||.+|.+++|||||.+-++..- -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 589999999999999999999999999999999977653322 2234689999999999999999998764 3569999
Q ss_pred EecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||||+. +|..++..- +++...++..++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+....+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 999965 999999764 599999999999999999999999999999999999999999999999999999998887777
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC--CC-----------------
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NP----------------- 229 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~--~~----------------- 229 (421)
...+-|.||.|||++.+...|+.++|+||+|||+.||+.+++.|.+....+.+.+|... .|
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 78899999999999999999999999999999999999999999999887777655210 00
Q ss_pred --CC---------Cch-HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 230 --PQ---------LDE-HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 230 --~~---------~~~-~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
+. +.. .++....+|++.+|..||.+|.||.|.|+|.||.+..
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 00 000 1457888999999999999999999999999998743
No 30
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=3.9e-51 Score=400.56 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=228.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
-..++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999986543 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
+||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998765332
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.... ..++..++..+++||.+|
T Consensus 172 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGL 249 (329)
T ss_pred cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHH
Confidence 2356899999999999876 47899999999999999999999999888777666665443 345556788999999999
Q ss_pred cccCCCCCcC-----HHHHHhChhccccc
Q 014610 248 LKKVPAERPS-----AKELLRHRFIRNAR 271 (421)
Q Consensus 248 L~~dP~~Rpt-----~~elL~hp~~~~~~ 271 (421)
|..||.+|++ +++++.||||....
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 9999999997 79999999998754
No 31
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.9e-51 Score=395.65 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=225.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999986543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---~~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWT 157 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC---Cccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999876533 2235
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
.+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+++||++||+.
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 158 LCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred ccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCC
Confidence 6799999999999775 48999999999999999999999999888776666655443 344556788999999999999
Q ss_pred CCCCCcC-----HHHHHhChhcccccC
Q 014610 251 VPAERPS-----AKELLRHRFIRNARK 272 (421)
Q Consensus 251 dP~~Rpt-----~~elL~hp~~~~~~~ 272 (421)
||.+|++ ++++++||||+....
T Consensus 236 dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred CHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999995 999999999986543
No 32
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=8.8e-51 Score=395.03 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=220.3
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 334456788999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcccc
Q 014610 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (421)
Q Consensus 99 ~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~ 178 (421)
.+++...+++++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888999999999999999999999999999999999999999999999999999876443333345578999999
Q ss_pred CcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCc--
Q 014610 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP-- 256 (421)
Q Consensus 179 aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-- 256 (421)
|||++.+. .++.++|||||||++|+|++|..||...+.......+... +..++..++..+++||.+||..||.+||
T Consensus 161 aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 161 APELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 99999875 4899999999999999999999999988777666665544 3455667899999999999999999997
Q ss_pred -CHHHHHhChhcccc
Q 014610 257 -SAKELLRHRFIRNA 270 (421)
Q Consensus 257 -t~~elL~hp~~~~~ 270 (421)
++.++|.||||...
T Consensus 239 ~~~~e~l~hp~~~~~ 253 (312)
T cd05585 239 NGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHHHcCCCcCCC
Confidence 58999999999876
No 33
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=7.4e-51 Score=401.38 Aligned_cols=260 Identities=31% Similarity=0.554 Sum_probs=234.4
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH--HHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCC
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 84 (421)
.......|++.+.||+|.||.||+|+.+.||+.||+|++++.... .....+.+|+.+|+++. |||||.++++|.+..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 355667899999999999999999999999999999999776543 24578999999999998 999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC----CCEEEeecccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVSAQ 160 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~----g~vkL~DFGla~~ 160 (421)
.+++|||+|.||.|++.+.+. .++|..+..+++|++.|++|||+.||+||||||+|+|+... +.+|++|||+|..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999775 49999999999999999999999999999999999999643 4799999999988
Q ss_pred cccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC---CCCchHHH
Q 014610 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFS 237 (421)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s 237 (421)
... .......+|||.|+|||++... .|+..+||||+||++|.|++|.+||.+.........+..... ...+..++
T Consensus 189 ~~~-~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 189 IKP-GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred ccC-CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 776 5566789999999999999765 599999999999999999999999999998777777766643 33456789
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
..+++||.+||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999999865
No 34
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=1.6e-50 Score=388.67 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=215.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++++.||.|+||.||+|++..+++.||+|+++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 36799999999999999999999999999999998765444344567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 9975 999988654 45899999999999999999999999999999999999999999999999998765433333345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC---C------------------C
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---N------------------P 229 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~---~------------------~ 229 (421)
..|++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+... . .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 678999999999876556899999999999999999999999877655443322110 0 0
Q ss_pred CC--------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 230 PQ--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 230 ~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+. ....++.++++||.+||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 012356789999999999999999999999999998
No 35
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.3e-52 Score=368.35 Aligned_cols=255 Identities=30% Similarity=0.486 Sum_probs=233.7
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..++|++.+.||+|-||.||.|+.++++-.||+|++.+.+. ....+++.+|++|-+.|+||||.++|++|.+...+||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45789999999999999999999999999999999876652 2235789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 89 IMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 89 V~E~~~gg~L~~~l~--~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
++||...|+|...++ ...++++..++.+++|++.||.|||.++||||||||+|+|++.+|.+||+|||.+.... ..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~ 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SN 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CC
Confidence 999999999999998 66789999999999999999999999999999999999999999999999999986543 56
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
++.+.|||.-|.+||+..+. .++..+|+|++|++.||++.|.+||......+.+..|.+... .++..++..++++|.+
T Consensus 178 kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPSTISGGAADLISR 255 (281)
T ss_pred CceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcccChhHHHHHHH
Confidence 77899999999999999886 489999999999999999999999999998888888766543 4567899999999999
Q ss_pred HcccCCCCCcCHHHHHhChhccc
Q 014610 247 CLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
||.++|.+|.+..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999964
No 36
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=5.6e-50 Score=391.40 Aligned_cols=251 Identities=30% Similarity=0.525 Sum_probs=220.2
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999986542 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcc
Q 014610 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (421)
Q Consensus 97 ~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~ 176 (421)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 99999988888999999999999999999999999999999999999999999999999998754333233345689999
Q ss_pred ccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCc
Q 014610 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (421)
Q Consensus 177 y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 256 (421)
|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..++++|.+||.+||.+|+
T Consensus 161 y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 9999999776 48999999999999999999999998887766655554333 234567889999999999999999998
Q ss_pred -----CHHHHHhChhccccc
Q 014610 257 -----SAKELLRHRFIRNAR 271 (421)
Q Consensus 257 -----t~~elL~hp~~~~~~ 271 (421)
++.++++|+||....
T Consensus 239 ~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
No 37
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.2e-51 Score=399.01 Aligned_cols=266 Identities=44% Similarity=0.789 Sum_probs=237.3
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
+.+...|.-++.||.|+||.||-|++..+.+.||||.+.... .....+++.+|++.|++++|||+|.+.++|..+...
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 344567899999999999999999999999999999987654 455678999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
||||||| -|+-.|++.- .+++.|.+|..|..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|.....
T Consensus 102 WLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9999999 4588887753 47899999999999999999999999999999999999999999999999998876543
Q ss_pred ccccccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCc-hHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKE 242 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~~ 242 (421)
.++++|||+|||||++.. ...|+.++||||||++..||...+||+...+-+..++.|.....|.+. ..+|..+.+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~ 256 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 256 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHH
Confidence 468999999999999863 235999999999999999999999999999999999988877766664 589999999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcccccCChhHHHH
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~ 279 (421)
||..||++-|.+|||.+++|.|+|....+....+.+.
T Consensus 257 Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dL 293 (948)
T KOG0577|consen 257 FVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDL 293 (948)
T ss_pred HHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHH
Confidence 9999999999999999999999999877766554443
No 38
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=1.9e-50 Score=390.75 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=214.6
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999999999999999998765443344567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+. ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++............
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 995 678777754 467999999999999999999999999999999999999999999999999998755433333345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHhhc---cCC-------------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFII---PRE------------------- 227 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~-~~~~i---~~~------------------- 227 (421)
.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+..... ....+ ...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 6789999999998766568899999999999999999999998754322 11111 000
Q ss_pred ----CCCCCch-----HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 228 ----NPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 228 ----~~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+..+.. .++..+++||.+||+.||.+|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000000 1346789999999999999999999999999998764
No 39
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=2.5e-50 Score=394.75 Aligned_cols=251 Identities=30% Similarity=0.524 Sum_probs=221.0
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999986543 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcc
Q 014610 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (421)
Q Consensus 97 ~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~ 176 (421)
+|..++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 99999988888999999999999999999999999999999999999999999999999998754333333345689999
Q ss_pred ccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCc
Q 014610 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (421)
Q Consensus 177 y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 256 (421)
|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++.++.+||.+||.+||.+|+
T Consensus 161 y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred ccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999766 48999999999999999999999998887766665554433 345567889999999999999999997
Q ss_pred -----CHHHHHhChhccccc
Q 014610 257 -----SAKELLRHRFIRNAR 271 (421)
Q Consensus 257 -----t~~elL~hp~~~~~~ 271 (421)
++.|+++||||....
T Consensus 239 ~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 899999999998654
No 40
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=2.2e-50 Score=397.00 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=226.1
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCC-cEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g-~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
..++|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.+++.+|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3468999999999999999999977654 789999986543 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
+||||+.+|+|.+++.+.+++++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---R 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---C
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999876532 2
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...+.......+..... .++..++..++++|++|
T Consensus 185 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 262 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKKL 262 (340)
T ss_pred cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHH
Confidence 2456899999999999875 488999999999999999999999998887666666654432 34566788999999999
Q ss_pred cccCCCCCc-----CHHHHHhChhcccccCC
Q 014610 248 LKKVPAERP-----SAKELLRHRFIRNARKS 273 (421)
Q Consensus 248 L~~dP~~Rp-----t~~elL~hp~~~~~~~~ 273 (421)
|+.||++|+ |++++++||||.+..+.
T Consensus 263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 263 LSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred cccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999995 89999999999876543
No 41
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-52 Score=381.59 Aligned_cols=271 Identities=30% Similarity=0.519 Sum_probs=245.7
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
....++|..+++||+|.||+|-+++.+.+|+.||||++++.- ..+.+.....|-++|+.++||.+..+...|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 345689999999999999999999999999999999997664 455677888999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
|+||||..||.|+-.+.+...++|+.++.+..+|+.||.|||+++||+||||.+|+|+|++|++||+|||+++.......
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999987777777
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
...++||||.|+|||++... .|+.++|+|.+||+||||++|+.||...+.......|.... ..++..++++++.|+..
T Consensus 324 t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-LKFPRTLSPEAKTLLSG 401 (516)
T ss_pred eeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-ccCCccCCHHHHHHHHH
Confidence 78899999999999999876 59999999999999999999999999998888777776554 35677899999999999
Q ss_pred HcccCCCCCc-----CHHHHHhChhcccccCChhHHHHhh
Q 014610 247 CLKKVPAERP-----SAKELLRHRFIRNARKSPRLLERIR 281 (421)
Q Consensus 247 ~L~~dP~~Rp-----t~~elL~hp~~~~~~~~~~~~~~~~ 281 (421)
+|.+||.+|. .+.||.+|+||..+.+.......+.
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIE 441 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccC
Confidence 9999999997 5899999999998876655544443
No 42
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=2.6e-50 Score=378.26 Aligned_cols=260 Identities=31% Similarity=0.473 Sum_probs=225.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCC-eeEEEEEEEeCC-----
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQT----- 84 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~----- 84 (421)
...|+.+++||+|+||+||+|+++.+|+.||+|.+..... +.......+|+.+|++|+|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5569999999999999999999999999999999987754 333456789999999999999 999999998877
Q ss_pred -EEEEEEecCCCCCHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 85 -KLWIIMEYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 85 -~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
.+++|+||++ -+|..++.... .++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 8999999995 59999997644 57888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC--CC--------
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NP-------- 229 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~--~~-------- 229 (421)
...-+.......++|.+|.|||++.+...|+..+||||+|||++||+++++.|.+....+.+..|... .|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 77666556677899999999999999888999999999999999999999999999887777655210 00
Q ss_pred ----------CCC--ch-------HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 230 ----------PQL--DE-------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 230 ----------~~~--~~-------~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
+.. +. ..+....+++.+||+.+|.+|.|++.+|.||||.....
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 000 11 12247889999999999999999999999999987643
No 43
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=7.4e-50 Score=390.57 Aligned_cols=254 Identities=29% Similarity=0.504 Sum_probs=220.7
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHH---HcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
|++++.||+|+||.||+|.+..+|+.||||+++... .....+.+.+|+.++ ++++||||+++++++..++.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999986543 223446677777665 567899999999999999999999
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999998865 6799999999999999999999999999999999999999999999999999875443333445
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
..+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....+ .++..++..+.++|.+||.
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 160 TFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRLLR 237 (324)
T ss_pred ccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhh
Confidence 67899999999999775 489999999999999999999999998887776666554433 3455678999999999999
Q ss_pred cCCCCCc-----CHHHHHhChhccccc
Q 014610 250 KVPAERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 250 ~dP~~Rp-----t~~elL~hp~~~~~~ 271 (421)
.||.+|| ++.++++||||+...
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999 799999999998764
No 44
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=6.3e-50 Score=397.24 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=219.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++.+.++..+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986543 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~---- 166 (421)
|||+||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875432100
Q ss_pred -------------------------------cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCC
Q 014610 167 -------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (421)
Q Consensus 167 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~ 215 (421)
.....+||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01245899999999999876 4899999999999999999999999988
Q ss_pred CHHHHHhhccCCC-CCCCc--hHHHHHHHHHHHHHccc--CCCCCcCHHHHHhChhccccc
Q 014610 216 HPMRVLFIIPREN-PPQLD--EHFSRLMKEFVSLCLKK--VPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 216 ~~~~~~~~i~~~~-~~~~~--~~~s~~l~~li~~~L~~--dP~~Rpt~~elL~hp~~~~~~ 271 (421)
+.......+.... ...++ ..++.+++++|.+|+.. ++..||+++||++||||+...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 8777666554321 11122 24688999999997752 233568999999999998764
No 45
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=5.5e-51 Score=398.12 Aligned_cols=258 Identities=36% Similarity=0.560 Sum_probs=240.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE-EEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK-LWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~l 88 (421)
..++|..+++||+|+||.++.++++..+..|++|.+..... ....+...+|+.++++++|||||.+.+.|..++. ++|
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 35789999999999999999999999999999999987763 3344578899999999999999999999999888 999
Q ss_pred EEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||+||+||+|.+.|++. .-++|+.+..|+.|++.||.|||+++|+|||||+.|||+++++.|||+|||+|+.+....+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999999753 5699999999999999999999999999999999999999999999999999999988766
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
...+++|||.||+||++.+.+ |+.++|||||||++|||++-+++|.+.+......+|.......++..++.+++.+|+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHH
Confidence 778899999999999999875 9999999999999999999999999999999999999888888899999999999999
Q ss_pred HcccCCCCCcCHHHHHhChhccc
Q 014610 247 CLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
||.++|..||++.++|.+|.+..
T Consensus 241 ~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999988764
No 46
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=1.6e-49 Score=396.87 Aligned_cols=260 Identities=27% Similarity=0.496 Sum_probs=219.5
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
+.|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999996543 2345677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----- 165 (421)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975331100
Q ss_pred ------------------------------------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHH
Q 014610 166 ------------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (421)
Q Consensus 166 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ 203 (421)
....+.+||+.|+|||++.+. .++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHH
Confidence 001245799999999999775 4899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHhhccCC-CCCCC--chHHHHHHHHHHHHHcc--cCCCCCcCHHHHHhChhcccccCC
Q 014610 204 EMAKGEPPLADLHPMRVLFIIPRE-NPPQL--DEHFSRLMKEFVSLCLK--KVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 204 ell~g~~pf~~~~~~~~~~~i~~~-~~~~~--~~~~s~~l~~li~~~L~--~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
||++|..||...+.......+... ..... ...++.++.+||.+||. .+|..|+++.+++.||||......
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 999999999887765554444321 11122 23578999999999654 455569999999999999876543
No 47
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=1.2e-49 Score=387.97 Aligned_cols=251 Identities=30% Similarity=0.553 Sum_probs=217.6
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.+..+++.||||++.... .....+.+..|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 223345566677777654 899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++....++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999876543333445678999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... .+.++..++.++.+||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 161 DYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred cccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999998764 899999999999999999999999988877766665443 334566788999999999999999999
Q ss_pred cCH-HHHHhChhccccc
Q 014610 256 PSA-KELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~-~elL~hp~~~~~~ 271 (421)
|++ .++++||||....
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 239 LGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 986 5888999998754
No 48
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.4e-51 Score=370.07 Aligned_cols=259 Identities=31% Similarity=0.536 Sum_probs=232.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-------HHHHHHHHHHHHHHHcC-CCCCeeEEEEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQC-RSPYITEYYGSYL 81 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-------~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 81 (421)
..-.+|.-.++||+|..++|.+++.+.+|..+|+|++..... ..-.+...+|+.||+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344678889999999999999999999999999999865431 22345667899999998 5999999999999
Q ss_pred eCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
.+..+++|+|+|..|.|++++...-.++|...+.+++||++|++|||.++||||||||+|||++++.++||+|||+|+.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999988
Q ss_pred ccccccccccccCccccCccccc-----CcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC---Cc
Q 014610 162 TRTISRRKTFVGTPFWMAPEVIQ-----NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LD 233 (421)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~ 233 (421)
... .+....||||+|+|||.+. +.++|+..+|+|++|||||-||.|-+||+....+-++..|..+.... -+
T Consensus 174 ~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 654 4556789999999999875 34578899999999999999999999999998888888887766432 35
Q ss_pred hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 234 ~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
.+++...++||.+||+.||.+|.|++|+|.||||..
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 678999999999999999999999999999999953
No 49
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=6e-50 Score=392.56 Aligned_cols=255 Identities=26% Similarity=0.476 Sum_probs=223.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.++++++||||+++++++..++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence 9999999999998888999999999999999999999999999999999999999999999999999876543 2345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----CCCC---chHHHHHHHHH
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQL---DEHFSRLMKEF 243 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~---~~~~s~~l~~l 243 (421)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+....+.... .+.. ...++.++.+|
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 158 VVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 6899999999999876 58999999999999999999999999887766554433211 1111 12568899999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
|.+||..+|.+||++.++++||||....
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 9999999999999999999999998753
No 50
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=6.7e-50 Score=391.52 Aligned_cols=249 Identities=35% Similarity=0.594 Sum_probs=218.9
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcE-EEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-EEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWII 89 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~-vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV 89 (421)
....+.+.||+|+||+||+|.+. |.. ||||++.... .......+.+|+.+|++++|||||+++|++.... .++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 44556677999999999999988 566 9999986554 2333779999999999999999999999999887 79999
Q ss_pred EecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEccCC-CEEEeeccccccccccc
Q 014610 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG-KIHRDIKAANILLTENG-DVKVADFGVSAQLTRTI 165 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~-iiHrDlkp~NILl~~~g-~vkL~DFGla~~~~~~~ 165 (421)
|||+++|+|.+++.+ ...++...+..++.||+.|+.|||+++ ||||||||+||||+.++ ++||||||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999999977 688999999999999999999999999 99999999999999998 99999999998766543
Q ss_pred ccccccccCccccCcccccC-cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc-CCCCCCCchHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~l 243 (421)
.......||+.|||||++.+ ...|+.++|||||||+||||+||..||.+.........+. ....+.++..++..+..+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 33344789999999999984 2459999999999999999999999999999866666554 566667777799999999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
+..||..||..||++.+++.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999985
No 51
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=1.9e-49 Score=387.60 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=224.4
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCC-CCeeEEEEEEEeCCEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~ 90 (421)
+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+..|+.+++.++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999986542 23345678889999999976 56889999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 99999999999988888999999999999999999999999999999999999999999999999998654322233345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ..++..++..+.++|.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 161 FCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred ecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 68999999999998764 8999999999999999999999999888777766665443 345567889999999999999
Q ss_pred CCCCCcCH-----HHHHhChhcccccC
Q 014610 251 VPAERPSA-----KELLRHRFIRNARK 272 (421)
Q Consensus 251 dP~~Rpt~-----~elL~hp~~~~~~~ 272 (421)
||.+|++. +++++||||.....
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999976 89999999987643
No 52
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=5.3e-50 Score=397.56 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=221.5
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.++..+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999986543 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~---- 166 (421)
|||.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999865422100
Q ss_pred ----------------------------------cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCC
Q 014610 167 ----------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL 212 (421)
Q Consensus 167 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf 212 (421)
.....+||+.|+|||++... .++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCC
Confidence 11135799999999998765 4899999999999999999999999
Q ss_pred CCCCHHHHHhhccCCC-CCCC--chHHHHHHHHHHHHHcccCCCCCcC---HHHHHhChhccccc
Q 014610 213 ADLHPMRVLFIIPREN-PPQL--DEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNAR 271 (421)
Q Consensus 213 ~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~~ 271 (421)
...+.......+.... ...+ ...++.++++||.+||. +|.+|++ +.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9888776665554322 1111 22468899999999996 9999998 99999999998764
No 53
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=1e-49 Score=382.40 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=217.7
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.|++++.||+|+||.||+|.+..+|+.||||.+..... ......+.+|+.++++++|+||+++++++.+++.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999865432 2234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence 9999999988754 346899999999999999999999999999999999999999999999999998765322 2223
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
..+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+... ............++..++..+.+||++
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 160 GRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 56799999999999876 48999999999999999999999998754322 122212223334556688999999999
Q ss_pred HcccCCCCCcC-----HHHHHhChhccccc
Q 014610 247 CLKKVPAERPS-----AKELLRHRFIRNAR 271 (421)
Q Consensus 247 ~L~~dP~~Rpt-----~~elL~hp~~~~~~ 271 (421)
||..||.+||+ ++++++||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 99999999997 89999999998765
No 54
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=6.7e-51 Score=384.02 Aligned_cols=256 Identities=27% Similarity=0.527 Sum_probs=233.2
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
....+|++.+.||+|.||+|-+|.....|+.||||.|++++ ++.++-.+++||+||+.|+||||+.+|++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34568999999999999999999999999999999997765 4566788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
|||||..+|.|.+++...+.|+|.+++.+++||..|+.|||.++++|||||.+|||+|.++++||+|||++..+... ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998766443 34
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
..++||+|.|.+||++.+...-++.+|.|||||+||-|..|..||++.+...+...|.++...... -+..+.-||+.|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~--~PSdA~gLIRwm 286 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE--TPSDASGLIRWM 286 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC--CCchHHHHHHHH
Confidence 568999999999999998876678999999999999999999999999999999999877643322 356788899999
Q ss_pred cccCCCCCcCHHHHHhChhcc
Q 014610 248 LKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~hp~~~ 268 (421)
|..||++|.|+.+|-.|=|+.
T Consensus 287 LmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HhcCcccchhHHHHhhhheee
Confidence 999999999999999997764
No 55
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=7.3e-50 Score=399.39 Aligned_cols=259 Identities=27% Similarity=0.508 Sum_probs=220.9
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999986543 2344677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----- 165 (421)
|||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHH
Q 014610 166 ------------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (421)
Q Consensus 166 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ 203 (421)
....+.+||+.|+|||++.+. .++.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHH
Confidence 001235799999999999776 4899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHhhccCCC-CCCC--chHHHHHHHHHHHHHcccCCCCCcC---HHHHHhChhcccccCC
Q 014610 204 EMAKGEPPLADLHPMRVLFIIPREN-PPQL--DEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARKS 273 (421)
Q Consensus 204 ell~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~~~~ 273 (421)
||++|++||...+.......+.... .... ...+++++.++|.+|+ .+|.+|++ +.++++||||+.....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999999887766555543321 1111 2457899999999976 59999997 9999999999876543
No 56
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=1.3e-49 Score=389.72 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=214.9
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
++||+|+||.||+|.+..+++.||||+++... .......+.+|+.+++.+ +||||+++++++.+.+.+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999997543 233456788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|.+++.+.+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333445678999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC--------HHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--------PMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
.|+|||++.+. .++.++|||||||++|+|++|+.||.... ...............++..++..+.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999875 48999999999999999999999996321 1111222222233345667889999999999
Q ss_pred cccCCCCCcC------HHHHHhChhccccc
Q 014610 248 LKKVPAERPS------AKELLRHRFIRNAR 271 (421)
Q Consensus 248 L~~dP~~Rpt------~~elL~hp~~~~~~ 271 (421)
|..||.+|+| ++++++||||....
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999987 78999999997654
No 57
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=8.2e-50 Score=398.12 Aligned_cols=257 Identities=27% Similarity=0.490 Sum_probs=219.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|++++||||+++++.+.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986432 1233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----- 165 (421)
|||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred --------------------------------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh
Q 014610 166 --------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK 207 (421)
Q Consensus 166 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~ 207 (421)
......+||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhh
Confidence 001235799999999999775 48999999999999999999
Q ss_pred CCCCCCCCCHHHHHhhccCCCC---CCCchHHHHHHHHHHHHHcccCCCCCc---CHHHHHhChhccccc
Q 014610 208 GEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNAR 271 (421)
Q Consensus 208 g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~elL~hp~~~~~~ 271 (421)
|+.||...+.......+..... ......++.++.++|.+|+ .+|.+|+ |+.++++||||+...
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 9999998877665544433211 1122357889999999976 5999999 999999999998754
No 58
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=1.2e-49 Score=388.58 Aligned_cols=251 Identities=29% Similarity=0.502 Sum_probs=219.9
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.++.+++.||||++.... .......+..|+.+++.+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986532 223456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333334568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..... .++..++.++.+||.+||++||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 161 DYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred cccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999765 489999999999999999999999998888777766654433 3455678999999999999999999
Q ss_pred cCH------HHHHhChhccccc
Q 014610 256 PSA------KELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~------~elL~hp~~~~~~ 271 (421)
|++ +++++||||....
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCCC
Confidence 998 9999999998764
No 59
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=9.2e-50 Score=382.26 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=214.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|++.+.||+|+||.||+|+++.+++.||||++..... ......+.+|+.++++++||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999865432 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~ 170 (421)
|++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 999888877766667899999999999999999999999999999999999999999999999999876543221 2234
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC---------------------CC
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------------------NP 229 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~---------------------~~ 229 (421)
..||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+..+....+... ..
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 67999999999998764 899999999999999999999999877654433221110 00
Q ss_pred C----------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 230 P----------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 230 ~----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+ .....++.++.+||.+||++||++|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0012367889999999999999999999999999998
No 60
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=5.2e-49 Score=385.77 Aligned_cols=258 Identities=34% Similarity=0.611 Sum_probs=222.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++++.||+|+||.||+|++..+|..||+|++...........+.+|+.+|++++||||+++++++..++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 57999999999999999999999999999999999766555556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 161 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 161 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cccc
Confidence 999999999998888899999999999999999999986 6999999999999999999999999998765432 2345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc-------------------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------------- 225 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~------------------------- 225 (421)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+.
T Consensus 162 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 6799999999999876 48999999999999999999999997655433322111
Q ss_pred ---------------------CCCCCCC-chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 226 ---------------------RENPPQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 226 ---------------------~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
...++.. ...++.++++||.+||.+||++|||+.+||+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 0011111 1246788999999999999999999999999999986543
No 61
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=2.7e-49 Score=385.36 Aligned_cols=251 Identities=27% Similarity=0.500 Sum_probs=217.2
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
++||+|+||.||+|.++.+|+.||||++.... .......+..|+.++..+ +||||+++++++.+++.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999986542 123445667788888754 899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++...+++++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865432223344678999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... +.++..++.+++++|.+||..||++|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 161 DYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999876 48999999999999999999999999887766665554333 34455678999999999999999999
Q ss_pred cCH-HHHHhChhccccc
Q 014610 256 PSA-KELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~-~elL~hp~~~~~~ 271 (421)
+++ +++++||||+...
T Consensus 239 ~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 239 LGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCChHHHHcCCCcCCCC
Confidence 998 5888999998764
No 62
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=3.3e-49 Score=385.48 Aligned_cols=251 Identities=28% Similarity=0.487 Sum_probs=220.2
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
++||+|+||.||+|.+..+++.||||++.... .......+..|+.+++.+ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999986542 233456677899998866 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875443333344568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..... ..+..++.++.++|.+||.+||++|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 161 DYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred cccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 99999999775 489999999999999999999999999888777776655442 3445578899999999999999999
Q ss_pred c-------CHHHHHhChhccccc
Q 014610 256 P-------SAKELLRHRFIRNAR 271 (421)
Q Consensus 256 p-------t~~elL~hp~~~~~~ 271 (421)
+ ++.++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCCCC
Confidence 9 999999999997654
No 63
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=2.1e-49 Score=387.20 Aligned_cols=252 Identities=28% Similarity=0.507 Sum_probs=219.9
Q ss_pred eceEeecCceEEEEEEEC---CCCcEEEEEEeccCC---CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 18 LELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++.||+|+||.||+|.+. .+++.||||++.... .......+..|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 478999999999999874 578999999986532 22334567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+.+|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987544333334456
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+.... ..++..++..+.+||.+||+++
T Consensus 161 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred CCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccC
Confidence 899999999999775 47899999999999999999999999888776666665443 2455567889999999999999
Q ss_pred CCCCc-----CHHHHHhChhccccc
Q 014610 252 PAERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 252 P~~Rp-----t~~elL~hp~~~~~~ 271 (421)
|++|| ++.+++.||||+...
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999 899999999998754
No 64
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=8.1e-50 Score=390.42 Aligned_cols=251 Identities=29% Similarity=0.526 Sum_probs=219.6
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|.+..+|+.||+|++.... .......+..|+.+++.++||||+++++++..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999986542 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 97 ~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888889999999999999999999997 7999999999999999999999999999875433333334568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++.++.+||.+||++||++|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 161 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred ccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 99999999776 48999999999999999999999998887766655554332 34556688999999999999999999
Q ss_pred c-----CHHHHHhChhccccc
Q 014610 256 P-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 256 p-----t~~elL~hp~~~~~~ 271 (421)
+ ++.++++||||....
T Consensus 239 ~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCCHHHHhcCCCcCCCC
Confidence 7 999999999998754
No 65
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=3.7e-49 Score=385.45 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=224.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
+|++++.||+|+||.||+|++..+++.||||++.... .......+..|..++..+ +||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999987543 223345667788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998754333333345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+..... .++..++.++.++|.+||++
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHHccc
Confidence 7899999999999876 489999999999999999999999998887777666654433 44566889999999999999
Q ss_pred CCCCCcC-----HHHHHhChhcccccC
Q 014610 251 VPAERPS-----AKELLRHRFIRNARK 272 (421)
Q Consensus 251 dP~~Rpt-----~~elL~hp~~~~~~~ 272 (421)
+|.+|++ ..++++||||+...+
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999997 489999999987643
No 66
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=1.6e-49 Score=396.18 Aligned_cols=257 Identities=29% Similarity=0.504 Sum_probs=218.5
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++.++..+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986543 2344677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~---- 166 (421)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999863211000
Q ss_pred -------------------------------------------cccccccCccccCcccccCcCCCCCccccHHHHHHHH
Q 014610 167 -------------------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (421)
Q Consensus 167 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ 203 (421)
.....+||+.|+|||++.+. .++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhh
Confidence 00125799999999999776 4899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHhhccCC-CCCCCc--hHHHHHHHHHHHHHcccCCCCC---cCHHHHHhChhccccc
Q 014610 204 EMAKGEPPLADLHPMRVLFIIPRE-NPPQLD--EHFSRLMKEFVSLCLKKVPAER---PSAKELLRHRFIRNAR 271 (421)
Q Consensus 204 ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~--~~~s~~l~~li~~~L~~dP~~R---pt~~elL~hp~~~~~~ 271 (421)
||++|.+||...+.......+... ....++ ..++.++++||.+||. +|.+| +|+.+++.||||+...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999999887776655554332 111222 2478899999999997 67765 5999999999998653
No 67
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=1.7e-49 Score=391.41 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=223.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986543 1234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----- 165 (421)
||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987654432
Q ss_pred ------------------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 014610 166 ------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (421)
Q Consensus 166 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~ 221 (421)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 122346799999999999876 5899999999999999999999999988876665
Q ss_pred hhccCC--C-CCCCchHHHHHHHHHHHHHcccCCCCCcC-HHHHHhChhccccc
Q 014610 222 FIIPRE--N-PPQLDEHFSRLMKEFVSLCLKKVPAERPS-AKELLRHRFIRNAR 271 (421)
Q Consensus 222 ~~i~~~--~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-~~elL~hp~~~~~~ 271 (421)
..+... . .......++..+.+||.+||. +|.+|++ ++++|+||||+...
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 555431 1 111122368999999999997 9999999 99999999998754
No 68
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=3e-49 Score=387.36 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=217.5
Q ss_pred CceeeceEeecCceEEEEEEEC---CCCcEEEEEEeccCC---CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~~~~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 86 (421)
+|++++.||+|+||+||+|.+. .+|+.||+|++.... .....+.+..|+.+++++ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 578999999986432 233456788999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~- 165 (421)
++|||||++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987653322
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHhhccCCCCCCCchHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPPQLDEHFSRLMK 241 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~ 241 (421)
......+||+.|+|||++.+...++.++|||||||++|||++|..||..... ......+... .+.++..++..++
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-DPPFPSFIGPEAQ 239 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Confidence 2233568999999999998655578899999999999999999999964322 2222223222 2344556889999
Q ss_pred HHHHHHcccCCCCCc-----CHHHHHhChhccccc
Q 014610 242 EFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 242 ~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~~ 271 (421)
++|.+||..||++|| +++++++||||+...
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999 889999999998754
No 69
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.6e-50 Score=378.02 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=220.2
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--C--
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--T-- 84 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~-- 84 (421)
+...-.|+..+++|.|+||.||+|...++++.||||.+-.+.. --.+|+.+|+.++|||||++..+|... +
T Consensus 20 ~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 20 KKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred cceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3455579999999999999999999999999999998754432 234799999999999999999988753 2
Q ss_pred -EEEEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeecccc
Q 014610 85 -KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVS 158 (421)
Q Consensus 85 -~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGla 158 (421)
++.+||||++ .+|.++++. +.+++.-.++-+.+||++||+|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 4579999996 599999974 5889999999999999999999999999999999999999977 99999999999
Q ss_pred cccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC------------
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~------------ 226 (421)
+.+... +...+++.|+.|+|||++.+...|+.+.||||.||++.||+-|++.|.+.+..+++..|.+
T Consensus 174 K~L~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeeccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 988755 4457889999999999999999999999999999999999999999999877666543321
Q ss_pred CCC-------CC---------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 227 ENP-------PQ---------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 227 ~~~-------~~---------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
.++ +. +....++++.+|+.++|..+|.+|.++.|+|.||||+..+..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 11 233567899999999999999999999999999999876543
No 70
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=7.9e-49 Score=382.17 Aligned_cols=251 Identities=30% Similarity=0.538 Sum_probs=217.5
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHc-CCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.+..+++.||||++.... ..........|..+++. ++||||+++++++.+++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999986542 12334556778888876 4899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875433323334568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....+ .++..++.++++||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 161 DYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-CYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred cccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHhccCHhhc
Confidence 99999999776 489999999999999999999999998887766665544432 3455678899999999999999999
Q ss_pred cCHH-HHHhChhccccc
Q 014610 256 PSAK-ELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~~-elL~hp~~~~~~ 271 (421)
|++. ++++||||+...
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 239 LGVKGDIRQHPFFREID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 9996 899999998764
No 71
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=7.2e-49 Score=382.65 Aligned_cols=252 Identities=28% Similarity=0.500 Sum_probs=220.3
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.+..+++.||||++.... .......+..|+.+++.+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987542 233456677899999888 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++.+.+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999998888999999999999999999999999999999999999999999999999999865433333334568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+..... .++..++..+.+||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 161 DYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred cccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHHHc
Confidence 99999999876 489999999999999999999999998877766665544433 4455678999999999999999999
Q ss_pred cCH-----HHHHhChhcccccC
Q 014610 256 PSA-----KELLRHRFIRNARK 272 (421)
Q Consensus 256 pt~-----~elL~hp~~~~~~~ 272 (421)
||+ .+++.||||+...+
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCCCH
Confidence 999 99999999987643
No 72
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=7.8e-49 Score=383.17 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=216.1
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHH-HHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|++..+|+.||||++.... .......+..|.. +++.++||||+++++++..++.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 1222344555554 56889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333344568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.++|.+||++||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 161 EYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred hhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 99999999775 48999999999999999999999999887776666554433 34455678999999999999999999
Q ss_pred cCH----HHHHhChhccccc
Q 014610 256 PSA----KELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~----~elL~hp~~~~~~ 271 (421)
|++ .++++||||....
T Consensus 239 ~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 239 LGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 987 6999999998764
No 73
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=8.1e-49 Score=384.45 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=211.3
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC-----CEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TKLW 87 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~ 87 (421)
+|++.+.||+|+||.||+|++..+|+.||||.+.... .......+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999986432 223346788999999999999999999988643 3589
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
+||||| +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 479999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred --cccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhc-------------------
Q 014610 167 --RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224 (421)
Q Consensus 167 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i------------------- 224 (421)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||...+.......+
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 12346799999999998652 35789999999999999999999999876543322111
Q ss_pred --------cCCCCCCCc---hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 225 --------PRENPPQLD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 225 --------~~~~~~~~~---~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
....+..+. ..++..+.++|.+||..||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 011111111 13467789999999999999999999999999998654
No 74
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=9.4e-49 Score=389.81 Aligned_cols=261 Identities=26% Similarity=0.463 Sum_probs=222.8
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..++|++++.||+|+||.||+|.+..+++.||||+++... .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999999999999999986532 22334567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-c
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 167 (421)
|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++........ .
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 9999999999999876 5689999999999999999999999999999999999999999999999999876543221 2
Q ss_pred ccccccCccccCcccccCcC---CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCCch--HHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDE--HFSRLMK 241 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~ 241 (421)
....+||+.|+|||++.+.. .++.++|||||||++|||++|.+||...+.......+.... ...++. .++.+++
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence 24568999999999986532 37889999999999999999999999888766666554322 122222 4789999
Q ss_pred HHHHHHcccCCCC--CcCHHHHHhChhcccccC
Q 014610 242 EFVSLCLKKVPAE--RPSAKELLRHRFIRNARK 272 (421)
Q Consensus 242 ~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~~ 272 (421)
+||.+||..+|.+ |+|++++++||||+....
T Consensus 280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred HHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 9999999999988 999999999999987543
No 75
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=7.5e-49 Score=384.41 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=213.9
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.+..+++.||+|++.... .......+..|+.++.++ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987542 334456788899998877 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++...+++++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333344578999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC--------HHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--------PMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||.... ...............++..++..+.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999876 48999999999999999999999995321 1111112112223345667889999999999
Q ss_pred cccCCCCCcC------HHHHHhChhccccc
Q 014610 248 LKKVPAERPS------AKELLRHRFIRNAR 271 (421)
Q Consensus 248 L~~dP~~Rpt------~~elL~hp~~~~~~ 271 (421)
|..||.+||| +.++++||||+...
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999998 58999999998753
No 76
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=4.4e-49 Score=390.71 Aligned_cols=258 Identities=29% Similarity=0.512 Sum_probs=220.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++.+++||||+++++.+.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 2334577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----- 165 (421)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999986442110
Q ss_pred ------------------------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCC
Q 014610 166 ------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (421)
Q Consensus 166 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~ 215 (421)
......+||+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCCC
Confidence 001245799999999999876 4899999999999999999999999988
Q ss_pred CHHHHHhhccCCC-CCCCc--hHHHHHHHHHHHHHcccCCCCCc---CHHHHHhChhcccccC
Q 014610 216 HPMRVLFIIPREN-PPQLD--EHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARK 272 (421)
Q Consensus 216 ~~~~~~~~i~~~~-~~~~~--~~~s~~l~~li~~~L~~dP~~Rp---t~~elL~hp~~~~~~~ 272 (421)
+.......+.... ...++ ..++.++++||.+|+ .||.+|+ ++.++++||||+...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 8776665554321 11122 236889999999987 4999998 5899999999997643
No 77
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=8.6e-49 Score=387.58 Aligned_cols=255 Identities=33% Similarity=0.531 Sum_probs=216.0
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|+.++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++|+||+++++++..++.+++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 46799999999999999999999999999999998766555556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
||++|+|... ....+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..........
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 9999998653 345788899999999999999999999999999999999999999999999987665433333456
Q ss_pred ccCccccCcccccCc----CCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 172 VGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHP---MRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
.||+.|+|||++... ...+.++|||||||++|||++|+.||..... ......+.....+..+..++.++++||
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 899999999987432 2245689999999999999999999974332 222222333334445566789999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+||..||++|||+.|+|+||||...
T Consensus 309 ~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 309 SCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999864
No 78
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=2.6e-48 Score=380.24 Aligned_cols=252 Identities=28% Similarity=0.500 Sum_probs=216.0
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997543 233456788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 99999998878999999999999999999999999999999999999999999999999999875433333345678999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCC------CHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL------HPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
.|+|||++.+. .++.++|||||||++|+|++|..||... +............+..++..++..+.++|.+||.
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999776 4899999999999999999999999632 2222222222333445666788999999999999
Q ss_pred cCCCCCcC------HHHHHhChhccccc
Q 014610 250 KVPAERPS------AKELLRHRFIRNAR 271 (421)
Q Consensus 250 ~dP~~Rpt------~~elL~hp~~~~~~ 271 (421)
+||.+|++ +.+++.||||+...
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99999998 57999999998764
No 79
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=3.2e-49 Score=386.97 Aligned_cols=251 Identities=30% Similarity=0.481 Sum_probs=215.6
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcC---CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
||+|+||+||+|++..+|+.||||++..... .........|..++..+ +||||+++++++.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999864321 22334455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||||+.++.++|+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875443333445678999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+...++.++|||||||++|+|++|..||...+.......+...........++..+.+||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 99999999766568899999999999999999999999887776666655443332233578899999999999999999
Q ss_pred c----CHHHHHhChhccccc
Q 014610 256 P----SAKELLRHRFIRNAR 271 (421)
Q Consensus 256 p----t~~elL~hp~~~~~~ 271 (421)
| ++.++++||||....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998754
No 80
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=1.4e-48 Score=382.19 Aligned_cols=258 Identities=30% Similarity=0.466 Sum_probs=221.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++.+.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++++.+++.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999875432 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cc
Q 014610 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~ 168 (421)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999875 6899999999999999999999999999999999999999999999999999976543322 12
Q ss_pred cccccCccccCcccccC-----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCC--chHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQL--DEHFSRLM 240 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l 240 (421)
...+||+.|+|||++.. ...++.++|||||||++|+|++|..||...+.......+.... ...+ ...++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 23579999999999863 2347889999999999999999999998887766655543321 1111 22478899
Q ss_pred HHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+||.+||. +|.+|||+++++.||||....
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 999999997 999999999999999998754
No 81
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=1.9e-48 Score=387.59 Aligned_cols=260 Identities=27% Similarity=0.486 Sum_probs=220.5
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.. .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999999999999999986432 22334567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-c
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 167 (421)
|||||++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|........ .
T Consensus 121 v~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 9999999999999976 5689999999999999999999999999999999999999999999999999976543221 2
Q ss_pred ccccccCccccCcccccCcC---CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCCc--hHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLD--EHFSRLMK 241 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~ 241 (421)
..+.+||+.|+|||++.+.. .++.++|||||||++|+|++|.+||...+.......+.... ...++ ..++..++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 24568999999999987542 36789999999999999999999999888766666554322 12222 24688999
Q ss_pred HHHHHHcccCCCC--CcCHHHHHhChhccccc
Q 014610 242 EFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (421)
Q Consensus 242 ~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~ 271 (421)
++|.+||..++.+ |+|+.|+++||||+...
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 9999999855543 89999999999998753
No 82
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4e-49 Score=381.16 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=235.0
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
+.+-|.+.+.||+|-|++|-+|++.-||..||||++++.+.. -...++.+|++.|+.++|||||++|++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 456799999999999999999999999999999999887743 3457899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeeccccccccccccc
Q 014610 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~~~~~~~~~ 167 (421)
+|+-++|+|+++|-+ ...++|+.+.+|++||+.|+.|||...+|||||||+||.+-+ -|-|||.||||+-.+.. ..+
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-G~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-GKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-cch
Confidence 999999999999865 468999999999999999999999999999999999987754 59999999999987754 356
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
..+.||+..|-|||++.+..+-.+++||||||||||-|.+|++||...++.+.+..|....+ ..+.+++.+.++||..|
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-tvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-TVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-cCchhhhHHHHHHHHHH
Confidence 67899999999999999987445789999999999999999999999999999988876654 67889999999999999
Q ss_pred cccCCCCCcCHHHHHhChhcccc
Q 014610 248 LKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
|+.||.+|.+.++|..|+|++..
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HhcCchhhccHHHHhccccccCC
Confidence 99999999999999999999864
No 83
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=2.1e-48 Score=377.51 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=216.2
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++++.||+|+||.||+|.+..+++.||||.++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 36899999999999999999999999999999998765544344567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+++ +|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 9975 88887765 345899999999999999999999999999999999999999999999999998765443333345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC----------------------C
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------------N 228 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~----------------------~ 228 (421)
..+|+.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+... .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 578999999999876556889999999999999999999999877654333222100 0
Q ss_pred CC-------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 229 PP-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 229 ~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+. .....++.++++||.+||..||.+|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00 0012357789999999999999999999999999999864
No 84
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=2e-48 Score=380.39 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=222.6
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 90 (421)
+|+..+.||+|+||+||+|.+..+|+.||||++.... .......+..|+.+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999987542 2334566778999998886 578889999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754333233345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
.+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+.... ..++..++..+.+++.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred ccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccc
Confidence 6799999999999775 48999999999999999999999999888776666655433 244566789999999999999
Q ss_pred CCCCCcC-----HHHHHhChhccccc
Q 014610 251 VPAERPS-----AKELLRHRFIRNAR 271 (421)
Q Consensus 251 dP~~Rpt-----~~elL~hp~~~~~~ 271 (421)
+|.+|++ ..++++||||+...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999997 57999999998754
No 85
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=5.9e-48 Score=378.72 Aligned_cols=258 Identities=34% Similarity=0.622 Sum_probs=220.0
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++.+.||+|+||.||+|.+..++..||+|++...........+.+|++++++++||||+++++++.+++.+++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 45899999999999999999999999999999999876655555678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
||+.+|+|.+++...+.+++..+..++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++...... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 160 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 160 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccc
Confidence 9999999999998888899999999999999999999985 7999999999999999999999999998755332 223
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhc-------------------------
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------------- 224 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i------------------------- 224 (421)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 46799999999999775 4889999999999999999999999765432221110
Q ss_pred -------------------cCCCCCCCc-hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 225 -------------------PRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 225 -------------------~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
....++.++ ..++.++++||.+||++||++|||+.|++.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 011111111 13567899999999999999999999999999998653
No 86
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1e-49 Score=395.24 Aligned_cols=259 Identities=32% Similarity=0.594 Sum_probs=224.8
Q ss_pred cchhhCCCc-eeeceEeecCceEEEEEEECCCCcEEE---EEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe
Q 014610 7 LQEAAGSRF-SSLELIGRGSFGDVYKAFDKELNKDVA---IKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (421)
Q Consensus 7 ~~~~~~~~y-~~~~~LG~G~~g~Vy~a~~~~~g~~vA---iK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 82 (421)
+-...+++| +...+||+|+|.+||+|.|..+|..|| ||.-++.+.+..++++..|+.+|+.|+|||||++|++|.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 344455666 456799999999999999999999999 6665666778888999999999999999999999999997
Q ss_pred CC--EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccC-CCEEEeeccc
Q 014610 83 QT--KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTEN-GDVKVADFGV 157 (421)
Q Consensus 83 ~~--~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~--iiHrDlkp~NILl~~~-g~vkL~DFGl 157 (421)
.. ++.+|+|++..|+|..|+++.++++...+..|++||++||.|||++. |||||||++||+|+.+ |.|||+|+||
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence 55 48999999999999999999999999999999999999999999994 9999999999999976 9999999999
Q ss_pred ccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHhhccCCCCC-CCchH
Q 014610 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPRENPP-QLDEH 235 (421)
Q Consensus 158 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~-~~~~i~~~~~~-~~~~~ 235 (421)
|+....... ...+|||.|||||++. +.|+..+||||||++|+||.|+..||..+.... .+.++..+..| .+..-
T Consensus 193 Atl~r~s~a--ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 193 ATLLRKSHA--KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred HHHhhcccc--ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc
Confidence 998766533 4589999999999997 459999999999999999999999999876554 44455444433 33333
Q ss_pred HHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 236 ~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
-.+++++||.+||.. .+.|+|+.|||.||||...
T Consensus 269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 368899999999999 8999999999999999864
No 87
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=8.4e-49 Score=382.00 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=219.3
Q ss_pred eceEeecCceEEEEEEE---CCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 18 LELIGRGSFGDVYKAFD---KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~---~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
++.||+|+||.||++.+ ..+|+.||+|++..... ......+..|+.+|++++||||+++++++..++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 46899999999999976 35789999999865432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccccc
Q 014610 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (421)
Q Consensus 94 ~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g 173 (421)
++|+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998765443333445789
Q ss_pred CccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCC
Q 014610 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (421)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 253 (421)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.... ..++..++..+.+||.+||+.||.
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 161 TVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred ChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHh
Confidence 9999999999765 47899999999999999999999999888777666654433 244556789999999999999999
Q ss_pred CCcC-----HHHHHhChhccccc
Q 014610 254 ERPS-----AKELLRHRFIRNAR 271 (421)
Q Consensus 254 ~Rpt-----~~elL~hp~~~~~~ 271 (421)
+||| +.+++.||||....
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999 78899999998764
No 88
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=2.6e-48 Score=394.84 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=209.2
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC------
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------ 83 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 83 (421)
....+|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 44578999999999999999999999999999999885432 2345799999999999999999987532
Q ss_pred --CEEEEEEecCCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-CEEEeecc
Q 014610 84 --TKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFG 156 (421)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-~vkL~DFG 156 (421)
..+++||||++ ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 24789999996 47777664 356799999999999999999999999999999999999998664 79999999
Q ss_pred cccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC--C------
Q 014610 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--N------ 228 (421)
Q Consensus 157 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~--~------ 228 (421)
+|...... ......+||+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+....+..+... .
T Consensus 217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 217 SAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred cchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 99865432 22345689999999999877656899999999999999999999999887655443322110 0
Q ss_pred -----------CC---------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 229 -----------PP---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 229 -----------~~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+ .++...+.++.+||.+||.+||.+|||+.|+|+||||....
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 01223567899999999999999999999999999997643
No 89
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=4.8e-48 Score=369.88 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=211.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||+|+||+||+|.+..+|+.||||.+..... ......+..|+.++++++||||+++++++..+..+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999865432 22346678899999999999999999999999999999999999999
Q ss_pred HHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccC
Q 014610 99 ADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (421)
Q Consensus 99 ~~~l~----~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 174 (421)
..++. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..............||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 98874 24579999999999999999999999999999999999999999999999999987654433333456899
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+. ..+..++..++..+.+++.+||..
T Consensus 161 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcC
Confidence 999999999876 4889999999999999999999999765321 1222222 223344566889999999999999
Q ss_pred CCCCCc-----CHHHHHhChhccccc
Q 014610 251 VPAERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 251 dP~~Rp-----t~~elL~hp~~~~~~ 271 (421)
||++|| |++++++||||+...
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 999999 899999999998754
No 90
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=1.2e-48 Score=390.71 Aligned_cols=255 Identities=31% Similarity=0.496 Sum_probs=218.0
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-C-----CCeeEEEEEEEe
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S-----PYITEYYGSYLH 82 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~ 82 (421)
+....+|.+++.||+|+||.|.+|.+..|++.||||+++... ....+...|+.+|..|+ | -|||+++++|..
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 344559999999999999999999999999999999986543 35677889999999997 4 489999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC--CCEEEeecccc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGVS 158 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~--g~vkL~DFGla 158 (421)
.+++|||+|++ +.+|.++++.+ .+++...++.++.||+.||.+||+.||||+||||+||||.+- ..|||+|||.|
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999999 56999999876 479999999999999999999999999999999999999754 47999999999
Q ss_pred cccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-----------
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------- 227 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~----------- 227 (421)
+..... ..+++-++.|+|||++.+.. |+.+.||||||||++||++|.+.|.+.+..+.+..|...
T Consensus 339 c~~~q~---vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQR---VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCc---ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876442 33889999999999999985 999999999999999999999999998887766544110
Q ss_pred -------------C------------------------------CC-C-------CchHHHHHHHHHHHHHcccCCCCCc
Q 014610 228 -------------N------------------------------PP-Q-------LDEHFSRLMKEFVSLCLKKVPAERP 256 (421)
Q Consensus 228 -------------~------------------------------~~-~-------~~~~~s~~l~~li~~~L~~dP~~Rp 256 (421)
. .+ . +...-...+.+||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0 00 0 0001134688999999999999999
Q ss_pred CHHHHHhChhcccc
Q 014610 257 SAKELLRHRFIRNA 270 (421)
Q Consensus 257 t~~elL~hp~~~~~ 270 (421)
|+.|+|+||||...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999843
No 91
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=6.5e-48 Score=386.20 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=207.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|++++.||+|+||.||+|++..+++.||||... ...+.+|+.+|++++||||++++++|..+...++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 468999999999999999999999999999999753 2456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc-cccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~ 170 (421)
++ +++|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|...... ......
T Consensus 164 ~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 99 4799999888788999999999999999999999999999999999999999999999999998653322 122335
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHhhc---c---------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-------MRVLFII---P--------------- 225 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~-------~~~~~~i---~--------------- 225 (421)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+..+ .
T Consensus 243 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 6899999999999775 489999999999999999999988653211 0000000 0
Q ss_pred -----------CCCCCC--Cc---hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 226 -----------RENPPQ--LD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 226 -----------~~~~~~--~~---~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
...+.. .. ..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000000 00 1346789999999999999999999999999999864
No 92
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=2e-48 Score=380.56 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=215.2
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHH-HHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEI-SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|++..+++.||+|++..... ......+..|. .+++.++||||+++++++..++.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999865421 12233444444 457889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876543333445678999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+... +..+...++..+.++|.+||++||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 161 EYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred cccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999876 4899999999999999999999999988877766555433 234455688999999999999999999
Q ss_pred cCHH----HHHhChhccccc
Q 014610 256 PSAK----ELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~~----elL~hp~~~~~~ 271 (421)
+++. ++++|+||....
T Consensus 239 ~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 239 LGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCCCCHHHHhcCcccCCCC
Confidence 9875 899999997654
No 93
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=8e-48 Score=383.25 Aligned_cols=261 Identities=27% Similarity=0.488 Sum_probs=220.8
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
...++|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34589999999999999999999999999999999986432 2233456789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
+|||||+||+|.++++. ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++........
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999999999999976 5689999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccCccccCcccccCcC---CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCC--chHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQL--DEHFSRLM 240 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l 240 (421)
.....+||+.|+|||++.+.. .++.++|||||||++|||++|.+||...+.......+.... ...+ ...++..+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 224568999999999987532 37789999999999999999999999888766666554322 1112 23678999
Q ss_pred HHHHHHHcccCCCC--CcCHHHHHhChhccccc
Q 014610 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (421)
Q Consensus 241 ~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~ 271 (421)
+++|.+||..++.+ |++++++++|+||++..
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 99999999844433 78999999999998753
No 94
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=4.8e-48 Score=377.93 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=215.0
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHH-HHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||+||+|.+..+|+.||||++.... .......+..|.. +++.++||||+++++++..++.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 2223345555655 57789999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|..++.+.+++++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333334568999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+..... .+...++..+.++|.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 161 EYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred hhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCHHhc
Confidence 99999999876 489999999999999999999999998877766665554332 3344578899999999999999999
Q ss_pred cCH----HHHHhChhccccc
Q 014610 256 PSA----KELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~----~elL~hp~~~~~~ 271 (421)
|++ .++++||||....
T Consensus 239 ~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 239 LGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 976 6999999998654
No 95
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=4.1e-48 Score=377.68 Aligned_cols=251 Identities=29% Similarity=0.427 Sum_probs=215.4
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHH-HHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
++||+|+||.||+|++..+|+.||||++..... ......+.+|+. +++.++||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999865431 223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
|+|...+...+.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875433333344578999
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
.|+|||++.+. .++.++|||||||++|||++|.+||...+.......+... +..++...+..+.++|.+||++||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 161 EYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred ccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 99999999765 4899999999999999999999999988776666655443 334555678899999999999999999
Q ss_pred cCH----HHHHhChhccccc
Q 014610 256 PSA----KELLRHRFIRNAR 271 (421)
Q Consensus 256 pt~----~elL~hp~~~~~~ 271 (421)
+++ .++++|+||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 239 LGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCCHHHHhCCCCcCCCC
Confidence 875 5999999998654
No 96
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.2e-47 Score=395.03 Aligned_cols=263 Identities=29% Similarity=0.434 Sum_probs=228.7
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT- 84 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 84 (421)
......++|++.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 44556789999999999999999999999999999999987654 3455677889999999999999999998776432
Q ss_pred -------EEEEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEe
Q 014610 85 -------KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (421)
Q Consensus 85 -------~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~ 153 (421)
.+++||||+++|+|.++++. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 37899999999999998864 3579999999999999999999999999999999999999999999999
Q ss_pred ecccccccccc--cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC
Q 014610 154 DFGVSAQLTRT--ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ 231 (421)
Q Consensus 154 DFGla~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 231 (421)
|||++...... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+.......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99998765432 1223457899999999999876 48999999999999999999999999888777776666555556
Q ss_pred CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 232 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
++..++.++.++|.+||..||.+||++.++++|||++..
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 677789999999999999999999999999999998753
No 97
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=2e-47 Score=363.70 Aligned_cols=259 Identities=72% Similarity=1.184 Sum_probs=232.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++..+..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999997765555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
+.+++|.+++... ++++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 9999999999864 899999999999999999999999999999999999999999999999999987765434445567
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchH-HHHHHHHHHHHHcccC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKV 251 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~l~~li~~~L~~d 251 (421)
|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....++.+... ++..+.++|.+||..+
T Consensus 160 ~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 160 GTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred CCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence 999999999998765 89999999999999999999999988777766666666655555555 8899999999999999
Q ss_pred CCCCcCHHHHHhChhcccccCC
Q 014610 252 PAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 252 P~~Rpt~~elL~hp~~~~~~~~ 273 (421)
|++|||++++++||||.+....
T Consensus 239 p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred hhhCcCHHHHhhChhhcCCCcc
Confidence 9999999999999999887655
No 98
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=1.2e-47 Score=376.13 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=217.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||+||+|.+..+++.||||++.+.. .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986432 2234566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cc
Q 014610 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~ 168 (421)
||+.||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999876543222 12
Q ss_pred cccccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----CCCCchHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l 240 (421)
...+||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+....+.... .+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23579999999999863 2346789999999999999999999998877666554443221 112223478899
Q ss_pred HHHHHHHcccCCCC--CcCHHHHHhChhccccc
Q 014610 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (421)
Q Consensus 241 ~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~ 271 (421)
++||.+||..++.+ |+++.++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99999998764443 78999999999997654
No 99
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=2.4e-47 Score=391.80 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=224.6
Q ss_pred CCCceeeceEeecCceEEEEEEECCC-CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+|+.++|||||++++++..++.+||||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 44599999999999999999999887 7889999875443 344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||++||+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999987743 45799999999999999999999999999999999999999999999999999986543221
Q ss_pred --cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 167 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+........+..++..+++||
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 23456799999999999775 489999999999999999999999998887776666655555555667889999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+||.+||++||++.++|.|+|++..
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999753
No 100
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=1.3e-47 Score=367.82 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=205.7
Q ss_pred CCceeeceEeecCceEEEEEEECC-CCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcC---CCCCeeEEEEEEEe-----
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEES-EDEIEDIQKEISVLSQC---RSPYITEYYGSYLH----- 82 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~----- 82 (421)
.+|++++.||+|+||+||+|.+.. +|+.||||++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 478999999865432 22234556777777765 69999999998853
Q ss_pred CCEEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999996 6999988653 4589999999999999999999999999999999999999999999999999876
Q ss_pred cccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC------------
Q 014610 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN------------ 228 (421)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~------------ 228 (421)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+....
T Consensus 160 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 160 YSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred ccCC-cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 5432 233456799999999999765 48999999999999999999999999877655443332100
Q ss_pred ----------CC----CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 229 ----------PP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 229 ----------~~----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+. .+...++..+++||.+||+.||++|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 00 0112356788999999999999999999999999997
No 101
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=1.5e-47 Score=381.34 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=216.7
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-----EEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 87 (421)
+|++++.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999999999999986432 2334567889999999999999999999998876 799
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999995 68999988888999999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC--------------------
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------------- 226 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~-------------------- 226 (421)
......+|+.|+|||++.+...++.++|||||||++|||++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 123357899999999998765688999999999999999999999988776544332211
Q ss_pred -----CCCC------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 227 -----ENPP------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 227 -----~~~~------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..++ .+....+.++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0011 11223477899999999999999999999999999998753
No 102
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=6.4e-47 Score=361.11 Aligned_cols=264 Identities=64% Similarity=1.094 Sum_probs=234.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.+.|+.++.||.|+||.||+|.+..++..||||++...........+.+|+.+++++.||||+++++++.++...|+|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45789999999999999999999999999999998876666667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+++++|.+++.. +++++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.............
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 9999999999876 679999999999999999999999999999999999999999999999999987664433333445
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
.++..|+|||++.+.. ++.++|+|||||++|+|++|.+||...........+....++.+...++..+.+||.+||..+
T Consensus 162 ~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 162 VGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred cCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence 7899999999987654 789999999999999999999999988877766666666666777788999999999999999
Q ss_pred CCCCcCHHHHHhChhcccccCChhHH
Q 014610 252 PAERPSAKELLRHRFIRNARKSPRLL 277 (421)
Q Consensus 252 P~~Rpt~~elL~hp~~~~~~~~~~~~ 277 (421)
|++||++.++++|+||.+.......+
T Consensus 241 p~~Rp~~~~il~~~~~~~~~~~~~~~ 266 (277)
T cd06640 241 PSFRPTAKELLKHKFIVKNAKKTSYL 266 (277)
T ss_pred cccCcCHHHHHhChHhhhcchhhhHH
Confidence 99999999999999998766544433
No 103
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=2.5e-47 Score=374.06 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=219.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||.||+++++.+++.||+|++.+.. .......+..|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986432 2233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cc
Q 014610 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~ 168 (421)
||+.+|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999875533222 22
Q ss_pred cccccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----CCCCchHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l 240 (421)
...+||+.|+|||++.. ...++.++|||||||++|||++|+.||...+.......+.... .+.....++.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34579999999999863 2347889999999999999999999999888777666554332 122234578999
Q ss_pred HHHHHHHcccCCCC--CcCHHHHHhChhccccc
Q 014610 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (421)
Q Consensus 241 ~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~ 271 (421)
++||.+||+.++.+ |+++.++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99999999765444 68999999999998764
No 104
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=3.4e-47 Score=363.15 Aligned_cols=263 Identities=45% Similarity=0.821 Sum_probs=228.1
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++++.||.|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++.+..+...|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 457899999999999999999999999999999998654 3445677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 91 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
||+++++|.+++.+ ..++++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 99999999999876 35799999999999999999999999999999999999999999999999999876554444445
Q ss_pred ccccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--chHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEF 243 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~l 243 (421)
...|++.|+|||++.. ...++.++|+|||||++|+|++|.+||...+.......+....++.+ +..++..+.++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 5679999999999752 22367789999999999999999999998877666665555443322 44678899999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhcccccCCh
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 274 (421)
|.+||..+|.+||++.++|+||||.+.....
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNK 272 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhcccchhH
Confidence 9999999999999999999999998765443
No 105
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=3e-47 Score=365.34 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=216.9
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
+|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999865432 2223556789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence 99999999888543 46999999999999999999999999999999999999999999999999998765322 1223
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHh---hccCCCCCCCchHHHHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---IIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
..+|++.|+|||++.+. .++.++||||+||++|+|++|..||...+...... .........++..++..+.+||.+
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 160 GRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred cccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 45799999999999765 48899999999999999999999998765432221 111222334455688999999999
Q ss_pred HcccCCCCCc-----CHHHHHhChhccccc
Q 014610 247 CLKKVPAERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 247 ~L~~dP~~Rp-----t~~elL~hp~~~~~~ 271 (421)
||..||.+|| +++++++||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 9999999999 999999999998653
No 106
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=8.2e-47 Score=356.60 Aligned_cols=254 Identities=39% Similarity=0.695 Sum_probs=221.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC----HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
+.|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++..+..+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999999999999999865432 2235678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987553321111
Q ss_pred ---cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc-CCCCCCCchHHHHHHHHHH
Q 014610 169 ---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 169 ---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~li 244 (421)
....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+. ......++..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 2456889999999998764 8899999999999999999999998876655544332 2233455667889999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.+||.++|.+|||+.++|+|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
No 107
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=1.1e-46 Score=354.00 Aligned_cols=253 Identities=34% Similarity=0.597 Sum_probs=225.9
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5889999999999999999999999999999986543 344567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999763 67999999999999999999999999999999999999999999999999998766544333445
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.......+.....+.+...++..+.++|.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 161 IVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred cccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 67999999999998764 88999999999999999999999998887776666666666666667889999999999999
Q ss_pred CCCCCcCHHHHHhChhc
Q 014610 251 VPAERPSAKELLRHRFI 267 (421)
Q Consensus 251 dP~~Rpt~~elL~hp~~ 267 (421)
+|++||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999985
No 108
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=3.7e-47 Score=367.25 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=216.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
-++|++++.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 36899999999999999999999999999999998765544444567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++............
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 996 589888765 457899999999999999999999999999999999999999999999999998765433333334
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---C------------------CC
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---E------------------NP 229 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~------------------~~ 229 (421)
..+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+.. . ..
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 56899999999987665678899999999999999999999987765433321110 0 00
Q ss_pred CC--------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 230 PQ--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 230 ~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+. ....++..+++||.+||+.||.+|||++|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 112457789999999999999999999999999999754
No 109
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=1.5e-46 Score=361.18 Aligned_cols=267 Identities=45% Similarity=0.792 Sum_probs=227.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.+.|++++.||.|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 47899999999999999999999999999999998654 34456778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+++++|..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 9999999988754 467899999999999999999999999999999999999999999999999998765443333445
Q ss_pred cccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCC--CCchHHHHHHHHHH
Q 014610 171 FVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFV 244 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li 244 (421)
..|++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+.....+ ..+..++..+.++|
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFL 249 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHH
Confidence 678999999999852 223678899999999999999999999887766555544433322 22446788999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccccCChhHHHH
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~ 279 (421)
.+||..+|++||+++++++||||......+.....
T Consensus 250 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~ 284 (292)
T cd06644 250 KTALDKHPETRPSAAQLLEHPFVSSVTSNRPLREL 284 (292)
T ss_pred HHHhcCCcccCcCHHHHhcCccccccccchhHHHH
Confidence 99999999999999999999999887666544333
No 110
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=9e-47 Score=373.92 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=209.5
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC----
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 84 (421)
...++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 56789999999999999999999999999999999986543 3344567889999999999999999999987543
Q ss_pred --EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccc
Q 014610 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (421)
Q Consensus 85 --~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~ 162 (421)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 6766664 358899999999999999999999999999999999999999999999999987543
Q ss_pred cccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC----------------
Q 014610 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (421)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---------------- 226 (421)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+..
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 22 222346799999999999876 489999999999999999999999987664332211100
Q ss_pred ------CCC--C-----------------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 227 ------ENP--P-----------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 227 ------~~~--~-----------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
..+ + ......+..+++||.+||..||++|||+.|+|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 0 001123567899999999999999999999999999975
No 111
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=1.6e-46 Score=353.42 Aligned_cols=253 Identities=30% Similarity=0.549 Sum_probs=221.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe-CCEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIME 91 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E 91 (421)
.|++++.||+|++|.||+|.+..+++.||+|.+.... .....+.+.+|+.++++++||||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999999999999999986544 33445678899999999999999999998764 446899999
Q ss_pred cCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+++++|.+++.. ...+++.++..++.|++.||++||++|++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999999875 35689999999999999999999999999999999999999999999999999876644333344
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
...|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.....+.++..++..+.+||.+||.
T Consensus 161 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence 567899999999998764 7889999999999999999999998877666555555555555666788999999999999
Q ss_pred cCCCCCcCHHHHHhChhc
Q 014610 250 KVPAERPSAKELLRHRFI 267 (421)
Q Consensus 250 ~dP~~Rpt~~elL~hp~~ 267 (421)
.+|.+|||+.++++||||
T Consensus 240 ~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 240 KRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999997
No 112
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=5e-47 Score=371.76 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=218.4
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986532 2233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cc
Q 014610 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~ 168 (421)
||+.||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999976 46899999999999999999999999999999999999999999999999999876543322 12
Q ss_pred cccccCccccCcccccCc----CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----CCCCchHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l 240 (421)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+.......+.... .+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 245799999999998652 247889999999999999999999999887766655553321 122223468899
Q ss_pred HHHHHHHcccCCCC--CcCHHHHHhChhccccc
Q 014610 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (421)
Q Consensus 241 ~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~ 271 (421)
+++|.+||+.++.+ |++++++++||||+...
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99999999876544 56999999999998654
No 113
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1.7e-47 Score=360.22 Aligned_cols=253 Identities=41% Similarity=0.680 Sum_probs=214.3
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHH-HHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
|++.+.||+|+||+||+|.+..+++.||+|++......... ....+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999877643332 34466999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccccc
Q 014610 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (421)
Q Consensus 94 ~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g 173 (421)
.+++|.+++...+.+++..+..++.||+.||++||++|++|+||||+|||++.++.++|+|||.+..............+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999987789999999999999999999999999999999999999999999999999998754333334456789
Q ss_pred CccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC------CCCchHHHHHHHHHHHHH
Q 014610 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP------PQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~~~~~s~~l~~li~~~ 247 (421)
++.|+|||++.....++.++||||||+++|+|++|..||...........+..... .......+..+.++|.+|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 99999999987334588999999999999999999999998743222222211100 000111247899999999
Q ss_pred cccCCCCCcCHHHHHhChhc
Q 014610 248 LKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~hp~~ 267 (421)
|..||++|||+.++++||||
T Consensus 241 l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTTHHHHHTSGGG
T ss_pred ccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999997
No 114
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=4.9e-47 Score=372.44 Aligned_cols=252 Identities=24% Similarity=0.435 Sum_probs=208.4
Q ss_pred hCCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC-
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ- 83 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~- 83 (421)
..++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4579999999999999999999752 346789999987655555567889999999999 899999999988764
Q ss_pred CEEEEEEecCCCCCHHHHHHcC----------------------------------------------------------
Q 014610 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------- 105 (421)
..+++|||||++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--cccccccCccccC
Q 014610 106 ----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMA 179 (421)
Q Consensus 106 ----~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~a 179 (421)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2478889999999999999999999999999999999999999999999999976532211 1223456788999
Q ss_pred cccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHH-HHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcC
Q 014610 180 PEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMR-VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPS 257 (421)
Q Consensus 180 PE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt 257 (421)
||++.+. .++.++|||||||+||||++ |..||....... ....+........+..++..+.++|.+||..||.+|||
T Consensus 245 PE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 245 PESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred cHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999775 48999999999999999997 999998755332 22333333334445567889999999999999999999
Q ss_pred HHHHHh
Q 014610 258 AKELLR 263 (421)
Q Consensus 258 ~~elL~ 263 (421)
+.++++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 999986
No 115
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=2.7e-47 Score=363.51 Aligned_cols=265 Identities=65% Similarity=1.085 Sum_probs=232.0
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.+.|+.++.||+|+||.||+|.+..+++.||+|.++..........+.+|+.++++++||||+++++++..+...|+|||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 45688999999999999999999999999999998766655566789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+++++|.+++.. +++++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 9999999999865 679999999999999999999999999999999999999999999999999987665433333445
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
.|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+....++.+...++..+.++|.+||..+
T Consensus 162 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06642 162 VGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240 (277)
T ss_pred cCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 789999999999776 4789999999999999999999999877766666555555555666677889999999999999
Q ss_pred CCCCcCHHHHHhChhcccccCChhHHH
Q 014610 252 PAERPSAKELLRHRFIRNARKSPRLLE 278 (421)
Q Consensus 252 P~~Rpt~~elL~hp~~~~~~~~~~~~~ 278 (421)
|++|||+.++++||||.........+.
T Consensus 241 p~~Rp~~~~il~~~~~~~~~~~~~~~~ 267 (277)
T cd06642 241 PRFRPTAKELLKHKFITRYTKKTSFLT 267 (277)
T ss_pred cccCcCHHHHHHhHHHHHHhhhHHHHH
Confidence 999999999999999987665544333
No 116
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=3.4e-47 Score=374.43 Aligned_cols=259 Identities=23% Similarity=0.436 Sum_probs=214.0
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-- 83 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 83 (421)
..-.+.++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|++++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 344567899999999999999999999999999999999865432 23345677899999999999999999988643
Q ss_pred ----CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 84 ----TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 84 ----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
...|+++|++ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 3579999998 7899988864 679999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---CC--------
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---EN-------- 228 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~~-------- 228 (421)
.... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...+.......+.. ..
T Consensus 167 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 167 QADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred ecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 6543 234568999999999997755688999999999999999999999987655433322210 00
Q ss_pred -----------CCCC--------chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 229 -----------PPQL--------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 229 -----------~~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+.. ....++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000 01235568899999999999999999999999999754
No 117
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=1.9e-46 Score=354.31 Aligned_cols=255 Identities=48% Similarity=0.901 Sum_probs=222.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||.|+||+||+|.+..++..||+|++...........+.+|+.+++.++|+||+++++.+..++..|+|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999999999999999997665555678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc--
Q 014610 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (421)
Q Consensus 93 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-- 167 (421)
+++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999764 45899999999999999999999999999999999999999999999999998766543222
Q ss_pred --ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCc-----hHHHHHH
Q 014610 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-----EHFSRLM 240 (421)
Q Consensus 168 --~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----~~~s~~l 240 (421)
.....|++.|+|||++.....++.++|+|||||++|+|++|+.||...+.......+....++.+. ..++..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 234578999999999876645889999999999999999999999887766555444433333222 2567899
Q ss_pred HHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.+||.+||.+||++|||+.+|++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
No 118
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=2.4e-46 Score=363.15 Aligned_cols=255 Identities=36% Similarity=0.634 Sum_probs=218.6
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||+|+||.||+|.+..++..||+|.+...........+.+|++++++++||||+++++++..++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999999999999999987655555567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
+++++|.+++++.+++++..+..++.||+.||.|||+ ++++||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 158 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF 158 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccC
Confidence 9999999999888889999999999999999999997 59999999999999999999999999998655332 22456
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC------------------------
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------------ 227 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------------------ 227 (421)
+|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 899999999998765 4889999999999999999999999765543332222110
Q ss_pred ------------CCCCCc-hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 228 ------------NPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 228 ------------~~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.++..+ ..++.++++||.+||..+|++|||+.++++||||.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 1357789999999999999999999999999999764
No 119
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=2.7e-46 Score=356.25 Aligned_cols=258 Identities=51% Similarity=0.960 Sum_probs=227.2
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC---CCCeeEEEEEEEeCCEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 90 (421)
.|++++.||.|+||.||+|.+..+++.||+|.++..........+.+|+.++++++ ||||+++++++..+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999999876655556678889999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+.+++|.++++. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 99999999999976 58999999999999999999999999999999999999999999999999998776554434445
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCch-HHHHHHHHHHHHHcc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCLK 249 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~l~~li~~~L~ 249 (421)
..|++.|+|||.+.+...++.++|+|||||++|+|++|..||...........+....++.+.. .++.++.+|+.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcC
Confidence 6799999999998765557889999999999999999999998877766655554444444444 378899999999999
Q ss_pred cCCCCCcCHHHHHhChhcccccC
Q 014610 250 KVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 250 ~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
.||++|||+.+++.|+||++...
T Consensus 241 ~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 241 EEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred CCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999987654
No 120
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.4e-46 Score=357.02 Aligned_cols=257 Identities=46% Similarity=0.852 Sum_probs=218.8
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC----
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ---- 83 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~---- 83 (421)
..+++.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++.+...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3578899999999999999999999999999999999865432 335788999999998 699999999998753
Q ss_pred --CEEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 84 --TKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999998753 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC-CCCch
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDE 234 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~ 234 (421)
.............|++.|+|||++.+ ...++.++|||||||++|+|++|..||...........+..... .....
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 65444344456789999999999863 22477899999999999999999999987766555544433322 22234
Q ss_pred HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 235 ~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.++..+.+||.+||..+|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 577899999999999999999999999999997
No 121
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.6e-46 Score=362.51 Aligned_cols=263 Identities=43% Similarity=0.763 Sum_probs=224.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
....+|++++.||+|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3448999999999999999999999999999999998755433 346688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 999999999999975 6789999999999999999999999999999999999999999999999999876544333334
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--CCCCchHHHHHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~li~~~ 247 (421)
...|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.... ....+..++..+++||.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 174 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred cccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 56799999999998765 47899999999999999999999998766544433332222 1223456788899999999
Q ss_pred cccCCCCCcCHHHHHhChhcccccCChh
Q 014610 248 LKKVPAERPSAKELLRHRFIRNARKSPR 275 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~hp~~~~~~~~~~ 275 (421)
|..+|++||++.++++||||+.++....
T Consensus 253 l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 253 LEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred ccCChhhCcCHHHHhcCchhcccccccc
Confidence 9999999999999999999987765544
No 122
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=8.7e-47 Score=361.64 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=204.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcC---CCCCeeEEEEEEEe-----CC
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLH-----QT 84 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~~ 84 (421)
+|++++.||+|+||+||+|.++.+|+.||||.+...... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 699999999999999999999999999999998654322 1223455677777665 79999999998865 34
Q ss_pred EEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~ 162 (421)
.+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5899999996 5898888653 458999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC----------------
Q 014610 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (421)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---------------- 226 (421)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+..
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 160 CQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred Cc-ccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 32 222346789999999999765 489999999999999999999999987765443322210
Q ss_pred --CC-----C---CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 227 --EN-----P---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 227 --~~-----~---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.. + ..+...++..+.++|.+||+.||.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0 00112457789999999999999999999999999998
No 123
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1.1e-46 Score=386.22 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=205.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC------CCeeEEEEEEEeC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS------PYITEYYGSYLHQ 83 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~~~ 83 (421)
...++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++|++++++|..+
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 34688999999999999999999999999999999986432 223455667777777654 5689999988764
Q ss_pred -CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCC-------------
Q 014610 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENG------------- 148 (421)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g------------- 148 (421)
.++|||||++ |++|.+++.+.+++++..+..++.||+.||+|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 77999998887899999999999999999999998 5999999999999998765
Q ss_pred ---CEEEeecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc
Q 014610 149 ---DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225 (421)
Q Consensus 149 ---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~ 225 (421)
.+||+|||++..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||...+..+....+.
T Consensus 283 ~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCceEEECCCCccccCcc---ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 499999998754322 23457899999999999876 48999999999999999999999998776544332221
Q ss_pred CC---CC-----------------------CCC-ch--------------HHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 226 RE---NP-----------------------PQL-DE--------------HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 226 ~~---~~-----------------------~~~-~~--------------~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.. .+ +.. +. ..+..+.+||.+||++||.+|||++|+|+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 10 00 000 00 113557899999999999999999999999
Q ss_pred hhcccc
Q 014610 265 RFIRNA 270 (421)
Q Consensus 265 p~~~~~ 270 (421)
|||...
T Consensus 439 p~~~~~ 444 (467)
T PTZ00284 439 PYVLKY 444 (467)
T ss_pred cccccc
Confidence 999753
No 124
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=2.5e-46 Score=359.59 Aligned_cols=255 Identities=28% Similarity=0.525 Sum_probs=225.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999986543 2234577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|.||||+.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765433 345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
.+|++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.... ..++..++..++++|.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 158 LCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-VRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-ccCCccCCHHHHHHHHHHccC
Confidence 6799999999998765 47889999999999999999999998877655555554333 345556789999999999999
Q ss_pred CCCCCc-----CHHHHHhChhcccccC
Q 014610 251 VPAERP-----SAKELLRHRFIRNARK 272 (421)
Q Consensus 251 dP~~Rp-----t~~elL~hp~~~~~~~ 272 (421)
||.+|+ +++++++||||....+
T Consensus 236 ~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred CHHHccCcccCCHHHHHcCcccccCCH
Confidence 999999 9999999999987653
No 125
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=2.1e-46 Score=355.10 Aligned_cols=257 Identities=48% Similarity=0.903 Sum_probs=218.2
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.....+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++..++.+++
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3456789999999999999999999999999999999865432 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||||+++++|.+++....++++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999999877889999999999999999999999999999999999999999999999999987664433334
Q ss_pred cccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--CCCC--chHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQL--DEHFSRLMKE 242 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~s~~l~~ 242 (421)
....|++.|+|||.+.. ...++.++|||||||++|||++|..||...........+.... ++.. ...++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 45679999999998742 2346788999999999999999999997665544333332221 1111 2346789999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChh
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRF 266 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~ 266 (421)
||.+||..+|++|||+++||+|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
No 126
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.3e-46 Score=356.45 Aligned_cols=254 Identities=50% Similarity=0.913 Sum_probs=216.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4689999999999999999999999999999999875543 334567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999987654433333456
Q ss_pred ccCccccCccccc--CcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--CCCC--chHHHHHHHHHHH
Q 014610 172 VGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQL--DEHFSRLMKEFVS 245 (421)
Q Consensus 172 ~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~s~~l~~li~ 245 (421)
.|++.|+|||++. ....++.++|+|||||++|+|++|..||................ ++.. ...++..+.+||.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 8999999999874 22347889999999999999999999997665544333222111 1111 1246788999999
Q ss_pred HHcccCCCCCcCHHHHHhChh
Q 014610 246 LCLKKVPAERPSAKELLRHRF 266 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~ 266 (421)
+||..+|++|||++++++|||
T Consensus 247 ~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 247 MALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999998
No 127
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=2e-46 Score=358.25 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=216.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999999999999999865432 2233567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+++++|..++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99999999888777789999999999999999999999999999999999999999999999999998765543333456
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC----------------------CCC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~----------------------~~~ 229 (421)
.++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.. ..+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 7899999999987655578899999999999999999999987765443322110 000
Q ss_pred C-----C---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 230 P-----Q---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 230 ~-----~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
. . ....++..+.+||.+||..+|++|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 0 012457889999999999999999999999999997
No 128
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=4.3e-46 Score=355.38 Aligned_cols=260 Identities=65% Similarity=1.112 Sum_probs=229.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+-|++++.||.|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++..+...|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45889999999999999999999999999999987666556667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999999875 5789999999999999999999999999999999999999999999999999876544332334567
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
|+..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+....++.+...++..+.++|.+||..+|
T Consensus 163 ~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 163 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 89999999998765 47889999999999999999999998887766666665555566666788999999999999999
Q ss_pred CCCcCHHHHHhChhcccccCCh
Q 014610 253 AERPSAKELLRHRFIRNARKSP 274 (421)
Q Consensus 253 ~~Rpt~~elL~hp~~~~~~~~~ 274 (421)
.+||++.++++||||.+.....
T Consensus 242 ~~Rp~~~~~l~~~~~~~~~~~~ 263 (277)
T cd06641 242 SFRPTAKELLKHKFIVRFAKKT 263 (277)
T ss_pred hhCcCHHHHHhCHHHhhhhhcc
Confidence 9999999999999998765443
No 129
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=2.2e-46 Score=359.38 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=215.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++++++|+||+++++.+.+++.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999865432 2234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cccc
Confidence 99999999988543 46999999999999999999999999999999999999999999999999998654322 1223
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---RVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
..+|++.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+........+..++..+++||.+
T Consensus 160 ~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 160 GRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 457999999999998764 899999999999999999999999865321 1222222222223445678899999999
Q ss_pred HcccCCCCCcC-----HHHHHhChhcccc
Q 014610 247 CLKKVPAERPS-----AKELLRHRFIRNA 270 (421)
Q Consensus 247 ~L~~dP~~Rpt-----~~elL~hp~~~~~ 270 (421)
||+.||++||| +.|+++||||+..
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999 9999999999864
No 130
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=4.9e-46 Score=358.90 Aligned_cols=258 Identities=43% Similarity=0.787 Sum_probs=222.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
...+|++++.||+|+||.||+|++..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 447999999999999999999999999999999998765443 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+++++|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.++.++|+|||++............
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 99999999999865 57899999999999999999999999999999999999999999999999998765433333344
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--CCCCchHHHHHHHHHHHHHc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~li~~~L 248 (421)
..|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+.... ....+..++..+.++|.+||
T Consensus 176 ~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred ccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 6799999999998765 47899999999999999999999998776654433332222 12234567888999999999
Q ss_pred ccCCCCCcCHHHHHhChhccccc
Q 014610 249 KKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..+|++|||+.++++||||....
T Consensus 255 ~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 255 DMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCCcccCcCHHHHhhChhhhccC
Confidence 99999999999999999998654
No 131
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=1.7e-46 Score=371.29 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=210.8
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC----
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ---- 83 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---- 83 (421)
....++|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 356789999999999999999999999999999999986543 334456788999999999999999999988654
Q ss_pred --CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 84 --TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999965 67777643 5889999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC--------------
Q 014610 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-------------- 227 (421)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~-------------- 227 (421)
... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCc-cccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 332 222356899999999999776 4899999999999999999999999876643332211000
Q ss_pred --------CC-------------------CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 228 --------NP-------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 228 --------~~-------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+ .......+..+++||.+||..||++|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 00011235678999999999999999999999999999744
No 132
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=3.7e-46 Score=353.15 Aligned_cols=253 Identities=36% Similarity=0.685 Sum_probs=221.2
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH--------HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--------DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999999999999999988654321 224678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
.++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987664211
Q ss_pred ------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHH
Q 014610 166 ------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (421)
Q Consensus 166 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 239 (421)
.......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.....+.++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 111235689999999998765 4788999999999999999999999987776665555445455566678899
Q ss_pred HHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 240 MKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 240 l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+.++|.+||+.+|.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 133
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=2.1e-46 Score=358.22 Aligned_cols=253 Identities=29% Similarity=0.468 Sum_probs=211.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++++.||.|++|.||+|.+..+|+.||||.+..... ......+.+|+.++++++||||+++++++.++..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999865432 22346678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 93 MAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 93 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
+. ++|.+++.. +..+++..++.++.||+.||+|||++|++||||||+|||++.+|.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 689888754 25689999999999999999999999999999999999999999999999999876543333333
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC-----------------------
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------- 226 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~----------------------- 226 (421)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||...........+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 456899999999987665578899999999999999999999987654332221100
Q ss_pred --CCC---CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 227 --ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 227 --~~~---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
... ......++.++.++|.+||..||.+|||+.+|+.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 00112367889999999999999999999999999997
No 134
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=6.4e-46 Score=350.08 Aligned_cols=254 Identities=55% Similarity=0.974 Sum_probs=221.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.++++++||||+++++++..+..+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 47899999999999999999999999999999998765433 56788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+++++|.+++... .++++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999999775 78999999999999999999999999999999999999999999999999998766544334445
Q ss_pred cccCccccCcccccCc--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC--CCC--CCchHHHHHHHHHH
Q 014610 171 FVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NPP--QLDEHFSRLMKEFV 244 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~--~~~--~~~~~~s~~l~~li 244 (421)
..|+..|+|||++.+. ..++.++|+|||||++|+|++|.+||...+.......+... .+. .....++.++.+||
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 6899999999998654 14788999999999999999999999988766655444333 111 12345678899999
Q ss_pred HHHcccCCCCCcCHHHHHhChh
Q 014610 245 SLCLKKVPAERPSAKELLRHRF 266 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~ 266 (421)
.+||..+|..|||+.+++.|+|
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
No 135
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.2e-46 Score=371.81 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=211.6
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC----
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ---- 83 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---- 83 (421)
....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 345789999999999999999999999999999999986543 233456788999999999999999999987643
Q ss_pred --CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 84 --TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999964 78777753 5889999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC------------
Q 014610 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP------------ 229 (421)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~------------ 229 (421)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....
T Consensus 177 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCC-CcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 332 122346799999999999876 489999999999999999999999987766544333211000
Q ss_pred ---------C--------------------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 230 ---------P--------------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 230 ---------~--------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+ ......+..+++||.+||+.||.+|||+.|+|+||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 0011124578999999999999999999999999999743
No 136
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=5.6e-46 Score=355.34 Aligned_cols=259 Identities=44% Similarity=0.783 Sum_probs=222.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+-|++++.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++..++..|+|+||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 44789999999999999999999999999999986543 34567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 93 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
+.+++|..++.+ ..++++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.............
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 999999998754 4679999999999999999999999999999999999999999999999999987654433334456
Q ss_pred ccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCC--CCchHHHHHHHHHHH
Q 014610 172 VGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVS 245 (421)
Q Consensus 172 ~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~ 245 (421)
.|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+....++ ..+..++..+++||.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 79999999999842 234678999999999999999999999888776655554433222 234467889999999
Q ss_pred HHcccCCCCCcCHHHHHhChhcccccC
Q 014610 246 LCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
+||..+|.+|||+.++++||||+....
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHccCChhhCcCHHHHhcCCCEeccCC
Confidence 999999999999999999999986543
No 137
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=4.1e-46 Score=364.51 Aligned_cols=256 Identities=32% Similarity=0.577 Sum_probs=209.3
Q ss_pred eeeceEeec--CceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 16 SSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 16 ~~~~~LG~G--~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+++++||+| +|++||++.++.+|+.||||.++.... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 367899999 789999999999999999999976543 34456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc---
Q 014610 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--- 167 (421)
Q Consensus 93 ~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~--- 167 (421)
+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999965 346899999999999999999999999999999999999999999999999875433221111
Q ss_pred ----ccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC-------------
Q 014610 168 ----RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP------------- 229 (421)
Q Consensus 168 ----~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~------------- 229 (421)
.....++..|+|||++.+. ..++.++|||||||++|||++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1123577889999998753 3588999999999999999999999986544332211111000
Q ss_pred --------------------------------CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 230 --------------------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 230 --------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
......++..+.+||.+||+.||++|||++|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 001223567899999999999999999999999999998754
No 138
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1e-45 Score=347.91 Aligned_cols=253 Identities=32% Similarity=0.558 Sum_probs=225.0
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++++.||.|+||.||.+.+..+++.|++|.+.... .......+.+|+.++++++|+||+++++++...+.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999987654 344567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 56899999999999999999999999999999999999999999999999998766544333345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
..|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+...........++..+.++|.+||.+
T Consensus 161 ~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 67999999999987764 78899999999999999999999988877776666655555555566789999999999999
Q ss_pred CCCCCcCHHHHHhChhc
Q 014610 251 VPAERPSAKELLRHRFI 267 (421)
Q Consensus 251 dP~~Rpt~~elL~hp~~ 267 (421)
+|.+||++.++|+|+|+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999986
No 139
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.6e-48 Score=400.99 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=229.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
.++|+++++||+|+||.|..++.+.|++.||+|++++-. ......-|+.|..+|...+.+.|+.++..|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 479999999999999999999999999999999987632 122346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-ccc
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-~~~ 168 (421)
|||+.||+|-.++.+..+++|..+++|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+..+...+ ...
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9999999999999988899999999999999999999999999999999999999999999999999887776433 344
Q ss_pred cccccCccccCcccccCc----CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-CCCCCc--hHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLD--EHFSRLMK 241 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~--~~~s~~l~ 241 (421)
...+|||-|.+||+++.. ..|+..+|+||+||++|||+.|..||...+-.+.+.+|..- ....+| ..+|.+++
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 567899999999999632 34789999999999999999999999999998888887653 222333 45899999
Q ss_pred HHHHHHcccCCCCCcC---HHHHHhChhcccccC
Q 014610 242 EFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt---~~elL~hp~~~~~~~ 272 (421)
+||.++++ +|+.|.. ++++..||||....+
T Consensus 314 dLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 314 DLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 99999985 5799988 999999999998866
No 140
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=2.7e-46 Score=357.19 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=207.2
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||+|+||.||++.++.+|+.||+|.+..... ......+..|+.++++++||||+++++++..+..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864321 22234566799999999999999999999999999999999999999
Q ss_pred HHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcc
Q 014610 99 ADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (421)
Q Consensus 99 ~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~ 176 (421)
.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 9888543 358999999999999999999999999999999999999999999999999987654321 2234579999
Q ss_pred ccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 177 y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+...........++.+++++|.+||++||
T Consensus 160 y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 99999998765 89999999999999999999999976432 22222222222222234678999999999999999
Q ss_pred CCCcCH----HHHHhChhcccc
Q 014610 253 AERPSA----KELLRHRFIRNA 270 (421)
Q Consensus 253 ~~Rpt~----~elL~hp~~~~~ 270 (421)
.+||++ .+++.|+||+..
T Consensus 239 ~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 239 EDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hhCCCCccchhhhhcChhhcCC
Confidence 999999 678899999865
No 141
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=7.5e-46 Score=354.26 Aligned_cols=253 Identities=35% Similarity=0.658 Sum_probs=215.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|+++++||+|+||.||+|++..+++.||||++...........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46899999999999999999999999999999987665555567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... .....+
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYV 154 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCC
Confidence 999999765 35789999999999999999999999999999999999999999999999998765432 233568
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHhhccCCCCCCC-chHHHHHHHHHH
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-------MRVLFIIPRENPPQL-DEHFSRLMKEFV 244 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~-~~~~s~~l~~li 244 (421)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+....++.+ ...++.++++||
T Consensus 155 ~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 999999999998764 88999999999999999999999965322 122222222222222 234678899999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
.+||..+|++||+++++++||||.....
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCcccccccC
Confidence 9999999999999999999999986543
No 142
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=7.7e-46 Score=348.80 Aligned_cols=250 Identities=31% Similarity=0.550 Sum_probs=222.7
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
+|++.+.||.|+||.||++.+..+++.||+|.++........+.+.+|+.++++++||||+++++.+..++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999999876655556788899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 94 AGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 94 ~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 99999998864 3568999999999999999999999999999999999999999999999999987665443334456
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
.|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.......++..++..+.+||.+||..|
T Consensus 161 ~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 161 VGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 7999999999987764 889999999999999999999999988776666666555555566678889999999999999
Q ss_pred CCCCcCHHHHHhC
Q 014610 252 PAERPSAKELLRH 264 (421)
Q Consensus 252 P~~Rpt~~elL~h 264 (421)
|++|||+.+++.-
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999863
No 143
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=7.9e-46 Score=357.58 Aligned_cols=257 Identities=42% Similarity=0.764 Sum_probs=222.8
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|++.+.||.|++|.||+|++..+|+.||||.+...... ....+.+|+.+++.++||||+++++.+..++.+|+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 35799999999999999999999999999999998654432 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+.+++|..++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.............
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9999999999875 579999999999999999999999999999999999999999999999999987654433333446
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--CCCCchHHHHHHHHHHHHHcc
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~li~~~L~ 249 (421)
.|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+.... ....+..++..+.+||.+||.
T Consensus 176 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (296)
T cd06655 176 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254 (296)
T ss_pred CCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence 789999999998765 47899999999999999999999998877655544433222 222345678899999999999
Q ss_pred cCCCCCcCHHHHHhChhccccc
Q 014610 250 KVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 250 ~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+|.+|||+.+++.||||+.+.
T Consensus 255 ~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 255 MDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999998654
No 144
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-47 Score=366.81 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=230.0
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
+....+.|+.-++||+|+||.||-++.+.||+-||+|.+.+... .........|..||.+++.++||.+-..|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45556789999999999999999999999999999998865432 2334567789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~ 163 (421)
+|+|+..|+||+|.-+|-..+ .++|..+..++.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998886644 799999999999999999999999999999999999999999999999999987765
Q ss_pred ccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHhhccCCCCCCCchHHHHHH
Q 014610 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---MRVLFIIPRENPPQLDEHFSRLM 240 (421)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l 240 (421)
.. .....+||.+|||||++.+.. |+...|+|||||++|||+.|+.||..... .+.+.......+..++..+|+++
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 43 334569999999999999876 99999999999999999999999976533 22333334455667788999999
Q ss_pred HHHHHHHcccCCCCCc-----CHHHHHhChhcccccCC
Q 014610 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNARKS 273 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~~~~ 273 (421)
++|.+.+|++||.+|. +++++.+||||+.+.+.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 9999999999999997 56899999999987543
No 145
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-46 Score=381.09 Aligned_cols=262 Identities=48% Similarity=0.893 Sum_probs=241.2
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEe----
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH---- 82 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---- 82 (421)
.....+.|++.++||.|.+|.||++.++.+|+.+|+|++......+ +.+..|+.||+.+ .|||++.+|++|..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3446789999999999999999999999999999999987665443 6788899999988 59999999999874
Q ss_pred -CCEEEEEEecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 83 -QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
++.+|||||||.||+..|++++ +.++.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 5679999999999999999975 5689999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCccccCcccccCcC----CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--c
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--D 233 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~ 233 (421)
++.....++++.+|||+|||||++...+ .|+.++|+||||++..||..|.+|+.+..++..+..|++.+|+.+ +
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence 9999989999999999999999997543 366789999999999999999999999999999999999999887 5
Q ss_pred hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 234 ~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..++.++.+||..||.+|-++||+..++|+|||+++..
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 68999999999999999999999999999999999655
No 146
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=5.3e-46 Score=356.02 Aligned_cols=258 Identities=33% Similarity=0.643 Sum_probs=222.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++++.||+|+||.||+|++..+|+.||+|.+...........+.+|+.++++++||||+++++.+..++.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999999999999999987655555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 93 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
+++++|..++... ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence 9999999998763 379999999999999999999997 59999999999999999999999999998765332 22
Q ss_pred cccccCccccCcccccCcC-----CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH---hhccCCCCCCCchHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPRENPPQLDEHFSRLM 240 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~s~~l 240 (421)
....|++.|+|||++.+.. .++.++|+|||||++|+|++|..||......... ..+....++.++..++.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 3457899999999985432 2577899999999999999999999765543322 2334445556666789999
Q ss_pred HHHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
.+||.+||..+|.+||++.+++.||||.....
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999999976543
No 147
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=1.1e-45 Score=347.75 Aligned_cols=253 Identities=33% Similarity=0.588 Sum_probs=223.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||+|+||.||++.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999986543 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999998653 36899999999999999999999999999999999999999999999999998765443333334
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+.....+..+..++..+.++|.+||..
T Consensus 161 ~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 56899999999987764 78899999999999999999999988877766666655555556667889999999999999
Q ss_pred CCCCCcCHHHHHhChhc
Q 014610 251 VPAERPSAKELLRHRFI 267 (421)
Q Consensus 251 dP~~Rpt~~elL~hp~~ 267 (421)
+|.+||++.++++||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999997
No 148
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=5.7e-46 Score=396.80 Aligned_cols=265 Identities=29% Similarity=0.493 Sum_probs=220.1
Q ss_pred ccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--
Q 014610 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-- 82 (421)
Q Consensus 6 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-- 82 (421)
.-.+...++|++++.||+|+||+||+|.+..++..||+|++.... .......+..|+.+|++|+|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 345667789999999999999999999999999999999987554 33456778899999999999999999998865
Q ss_pred CCEEEEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCcEEEccC----
Q 014610 83 QTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-------GKIHRDIKAANILLTEN---- 147 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~-------~iiHrDlkp~NILl~~~---- 147 (421)
...+|||||||++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4579999999999999999864 35799999999999999999999984 49999999999999642
Q ss_pred -------------CCEEEeecccccccccccccccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCC
Q 014610 148 -------------GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLA 213 (421)
Q Consensus 148 -------------g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~ 213 (421)
+.+||+|||++...... ......+||+.|+|||++.+. ..++.++||||||||||+|++|..||.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 34899999998765332 222456799999999998643 347889999999999999999999998
Q ss_pred CCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 214 DLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..+....+.......+......++.++.+||..||..+|.+||++.|+|.|+|++...
T Consensus 245 ~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred cCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 7665544433332322222345688999999999999999999999999999998654
No 149
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.6e-46 Score=359.05 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=208.7
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||+|+||.||+|++..+|+.||+|.++.... ......+.+|+.++++++||||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 69999999999999999999999999999999865432 22235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 93 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
++ ++|.+++.. .+.+++..++.++.||++||.|||++|++||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 96 578887754 5679999999999999999999999999999999999999999999999999987654333333345
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHhhcc------------------C-CCCC-
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIP------------------R-ENPP- 230 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~-~~~~~~~~~i~------------------~-~~~~- 230 (421)
.+++.|+|||++.+...++.++|||||||++|+|++|..|+.. .+.......+. . ...+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 7899999999987765678999999999999999999888543 33222211110 0 0000
Q ss_pred --------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 231 --------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 231 --------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.....++.++++||.+||..||.+|||+++++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1112467889999999999999999999999999997
No 150
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=1.4e-45 Score=353.67 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=217.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.|+..+.||+|+||+||+|.+..+++.||+|.+..... ......+.+|+.+|++++|+||+++++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999865432 2234557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+.+++|.+++.. ..++++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence 9999999988854 346999999999999999999999999999999999999999999999999998654322 2223
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc---CCCCCCCchHHHHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~l~~li~~ 246 (421)
...|++.|+|||++.+. .++.++|+|||||++|+|++|..||...........+. ......+...++..+.+|+.+
T Consensus 160 ~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 46799999999999775 48999999999999999999999998766543222221 112223445678889999999
Q ss_pred HcccCCCCCcC-----HHHHHhChhcccccC
Q 014610 247 CLKKVPAERPS-----AKELLRHRFIRNARK 272 (421)
Q Consensus 247 ~L~~dP~~Rpt-----~~elL~hp~~~~~~~ 272 (421)
||..||++||| +.+++.|+||+....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 99999999999 899999999987643
No 151
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.2e-45 Score=346.54 Aligned_cols=257 Identities=40% Similarity=0.712 Sum_probs=227.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||+|++|.||+|.+..+++.||||.+...........+.+|+.++++++||||+++++++.....+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47999999999999999999999999999999987765545568899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
+++++|.+++....++++..+..++.||+.||+|||+ +|++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999887889999999999999999999999 999999999999999999999999999988765443333456
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC---HHHHHhhccCCCCCCCchH-HHHHHHHHHHHH
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENPPQLDEH-FSRLMKEFVSLC 247 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~-~s~~l~~li~~~ 247 (421)
.++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... .......+.....+..+.. ++..+.++|.+|
T Consensus 161 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 789999999998776 58899999999999999999999998773 3444444444444555555 889999999999
Q ss_pred cccCCCCCcCHHHHHhChhcccc
Q 014610 248 LKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
|..+|++|||+.++++|||++..
T Consensus 240 l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 240 LQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999765
No 152
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=2.6e-45 Score=352.27 Aligned_cols=257 Identities=45% Similarity=0.812 Sum_probs=217.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC-----
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ----- 83 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----- 83 (421)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 357899999999999999999999999999999999865432 235678899999999 799999999998753
Q ss_pred CEEEEEEecCCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 84 TKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
...|+||||+++++|.++++ ....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 46899999999999999885 34678999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccccCccccCcccccCcC----CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--c
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--D 233 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~ 233 (421)
.............|++.|+|||++.... .++.++|||||||++|+|++|++||...+.......+....++.+ +
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc
Confidence 6544332334567899999999985432 257899999999999999999999988877666655544433322 3
Q ss_pred hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 234 ~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
..++..+.++|.+||..+|++||++.++++||||+
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 35677899999999999999999999999999984
No 153
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=6.2e-46 Score=361.16 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=194.4
Q ss_pred eceEeecCceEEEEEEEC--CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEEEEEEecC
Q 014610 18 LELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYM 93 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~--~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 93 (421)
.++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|++++||||+++++++.. +..+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999976 4678999999865432 2446789999999999999999999865 45789999999
Q ss_pred CCCCHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----ccCCCEEEeecccccc
Q 014610 94 AGGSVADLIQSG---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSAQ 160 (421)
Q Consensus 94 ~gg~L~~~l~~~---------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl----~~~g~vkL~DFGla~~ 160 (421)
. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 5 5898887531 358999999999999999999999999999999999999 4557899999999976
Q ss_pred cccccc---cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---------HHHhhc---c
Q 014610 161 LTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------RVLFII---P 225 (421)
Q Consensus 161 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~---------~~~~~i---~ 225 (421)
...... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||...... .....+ .
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 543221 2235689999999999987656899999999999999999999999643210 000000 0
Q ss_pred CCC----------CC-----------------CC-------chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 226 REN----------PP-----------------QL-------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 226 ~~~----------~~-----------------~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
... .+ .+ ....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 00 00 00124568899999999999999999999999998
No 154
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=1.2e-45 Score=350.05 Aligned_cols=256 Identities=50% Similarity=0.912 Sum_probs=219.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCC----
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT---- 84 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~---- 84 (421)
...++|++.+.||+|++|.||+|.+..+++.|++|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 456899999999999999999999999999999999875543 346789999999999 7999999999997644
Q ss_pred --EEEEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 85 --KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 85 --~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
.+|+||||+++++|.+++.. +.++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999998864 357999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccCccccCcccccCc----CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCc-
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD- 233 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~- 233 (421)
..............|++.|+|||++... ..++.++|||||||+||+|++|.+||...+.......+.....+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 7655444444566799999999987532 24677899999999999999999999877766666555544433332
Q ss_pred -hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 234 -EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 234 -~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
..++..+++||.+||..||.+|||+.++++|||+
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3477899999999999999999999999999996
No 155
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-47 Score=378.42 Aligned_cols=250 Identities=37% Similarity=0.665 Sum_probs=221.9
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCHH
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVA 99 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~ 99 (421)
+||+|.||+||.|+|..|....|||-++...+ ...+-+..||.+.++|+|.|||+++|++..++.+-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 89999999999999999999999999975543 35678999999999999999999999999999999999999999999
Q ss_pred HHHHc-CCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeecccccccccccccccccccCc
Q 014610 100 DLIQS-GPPL--DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (421)
Q Consensus 100 ~~l~~-~~~l--~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~ 175 (421)
++++. .+|+ +|..+..+.+||++||.|||++.|||||||-+||||+. .|.+||+|||-++.+..-+....++.||.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 99975 4788 89999999999999999999999999999999999975 58999999999998876666667899999
Q ss_pred cccCccccc-CcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHhhcc-CCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 176 FWMAPEVIQ-NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIP-RENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 176 ~y~aPE~~~-~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~-~~~~i~-~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
.|||||++. +..+|+.++|||||||++.||.||++||....... ...++- -..-|.++..++.++++||.+|+.++|
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~ 820 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDP 820 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCc
Confidence 999999996 44579999999999999999999999998765433 333221 123467788999999999999999999
Q ss_pred CCCcCHHHHHhChhcccc
Q 014610 253 AERPSAKELLRHRFIRNA 270 (421)
Q Consensus 253 ~~Rpt~~elL~hp~~~~~ 270 (421)
.+||+|.++|+.||++..
T Consensus 821 ~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 821 CDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ccCccHHHhccCcccccC
Confidence 999999999999999865
No 156
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=8.7e-46 Score=353.80 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=220.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCC-----cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g-----~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
.++|++++.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 358999999999999999999886655 789999987665556667889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCE
Q 014610 87 WIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~v 150 (421)
|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 9999999999999999754 457889999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCC
Q 014610 151 KVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE 227 (421)
Q Consensus 151 kL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~ 227 (421)
+|+|||++....... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999987553321 1123346788999999987654 8999999999999999997 99999988887777777666
Q ss_pred CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 228 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.....+..++.++.+|+.+||..||.+||++.+|+++
T Consensus 243 ~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6666677889999999999999999999999999875
No 157
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=4e-47 Score=346.66 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=214.2
Q ss_pred hCCCceee-ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEe----CC
Q 014610 11 AGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH----QT 84 (421)
Q Consensus 11 ~~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~ 84 (421)
++++|.+- ++||-|-.|+|..+.++.||+.+|+|++... +..++|+++..+. .|||||.++++|.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 56777765 5899999999999999999999999997522 5678899987776 59999999998864 56
Q ss_pred EEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC---CCEEEeeccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSA 159 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~---g~vkL~DFGla~ 159 (421)
++.+|||.++||.|+..+... +.++|.++..|++||+.|+.|||+.+|.||||||+|+|.+.. ..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 789999999999999999765 469999999999999999999999999999999999999754 469999999998
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHhhccCCC---CCCC
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPREN---PPQL 232 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~----~~~~~i~~~~---~~~~ 232 (421)
.-... ....+-|.||+|.|||++-.. .|+..+|+||+||+||.||+|.+||...... .+..+|..+. |..-
T Consensus 213 ~t~~~-~~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 213 ETQEP-GDLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccCCC-ccccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 65543 344577999999999999665 4999999999999999999999999876542 2223443333 3344
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+..+|+.++++|+++|..+|++|.|+.+++.|||+..-
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 56789999999999999999999999999999999753
No 158
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1.3e-45 Score=346.74 Aligned_cols=252 Identities=58% Similarity=0.999 Sum_probs=220.8
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++.+.||.|+||.||+|++..+++.|++|.+.... ..+.+.+|+.++++++||||+++++++..+...|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 478999999999999999999999999999999986543 26789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++............
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9999999999975 467899999999999999999999999999999999999999999999999998876544333345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC--CchHHHHHHHHHHHHHc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~li~~~L 248 (421)
..|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....... .+..++..+.+||.+||
T Consensus 159 ~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 159 VIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred ccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 6689999999998776 48899999999999999999999998876655554443332222 23457789999999999
Q ss_pred ccCCCCCcCHHHHHhChhc
Q 014610 249 KKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~ 267 (421)
..+|.+|||+.|+|+||||
T Consensus 238 ~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 238 VKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
No 159
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=6e-46 Score=351.08 Aligned_cols=254 Identities=41% Similarity=0.708 Sum_probs=221.9
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47899999999999999999999999999999987765556667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
+.+++|.+++... .++++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 158 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KT 158 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hc
Confidence 9999999999875 789999999999999999999999 9999999999999999999999999999876543322 22
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC-----HHHHHhhccCCCCCCCchH-HHHHHHHHH
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-----PMRVLFIIPRENPPQLDEH-FSRLMKEFV 244 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~-~s~~l~~li 244 (421)
..|+..|+|||.+.+. .++.++||||||+++|+|++|..||...+ .......+.....+.++.. ++..+.+||
T Consensus 159 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 159 FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 6789999999998776 58999999999999999999999997652 2333333333444444444 889999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhccc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
.+||..+|.+|||+.+++.||||+.
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999999964
No 160
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=2.8e-45 Score=347.54 Aligned_cols=254 Identities=39% Similarity=0.700 Sum_probs=216.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC----CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 86 (421)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999986542 22345678899999999999999999998876 4678
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~- 165 (421)
++++||+++++|.+++...+.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987543211
Q ss_pred --ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC-CCCCCCchHHHHHHHH
Q 014610 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKE 242 (421)
Q Consensus 166 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~ 242 (421)
.......|+..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.. ...+.++..++..+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 111235689999999999775 478999999999999999999999987766554443332 2334556677888999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
+| +||..+|++|||++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 67778999999999999999996
No 161
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=2.2e-45 Score=345.39 Aligned_cols=253 Identities=41% Similarity=0.750 Sum_probs=221.6
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC----CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
+|+..+.||+|+||+||+|.+..+++.|++|.+.... .....+.+.+|+.+++.++||||+++++++..+..+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999999899999999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
+||+++++|.+++.+..++++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence 9999999999999887889999999999999999999999999999999999999999999999999987654332 234
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC-CCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~~L 248 (421)
...|++.|+|||.+.....++.++|+|||||++|+|++|..||...........+.. ...+.++..++..+.+|+.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 567899999999986543378899999999999999999999988776555544443 3344556677899999999999
Q ss_pred ccCCCCCcCHHHHHhChhc
Q 014610 249 KKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~ 267 (421)
..+|.+|||+.+++.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
No 162
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=2.4e-45 Score=345.86 Aligned_cols=253 Identities=36% Similarity=0.592 Sum_probs=223.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~ 90 (421)
+|++++.||.|+||.||+|.+..+|+.||+|.+.... .....+.+..|+.++++++||||+++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986543 34456778899999999999999999998764 45689999
Q ss_pred ecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLH-----NEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 91 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH-----~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999865 467999999999999999999999 999999999999999999999999999998876
Q ss_pred ccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHH
Q 014610 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (421)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 241 (421)
...........|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.....+.++..++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 55433234567999999999997764 78899999999999999999999998876666666666666667778899999
Q ss_pred HHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 242 EFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+++.+||..+|++|||+.+|++|||+
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999996
No 163
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=1.8e-45 Score=353.37 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=209.2
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
+.++|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++|+||+++++++..+...|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45889999999999999999999999999999999865543333346678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 91 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9995 677766643 45688999999999999999999999999999999999999999999999999876544333334
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHhhc------------------cCCC--
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFII------------------PREN-- 228 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~-~~~~i------------------~~~~-- 228 (421)
...+++.|+|||++.+...++.++|||||||++|+|++|..||...+... ....+ ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 45689999999998765557889999999999999999999997655321 11110 0000
Q ss_pred ------CCCCc---h--HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 229 ------PPQLD---E--HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 229 ------~~~~~---~--~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+..+. . ..+..+.++|.+||..||++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0 124678999999999999999999999999997
No 164
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=2e-45 Score=347.91 Aligned_cols=252 Identities=39% Similarity=0.729 Sum_probs=216.2
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-----HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
+|++.+.||+|+||.||+|.+. +|+.+|+|.+..... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999874 689999999865431 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc----
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---- 164 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~---- 164 (421)
|+||+.+++|.+++.+..++++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999998754221
Q ss_pred --cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC--CCCCCCchHHHHHH
Q 014610 165 --ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--ENPPQLDEHFSRLM 240 (421)
Q Consensus 165 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~l 240 (421)
........|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.. ...+.++..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1112245689999999998765 478999999999999999999999987765544433322 22344556788999
Q ss_pred HHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.+||.+||.++|.+|||+.++|+||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
No 165
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=1.8e-45 Score=349.21 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=215.2
Q ss_pred CCCceeeceEeecCceEEEEEEEC---CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++..........+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999999865 45679999998766555556778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||.+........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999998763 5799999999999999999999999999999999999999999999999998754322111
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~ 245 (421)
......+++.|+|||++.+. .++.++|||||||++|||++ |..||...........+........+..++..+.+++.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11123456789999998775 48999999999999999775 99999988877766666555444556678899999999
Q ss_pred HHcccCCCCCcCHHHHHh
Q 014610 246 LCLKKVPAERPSAKELLR 263 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~ 263 (421)
+||..+|.+|||+.+|++
T Consensus 243 ~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 243 DCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHcCCCchhCCCHHHHHH
Confidence 999999999999999976
No 166
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=1.3e-45 Score=352.55 Aligned_cols=256 Identities=48% Similarity=0.881 Sum_probs=217.2
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEe------
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH------ 82 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------ 82 (421)
.+.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 46689999999999999999999999999999999986543 2346688999999998 69999999999853
Q ss_pred CCEEEEEEecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
+..+|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 4678999999999999999965 34688999999999999999999999999999999999999999999999999876
Q ss_pred cccccccccccccCccccCcccccC----cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC-CchH
Q 014610 161 LTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ-LDEH 235 (421)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~ 235 (421)
............|++.|+|||++.. ...++.++|||||||++|+|++|..||....+......+....+.. ....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 5433333445679999999998853 2347789999999999999999999998776655554443333222 2335
Q ss_pred HHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 236 ~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
++..+.+||.+||..||.+|||+.|||+||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
No 167
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=4.7e-46 Score=358.47 Aligned_cols=264 Identities=38% Similarity=0.716 Sum_probs=224.5
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
.....+.|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.++++++||||+++++.+..++..|
T Consensus 17 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 17 PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred cCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 3445567788889999999999999999999999999986543 334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
+||||+++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999999999998865 57999999999999999999999999999999999999999999999999998765444333
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--chHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~li~ 245 (421)
.....|++.|+|||++.+. .++.++||||||+++|||++|..||...+.......+....+..+ ...++..+.++|.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 4456799999999998765 488999999999999999999999988776655444433222222 2246788999999
Q ss_pred HHcccCCCCCcCHHHHHhChhcccccCCh
Q 014610 246 LCLKKVPAERPSAKELLRHRFIRNARKSP 274 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 274 (421)
+||..||.+|||++++++||||.......
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999998665443
No 168
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-47 Score=360.25 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=234.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 88 (421)
..+|..+.+||+|+||+|.+|..+.+.+.||||+++++-. .++.+-...|-++|... +-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4689999999999999999999999999999999876542 23345556788888877 57899999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||||+.||+|--.|+.-+++.|..+..++.+|+-||-+||++|||+||||.+||||+.+|++||+|||+++...-.....
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998766666667
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
.++||||.|+|||++.-. +|+.++|+||+||+||||+.|++||.+.+..++...|...+ ..++..+|.++.++++..|
T Consensus 508 kTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsyPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSYPKSLSKEAVAICKGLL 585 (683)
T ss_pred eeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcCcccccHHHHHHHHHHh
Confidence 789999999999999876 59999999999999999999999999999998888886555 3677889999999999999
Q ss_pred ccCCCCCcCH-----HHHHhChhcccccCCh
Q 014610 249 KKVPAERPSA-----KELLRHRFIRNARKSP 274 (421)
Q Consensus 249 ~~dP~~Rpt~-----~elL~hp~~~~~~~~~ 274 (421)
.+.|.+|..+ .+|-.||||+.+.+..
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhccHHH
Confidence 9999999754 6789999999886543
No 169
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=2.2e-45 Score=357.12 Aligned_cols=258 Identities=31% Similarity=0.499 Sum_probs=221.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH--HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
.+|++.+.||+|+||.||+|.+..+++.||||.+...... .....+..|+.++++++||||+++++.+..+...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999999999999999998765433 35677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--
Q 014610 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-- 166 (421)
||+.+++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+|+.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 5799999999999999999999999999999999999999999999999999865422110
Q ss_pred ---------------------------cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Q 014610 167 ---------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR 219 (421)
Q Consensus 167 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~ 219 (421)
......||..|+|||++.+. .++.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 11234789999999999776 47899999999999999999999998877666
Q ss_pred HHhhccCCCCCC-CchHHHHHHHHHHHHHcccCCCCCcC----HHHHHhChhccccc
Q 014610 220 VLFIIPRENPPQ-LDEHFSRLMKEFVSLCLKKVPAERPS----AKELLRHRFIRNAR 271 (421)
Q Consensus 220 ~~~~i~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rpt----~~elL~hp~~~~~~ 271 (421)
....+....... ....++..+++||.+||..+|++||| ++++|.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 555444322211 12236899999999999999999999 99999999998754
No 170
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=1.9e-45 Score=354.23 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=216.6
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH----HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... .....+..|+.++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999998655422 2345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
|||+ +|+|.+++.... .+++..+..++.||++||.|||++|++||||||+|||++.+|.++|+|||++..........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999998765 79999999999999999999999999999999999999999999999999997765543333
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC---------------------
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------------------- 227 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~--------------------- 227 (421)
....+++.|+|||.+.+...++.++|||||||++|+|++|.+||...........+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 44567889999999866556789999999999999999998888776654433222110
Q ss_pred -CCC-----CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 228 -NPP-----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 228 -~~~-----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
... ......+..+.+||.+||.++|++|||+.|+|.|+||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000 01123567899999999999999999999999999998753
No 171
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=3.1e-45 Score=350.49 Aligned_cols=256 Identities=45% Similarity=0.827 Sum_probs=215.0
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEE-----eC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYL-----HQ 83 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~ 83 (421)
.+.++|++++.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++++ +||||+++++++. .+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 456899999999999999999999999999999998764332 235678899999999 6999999999874 34
Q ss_pred CEEEEEEecCCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 84 TKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
...++||||+++++|.+++. ....+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67899999999999999875 33578999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccccCccccCcccccCc----CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC--Cc
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LD 233 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~ 233 (421)
.............|++.|+|||++... ..++.++|||||||++|+|++|..||...........+.....+. .+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCC
Confidence 664433333456799999999987532 237889999999999999999999998877655554443332222 23
Q ss_pred hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 234 ~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
..++..+.++|.+||..||++|||+.+|++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 3467889999999999999999999999999997
No 172
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=6.3e-45 Score=344.74 Aligned_cols=254 Identities=38% Similarity=0.672 Sum_probs=216.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC----CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 86 (421)
.+|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 68999999999999999999999999999999885432 23346788899999999999999999999876 3568
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc--
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-- 164 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~-- 164 (421)
++||||+++++|.+++.+...+++..+..++.|++.||+|||+++++|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999988778999999999999999999999999999999999999999999999999998754321
Q ss_pred -cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-CCCCCchHHHHHHHH
Q 014610 165 -ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKE 242 (421)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~ 242 (421)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+... ..+..+..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1122345689999999998775 4789999999999999999999999877655544443322 234456678889999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
+|.+||. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999974
No 173
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.6e-45 Score=369.34 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=207.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEEC--CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~--~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
....+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+.+|++++||||+++++++.....+|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 34568999999999999999999764 35688999987543 23468999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
+|||++. ++|.+++....++++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999995 68999997778899999999999999999999999999999999999999999999999999876543221
Q ss_pred -cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHhhcc---C-------------
Q 014610 167 -RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---RVLFIIP---R------------- 226 (421)
Q Consensus 167 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~---~~~~~i~---~------------- 226 (421)
......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... ..+..+. .
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 12346799999999999775 4899999999999999999999999765321 0110000 0
Q ss_pred ------------CCCCCCc-----hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 227 ------------ENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 227 ------------~~~~~~~-----~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
..+...+ ..++.++++||.+||..||.+|||+.++|.||||...
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000011 1346678999999999999999999999999999754
No 174
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.4e-46 Score=370.94 Aligned_cols=260 Identities=25% Similarity=0.445 Sum_probs=232.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
...+.|.+++.||+|.|++|.+|++..||..||||.+++... ....+.+.+|+++|+.|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345789999999999999999999999999999999987763 3445679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||||+.+|.+++++.+++++.+..++.++.|++.|++|||+++|||||||++||||+.+-++||+|||++..+.. ....
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~l 211 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLML 211 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-cccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988763 3455
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
.+.||++.|.|||++.+.+..++.+|+||+|+++|-|++|.+||.+.+............ ..++.-++.+.+++|+++|
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~l 290 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFL 290 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHHHhh
Confidence 789999999999999998866789999999999999999999999877655444433332 2445557889999999999
Q ss_pred ccCCCCCcCHHHHHhChhccccc
Q 014610 249 KKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..+|.+|++++++..|.|.....
T Consensus 291 vl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 291 VLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ccCccccCCHHHhhhhcccchhh
Confidence 99999999999999999997543
No 175
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=5.1e-45 Score=342.71 Aligned_cols=252 Identities=32% Similarity=0.532 Sum_probs=221.0
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999987654 334567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeeccccccccccccccc
Q 014610 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 93 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGla~~~~~~~~~~~ 169 (421)
+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence 9999999999763 458999999999999999999999999999999999999865 458999999987664332 223
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
...|++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.......++..++..+.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 45789999999999765 47889999999999999999999998887766666665555555666788999999999999
Q ss_pred cCCCCCcCHHHHHhChhc
Q 014610 250 KVPAERPSAKELLRHRFI 267 (421)
Q Consensus 250 ~dP~~Rpt~~elL~hp~~ 267 (421)
.+|++|||+.|+++||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999996
No 176
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=9.3e-46 Score=353.94 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=215.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++..++..|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4799999999999999999999999999999997654322 234667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+++++|..+......+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 99999999988776779999999999999999999999999999999999999999999999999987665443333456
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---------------------CCCC
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------ENPP 230 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---------------------~~~~ 230 (421)
.++..|+|||++.+...++.++|||||||++|+|++|++||...........+.. ...+
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 7899999999987655578899999999999999999999976554332211110 0000
Q ss_pred ---------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 231 ---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 231 ---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.....++..+.+|+.+||..+|++|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0112457889999999999999999999999999997
No 177
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=5.3e-45 Score=349.29 Aligned_cols=264 Identities=47% Similarity=0.845 Sum_probs=229.3
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
+.....|++.+.||+|++|.||+|.+..++..|++|++..... ....+.+|+.++++++|+||+++++++......|+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4577889999999999999999999998999999999876543 45778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
|+||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999998866 8999999999999999999999999999999999999999999999999998765544333
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC--chHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~li~ 245 (421)
.....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+.....+.. ...++..+++||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 3456789999999998765 488999999999999999999999988776655544433333332 2337889999999
Q ss_pred HHcccCCCCCcCHHHHHhChhcccccCChh
Q 014610 246 LCLKKVPAERPSAKELLRHRFIRNARKSPR 275 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~ 275 (421)
+||+.+|.+|||+.++++|+||..+...+.
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 281 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKACPKEE 281 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhccCchHh
Confidence 999999999999999999999998554443
No 178
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=4.7e-45 Score=350.08 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=207.0
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe----CCEEEEEEec
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTKLWIIMEY 92 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 92 (421)
..||+|++|.||+|.. +|+.||||++..... ....+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6899999999999987 589999999865432 2235778899999999999999999999877 4578999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|++|+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~ 180 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN 180 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence 99999999998888899999999999999999999984 9999999999999999999999999998765432 2345
Q ss_pred ccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc-CCCCCCCchHHHHHHHHHHHHHcc
Q 014610 172 VGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
+|++.|+|||++.+. ..++.++|||||||++|||++|..||...+.......+. ....+.++..++..+++||.+||+
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 789999999998652 358999999999999999999999999887766665553 233344555678999999999999
Q ss_pred cCCCCCcCHHHHHh
Q 014610 250 KVPAERPSAKELLR 263 (421)
Q Consensus 250 ~dP~~Rpt~~elL~ 263 (421)
.||++|||+.++++
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999986
No 179
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=4.7e-45 Score=345.52 Aligned_cols=254 Identities=31% Similarity=0.597 Sum_probs=216.4
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-----HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
+|+..+.||+|++|.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999999999999999865432 2235778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-CEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 167 (421)
|+||+.+++|.+++...+++++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 5999999998765433111
Q ss_pred ----ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHhhc-cCCCCCCCchHHHHH
Q 014610 168 ----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFII-PRENPPQLDEHFSRL 239 (421)
Q Consensus 168 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~---~~~~i-~~~~~~~~~~~~s~~ 239 (421)
.....|+..|+|||++.+. .++.++||||||+++|+|++|..||....... ....+ .....+..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1235689999999998765 47899999999999999999999997544322 11111 122334556678899
Q ss_pred HHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 240 l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
+.+++.+||..+|++|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
No 180
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=3.6e-45 Score=349.63 Aligned_cols=254 Identities=29% Similarity=0.539 Sum_probs=214.7
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 68999999999999999999999999999999876542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cccc
Q 014610 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~ 170 (421)
+ +++|.+++.. ..++++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999864 46799999999999999999999999999999999999999999999999999876644321 1234
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-----------------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------------- 227 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~----------------------- 227 (421)
..|++.|+|||++.+...++.++|||||||++|+|++|.+||...........+...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 578999999999876655789999999999999999999988776654433222110
Q ss_pred --CCC----CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 228 --NPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 228 --~~~----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
... ......+..+.++|.+||..+|.+|||++++|+||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 01123468899999999999999999999999999983
No 181
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-46 Score=363.24 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=217.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
..+++++.||+|-||.||.|.+.. ...||+|.+..... ..+.+.+|+++|++|+|+|||++++++..++.+||||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 456788999999999999999884 44899999865432 235677999999999999999999999998899999999
Q ss_pred CCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-ccc
Q 014610 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (421)
Q Consensus 93 ~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~ 169 (421)
+..|+|.++++. +..+...+...++.||++|++||+++++|||||...||||++++.+||+|||+|+...+..- ...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999999986 56799999999999999999999999999999999999999999999999999995433211 111
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
...-...|.|||.+.... ++.++|||||||+||||+| |+.||......+++..+.++.....|..+|..+.+++..||
T Consensus 363 ~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW 441 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCW 441 (468)
T ss_pred CCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHh
Confidence 122345699999998775 9999999999999999997 99999999999999999999988888999999999999999
Q ss_pred ccCCCCCcCHHHHH
Q 014610 249 KKVPAERPSAKELL 262 (421)
Q Consensus 249 ~~dP~~Rpt~~elL 262 (421)
..+|++|||++.+.
T Consensus 442 ~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 442 HEDPEDRPTFETLR 455 (468)
T ss_pred hCCcccCCCHHHHH
Confidence 99999999999765
No 182
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=3.8e-45 Score=352.21 Aligned_cols=262 Identities=43% Similarity=0.782 Sum_probs=223.9
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++++.||+|+||.||++.+..++..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..|+|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 357999999999999999999999999999999998654332 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999999999976 56899999999999999999999999999999999999999999999999998765544333445
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC--CchHHHHHHHHHHHHHc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~li~~~L 248 (421)
..|++.|+|||.+... .++.++|+|||||++|+|++|..||...+.......+.....+. .+..++..++++|.+||
T Consensus 175 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (293)
T cd06647 175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253 (293)
T ss_pred ccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence 6799999999998765 47899999999999999999999998776654443332222222 23456788999999999
Q ss_pred ccCCCCCcCHHHHHhChhcccccCChh
Q 014610 249 KKVPAERPSAKELLRHRFIRNARKSPR 275 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~~~~~~~~~ 275 (421)
..+|.+||++.+++.|+||+..+....
T Consensus 254 ~~~p~~Rp~~~~il~h~~~~~~~~~~~ 280 (293)
T cd06647 254 EMDVEKRGSAKELLQHPFLKIAKPLSS 280 (293)
T ss_pred cCChhhCcCHHHHhcCHHHhcCccccc
Confidence 999999999999999999987764433
No 183
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.5e-45 Score=350.38 Aligned_cols=256 Identities=34% Similarity=0.614 Sum_probs=220.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++++.||+|+||+||+|.+..+|+.||+|++...........+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46899999999999999999999999999999998765555556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+++++|.+++.+.+++++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++...... ....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~ 161 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADT 161 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCc
Confidence 99999999999888889999999999999999999997 69999999999999999999999999998654322 2234
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----------HHHhhccCCCCCCCch-HHHH
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-----------RVLFIIPRENPPQLDE-HFSR 238 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~-~~s~ 238 (421)
..|+..|+|||++.+. .++.++|+|||||++|+|++|..||...... .....+....++.++. .++.
T Consensus 162 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 6799999999998765 4889999999999999999999999865442 2222333333333333 3778
Q ss_pred HHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 239 ~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+.+||.+||..||++|||+.|+++|+||...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 89999999999999999999999999999654
No 184
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=9.3e-45 Score=351.25 Aligned_cols=258 Identities=30% Similarity=0.527 Sum_probs=220.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++++.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999865532 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-----
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----- 165 (421)
||++|++|.++++..+++++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999876321100
Q ss_pred ----------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC--CCCc
Q 014610 166 ----------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQLD 233 (421)
Q Consensus 166 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~ 233 (421)
.......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+....+....+..... +...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001124678899999998765 489999999999999999999999988776665555443321 2222
Q ss_pred hHHHHHHHHHHHHHcccCCCCCcC---HHHHHhChhccccc
Q 014610 234 EHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNAR 271 (421)
Q Consensus 234 ~~~s~~l~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~~ 271 (421)
..++.++.+||.+||..+|++||+ +.++|+||||....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 357889999999999999999997 79999999997654
No 185
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=2e-45 Score=351.45 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=211.3
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++++.||.|++|.||+|++..+|+.||||.+..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58999999999999999999999999999999865432 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
+. ++|..++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++............
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 689988864 357899999999999999999999999999999999999999999999999998765443333344
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-----------------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------------- 227 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~----------------------- 227 (421)
..+++.|+|||++.+...++.++|||||||++|+|++|+.||...+.......+...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 568899999999876555688999999999999999999999876554333221100
Q ss_pred --CCC---CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 228 --NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 228 --~~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
... .....++..++++|.+||+.||.+|||++++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 0112356788999999999999999999999999998
No 186
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.9e-45 Score=364.37 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=200.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++||||+++++++..+...++|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 45799999999999999999999999999999985432 23468999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
++. ++|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~ 215 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLG 215 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccccc
Confidence 995 588887754 567999999999999999999999999999999999999999999999999998643322 12234
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCC-CCCCCHH---------HHHhh-cc--CCCCCCCc----
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP-LADLHPM---------RVLFI-IP--RENPPQLD---- 233 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~p-f~~~~~~---------~~~~~-i~--~~~~~~~~---- 233 (421)
..||+.|+|||++.+. .++.++|||||||++|||+++..| |...... ..+.. +. ...+..++
T Consensus 216 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 6799999999999876 489999999999999999985444 4332110 00000 00 00000000
Q ss_pred --------------------------hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 234 --------------------------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 234 --------------------------~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
..++..+.+||.+||..||.+|||+.|+|+||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134556778999999999999999999999999975
No 187
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=5e-45 Score=348.96 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=206.5
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHH---HHcCCCCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISV---LSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~i---l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
.||+|+||.||+|.+..+++.||||.+..... ........+|..+ +...+||||+.+++.+..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999865432 1112233344433 344579999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccC
Q 014610 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (421)
Q Consensus 95 gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 174 (421)
+|+|.+++...+.+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++...... ......|+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT 158 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998655332 22345799
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
+.|+|||.+.+...++.++|||||||++|+|++|..||..... ..............++..++..++++|.+||..||
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 9999999986544578999999999999999999999975432 11222222223345566788999999999999999
Q ss_pred CCCc-----CHHHHHhChhcccccC
Q 014610 253 AERP-----SAKELLRHRFIRNARK 272 (421)
Q Consensus 253 ~~Rp-----t~~elL~hp~~~~~~~ 272 (421)
.+|+ |++++++||||+....
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCCH
Confidence 9999 6999999999987653
No 188
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=1.7e-45 Score=347.14 Aligned_cols=252 Identities=26% Similarity=0.497 Sum_probs=220.2
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999999999999987543 22456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
|+.|++|.+++....++++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST 159 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence 99999999999887799999999999999999999999999999999999999999999999999987654332 22346
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
.|+..|+|||++.+.. ++.++|+||||+++|+|++|..||...+. ...............+..++..+.++|.+||.
T Consensus 160 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 160 SGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence 7899999999997764 88999999999999999999999987763 22222222223445556788999999999999
Q ss_pred cCCCCCcCH--HHHHhChhc
Q 014610 250 KVPAERPSA--KELLRHRFI 267 (421)
Q Consensus 250 ~dP~~Rpt~--~elL~hp~~ 267 (421)
.||.+||++ .|+++||||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999997
No 189
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=5.8e-45 Score=349.72 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=208.0
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.++|++.+.||+|++|.||+|.++.+++.||||.+...........+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999999999999999998654433233456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|+. ++|.+++... ..+++..+..++.||++||.|||++|++||||||+|||++.+|.+||+|||++............
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 997 5999988653 57899999999999999999999999999999999999999999999999998654322222233
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHhhcc---CCC------------------
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIP---REN------------------ 228 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~~~~~i~---~~~------------------ 228 (421)
..+++.|+|||++.+...++.++|||||||++|+|++|..||..... .+....+. ...
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 45788999999987655578899999999999999999999976552 11111100 000
Q ss_pred -----CCCC---chHHH--HHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 229 -----PPQL---DEHFS--RLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 229 -----~~~~---~~~~s--~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
...+ ...++ ..+.++|.+||..+|++|||+.++|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01223 778899999999999999999999999998
No 190
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=4e-45 Score=354.31 Aligned_cols=259 Identities=27% Similarity=0.476 Sum_probs=214.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 87 (421)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999999999999999998654322 1223466899999999999999999998765 5689
Q ss_pred EEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999996 588888865 46799999999999999999999999999999999999999999999999999876654333
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC------------------
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN------------------ 228 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~------------------ 228 (421)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 33344568899999998765568899999999999999999999998877665544322100
Q ss_pred -------C-CCC---chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 229 -------P-PQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 229 -------~-~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+ ..+ ...++..+.+||.+||..||++|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0 000 01247789999999999999999999999999999753
No 191
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=4.2e-45 Score=349.03 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=212.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
+|++++.||.|++|.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999876654444566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 94 AGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 94 ~gg~L~~~l~~~---~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
++ +|.+++... .++++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 75 888887653 46899999999999999999999999999999999999999999999999998755433223334
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC--------------------CCCC
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------------ENPP 230 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~--------------------~~~~ 230 (421)
..+++.|++||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.. ...+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 56889999999987655578899999999999999999999987665433222110 0000
Q ss_pred C--------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 231 Q--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 231 ~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
. +...++..+.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 112346789999999999999999999999999998
No 192
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=7.6e-45 Score=343.41 Aligned_cols=248 Identities=31% Similarity=0.589 Sum_probs=216.0
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||.|++|.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++.+.++..+++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999999999999999875442 34457799999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcccc
Q 014610 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (421)
Q Consensus 99 ~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~ 178 (421)
.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 9999887889999999999999999999999999999999999999999999999999987664432 223457899999
Q ss_pred CcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC--HHHHHhhccC-CCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 179 aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~--~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
+||.+... .++.++|+||||+++|+|++|..||.... .......+.. ......+...+..+.+||.+||..+|++|
T Consensus 160 ~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 160 APEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred ChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 99998765 47899999999999999999999998776 4444444432 22334445558899999999999999999
Q ss_pred cC-----HHHHHhChhcccc
Q 014610 256 PS-----AKELLRHRFIRNA 270 (421)
Q Consensus 256 pt-----~~elL~hp~~~~~ 270 (421)
|+ ++|+++||||+..
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999864
No 193
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-46 Score=337.58 Aligned_cols=257 Identities=32% Similarity=0.584 Sum_probs=224.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++.+.+..||.|+.|+|++++.+.+|...|||.+..........++...++++.... .|+||+++|+|..+..++|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345678899999999999999999999999999998888888899999999887765 8999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
.|. ..+..++++ .++++|..+-++...+++||.||.+ +||||||+||+|||+|..|++||||||++..+...... .
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-t 249 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-T 249 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc-c
Confidence 994 355555554 5789999999999999999999995 58999999999999999999999999999888765433 3
Q ss_pred ccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHhhccCCCCCCCch--HHHHHHHHHH
Q 014610 170 TFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDE--HFSRLMKEFV 244 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~--~~s~~l~~li 244 (421)
...|.+.|||||.+.- ...|+.++||||||++|+||.||..||.+.+ +.+++.++....|+.++. .+|..+.+|+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 4579999999999863 3458899999999999999999999999864 466777777777777754 5899999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhccccc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..||.+|+.+||...++|+|||+..-.
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHhhcCcccCcchHHHhcCcceeecc
Confidence 999999999999999999999997543
No 194
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=9.1e-45 Score=351.02 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=206.3
Q ss_pred hCCCceeeceEeecCceEEEEEEECC----------------CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCee
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKE----------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv 74 (421)
..++|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.+|++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 35789999999999999999998642 34579999987665555667899999999999999999
Q ss_pred EEEEEEEeCCEEEEEEecCCCCCHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 014610 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHR 135 (421)
Q Consensus 75 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHr 135 (421)
++++++.+.+..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999998642 236778899999999999999999999999
Q ss_pred CCCCCcEEEccCCCEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh--CCCC
Q 014610 136 DIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPP 211 (421)
Q Consensus 136 Dlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~--g~~p 211 (421)
||||+|||++.++.+||+|||++........ ......+++.|+|||++.+.. ++.++|||||||++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999875533211 122345678899999987654 8999999999999999986 6778
Q ss_pred CCCCCHHHHHhhcc-------CCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 212 LADLHPMRVLFIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 212 f~~~~~~~~~~~i~-------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
|...+.......+. .......+..++..+.+|+.+||..+|.+|||+.+|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88766554432221 11111223346788999999999999999999999954
No 195
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=9.5e-45 Score=347.97 Aligned_cols=258 Identities=41% Similarity=0.732 Sum_probs=223.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
..|...+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 467788899999999999999999999999999865432 3346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
+.+++|.+++.. .++++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..............
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999999987 6799999999999999999999999999999999999999999999999998765543323334467
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCc--hHHHHHHHHHHHHHccc
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~s~~l~~li~~~L~~ 250 (421)
|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+....++... ..++..+.+||.+||..
T Consensus 177 ~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 99999999998765 4889999999999999999999999887776665555544333332 23678999999999999
Q ss_pred CCCCCcCHHHHHhChhcccccCC
Q 014610 251 VPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 251 dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
+|++|||+.++++||||+++...
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred ChhhCcCHHHHccCcccccCCCc
Confidence 99999999999999999876543
No 196
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=2.3e-44 Score=348.86 Aligned_cols=263 Identities=44% Similarity=0.809 Sum_probs=223.1
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 445578999999999999999999999999999999986443 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
|+|+||+. |+|.+++. ..+++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99999996 57777664 3567999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC-chHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKE 242 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~ 242 (421)
....|++.|+|||++.+ ...++.++||||||+++|+|++|.+||...+.......+....++.+ ...++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 34678999999998752 23478899999999999999999999988877666555544433333 3457889999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcccccCChhH
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~ 276 (421)
+|.+||..+|.+||++.+++.||||.........
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~ 279 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcccCCcHHH
Confidence 9999999999999999999999999876544433
No 197
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=6.3e-45 Score=347.14 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=217.4
Q ss_pred CCCceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
..+|.+++.||+|+||.||+|.+.. +++.||||.+.........+.+.+|+.+|++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998753 46899999987665555668899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEE
Q 014610 87 WIIMEYMAGGSVADLIQSG--------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~--------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL 152 (421)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999999754 24789999999999999999999999999999999999999999999
Q ss_pred eeccccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCC
Q 014610 153 ADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP 229 (421)
Q Consensus 153 ~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~ 229 (421)
+|||++....... .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+.....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999987543221 1122345678999999997764 8999999999999999998 9999988887777766665555
Q ss_pred CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 230 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
...+..++..+.+++.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5555678899999999999999999999999986
No 198
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=2e-44 Score=340.22 Aligned_cols=254 Identities=38% Similarity=0.728 Sum_probs=218.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ......+..|+.++++++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 68999999999999999999999999999999876543 34678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc----
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---- 168 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~---- 168 (421)
+++++|.+++..+..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999999999887789999999999999999999999999999999999999999999999999987654332211
Q ss_pred cccccCccccCcccccCcC--CCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHhhccCCCCCCCchH--HHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDEH--FSRLMKEF 243 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~--~s~~l~~l 243 (421)
....+++.|+|||++.+.. .++.++||||||+++|+|++|..||.... .......+.....+.++.. ++..+.+|
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHH
Confidence 2356889999999987543 26789999999999999999999997653 3333333333333344443 48889999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhc
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
|.+||+.+|.+|||+.+++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999996
No 199
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5.5e-45 Score=370.65 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
+..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++++|||||++++++..++..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999999999999999642 2345689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--cc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RR 168 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~ 168 (421)
++. ++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ..
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 995 688888765 35799999999999999999999999999999999999999999999999999876533211 12
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC--------HHHHHhhccCC------CCC----
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--------PMRVLFIIPRE------NPP---- 230 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~--------~~~~~~~i~~~------~~~---- 230 (421)
...+||+.|+|||++.+. .++.++|||||||+||||++|..|+.... .......+... .+.
T Consensus 320 ~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 245799999999999876 48999999999999999999876543221 11111111110 000
Q ss_pred ----------------C----Cc---hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 231 ----------------Q----LD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 231 ----------------~----~~---~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
. .+ ..++..+.+||.+||+.||.+|||+.|||+||||+.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00 123457899999999999999999999999999964
No 200
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=3.7e-45 Score=364.49 Aligned_cols=251 Identities=24% Similarity=0.424 Sum_probs=208.0
Q ss_pred CCCceeeceEeecCceEEEEEEECCC-----CcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 85 (421)
.++|++.+.||+|+||.||+|++..+ +..||||++...........+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35799999999999999999987544 3589999997665555667889999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcC------------------------------------------------------------
Q 014610 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~------------------------------------------------------------ 105 (421)
+++|||||.+|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999988542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--ccccccc
Q 014610 106 ----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVG 173 (421)
Q Consensus 106 ----------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~g 173 (421)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 2478889999999999999999999999999999999999999999999999876543211 1112345
Q ss_pred CccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhc-cCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII-PRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+ ........+..++.++.++|.+||..|
T Consensus 277 ~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 355 (374)
T cd05106 277 PVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLE 355 (374)
T ss_pred ccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCC
Confidence 6789999999765 48999999999999999997 99999876543333222 222223334456889999999999999
Q ss_pred CCCCcCHHHHHh
Q 014610 252 PAERPSAKELLR 263 (421)
Q Consensus 252 P~~Rpt~~elL~ 263 (421)
|.+|||+.++++
T Consensus 356 p~~RPs~~~l~~ 367 (374)
T cd05106 356 PTERPTFSQISQ 367 (374)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
No 201
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=3.8e-45 Score=352.95 Aligned_cols=259 Identities=39% Similarity=0.712 Sum_probs=222.7
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
....|+....||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..++..|+|+
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34667778899999999999999999999999999865433 23466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||+++++|..++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++............
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 99999999998865 67899999999999999999999999999999999999999999999999998765444333445
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCC--CCchHHHHHHHHHHHHHc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L 248 (421)
.+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+...... .....++..+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 68999999999997764 789999999999999999999999877766655554333222 123356788999999999
Q ss_pred ccCCCCCcCHHHHHhChhcccccC
Q 014610 249 KKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
+.+|.+||++.++++||||.+...
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCCC
Confidence 999999999999999999987654
No 202
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=1.1e-44 Score=345.51 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=214.6
Q ss_pred hhCCCceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
..+++|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356889999999999999999998752 357899999865544445567889999999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEee
Q 014610 85 KLWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~D 154 (421)
..++||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 999999999999999998652 2357788999999999999999999999999999999999999999999
Q ss_pred cccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCC
Q 014610 155 FGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (421)
Q Consensus 155 FGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 231 (421)
||++........ ......+++.|+|||++.+. .++.++|||||||++|||++ |..||...+.......+.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875432211 11123567889999999765 48999999999999999998 799998887777666555555455
Q ss_pred CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 232 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.+..++..+.+++.+||+.+|++|||+.|++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566778899999999999999999999999874
No 203
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=6.1e-45 Score=350.04 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=210.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCE-----
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK----- 85 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~----- 85 (421)
++|++.+.||+|+||.||+|.+..+|+.||||.+...... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998654322 23456788999999995 6999999999887665
Q ss_pred EEEEEecCCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeeccccc
Q 014610 86 LWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSA 159 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~ 159 (421)
.|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 88888754 246899999999999999999999999999999999999998 8899999999987
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC------------
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------ 227 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------ 227 (421)
.............+++.|+|||++.+...++.++||||||+++|+|++|.+||...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 65443333334567899999999876555789999999999999999999999877665443322110
Q ss_pred ------------CCC---CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 228 ------------NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 228 ------------~~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
.+. .....++..+.+||.+||..||.+|||+.|+|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 00124678899999999999999999999999999984
No 204
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-46 Score=318.06 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=222.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHH-HHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.+|..+++||+|.||+||+|+++++++.||+|.+..+...+. .....+|+.+|+.++|.|||+++++...++.+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 468889999999999999999999999999999987764333 4567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
||. .+|..+... ++.+..+.++.++.|+++||.+||++++.||||||.|+||+.+|.+||+|||+++-+.-+....+.
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 995 588888764 678999999999999999999999999999999999999999999999999999988776555566
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHHhhccCC-------C------------CC
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRE-------N------------PP 230 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-~g~~pf~~~~~~~~~~~i~~~-------~------------~~ 230 (421)
.+-|.+|.+|.++.+.+-|+...|+||.|||+.|+. .|++.|.+.+-.+.+..|.+. . .+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 678999999999999888999999999999999999 588889988877666554211 0 01
Q ss_pred CC---------chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 231 QL---------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 231 ~~---------~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+ ...++..-++++.++|..+|.+|++++++|+||||.+.
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 11334457899999999999999999999999999754
No 205
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=2.2e-44 Score=343.86 Aligned_cols=259 Identities=34% Similarity=0.610 Sum_probs=212.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHH-HHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|++++.||+|+||.||+|.+..+|+.||||.++..........+..|+.+ ++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999998765443344555666665 667799999999999999999999999
Q ss_pred cCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 92 YMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 92 ~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
|++ |+|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 996 688877753 35789999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccCccccCcccccCc---CCCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHhhccCCCCCCC-chHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQL-DEHFSRLMK 241 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~-~~~~s~~l~ 241 (421)
......|+..|+|||++.+. ..++.++|+|||||++|+|++|..||.... .......+.....+.+ ...++.++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 12335789999999988642 246789999999999999999999997542 2222222222222333 235788999
Q ss_pred HHHHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
+||.+||..+|.+|||+.++++||||......
T Consensus 239 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 239 DFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 99999999999999999999999999876544
No 206
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.8e-44 Score=338.34 Aligned_cols=253 Identities=38% Similarity=0.639 Sum_probs=226.3
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 68999999999999999999999999999999876543 34567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 93 MAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 93 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999763 779999999999999999999999999999999999999999999999999987665543334
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
....|++.|+|||.+.+.. ++.++|+||+|+++++|++|..||...+.......+.......++..++..+.+++.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 4567999999999987664 789999999999999999999999888776666666555566667778899999999999
Q ss_pred ccCCCCCcCHHHHHhChhc
Q 014610 249 KKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~ 267 (421)
..+|++|||+.++|+||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
No 207
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=7.9e-45 Score=341.64 Aligned_cols=253 Identities=32% Similarity=0.587 Sum_probs=220.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... ....+.+.+|+.++++++||||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 68999999999999999999999999999999865432 23446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC-EEEeeccccccccccccccc
Q 014610 93 MAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-VKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 93 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~-vkL~DFGla~~~~~~~~~~~ 169 (421)
+.+++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999987543 5799999999999999999999999999999999999998864 69999999876654433334
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
...|++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+...........++..+.++|.+||.
T Consensus 161 ~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 45789999999998765 47899999999999999999999998877766665555554445555678899999999999
Q ss_pred cCCCCCcCHHHHHhChhc
Q 014610 250 KVPAERPSAKELLRHRFI 267 (421)
Q Consensus 250 ~dP~~Rpt~~elL~hp~~ 267 (421)
.+|++|||+.++++||||
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999997
No 208
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=6e-45 Score=363.10 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=207.8
Q ss_pred CCCceeeceEeecCceEEEEEEE-----CCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 85 (421)
.++|++.+.||+|+||+||+|.+ ..++..||||+++........+.+.+|+.+|+.+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34799999999999999999974 4567799999987555445567788999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcC------------------------------------------------------------
Q 014610 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~------------------------------------------------------------ 105 (421)
.++|||||++|+|.++++..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999988642
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc--c
Q 014610 106 ---------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--R 168 (421)
Q Consensus 106 ---------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~--~ 168 (421)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 14788899999999999999999999999999999999999999999999998765432211 1
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHH-HhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
....++..|+|||++.+. .++.++|||||||++|||++ |..||........ ...+........+...+.++++||.+
T Consensus 274 ~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 274 GNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred CCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 123456679999999776 48999999999999999997 9999987654332 22233232233344567889999999
Q ss_pred HcccCCCCCcCHHHHHhC
Q 014610 247 CLKKVPAERPSAKELLRH 264 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~h 264 (421)
||..||++|||+.+|++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999864
No 209
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=7.2e-45 Score=357.02 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=212.3
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC-----CE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TK 85 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 85 (421)
.+++|++.+.||+|+||.||+|++..+|+.||||++...........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 5689999999999999999999999999999999986544444556788899999999999999999987654 35
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+|+|+||+. ++|.+++.. +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999995 589888865 679999999999999999999999999999999999999999999999999987654321
Q ss_pred c---cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc---C-------------
Q 014610 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---R------------- 226 (421)
Q Consensus 166 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~---~------------- 226 (421)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+. .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 11235789999999987665558899999999999999999999997665432221110 0
Q ss_pred -----------CCCCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 227 -----------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 227 -----------~~~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..... ....++..+.+||.+||..+|++|||+.|+++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 1123467899999999999999999999999999998653
No 210
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.4e-44 Score=345.82 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=215.2
Q ss_pred CCceeeceEeecCceEEEEEEE----CCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFD----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~----~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..|++.+.||+|+||+||+|.+ ..+++.||+|.+...........+.+|+.++++++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5799999999999999999985 345689999998766555666788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEE
Q 014610 89 IMEYMAGGSVADLIQSG-----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~-----------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vk 151 (421)
||||+.+++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999999998532 2478889999999999999999999999999999999999999999
Q ss_pred Eeeccccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCC
Q 014610 152 VADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (421)
Q Consensus 152 L~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~ 228 (421)
|+|||++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |.+||...........+....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987653321 1123345677899999987654 8899999999999999998 999998877766666555555
Q ss_pred CCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 229 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
....+..++..+.+++.+||..||++||++.+|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 555566788999999999999999999999999875
No 211
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.7e-44 Score=344.89 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=207.7
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCCH--HHHHHHHHH---HHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKE---ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~--~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
+||+|+||.||+|.+..+++.||||.+...... ........| +.+++...||+|+++++.+..++.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998654321 111222333 344555689999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccC
Q 014610 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (421)
Q Consensus 95 gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 174 (421)
||+|..++...+.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...... .....+|+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT 158 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998755432 22345799
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC---HHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
+.|+|||++.+...++.++||||+||++|+|++|..||.... .......+ ......++..++..+.++|.+||..+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRD 237 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhhcC
Confidence 999999998755458899999999999999999999998663 22222222 22233455567899999999999999
Q ss_pred CCCCc-----CHHHHHhChhcccccCC
Q 014610 252 PAERP-----SAKELLRHRFIRNARKS 273 (421)
Q Consensus 252 P~~Rp-----t~~elL~hp~~~~~~~~ 273 (421)
|.+|| ++.++++||||+.....
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccCCCch
Confidence 99999 99999999999876543
No 212
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=2e-44 Score=345.97 Aligned_cols=260 Identities=23% Similarity=0.409 Sum_probs=217.0
Q ss_pred hhCCCceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
...++|++.+.||+|+||.||+|.++. .+..||+|.+...........+.+|+.++++++||||+++++++..+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346799999999999999999997652 356899999876554445566889999999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEee
Q 014610 85 KLWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~D 154 (421)
..++||||+.+|+|.+++... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999999642 2356778899999999999999999999999999999999999999999
Q ss_pred cccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCC
Q 014610 155 FGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (421)
Q Consensus 155 FGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 231 (421)
||++........ ......++..|+|||.+.+. .++.++|||||||++|||++ |..||......+....+.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999875432211 11223457789999998765 48899999999999999998 899998887766666555444444
Q ss_pred CchHHHHHHHHHHHHHcccCCCCCcCHHHHHh------Chhcccc
Q 014610 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLR------HRFIRNA 270 (421)
Q Consensus 232 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~------hp~~~~~ 270 (421)
.+..++..+.+++.+||..+|.+|||+.++++ ||||+.+
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 55566789999999999999999999999986 7887654
No 213
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=3.7e-44 Score=335.94 Aligned_cols=253 Identities=45% Similarity=0.764 Sum_probs=225.6
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||+|++|.||+|.+..+++.||||.+..... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999999999999999865542 24567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998888999999999999999999999999999999999999999999999999999987655433334567
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
|+..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.....+.++..++..+.+++.+||..+|
T Consensus 161 ~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 161 GTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred cchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 899999999987664 7889999999999999999999998877665555554445555666788999999999999999
Q ss_pred CCCcCHHHHHhChhc
Q 014610 253 AERPSAKELLRHRFI 267 (421)
Q Consensus 253 ~~Rpt~~elL~hp~~ 267 (421)
++|||+.+++.||||
T Consensus 240 ~~R~~~~~~l~~~~~ 254 (254)
T cd06627 240 NLRPTAKQLLKHPWI 254 (254)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
No 214
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1.1e-44 Score=346.71 Aligned_cols=255 Identities=29% Similarity=0.523 Sum_probs=215.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|++.+.||+|+||.||+|.+..+++.||||+++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 479999999999999999999999999999999865432 3335778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-cccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~ 170 (421)
|++++.+..++.+...+++..+..++.||+.||.|||+++++||||+|+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 999888887777767899999999999999999999999999999999999999999999999999877654432 3345
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC----------------------CC
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------EN 228 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~----------------------~~ 228 (421)
..+++.|+|||++.+...++.++||||||+++|+|++|.+||...........+.. ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 67899999999998764588999999999999999999999987655433221100 00
Q ss_pred CC---------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 229 PP---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 229 ~~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+. ..+..++.++.+||++||..+|++|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 0122347889999999999999999999999999997
No 215
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=2.5e-44 Score=341.23 Aligned_cols=255 Identities=35% Similarity=0.597 Sum_probs=212.7
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
.+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 445556679999999999999999999999999986543 3345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeeccccccccccccc
Q 014610 92 YMAGGSVADLIQSG-PPL--DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l--~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~~~~~~~~~ 167 (421)
|+.+++|.+++... .++ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99999999999764 456 88999999999999999999999999999999999986 679999999998765433222
Q ss_pred ccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH-hhc-cCCCCCCCchHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FII-PRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~-~~i-~~~~~~~~~~~~s~~l~~li 244 (421)
.....|++.|+|||++.+. ..++.++||||||+++|+|++|..||......... ... .....+.++..++.++++|+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 3345689999999998653 23788999999999999999999999765432211 111 11223345667888999999
Q ss_pred HHHcccCCCCCcCHHHHHhChhc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.+||..+|.+|||+.|++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
No 216
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=1.4e-44 Score=347.80 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=212.6
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|++.+.||+|++|.||+|.+..+|+.||||.+..... ......+.+|+.++++++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999999999999999865432 2334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeecccccccccccccc
Q 014610 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~~~~~~~~~~ 168 (421)
|++ ++|.+.+.... .+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++..........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 995 58888876543 3588899999999999999999999999999999999985 4679999999987554332223
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---CC-----------------
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---EN----------------- 228 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~~----------------- 228 (421)
....|++.|+|||++.+...++.++|||||||++|+|++|.+||......+....+.. ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 3456889999999987655578899999999999999999999987665444332210 00
Q ss_pred -----CCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 229 -----PPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 229 -----~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
... ....++..+.++|.+||..+|++||++.++++||||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 000 0123577899999999999999999999999999998754
No 217
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=1e-44 Score=348.53 Aligned_cols=254 Identities=25% Similarity=0.449 Sum_probs=212.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWII 89 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 89 (421)
++|++.+.||.|+||.||+|.+..+++.||||.++..... .....+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5799999999999999999999999999999998654422 2234567899999999999999999999887 889999
Q ss_pred EecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
|||+. ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++..........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99996 5999988654 459999999999999999999999999999999999999999999999999988765543333
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--------------------
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------------------- 228 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-------------------- 228 (421)
....+++.|+|||++.+...++.++|+||||+++|+|++|.+||...........+....
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 455789999999998765556889999999999999999999998776554433221100
Q ss_pred ----------CCCCchH-HHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 229 ----------PPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 229 ----------~~~~~~~-~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
...++.. ++..+.++|++||+.+|++|||+.|+|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011111 47789999999999999999999999999997
No 218
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=6.3e-44 Score=342.36 Aligned_cols=258 Identities=37% Similarity=0.663 Sum_probs=215.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~ 90 (421)
++|+..+.||.|++|.||+|.+..+++.||+|.+...........+.+|++++++++||||+++++++.+ +..+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4799999999999999999999999999999998766555566788999999999999999999998865 34789999
Q ss_pred ecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999987643 4568999999999999999999999999999999999999999999999999986554321
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC-----HHHHHhhccCCCCCCC------chH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-----PMRVLFIIPRENPPQL------DEH 235 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~------~~~ 235 (421)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||.... ..+....+.....+.+ ...
T Consensus 160 -~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred -cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 1245688999999998765 48899999999999999999999997652 2232332222111111 124
Q ss_pred HHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 236 ~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
++..+.+||.+||..+|.+|||+.|+++||||++....
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 67889999999999999999999999999999766544
No 219
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=2.1e-44 Score=338.41 Aligned_cols=244 Identities=27% Similarity=0.432 Sum_probs=208.5
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
+.||+|+||.||+|.+..+++.||+|.+......+....+.+|+.++++++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999999999999999986555555667899999999999999999999999999999999999999999
Q ss_pred HHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc--ccccccCc
Q 014610 99 ADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RKTFVGTP 175 (421)
Q Consensus 99 ~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~ 175 (421)
.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... .....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 9999654 46899999999999999999999999999999999999999999999999998654321110 01112345
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 254 (421)
.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...........+....+...+..++..+.+|+.+||..+|++
T Consensus 161 ~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 161 KWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 699999987764 8899999999999999997 99999877766655555544444556677889999999999999999
Q ss_pred CcCHHHHHh
Q 014610 255 RPSAKELLR 263 (421)
Q Consensus 255 Rpt~~elL~ 263 (421)
|||+.++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999975
No 220
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=1.4e-44 Score=344.96 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=206.0
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeC--CEEEEEEe
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ--TKLWIIME 91 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lV~E 91 (421)
|++++.||+|+||.||+|.+..+++.||||.+.............+|+.+++++. ||||+++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999999865433223334457899999885 99999999999987 88999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
|++ |+|.+.+.. ...+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||++....... ....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~ 157 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE 157 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence 996 578877765 457899999999999999999999999999999999999999 999999999987654332 2234
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---C------------------CC
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---E------------------NP 229 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~------------------~~ 229 (421)
..+++.|+|||++.....++.++|||||||++|||++|.+||...+..+....+.. . .+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 56899999999876554578899999999999999999999987765443322210 0 00
Q ss_pred C-------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 230 ~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
. .+...++..+.+||.+||.++|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 0112457899999999999999999999999999997
No 221
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=2.2e-44 Score=342.14 Aligned_cols=254 Identities=33% Similarity=0.662 Sum_probs=214.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC---------HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~---------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
+|.+.+.||.|+||.||+|.+..+|+.||||.+..... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999999999999998754321 112456788999999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
..++||||+.+++|.+++++.+++++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cc--cccccccCccccCcccccCcC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-C----CCCCchHH
Q 014610 165 IS--RRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-N----PPQLDEHF 236 (421)
Q Consensus 165 ~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~-~----~~~~~~~~ 236 (421)
.. ......|+..|+|||++.... .++.++|+||||+++|+|++|..||...........+... . +......+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 11 123456899999999987543 4788999999999999999999999776655444332211 1 11222356
Q ss_pred HHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 237 s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+..+.++|.+||..+|.+|||++++|+|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
No 222
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=1.9e-44 Score=344.03 Aligned_cols=254 Identities=25% Similarity=0.439 Sum_probs=216.4
Q ss_pred hhCCCceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
..+++|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 346789999999999999999999987 788999999876655555677899999999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC---CEEEee
Q 014610 85 KLWIIMEYMAGGSVADLIQSGP-------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVAD 154 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g---~vkL~D 154 (421)
..++||||+.|++|.+++...+ .+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997643 589999999999999999999999999999999999998765 599999
Q ss_pred cccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCC
Q 014610 155 FGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (421)
Q Consensus 155 FGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 231 (421)
||++........ ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999876532211 111223456899999997764 8999999999999999996 999999887766666555444445
Q ss_pred CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 232 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.+..++..+.+|+.+||+.+|++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 556678899999999999999999999999986
No 223
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=2.1e-44 Score=356.15 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=213.4
Q ss_pred ccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC-
Q 014610 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ- 83 (421)
Q Consensus 6 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~- 83 (421)
...-....+|++++.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.++++++||||++++++|...
T Consensus 9 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 9 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred chhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 334456899999999999999999999999999999999986532 333456678899999999999999999988654
Q ss_pred -----CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 84 -----TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 84 -----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
...|+||||+. ++|.+.+... +++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5898888653 899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-----------
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------- 227 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~----------- 227 (421)
...... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...
T Consensus 166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCC-CCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 765432 122345789999999999776 4899999999999999999999999876643322221100
Q ss_pred -----------CC----CC----------------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 228 -----------NP----PQ----------------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 228 -----------~~----~~----------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+ .. .....+..+++||.+||+.||.+|||+.|+|.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 00 00 0113466789999999999999999999999999998543
No 224
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=2.2e-44 Score=349.87 Aligned_cols=245 Identities=25% Similarity=0.418 Sum_probs=192.7
Q ss_pred ceEeecCceEEEEEEECC--CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEEEEEEecCC
Q 014610 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYMA 94 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~--~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ 94 (421)
..||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.++++++||||+++++++.. +..+++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 589999999999999754 678999999865432 2457789999999999999999998864 567899999995
Q ss_pred CCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----ccCCCEEEeeccccccc
Q 014610 95 GGSVADLIQS---------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSAQL 161 (421)
Q Consensus 95 gg~L~~~l~~---------~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl----~~~g~vkL~DFGla~~~ 161 (421)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 588887742 1358899999999999999999999999999999999999 45678999999999765
Q ss_pred ccccc---cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---------HHHh---hccC
Q 014610 162 TRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------RVLF---IIPR 226 (421)
Q Consensus 162 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~---------~~~~---~i~~ 226 (421)
..... ......||+.|+|||++.+...++.++|||||||++|||++|.+||...... .... ....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43321 2234578999999999977556889999999999999999999999643211 0000 0000
Q ss_pred C-----------C----------------CC-------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 227 E-----------N----------------PP-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 227 ~-----------~----------------~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
. . .. ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0 00 0001124568899999999999999999999999998
No 225
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=5.3e-44 Score=338.37 Aligned_cols=251 Identities=32% Similarity=0.536 Sum_probs=213.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++.+.||+|+||.||+|++..+++.||||.+.... .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999876432 3444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988852 34589999999999999999999999999999999999999999999999999876654333
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC--HHHHHhhccCCCC-CCCchHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPRENP-PQLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~--~~~~~~~i~~~~~-~~~~~~~s~~l~~l 243 (421)
......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||.... .......+..... +.....++..+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 33456789999999998765 47889999999999999999999996543 2333333333222 23334678899999
Q ss_pred HHHHcccCCCCCcCHHHHHhC
Q 014610 244 VSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~h 264 (421)
|.+||..+|++|||+.++++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999873
No 226
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=5.1e-44 Score=338.73 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=216.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCC---CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.++|++.+.||+|+||+||+|.+..+ ...||||.++..........+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 36799999999999999999998754 458999998766666666788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
||||+++++|.+++... +.+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999998653 57899999999999999999999999999999999999999999999999999876422222
Q ss_pred cc--ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 168 RK--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 168 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
.. ...+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+........+..++..+.+++
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM 241 (266)
T ss_pred eeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11 22346789999998765 48899999999999999997 9999988877776666655444444556788999999
Q ss_pred HHHcccCCCCCcCHHHHHhC
Q 014610 245 SLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~h 264 (421)
.+||..+|++||++.+++++
T Consensus 242 ~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 242 LDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999875
No 227
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=1e-44 Score=356.09 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=214.7
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC-----C
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 84 (421)
+..+|++++.||+|+||+||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4678999999999999999999999999999999986532 223345677899999999999999999987654 3
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
.+|+|+||+. ++|.+++...+++++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 799999988889999999999999999999999999999999999999999999999999998765443
Q ss_pred cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhc--------------------
Q 014610 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------- 224 (421)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i-------------------- 224 (421)
........|+..|+|||.+.+...++.++|||||||++|+|++|.+||...+.......+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 333345678999999999876445889999999999999999999999765432211111
Q ss_pred -------cCCCCC---CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 225 -------PRENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 225 -------~~~~~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
...... .....++..+.+||.+||..+|++|||++++|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 1123467889999999999999999999999999999754
No 228
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=2.7e-44 Score=349.89 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=211.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcE----EEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~----vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
..+|++++.||+|+||.||+|.+..+|.. ||||++.........+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999998766654 8999987655555667899999999999999999999988764 578
Q ss_pred EEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999999764 4689999999999999999999999999999999999999999999999999986643222
Q ss_pred cc--cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 167 RR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
.. ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.........+........+..++..+.++
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred ceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 11 123346789999999765 48999999999999999997 999998877655544444444334445567889999
Q ss_pred HHHHcccCCCCCcCHHHHHhC
Q 014610 244 VSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~h 264 (421)
+.+||..+|++|||+.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999975
No 229
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=3e-44 Score=342.69 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=210.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||+|+||+||+|.+..+|+.||+|.+.... .......+..|+.+|++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999986533 222345667899999999999999999999999999999999999999
Q ss_pred HHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcc
Q 014610 99 ADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (421)
Q Consensus 99 ~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~ 176 (421)
.+++.+.+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......|+..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence 99997655 7999999999999999999999999999999999999999999999999998755431 22234568899
Q ss_pred ccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCC
Q 014610 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (421)
Q Consensus 177 y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 253 (421)
|+|||++.+.. ++.++|||||||++|+|++|+.||..... ...........+...+..++..+.++|.+||..+|.
T Consensus 160 y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 99999987765 88999999999999999999999976543 111122122233345556789999999999999999
Q ss_pred CCc-----CHHHHHhChhccccc
Q 014610 254 ERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 254 ~Rp-----t~~elL~hp~~~~~~ 271 (421)
+|| ++.+++.||||....
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCC
Confidence 999 999999999998654
No 230
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=8.3e-46 Score=358.95 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=225.3
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
.++||.|-||+||-|+++.+|+.||||+|++.. ......+++.|+.||.++.||.||.+-..|+..+.+++|||.+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 479999999999999999999999999997765 3445688999999999999999999999999999999999999 55
Q ss_pred CHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC---CCEEEeeccccccccccccccccc
Q 014610 97 SVADLIQ--SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 97 ~L~~~l~--~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~---g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
++.++|- ..++|++.....++.||+.||+|||.++|+|+||||+|||+... -++||||||+|+.+... ..+.++
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV 726 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence 7777663 35899999999999999999999999999999999999999754 47999999999887543 456788
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHhhccCCCCCCCchHHHHHHHHHHHHHccc
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 250 (421)
+|||.|+|||++++. +|+..-|+||.|||+|--|+|..||.+..+ .+.+....-..|+..+..++.++.+||+.+|+.
T Consensus 727 VGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV 805 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV 805 (888)
T ss_pred cCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence 999999999999886 599999999999999999999999976543 344444444567777889999999999999999
Q ss_pred CCCCCcCHHHHHhChhcccccCChhHHH
Q 014610 251 VPAERPSAKELLRHRFIRNARKSPRLLE 278 (421)
Q Consensus 251 dP~~Rpt~~elL~hp~~~~~~~~~~~~~ 278 (421)
.-.+|.|.++.|.|||+++-..+..+.+
T Consensus 806 km~kRysvdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 806 KMRKRYSVDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred HHHHhcchHhhccchhhhcchHHHHHHH
Confidence 9999999999999999997665554443
No 231
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-45 Score=338.70 Aligned_cols=253 Identities=26% Similarity=0.476 Sum_probs=214.8
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
.+.||+|+|+.|-.+++..+|.+||||++++.. .....++.+|++++.+++ |+||++++++|+++..+|||||.+.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 368999999999999999999999999998774 445678999999999995 999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC---CEEEeecccccccccc--c-----c
Q 014610 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQLTRT--I-----S 166 (421)
Q Consensus 97 ~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g---~vkL~DFGla~~~~~~--~-----~ 166 (421)
+|...|.+.+.++|.++..+.+.|+.||.|||.+||.||||||+|||-.+.. .||||||.+...+.-. . .
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9999999999999999999999999999999999999999999999996553 5899999987543211 1 1
Q ss_pred cccccccCccccCccccc----CcCCCCCccccHHHHHHHHHHHhCCCCCCCC-------C--------HHHHHhhccCC
Q 014610 167 RRKTFVGTPFWMAPEVIQ----NSEGYNEKADIWSLGITVIEMAKGEPPLADL-------H--------PMRVLFIIPRE 227 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGvil~ell~g~~pf~~~-------~--------~~~~~~~i~~~ 227 (421)
...+-+|+..|||||+.. ....|+.++|.||||||||.||+|.+||.+. + .......|..+
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 223568999999999863 2235889999999999999999999999643 1 12333455544
Q ss_pred CCC---CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 228 NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 228 ~~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
... .-+.++|.+++++|..+|..++.+|.++.++++|||+....
T Consensus 322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 432 23457899999999999999999999999999999998654
No 232
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-43 Score=364.60 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=210.4
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEE-EEe---C
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGS-YLH---Q 83 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~~---~ 83 (421)
.....+++|.++|.+|||+.||+|.+...|..||+|.+-.. .+..++.+.+||++|++|+ |+|||.+++. ... +
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 34456899999999999999999999998899999997555 6778899999999999997 9999999993 322 1
Q ss_pred ---CEEEEEEecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCEEEeecc
Q 014610 84 ---TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFG 156 (421)
Q Consensus 84 ---~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~--iiHrDlkp~NILl~~~g~vkL~DFG 156 (421)
-.++|+||||.||.|-+++.. ..+|+|.++++|++|+++|+++||... |||||||-|||||+.+|+.||||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 247899999999999999974 356999999999999999999999997 9999999999999999999999999
Q ss_pred ccccccccccccc---------ccccCccccCccccc--CcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc
Q 014610 157 VSAQLTRTISRRK---------TFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225 (421)
Q Consensus 157 la~~~~~~~~~~~---------~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~ 225 (421)
.|+.......... ...-|+.|+|||++. ...+.+.|+|||+|||+||-||....||...... .|.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIl 267 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AIL 267 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEE
Confidence 9875443322111 134799999999975 2334789999999999999999999999876432 233
Q ss_pred CCCCCCC-chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 226 RENPPQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 226 ~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
....... ...++..+++||+.||+.||++||++-|++.+-+.
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 3332222 24789999999999999999999999999976443
No 233
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=1.6e-44 Score=345.11 Aligned_cols=252 Identities=31% Similarity=0.480 Sum_probs=211.0
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
|++++.||.|++|.||+|.+..+|..||||++...... .....+.+|+.++++++||||+++++++.++...|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999998755422 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 94 AGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 94 ~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
+ ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 69999987655 79999999999999999999999999999999999999999999999999987654332223344
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC-------------------------
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------- 226 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~------------------------- 226 (421)
.+++.|+|||++.+...++.++||||||+++|+|++|.+||...+.......+..
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 6789999999887655578899999999999999999999987665433222110
Q ss_pred CCC---CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 227 ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 227 ~~~---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
... ......++..+.++|.+||+.+|.+|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 11123456789999999999999999999999999997
No 234
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=6.7e-44 Score=335.16 Aligned_cols=245 Identities=28% Similarity=0.489 Sum_probs=217.5
Q ss_pred ceEeecCceEEEEEEECCC---CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~---g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||.||+|.+... +..||+|++...........+.+|+.+++.++|+||+++++++.....+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999876 8999999997766555678899999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-
Q 014610 96 GSVADLIQSG---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (421)
Q Consensus 96 g~L~~~l~~~---------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~- 165 (421)
++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 789999999999999999999999999999999999999999999999999997665432
Q ss_pred -ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 166 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
.......+++.|+|||.+... .++.++|||||||++|+|++ |..||...........+........+..++.++.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 223345688999999998775 48999999999999999998 699999988777777776555555666778999999
Q ss_pred HHHHcccCCCCCcCHHHHHhC
Q 014610 244 VSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~h 264 (421)
+.+||..+|.+|||+.+++++
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
No 235
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=3.8e-44 Score=345.22 Aligned_cols=259 Identities=39% Similarity=0.684 Sum_probs=219.3
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
.|+....||+|+||.||+|.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 3444578999999999999999999999999986443 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccccc
Q 014610 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (421)
Q Consensus 94 ~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g 173 (421)
++++|.+++.. .++++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..............|
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 99999998865 57899999999999999999999999999999999999999999999999998655433323344678
Q ss_pred CccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC--CchHHHHHHHHHHHHHcccC
Q 014610 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~li~~~L~~d 251 (421)
++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+....+.. ....++..+.+++.+||..+
T Consensus 179 ~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 99999999987654 7889999999999999999999998876665544443222222 22346788999999999999
Q ss_pred CCCCcCHHHHHhChhcccccCChh
Q 014610 252 PAERPSAKELLRHRFIRNARKSPR 275 (421)
Q Consensus 252 P~~Rpt~~elL~hp~~~~~~~~~~ 275 (421)
|.+||++.++|+||||........
T Consensus 258 P~~R~~~~~ll~~~~~~~~~~~~~ 281 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAGPPSC 281 (292)
T ss_pred cccCcCHHHHhcChHHhccCCCcc
Confidence 999999999999999988765443
No 236
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=5.9e-44 Score=336.98 Aligned_cols=249 Identities=32% Similarity=0.545 Sum_probs=210.1
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHH-HHcCCCCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
++.||.|+||.||+|.+..+|+.||||++..... ......+..|..+ ...++||||+++++++..++.+|+|+||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 3679999999999999999999999999865432 2223344555554 445689999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccC
Q 014610 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (421)
Q Consensus 95 gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 174 (421)
+++|.+++...+.+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++..... .....|+
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT 156 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence 999999998888899999999999999999999999999999999999999999999999999865432 2345789
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC---CCCCchHHHHHHHHHHHHHcccC
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~li~~~L~~d 251 (421)
+.|+|||.+.+.. ++.++||||||+++|+|++|.+||...+.......+.... +......++..+.++|.+||..+
T Consensus 157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 9999999988764 7899999999999999999999998877766554443222 22333457899999999999999
Q ss_pred CCCCc---CHHHHHhChhccccc
Q 014610 252 PAERP---SAKELLRHRFIRNAR 271 (421)
Q Consensus 252 P~~Rp---t~~elL~hp~~~~~~ 271 (421)
|++|| +++|+|.||||++..
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcCC
Confidence 99999 458999999998754
No 237
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1.1e-43 Score=331.21 Aligned_cols=250 Identities=54% Similarity=0.965 Sum_probs=218.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
+|++.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+.++++++||||+++++.+......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 58899999999999999999999999999999866543 35678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 94 ~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 158 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV 158 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cccee
Confidence 999999999775 6899999999999999999999999999999999999999999999999999876654322 34567
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchH--HHHHHHHHHHHHccc
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKK 250 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~li~~~L~~ 250 (421)
|+..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....+..... ++..+.++|.+||..
T Consensus 159 ~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 899999999987664 78899999999999999999999988765555444433333333332 378899999999999
Q ss_pred CCCCCcCHHHHHhChh
Q 014610 251 VPAERPSAKELLRHRF 266 (421)
Q Consensus 251 dP~~Rpt~~elL~hp~ 266 (421)
||.+|||+.++|+|||
T Consensus 238 ~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 238 NPEKRPTAEQLLKHPF 253 (253)
T ss_pred ChhhCCCHHHHhcCCC
Confidence 9999999999999998
No 238
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=1.4e-43 Score=335.59 Aligned_cols=253 Identities=36% Similarity=0.680 Sum_probs=218.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC----CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 86 (421)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 58999999999999999999999999999999875432 234567888999999999999999999998764 568
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~- 165 (421)
++|+||+.+++|.+++...+++++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999987653211
Q ss_pred --ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-CCCCCchHHHHHHHH
Q 014610 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKE 242 (421)
Q Consensus 166 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~ 242 (421)
.......|+..|+|||++.+. .++.++|+|||||++|+|++|+.||...........+... ..+.++..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 111245689999999999775 4789999999999999999999999887666655544332 345567788999999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhc
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+|.+||. +|..|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
No 239
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=4.6e-44 Score=346.32 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=210.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcE--EEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~--vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 88 (421)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+...........+.+|+.++.++ +||||+++++++..++.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999999887764 5777765444455567888999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEE
Q 014610 89 IMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL 152 (421)
||||+++++|.+++.+.+ .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 999999999999996532 5789999999999999999999999999999999999999999999
Q ss_pred eecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCC
Q 014610 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (421)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 231 (421)
+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 166 ADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred CccccCcccchhh-hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 9999985332111 11122346679999998765 48899999999999999998 999998777666665554443334
Q ss_pred CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 232 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.+..++..+.+||.+||..+|++||+++++|.+
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 445578899999999999999999999999975
No 240
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=4.2e-44 Score=342.37 Aligned_cols=251 Identities=21% Similarity=0.367 Sum_probs=216.5
Q ss_pred CCceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
.+|++++.||+|+||.||+|.+.. .++.||||++...........+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 468999999999999999998754 367899999976655555677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEE
Q 014610 88 IIMEYMAGGSVADLIQS----------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~----------------~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vk 151 (421)
+++||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999999853 13588889999999999999999999999999999999999999999
Q ss_pred Eeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCC
Q 014610 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (421)
Q Consensus 152 L~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~ 228 (421)
|+|||++........ ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999876533211 122345678999999987654 8899999999999999998 999999888877777776666
Q ss_pred CCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 229 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
....+..++..+.+|+.+||+.+|.+||++++|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 666667789999999999999999999999999863
No 241
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=7.8e-44 Score=339.03 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=216.0
Q ss_pred hCCCceeeceEeecCceEEEEEEECCC-----CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
..++|++.+.||+|+||.||+|.+... +..||+|.+...........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 346899999999999999999998754 489999998655555556778899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeec
Q 014610 86 LWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DF 155 (421)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 99999999999999998642 24678899999999999999999999999999999999999999999999
Q ss_pred cccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCC
Q 014610 156 GVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (421)
Q Consensus 156 Gla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 232 (421)
|++....... .......++..|+|||.+.+. .++.++|||||||++|||++ |..||...+.......+........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 9987553321 122344578899999998765 48899999999999999998 9999988877776666655545555
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
+..++..+.++|.+||+.+|++|||+.+++.
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6667899999999999999999999999986
No 242
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=5.7e-44 Score=342.29 Aligned_cols=257 Identities=36% Similarity=0.628 Sum_probs=212.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++|+..+.||+|+||.||++.+..+|+.||||.+...........+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467888999999999999999999999999999876655556677889999999996 9999999999999999999999
Q ss_pred cCCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 92 YMAGGSVADLIQ-----SGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 92 ~~~gg~L~~~l~-----~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
|+. ++|.++.. ..+.+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 995 46655432 246799999999999999999999975 99999999999999999999999999987654332
Q ss_pred ccccccccCccccCcccccCc--CCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHhhccCCCCCCC----chHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQL----DEHFSR 238 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~----~~~~s~ 238 (421)
. .....|++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ......+....++.+ ...++.
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 163 A-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred c-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 1 2334689999999998765 3588999999999999999999999976542 222222222222222 234788
Q ss_pred HHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 239 ~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.+.+||.+||.++|++|||++++++||||+...
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 999999999999999999999999999997643
No 243
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=8e-44 Score=343.43 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=211.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCc--EEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~--~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 89 (421)
++|++.+.||+|+||.||+|.+..++. .+++|.+.........+.+.+|+.+++++ +||||+++++++.....+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 589999999999999999999987765 46888876444445567789999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEe
Q 014610 90 MEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~ 153 (421)
+||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999996532 48899999999999999999999999999999999999999999999
Q ss_pred ecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCC
Q 014610 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (421)
Q Consensus 154 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 232 (421)
|||++....... .......+..|+|||++.+. .++.++|||||||++|||++ |..||...........+........
T Consensus 162 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 162 DFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CcCCCcccccee-ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999986432211 11122335579999998765 48999999999999999997 9999998887776666655544445
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
+..++..+.+||.+||..+|.+|||++++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56688999999999999999999999999864
No 244
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=2.3e-43 Score=330.51 Aligned_cols=253 Identities=45% Similarity=0.810 Sum_probs=221.4
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 90 (421)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ....+.+.+|+.++++++||||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999866543 34568889999999999999999999999988 8999999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--cc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~ 168 (421)
||+++++|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999998877999999999999999999999999999999999999999999999999999876654432 13
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHhhccC-CCCCCCchHHHHHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPR-ENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~ 246 (421)
....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... .......+.. ...+.++..++..+++||.+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence 4467899999999987664 7899999999999999999999998765 2333333322 34445666778999999999
Q ss_pred HcccCCCCCcCHHHHHhChhc
Q 014610 247 CLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~hp~~ 267 (421)
||..+|.+||++.+++.||||
T Consensus 240 ~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 240 CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
No 245
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=1.1e-43 Score=334.65 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=210.9
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||+|+||.||+|.++. +..+|+|.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 579999999999999999998865 56899998764332 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-ccc
Q 014610 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~ 170 (421)
+++|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 999999999875 356899999999999999999999999999999999999999999999999998755332111 112
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
..++..|+|||++.+. .++.++||||||+++|+|++ |+.||...+..+....+........+...+..+.+++.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~ 239 (256)
T cd05114 161 AKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239 (256)
T ss_pred CCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 3456689999998765 48899999999999999999 999999888777777666554444455567889999999999
Q ss_pred cCCCCCcCHHHHHh
Q 014610 250 KVPAERPSAKELLR 263 (421)
Q Consensus 250 ~dP~~Rpt~~elL~ 263 (421)
.+|.+|||++++++
T Consensus 240 ~~p~~Rps~~~l~~ 253 (256)
T cd05114 240 EKPEGRPTFAELLR 253 (256)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999986
No 246
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=4.1e-44 Score=352.09 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=208.9
Q ss_pred hCCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEe-C
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-Q 83 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~ 83 (421)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.........+.+.+|+.+++++ +||||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4579999999999999999999754 345899999987655555567788999999999 89999999998765 4
Q ss_pred CEEEEEEecCCCCCHHHHHHcC----------------------------------------------------------
Q 014610 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------- 105 (421)
..++++|||+.+++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999998542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--cccccccCccccCc
Q 014610 106 ---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAP 180 (421)
Q Consensus 106 ---~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aP 180 (421)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2688999999999999999999999999999999999999999999999999976533211 12234567789999
Q ss_pred ccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHH-HhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCH
Q 014610 181 EVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (421)
Q Consensus 181 E~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 258 (421)
|++.+. .++.++|||||||++|||++ |..||......+. ...+........+..++..+.+++.+||+.+|++||++
T Consensus 245 E~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999776 48999999999999999997 9999976543222 22333333334445677889999999999999999999
Q ss_pred HHHHhC
Q 014610 259 KELLRH 264 (421)
Q Consensus 259 ~elL~h 264 (421)
.|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999985
No 247
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=1e-43 Score=336.31 Aligned_cols=249 Identities=26% Similarity=0.461 Sum_probs=214.6
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++.....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 457999999999999999999999999999999986432 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-c
Q 014610 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-R 168 (421)
Q Consensus 92 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-~ 168 (421)
|+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++......... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999998653 46899999999999999999999999999999999999999999999999998765432111 1
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
....+++.|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+........+..++..+.++|.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 163 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred CCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 122346789999998765 48899999999999999998 9999988777666666655545555667889999999999
Q ss_pred cccCCCCCcCHHHHHh
Q 014610 248 LKKVPAERPSAKELLR 263 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~ 263 (421)
|..+|++|||+.++++
T Consensus 242 l~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 242 WQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ccCCcccCCCHHHHHH
Confidence 9999999999999976
No 248
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-45 Score=357.43 Aligned_cols=240 Identities=32% Similarity=0.553 Sum_probs=210.4
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+...-++-||.|+-|.||+|+.. ++.||||.++ +.-..+|+.|++|+||||+.+.++|...-++||||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc--CceehhHHHh--------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 34445778999999999999877 8999999864 2224678999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
|..|-|..+++.+.+++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++..... ...-.++
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFa 272 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFA 272 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999998876554 3334689
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCCchHHHHHHHHHHHHHcccC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~li~~~L~~d 251 (421)
||..|||||++.+. +.+.|+|||||||+|||||||..||.+.+....+.-+-... -...+..+++-++=||++||...
T Consensus 273 GTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 99999999999876 58999999999999999999999999887765544332221 22345678889999999999999
Q ss_pred CCCCcCHHHHHhC
Q 014610 252 PAERPSAKELLRH 264 (421)
Q Consensus 252 P~~Rpt~~elL~h 264 (421)
|..||++.+||.|
T Consensus 352 pRNRPSFrqil~H 364 (904)
T KOG4721|consen 352 PRNRPSFRQILLH 364 (904)
T ss_pred CCCCccHHHHHHH
Confidence 9999999999998
No 249
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=8.8e-44 Score=341.85 Aligned_cols=255 Identities=24% Similarity=0.467 Sum_probs=216.3
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCC-----CcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEe
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 82 (421)
+...++|++.+.||+|+||.||+|.+... ...||+|.+...........+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34457899999999999999999988644 3789999987665555667789999999999 89999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQS----------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~----------------~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~ 146 (421)
++.+++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999999854 246889999999999999999999999999999999999999
Q ss_pred CCCEEEeeccccccccccccc--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhh
Q 014610 147 NGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (421)
Q Consensus 147 ~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~ 223 (421)
++.+||+|||++......... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999998765432111 1122356789999998765 48899999999999999997 9999998877666665
Q ss_pred ccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 224 i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
+........+..++..+.+|+.+||..+|++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 55544444455678899999999999999999999999975
No 250
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=1.4e-43 Score=340.21 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=213.6
Q ss_pred CCCceeeceEeecCceEEEEEEE-----CCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
..+|.+.+.||+|+||+||++.+ ..++..||+|.+.... ......+.+|+.++++++||||+++++++...+.+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35799999999999999999985 3356779999886543 34467789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEe
Q 014610 87 WIIMEYMAGGSVADLIQSGP-------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~-------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~ 153 (421)
++||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999997533 48999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCC
Q 014610 154 DFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP 230 (421)
Q Consensus 154 DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 230 (421)
|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+......
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875532211 11233467889999998765 48899999999999999998 99999888877766666665555
Q ss_pred CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 231 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+..++..+.+|+.+||..||.+|||+.+++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 555667889999999999999999999999965
No 251
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=1.3e-43 Score=332.88 Aligned_cols=251 Identities=35% Similarity=0.558 Sum_probs=223.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+|++.+.||+|+||.||++.+..+++.||||.+.... .......+.+|+.++++++||||+++++++......|+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987543 334456778999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 93 MAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 93 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
+++++|.+++.+ ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 999999999865 457899999999999999999999999999999999999999999999999998766443 22
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
....|++.|++||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.....+.++..++.+++++|.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 345789999999999775 4788999999999999999999999988876666666666666666788999999999999
Q ss_pred ccCCCCCcCHHHHHhChhc
Q 014610 249 KKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~hp~~ 267 (421)
..+|++|||+.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999974
No 252
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=3.2e-43 Score=332.60 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=212.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999886432 2334577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 35689999999999999999999999999999999999999999999999999876544333
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC--HHHHHhhccCCCCCCCch-HHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPRENPPQLDE-HFSRLMKEF 243 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~-~~s~~l~~l 243 (421)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.... .......+.....+..+. .++..+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 33456789999999998765 48899999999999999999999996543 223333333333333333 678899999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
|.+||..+|++|||+.+|++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999985
No 253
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=2.8e-44 Score=340.08 Aligned_cols=247 Identities=32% Similarity=0.585 Sum_probs=210.1
Q ss_pred eeeceEeecCceEEEEEEEC----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 16 SSLELIGRGSFGDVYKAFDK----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 16 ~~~~~LG~G~~g~Vy~a~~~----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
++.+.||.|+||.||+|... ..+..|+||.+.........+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999988 45778999999766666668899999999999999999999999998888999999
Q ss_pred cCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc--ccc
Q 014610 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISR 167 (421)
Q Consensus 92 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~--~~~ 167 (421)
||.+|+|.+++... ..+++..+..++.||+.||.|||+++++|+||++.|||++.++.+||+|||++...... ...
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999876 68999999999999999999999999999999999999999999999999998766221 112
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....+...|+|||.+.... ++.++||||||+++|||++ |+.||.+.+.......+........+..++..+.++|..
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp STTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence 23345778899999997764 8999999999999999999 789999998888777776666666677789999999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||..+|.+|||+.+|++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999985
No 254
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=5.3e-44 Score=336.75 Aligned_cols=249 Identities=33% Similarity=0.562 Sum_probs=215.2
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||.|+||.||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++.+..+...|+|+||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999865432 24567888999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--------cccc
Q 014610 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--------RRKT 170 (421)
Q Consensus 99 ~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--------~~~~ 170 (421)
.+++.+.+.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999999999999999875433211 2234
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchH--HHHHHHHHHHHHc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCL 248 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~li~~~L 248 (421)
..+++.|+|||.+.... ++.++||||||+++|+|++|..||...........+..... ..+.. ++..+.+||.+||
T Consensus 161 ~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 238 (265)
T cd05579 161 IVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLL 238 (265)
T ss_pred cccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHh
Confidence 57889999999987764 78899999999999999999999988877666555543222 22222 4889999999999
Q ss_pred ccCCCCCcCH---HHHHhChhccccc
Q 014610 249 KKVPAERPSA---KELLRHRFIRNAR 271 (421)
Q Consensus 249 ~~dP~~Rpt~---~elL~hp~~~~~~ 271 (421)
+.+|.+|||+ .++|+||||+++.
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccCCC
Confidence 9999999999 9999999998653
No 255
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=1.6e-43 Score=337.81 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=212.5
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCc----EEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
...+|++++.||+|+||+||+|.+..+|. .||+|++...........+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 35789999999999999999999877776 4899998766666667789999999999999999999998875 457
Q ss_pred EEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
++++||+++|+|.+++..+ +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 8999999999999999763 579999999999999999999999999999999999999999999999999987654322
Q ss_pred ccc--cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHH
Q 014610 166 SRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (421)
Q Consensus 166 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 242 (421)
... ....+++.|+|||.+.+. .++.++|||||||++|||++ |..||...........+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 111 122356789999998765 48899999999999999998 99999877666555555444444445567889999
Q ss_pred HHHHHcccCCCCCcCHHHHHh
Q 014610 243 FVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~ 263 (421)
++.+||..||++||++.+++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
No 256
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=3.7e-44 Score=351.66 Aligned_cols=259 Identities=26% Similarity=0.446 Sum_probs=214.5
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe----CCE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTK 85 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~ 85 (421)
++.+|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 46899999999999999999999999999999999865432 2345677889999999999999999998763 457
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+++||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.+|.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 6999999877889999999999999999999999999999999999999999999999999987654322
Q ss_pred cc----ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---------------
Q 014610 166 SR----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------- 226 (421)
Q Consensus 166 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~--------------- 226 (421)
.. .....|+..|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 21 12357899999999987655588999999999999999999999987654332211100
Q ss_pred ----------CCCCC-----CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 227 ----------ENPPQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 227 ----------~~~~~-----~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
..... +....+..+.++|.+||+.+|.+|||+++++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00001 112357889999999999999999999999999999754
No 257
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=1e-43 Score=347.63 Aligned_cols=255 Identities=32% Similarity=0.561 Sum_probs=207.0
Q ss_pred eceEeec--CceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 18 LELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 18 ~~~LG~G--~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
...||+| +||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||++++++|..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 99999999999999999999987654 34456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc---
Q 014610 95 GGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK--- 169 (421)
Q Consensus 95 gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~--- 169 (421)
+++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++++|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 3589999999999999999999999999999999999999999999999986543322111111
Q ss_pred ----ccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC---------------
Q 014610 170 ----TFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--------------- 229 (421)
Q Consensus 170 ----~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~--------------- 229 (421)
...++..|+|||++.+. ..++.++|||||||++|+|++|.+||................+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 12356679999998753 3478899999999999999999999987654333222111100
Q ss_pred -------------------------------CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 230 -------------------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 230 -------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
......++..+.+||.+||+.||++|||+.|+|+||||+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0112346778999999999999999999999999999986543
No 258
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=5.2e-44 Score=337.29 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=216.5
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
...+|++.+.||.|+||.||+|.+.. ++.||+|++..... .....+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 45689999999999999999999988 89999999865542 23567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 99999999999975 3568999999999999999999999999999999999999999999999999987654332222
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
....++..|+|||.+... .++.++||||||+++|+|++ |..||...+.......+........+..++..+.++|.+|
T Consensus 162 ~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 162 SDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred cCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence 234467789999998765 48899999999999999998 8999988877766666655444455567788999999999
Q ss_pred cccCCCCCcCHHHHHh
Q 014610 248 LKKVPAERPSAKELLR 263 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~ 263 (421)
|..+|.+|||+.++++
T Consensus 241 l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 241 WAAEPEDRPSFKALRE 256 (261)
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999986
No 259
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-46 Score=359.09 Aligned_cols=264 Identities=25% Similarity=0.512 Sum_probs=238.7
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
.+...++++++..||-|+||.|=++........+|+|++++.. ...+.+++..|..||..++.|+||++|--|.+.+.
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 4455678899999999999999999877666679999987665 34567889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+|++||-|-||.|+..++..+.+.+..+++++..+++|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCCchHHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFV 244 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~li 244 (421)
.+..++||||.|+|||++.+. +.+.++|.||||+++||||+|.+||.+.+++..+..|.++. ...+|..++..+.++|
T Consensus 574 ~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 566789999999999999987 48999999999999999999999999999999999887653 3455678899999999
Q ss_pred HHHcccCCCCCcC-----HHHHHhChhcccccCC
Q 014610 245 SLCLKKVPAERPS-----AKELLRHRFIRNARKS 273 (421)
Q Consensus 245 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~~~~ 273 (421)
+++...+|.+|.. +.+|-+|.||....+.
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 9999999999985 8999999999876543
No 260
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=1.6e-43 Score=335.75 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=213.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCC---cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g---~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..+|++.+.||+|+||.||+|.+..++ ..||+|.++..........+.+|+.++++++||||+++++++..++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 468999999999999999999987544 37999998765555566788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999999764 56899999999999999999999999999999999999999999999999998765433221
Q ss_pred cc---ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 168 RK---TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 168 ~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
.. ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||......+....+........+..++..+.++
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL 241 (267)
T ss_pred eeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHH
Confidence 11 12235689999999765 48999999999999999886 999998877666655555444334445678899999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
+.+||+++|.+||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 242 MLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHcccCchhCCCHHHHHH
Confidence 99999999999999999986
No 261
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=1e-43 Score=343.44 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=205.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC------
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------ 84 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 84 (421)
-++|++++.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 3579999999999999999999999999999998865432 222345678999999999999999999887643
Q ss_pred --EEEEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 85 --KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 85 --~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
..++||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4599999995 5888877653 47899999999999999999999999999999999999999999999999998765
Q ss_pred ccccc----cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---CCC-----
Q 014610 162 TRTIS----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENP----- 229 (421)
Q Consensus 162 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~~~----- 229 (421)
..... ......++..|+|||++.+...++.++||||||+++|+|++|.+||...+.......+.. ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 43221 112356788999999987655578899999999999999999999987765433221110 000
Q ss_pred --------------CC----C-----chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 230 --------------PQ----L-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 230 --------------~~----~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.. . ....+..+.+||.+||..||.+|||++|+|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 0 00124567899999999999999999999999998
No 262
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=5.2e-44 Score=349.55 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=217.7
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-----EEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 87 (421)
+|++.+.||.|++|.||+|++..+|+.||||.+..... ....+.+.+|+.++++++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999865432 344577899999999999999999999988775 789
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc--
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-- 165 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-- 165 (421)
+||||+. ++|.+++.++.++++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 5899999887899999999999999999999999999999999999999999999999999998765432
Q ss_pred -ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC---------------
Q 014610 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--------------- 229 (421)
Q Consensus 166 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~--------------- 229 (421)
.......+++.|+|||++.+...++.++|+||||+++|+|++|.+||...+.......+.....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1233457899999999998764688999999999999999999999987765443332211000
Q ss_pred ---------------CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 230 ---------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 230 ---------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
......++..+.+||.+||+++|++|||+.+++.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 001123567899999999999999999999999999998654
No 263
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=9.1e-44 Score=348.85 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=214.5
Q ss_pred hhCCCceee-ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHH-------------HHHHHHHHHHHHHcCCCCCeeE
Q 014610 10 AAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-------------EIEDIQKEISVLSQCRSPYITE 75 (421)
Q Consensus 10 ~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~-------------~~~~~~~E~~il~~l~hpnIv~ 75 (421)
...++|..+ +.||.|+||+||+|.+..+++.||||++....... ....+.+|+.++++++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 456788765 67999999999999999999999999986543211 0124778999999999999999
Q ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeec
Q 014610 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (421)
Q Consensus 76 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DF 155 (421)
+++++..++..++||||+. |+|.+++.....+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999996 699999988788999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--------------ccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 014610 156 GVSAQLTR--------------TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (421)
Q Consensus 156 Gla~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~ 221 (421)
|++..... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99875541 1111223457889999999876655788999999999999999999999887765544
Q ss_pred hhccC---CC---------------------CCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 222 FIIPR---EN---------------------PPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 222 ~~i~~---~~---------------------~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
..+.. .. +.. .....+..+.++|.+||..+|++|||++++|.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 32210 00 000 012346789999999999999999999999999999754
No 264
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=4.7e-44 Score=340.35 Aligned_cols=253 Identities=30% Similarity=0.527 Sum_probs=220.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 89 (421)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++++. ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999986533 2334577889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc----
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---- 165 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~---- 165 (421)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987654322
Q ss_pred ----------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC
Q 014610 166 ----------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229 (421)
Q Consensus 166 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~ 229 (421)
.......|+..|+|||++.+.. ++.++|+||||+++++|++|..||...........+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-E 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-C
Confidence 2223456889999999987654 788999999999999999999999987765554444322 2
Q ss_pred CCCchHHHHHHHHHHHHHcccCCCCCcCH----HHHHhChhc
Q 014610 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSA----KELLRHRFI 267 (421)
Q Consensus 230 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~elL~hp~~ 267 (421)
..++..++..+.+||.+||..+|.+|||+ .++|+||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 23445678899999999999999999999 999999997
No 265
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=8e-44 Score=345.39 Aligned_cols=253 Identities=24% Similarity=0.425 Sum_probs=205.2
Q ss_pred CceeeceEeecCceEEEEEEECC--CCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~--~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 87 (421)
+|++.+.||+|+||.||+|.+.. +++.||||.+.... .......+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987632 122345678899999999999999999999988 8899
Q ss_pred EEEecCCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc----CCCEEEeecccc
Q 014610 88 IIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE----NGDVKVADFGVS 158 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~----~g~vkL~DFGla 158 (421)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 77776642 237899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccc---cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---------HH----h
Q 014610 159 AQLTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---------VL----F 222 (421)
Q Consensus 159 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~---------~~----~ 222 (421)
........ .....++++.|+|||++.+...++.++|||||||++|+|++|++||....... .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543322 12345789999999998776568899999999999999999999997554321 00 0
Q ss_pred hcc------------------------CCCCC--CCch------HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 223 IIP------------------------RENPP--QLDE------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 223 ~i~------------------------~~~~~--~~~~------~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.+. ....+ .+.. ..+..+.++|.+||..||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 00000 0000 345678999999999999999999999999998
No 266
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=2.1e-43 Score=339.13 Aligned_cols=249 Identities=26% Similarity=0.454 Sum_probs=211.7
Q ss_pred CceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...........+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2367999998766555566789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 014610 89 IMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl 144 (421)
|+||+.+|+|.+++... .++++..+..++.|++.||.|||+++++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998642 347889999999999999999999999999999999999
Q ss_pred ccCCCEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014610 145 TENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (421)
Q Consensus 145 ~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~ 221 (421)
++++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.........
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999875533221 11233567789999998765 48899999999999999998 99999888777666
Q ss_pred hhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 222 ~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+........+..++..+.+|+..||+.+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 555444334445667889999999999999999999999986
No 267
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.8e-43 Score=342.54 Aligned_cols=252 Identities=23% Similarity=0.430 Sum_probs=212.7
Q ss_pred CCCceeeceEeecCceEEEEEEECC-------CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 83 (421)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.+ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4789999999999999999998753 23579999987655555567788999999999 799999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~ 147 (421)
+..|+||||+.+|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999999997532 47889999999999999999999999999999999999999
Q ss_pred CCEEEeeccccccccccccc--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhc
Q 014610 148 GDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (421)
Q Consensus 148 g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i 224 (421)
+.+||+|||++......... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+.......+
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 255 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 99999999998755322111 1122345789999998775 48899999999999999998 89999887766655555
Q ss_pred cCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 225 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
........+..++.++.+||.+||..+|.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 256 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5444445556778999999999999999999999999874
No 268
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=4.2e-43 Score=341.23 Aligned_cols=262 Identities=44% Similarity=0.789 Sum_probs=220.3
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
...+.|...+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++.+....|
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34456888899999999999999999999999999986543 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+||||+. |+|.+++.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 9999995 577777654 5679999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCC-CCchHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP-QLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~l 243 (421)
......|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+.....+ .....++..+++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 2235678999999999852 234788999999999999999999999888766655554433332 2334577889999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhcccccCChhH
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~ 276 (421)
|.+||+.+|.+||++.+++.||||+.......+
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~ 285 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDRPARVL 285 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCchhHHH
Confidence 999999999999999999999999876544443
No 269
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.6e-43 Score=355.06 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=208.8
Q ss_pred CCCceeeceEeecCceEEEEEEECCC-----CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 85 (421)
.++|++.+.||+|+||.||+|.+... +..||||++.........+.+.+|+.+|+++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56888999999999999999987533 35799999976655555678999999999996 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcC------------------------------------------------------------
Q 014610 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~------------------------------------------------------------ 105 (421)
+|||||||++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988542
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 014610 106 ------------------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (421)
Q Consensus 106 ------------------------------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~ 149 (421)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 24778889999999999999999999999999999999999999
Q ss_pred EEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHH-Hhhcc
Q 014610 150 VKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIP 225 (421)
Q Consensus 150 vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~-~~~i~ 225 (421)
+||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|||++ |..||........ ...+.
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 99999999876533211 12234577889999998775 48999999999999999997 9999987543332 22333
Q ss_pred CCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 226 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.......+..++..+.+++.+||..+|++|||+.+|.+
T Consensus 355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33333445567889999999999999999999999876
No 270
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=1.4e-43 Score=349.02 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=217.6
Q ss_pred ccccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe
Q 014610 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (421)
Q Consensus 4 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 82 (421)
+........++|++++.||+|+||.||+|.+..+|..||||.+.... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 44556667899999999999999999999999999999999986433 23334668899999999999999999999876
Q ss_pred CC------EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecc
Q 014610 83 QT------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (421)
Q Consensus 83 ~~------~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFG 156 (421)
.. ..++||||+ +++|.+++.. .++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 54 458999999 7799998875 679999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC--------
Q 014610 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------- 228 (421)
Q Consensus 157 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-------- 228 (421)
++...... .....+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+.......+....
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98765332 2345789999999998764457889999999999999999999998766543332211100
Q ss_pred -------------------C---CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 229 -------------------P---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 229 -------------------~---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
+ ..+...++..+.++|.+||..||.+|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 011124567799999999999999999999999999998653
No 271
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1.7e-43 Score=334.91 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=211.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++.+.||+|+||.||+|++..+++.||||.+.... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999876533 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 91 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 45689999999999999999999999999999999999999999999999999876544333
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHHhhccCCCCC-CCchHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPP-QLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~--~~~~~~i~~~~~~-~~~~~~s~~l~~l 243 (421)
......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ......+.....+ .....++..++++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 33456799999999998765 478899999999999999999999975433 2222333222222 2234678899999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
|.+||..+|.+|||+.+|++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhcCCCcccCCCHHHHHH
Confidence 99999999999999998875
No 272
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-46 Score=392.41 Aligned_cols=261 Identities=37% Similarity=0.665 Sum_probs=231.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.+.-++.-.-.||.|.||.||.|.+..+|...|+|-+..... ......+.+|..++..++|||+|++|++-.+++.++|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344566777899999999999999999999999998876653 3346788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc---
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--- 165 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~--- 165 (421)
.||||+||+|.+++..++-.+|...+.+-.|++.|++|||++|||||||||.||||+.+|-+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 99999999999999998888888999999999999999999999999999999999999999999999997765442
Q ss_pred -ccccccccCccccCcccccCcC--CCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHhhccCCCCCCCchHHHHHHH
Q 014610 166 -SRRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMK 241 (421)
Q Consensus 166 -~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~l~ 241 (421)
+......|||.|||||++.+.. +...++|||||||++.||+||+.||...+. -...+.+..+..|++|..++.+.+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 2335678999999999997653 456789999999999999999999987654 455566667778899999999999
Q ss_pred HHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 242 EFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+||.+||..||.+|.++.|||+|.|-+..
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999999999999999999887654
No 273
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=2.4e-43 Score=332.60 Aligned_cols=243 Identities=24% Similarity=0.412 Sum_probs=208.1
Q ss_pred ceEeecCceEEEEEEE--CCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFD--KELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~--~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999965 4568899999986544 2344677899999999999999999999875 5567999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc---ccccc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFV 172 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~---~~~~~ 172 (421)
|+|.+++.....+++..+..++.|++.||+|||++|++||||||.|||++.++.+||+|||++......... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988788999999999999999999999999999999999999999999999999998765433221 11223
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
+++.|+|||.+... .++.++|||||||++|||++ |..||...+.......+.....+..+..++.++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 46789999998765 47889999999999999997 99999988877777777666656666778999999999999999
Q ss_pred CCCCcCHHHHHh
Q 014610 252 PAERPSAKELLR 263 (421)
Q Consensus 252 P~~Rpt~~elL~ 263 (421)
|++||++++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999865
No 274
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3e-44 Score=354.34 Aligned_cols=263 Identities=26% Similarity=0.475 Sum_probs=226.3
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
+-.+-|..++.||-|+||.|.+++..+|...||+|.+.+.+ ...++..++.|.+||..-+++.||+||..|++.+++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34567899999999999999999999999999999987665 3566788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~- 166 (421)
+||+|+.||++-.+|.+-+-|.|..+++++.+|..|+++.|..|+|||||||+|||||.+|++||.||||+..+.-...
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999865421000
Q ss_pred -----------------------------------------cccccccCccccCcccccCcCCCCCccccHHHHHHHHHH
Q 014610 167 -----------------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205 (421)
Q Consensus 167 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~el 205 (421)
.....+||+.|+|||++... +|+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHH
Confidence 01245799999999999875 599999999999999999
Q ss_pred HhCCCCCCCCCHHHHHhhccCCC-CCCC--chHHHHHHHHHHHHHcccCCCCCc---CHHHHHhChhcccccCCh
Q 014610 206 AKGEPPLADLHPMRVLFIIPREN-PPQL--DEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKSP 274 (421)
Q Consensus 206 l~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l~~li~~~L~~dP~~Rp---t~~elL~hp~~~~~~~~~ 274 (421)
+.|++||-+..+.+...++.++. ...+ ..+++.++.++|.+++ .+++.|+ .++||..||||+.+....
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence 99999999888777666554432 2222 3478999999998865 4568887 578899999999876554
No 275
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=2.3e-43 Score=333.12 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=212.1
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++++.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++.+...+..++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 35789999999999999999998754 67899998754332 3567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-c
Q 014610 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 167 (421)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999999865 35688999999999999999999999999999999999999999999999999976543221 1
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||++.... ++.++|||||||++|+|++ |..||...........+...........++..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 12234677899999987654 7889999999999999998 999998887766666655444444445678899999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||..+|++|||++++++
T Consensus 240 ~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 240 CWKEKAEERPTFDYLQS 256 (261)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
No 276
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=2.1e-43 Score=335.60 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=204.3
Q ss_pred CCCceeeceE--eecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELI--GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~L--G~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 88 (421)
.++|++.+.+ |+|+||.||++.++.+++.+|+|.+....... .|+.....+ +||||+++++++..++..|+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 4678888877 99999999999999999999999986543211 122222222 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-CEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 167 (421)
||||+++++|.+++....++++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999999998877999999999999999999999999999999999999999988 9999999998755322
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HHhhccCCCCCCCchHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-----VLFIIPRENPPQLDEHFSRLMKE 242 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~s~~l~~ 242 (421)
....|++.|+|||++.+. .++.++|||||||++|+|++|..||....... ..... .........++..+.+
T Consensus 164 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNAND 239 (267)
T ss_pred -ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHH
Confidence 345789999999999775 48899999999999999999999997543221 11111 2222344568899999
Q ss_pred HHHHHcccCCCCCcC-HHHHHhChhccc
Q 014610 243 FVSLCLKKVPAERPS-AKELLRHRFIRN 269 (421)
Q Consensus 243 li~~~L~~dP~~Rpt-~~elL~hp~~~~ 269 (421)
||.+||+.+|.+||+ ++|+|+||||++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999996 599999999963
No 277
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=2.3e-43 Score=375.38 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=207.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+++.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999986543 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 91 EYMAGGSVADLIQSG-----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 91 E~~~gg~L~~~l~~~-----------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988631 235567788999999999999999999999999999999999999999999997
Q ss_pred cccccc------------------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 014610 160 QLTRTI------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (421)
Q Consensus 160 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~ 221 (421)
...... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 652110 0112357999999999998764 899999999999999999999999875544333
Q ss_pred hhccCCCCCCC--chHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 222 FIIPRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 222 ~~i~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.......+... ...++..+.+++.+||..||++|++..+.+.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22211111111 23567889999999999999999887766654
No 278
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=3e-43 Score=336.46 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=209.7
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCc----EEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
.++|++++.||+|+||+||+|.+..+|+ .|++|.+...........+..|+.+++++.||||+++++++. +...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 3689999999999999999999987776 477777754444445577888999999999999999999875 45678
Q ss_pred EEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+|+||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999999999975 46789999999999999999999999999999999999999999999999999876533211
Q ss_pred --cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 167 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
......|+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.........+........+...+..+.++
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV 243 (279)
T ss_pred ccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHH
Confidence 112345778899999997664 8999999999999999998 999998887766555555444444445567788999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
+.+||..+|++|||+.|+++
T Consensus 244 i~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999976
No 279
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=3.9e-43 Score=331.00 Aligned_cols=243 Identities=24% Similarity=0.406 Sum_probs=208.0
Q ss_pred ceEeecCceEEEEEEECCCC---cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g---~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.++++++||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876654 7999999876665455678899999999999999999999875 5568999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc---ccc
Q 014610 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK---TFV 172 (421)
Q Consensus 96 g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~---~~~ 172 (421)
|+|.+++.....+++..+..++.|++.||+|||.++++||||||+|||++.++.+||+|||++........... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 99999998878899999999999999999999999999999999999999999999999999876543322111 112
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~d 251 (421)
++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+....+...+..++..++++|.+||..+
T Consensus 160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 160 WPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred ccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 34679999998765 48999999999999999997 99999988877766666555555556677899999999999999
Q ss_pred CCCCcCHHHHHh
Q 014610 252 PAERPSAKELLR 263 (421)
Q Consensus 252 P~~Rpt~~elL~ 263 (421)
|++|||+.++++
T Consensus 239 p~~Rp~~~~l~~ 250 (257)
T cd05060 239 PEDRPTFSELES 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
No 280
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=3.6e-43 Score=337.90 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=211.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCCC----------------cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELN----------------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g----------------~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 75 (421)
.++|++++.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999877544 5689999887666666788999999999999999999
Q ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 014610 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-----------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (421)
Q Consensus 76 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl 144 (421)
+++++..+...++|||++.+++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999997655 78999999999999999999999999999999999999
Q ss_pred ccCCCEEEeeccccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh--CCCCCCCCCHHHH
Q 014610 145 TENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRV 220 (421)
Q Consensus 145 ~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~--g~~pf~~~~~~~~ 220 (421)
+.++.++|+|||++....... .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||...+....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 999999999999987543221 1123445778999999987654 8999999999999999998 7889887766554
Q ss_pred HhhccCC-------CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 221 LFIIPRE-------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 221 ~~~i~~~-------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
...+... .....+..++.++.+++.+||+.||.+|||+.||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 4433211 111223356789999999999999999999999975
No 281
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=3e-43 Score=332.05 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=210.6
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++++.||+|+||+||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++.....+++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 579999999999999999998764 45699998864432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-ccc
Q 014610 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~ 170 (421)
+.+|+|.+++... ..+++..+..++.||+.||+|||++|++|+||||+|||++.++.+||+|||++......... ...
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999999763 47899999999999999999999999999999999999999999999999998755332111 112
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
..++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+........+...+..+.+++.+||.
T Consensus 161 ~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05113 161 SKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239 (256)
T ss_pred CccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 23567799999997654 8899999999999999998 999998887766666665554444455678899999999999
Q ss_pred cCCCCCcCHHHHHhC
Q 014610 250 KVPAERPSAKELLRH 264 (421)
Q Consensus 250 ~dP~~Rpt~~elL~h 264 (421)
.+|.+|||+.+|+.+
T Consensus 240 ~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 240 EKAEERPTFQQLLSS 254 (256)
T ss_pred CCcccCCCHHHHHHh
Confidence 999999999999864
No 282
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=1.3e-43 Score=349.09 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=210.3
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC-------
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------- 83 (421)
.+++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 46899999999999999999999999999999999866543 3456788999999999999999999876653
Q ss_pred -------CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeec
Q 014610 84 -------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADF 155 (421)
Q Consensus 84 -------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DF 155 (421)
...|+||||+. ++|.+++.. .++++..++.++.||+.||.|||++|++||||||+||+++. ++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999996 599998865 57999999999999999999999999999999999999975 467899999
Q ss_pred ccccccccccc---cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----
Q 014610 156 GVSAQLTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---- 228 (421)
Q Consensus 156 Gla~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~---- 228 (421)
|++........ ......|+..|+|||++.....++.++|||||||++|+|++|..||...+.......+....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876532211 11224688999999987665568889999999999999999999998776544333221110
Q ss_pred --------------------CCC-----CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 229 --------------------PPQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 229 --------------------~~~-----~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
... +...++.++.+||.+||..||.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000 112356789999999999999999999999999999743
No 283
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=3.7e-43 Score=333.49 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=207.8
Q ss_pred ceeeceEeecCceEEEEEEECCCCc--EEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC------CE
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TK 85 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~--~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~ 85 (421)
|.+.+.||+|+||.||+|.+..++. .||||.++... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999987775 69999986543 345567889999999999999999999976432 24
Q ss_pred EEEEEecCCCCCHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 86 LWIIMEYMAGGSVADLIQS------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~------~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
.++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999999999998742 2358999999999999999999999999999999999999999999999999987
Q ss_pred ccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHH
Q 014610 160 QLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHF 236 (421)
Q Consensus 160 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 236 (421)
....... ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||...........+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6543211 11233567789999998765 48999999999999999998 89999887776666666555544455567
Q ss_pred HHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 237 s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
+..+.++|.+||+.+|++|||+.+|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8889999999999999999999999864
No 284
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=5.7e-43 Score=331.70 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=214.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCc---EEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.++|+..+.||+|+||.||+|.+..++. .||||.+.........+.+..|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4689999999999999999999886655 7999998766555556788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
||||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999999999975 367899999999999999999999999999999999999999999999999998765432211
Q ss_pred cc---ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 168 RK---TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 168 ~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
.. ....++.|+|||++... .++.++|||||||++|||++ |..||...+..+....+...........++..+.++
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 242 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL 242 (268)
T ss_pred ceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11 11234579999998765 47899999999999999997 999998887777666665444434445678889999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
+.+||..+|++||++.++++
T Consensus 243 i~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 243 MLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999986
No 285
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=4.9e-43 Score=330.96 Aligned_cols=242 Identities=25% Similarity=0.417 Sum_probs=206.1
Q ss_pred eEeecCceEEEEEEEC--CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCC
Q 014610 20 LIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~--~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 97 (421)
.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999875 4466799999876655555677999999999999999999999875 457899999999999
Q ss_pred HHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc---ccccc
Q 014610 98 VADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---KTFVG 173 (421)
Q Consensus 98 L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~---~~~~g 173 (421)
|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9999874 4579999999999999999999999999999999999999999999999999987543322111 11223
Q ss_pred CccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+...+.++.++|.+||..+|
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 161 PLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 5789999998765 48899999999999999996 999999888877776666666566667778999999999999999
Q ss_pred CCCcCHHHHHh
Q 014610 253 AERPSAKELLR 263 (421)
Q Consensus 253 ~~Rpt~~elL~ 263 (421)
++||++.++++
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05115 240 EDRPNFAKVEE 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
No 286
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=6e-43 Score=330.48 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=211.9
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++.+.||+|++|.||+|.+.. ++.||||.+..... ....+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45789999999999999999999764 57899999865432 2466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-
Q 014610 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~- 167 (421)
||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999999997643 6899999999999999999999999999999999999999999999999998766432111
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||++.+. .++.++||||||+++|+|++ |+.||...+.......+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 1112234579999998765 48899999999999999999 999999888777666665554444455678899999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||..+|.+||++.++++
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999975
No 287
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=3.7e-43 Score=346.29 Aligned_cols=261 Identities=21% Similarity=0.398 Sum_probs=214.6
Q ss_pred cccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC
Q 014610 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (421)
Q Consensus 5 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 83 (421)
.+....+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3445667899999999999999999999999999999999986543 223346678899999999999999999988653
Q ss_pred ------CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccc
Q 014610 84 ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 84 ------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGl 157 (421)
...|++++++ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3478899988 7899998865 5799999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC----------
Q 014610 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------- 227 (421)
Q Consensus 158 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~---------- 227 (421)
+..... ......|++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+...
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 167 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 875432 2234578999999999876545788999999999999999999999776554332221100
Q ss_pred -----------------C---CCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 228 -----------------N---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 228 -----------------~---~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
. ........+..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0 000011246788999999999999999999999999999854
No 288
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=5.1e-43 Score=340.06 Aligned_cols=254 Identities=36% Similarity=0.608 Sum_probs=206.3
Q ss_pred ceEeec--CceEEEEEEECCCCcEEEEEEeccC-CCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRG--SFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G--~~g~Vy~a~~~~~g~~vAiK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
.+||+| ++|.||.+++..+++.||||++... ........+.+|+.++++++||||+++++++...+..+++|||+.+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 345554 5566777777889999999998765 3455678899999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-------
Q 014610 96 GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS------- 166 (421)
Q Consensus 96 g~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~------- 166 (421)
|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999999753 4689999999999999999999999999999999999999999999999998865432211
Q ss_pred cccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHh-hccCC-----------------
Q 014610 167 RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRE----------------- 227 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~-~i~~~----------------- 227 (421)
......++..|+|||++... ..++.++|||||||++|+|++|..||.......... .+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 11234578899999998653 347889999999999999999999998765433221 11000
Q ss_pred ---------------CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 228 ---------------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 228 ---------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
........++.++.+|+.+||..||++|||++++|+||||+..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 001112345678999999999999999999999999999987653
No 289
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=1.5e-43 Score=334.20 Aligned_cols=252 Identities=34% Similarity=0.573 Sum_probs=217.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC----CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
+|.+.+.||+|+||.||+|.+..++..+++|++.... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999999888777777764322 223345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 90 MEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998853 457999999999999999999999999999999999999975 679999999987665443
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~ 245 (421)
.......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....+..+..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 334456789999999998765 4788999999999999999999999877776666666555566667788999999999
Q ss_pred HHcccCCCCCcCHHHHHhChhc
Q 014610 246 LCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
+||..+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
No 290
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5.6e-43 Score=340.33 Aligned_cols=254 Identities=24% Similarity=0.432 Sum_probs=214.5
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECC-------CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 80 (421)
+...++|.+.+.||+|+||.||+|.+.. .+..||+|.+...........+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3445799999999999999999998642 35579999987655555677889999999999 699999999999
Q ss_pred EeCCEEEEEEecCCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 014610 81 LHQTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (421)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl 144 (421)
..++.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999653 348889999999999999999999999999999999999
Q ss_pred ccCCCEEEeeccccccccccccc--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014610 145 TENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (421)
Q Consensus 145 ~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~ 221 (421)
+.++.+||+|||++......... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999998755322111 1122345679999998765 48899999999999999998 99999888777766
Q ss_pred hhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 222 ~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+........+..++..+.+++.+||..+|++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 666555444555667889999999999999999999999986
No 291
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=5.3e-43 Score=332.13 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=210.7
Q ss_pred ceeeceEeecCceEEEEEEECC---CCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE-----
Q 014610 15 FSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK----- 85 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 85 (421)
|++.+.||+|+||.||+|.+.. ++..||||.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998765 34889999987653 34456788999999999999999999998866554
Q ss_pred -EEEEEecCCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 86 -LWIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 86 -~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
.++|+||+.+|+|..++... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999988432 36899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccc--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchH
Q 014610 159 AQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (421)
Q Consensus 159 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 235 (421)
......... .....++..|+|||.+.+. .++.++|||||||++|||++ |.+||.+....+....+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 765432211 1123456789999998665 48899999999999999998 9999988887777766665555556677
Q ss_pred HHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 236 ~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
++..+.+++.+||..||.+|||+.+++++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999999999999999874
No 292
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=5.5e-43 Score=331.39 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=208.9
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ....+.+|+.++++++||||+++++.+. ....++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 357899999999999999999998765 4599999875433 2356889999999999999999999874 45689999
Q ss_pred ecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-c
Q 014610 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 167 (421)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++........ .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999753 4589999999999999999999999999999999999999999999999999876543221 1
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...........+...........++..+.++|.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 12334677899999987654 8999999999999999999 899998887766666655544444456678899999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||+++|++|||++++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999975
No 293
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=3.8e-43 Score=336.77 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=214.8
Q ss_pred hCCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
..++|++++.||+|+||.||+|.+. .++..||||++...........+.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3578999999999999999999875 36789999998766555566779999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 014610 86 LWIIMEYMAGGSVADLIQSGP----------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANIL 143 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~----------------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NIL 143 (421)
.++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999997432 4788899999999999999999999999999999999
Q ss_pred EccCCCEEEeeccccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014610 144 LTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV 220 (421)
Q Consensus 144 l~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~ 220 (421)
++.++.++|+|||++....... .......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999986543221 111223456779999998766 48999999999999999997 8899988877777
Q ss_pred HhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 221 LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 221 ~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
...+........+..++..+.+||.+||+.+|.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6666555544445567889999999999999999999999975
No 294
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=5.8e-43 Score=336.34 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=213.1
Q ss_pred CCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+.... ....+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 457999999999999999999854 345679999875433 33446788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCE
Q 014610 87 WIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~v 150 (421)
++||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999997532 38899999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCC
Q 014610 151 KVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE 227 (421)
Q Consensus 151 kL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~ 227 (421)
+|+|||++....... .......|++.|+|||.+.+. .++.++|||||||++|+|++ |..||...+.......+...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 999999987543321 112234578899999998765 48899999999999999998 99999888877766666555
Q ss_pred CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 228 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.....+..++..+.+++.+||..+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 555555667889999999999999999999999986
No 295
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=4.5e-43 Score=330.58 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=209.8
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 356899999999999999999886 467899999864332 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-cc
Q 014610 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~ 169 (421)
|+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......... ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999999999875 357899999999999999999999999999999999999999999999999998755322111 11
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
...++..|+|||++.+. .++.++||||||+++|+|++ |..||......+....+........+..++..+.+++.+||
T Consensus 160 ~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05059 160 GTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238 (256)
T ss_pred CCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 11234579999998765 48899999999999999998 89999887776666666555444455567899999999999
Q ss_pred ccCCCCCcCHHHHHhC
Q 014610 249 KKVPAERPSAKELLRH 264 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~h 264 (421)
..+|++|||+.++++.
T Consensus 239 ~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 239 HEKPEDRPAFKKLLSQ 254 (256)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999874
No 296
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.4e-42 Score=337.98 Aligned_cols=259 Identities=43% Similarity=0.775 Sum_probs=219.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
.....|+..+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++..+...+
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 34466999999999999999999999999999999986543 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+||||+.| +|.+++.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 99999964 77777643 56799999999999999999999999999999999999999999999999998764432
Q ss_pred cccccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC-CCCchHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~l 243 (421)
.....|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+..... ......++..+++|
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 234578999999999742 23478899999999999999999999988776665555544332 22334678889999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
|.+||..+|.+||++.++++|+|+......
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 999999999999999999999999765443
No 297
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5.6e-43 Score=338.53 Aligned_cols=255 Identities=22% Similarity=0.434 Sum_probs=216.3
Q ss_pred hhhCCCceeeceEeecCceEEEEEEEC-------CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 80 (421)
.....+|++.+.||+|+||.||+|++. .++..||+|.+...........+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 445679999999999999999999753 235689999987554455667899999999999 899999999999
Q ss_pred EeCCEEEEEEecCCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 014610 81 LHQTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (421)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl 144 (421)
......|+||||+.+|+|.+++... ..++...+..++.||+.||.|||++|++||||||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 9999999999999999999999753 246788899999999999999999999999999999999
Q ss_pred ccCCCEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014610 145 TENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (421)
Q Consensus 145 ~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~ 221 (421)
+.++.+||+|||++........ ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999876543211 12233567889999998765 48999999999999999998 89999888777776
Q ss_pred hhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 222 ~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
..+........+..++..+++||.+||..+|.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6665555444556778999999999999999999999999874
No 298
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-44 Score=354.52 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=215.5
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
..+...+.+.+.+.||+|+||+||+|++-. .||||+++... .++..+.|+.|+.++++-+|.||+-+.|++.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 345566788899999999999999999875 79999998776 56678999999999999999999999999988777
Q ss_pred EEEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
.||+.||+|.+|+.++.- ...|.....+.|++||++|+.|||.++|||||||..||||.+++.|||+|||++.....-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999999864 246888999999999999999999999999999999999999999999999998654322
Q ss_pred --cccccccccCccccCcccccCc--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----CCCCchHH
Q 014610 165 --ISRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHF 236 (421)
Q Consensus 165 --~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~ 236 (421)
......--|...|||||++... .+|+..+|||||||++|||++|..||...+....+..+-++. ........
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 1122344688899999998643 358899999999999999999999999666666666665552 12233466
Q ss_pred HHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 237 s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
+.++++|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 789999999999999999999999986
No 299
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=1.7e-43 Score=348.40 Aligned_cols=261 Identities=23% Similarity=0.426 Sum_probs=217.6
Q ss_pred ccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 6 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
......+++|++.+.||+|++|.||+|++..+++.||||++.... .......+.+|+.++++++||||+++++++...+
T Consensus 8 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 344556889999999999999999999999999999999986543 2334466788999999999999999999887655
Q ss_pred E------EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 85 K------LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 85 ~------~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
. .++|+||+ +++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 4 89999999 6799999876 67999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----------
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---------- 228 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~---------- 228 (421)
...... .....+++.|+|||++.+...++.++|||||||++|+|++|+.||...+.......+....
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 166 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 765432 3355789999999998664457889999999999999999999998776654433221100
Q ss_pred -----------------CCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 229 -----------------PPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 229 -----------------~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
... ....++..+.+||.+||..+|.+|||+.+|++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 000 0113478899999999999999999999999999998653
No 300
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=5.8e-43 Score=334.47 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=212.2
Q ss_pred CCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
..+|.+.+.||+|+||.||+|... .++..||+|.+... .......+.+|+.+++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 357889999999999999999753 35778999987644 344567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEE
Q 014610 87 WIIMEYMAGGSVADLIQSGP---------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~---------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vk 151 (421)
++||||+.+++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999997643 488999999999999999999999999999999999999999999
Q ss_pred Eeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCC
Q 014610 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (421)
Q Consensus 152 L~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~ 228 (421)
|+|||++........ ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...........+....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 999999865432211 112334578899999987764 8999999999999999998 999998887776666665554
Q ss_pred CCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 229 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
....+..++..+.+||.+||+.||.+||++++|++
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44555667889999999999999999999999975
No 301
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=2.8e-43 Score=345.73 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=213.8
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC--C
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ--T 84 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~ 84 (421)
..+.++|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++++ +||||+++++++... .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 346789999999999999999999999999999999875432 233445677899999999 999999999988653 4
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
..|+||||+. ++|..++..+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999996 5999999775 8899999999999999999999999999999999999999999999999998765432
Q ss_pred cc-----cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC-------------
Q 014610 165 IS-----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------- 226 (421)
Q Consensus 165 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~------------- 226 (421)
.. ......|++.|+|||++.+...++.++||||||+++|+|++|++||...........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 223457899999999887655678899999999999999999999976654332221100
Q ss_pred --------------CC---CCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 227 --------------EN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 227 --------------~~---~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.. .......++.++.++|.+||+.+|++|||+.++++|||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 011112367889999999999999999999999999999864
No 302
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=8.9e-43 Score=328.14 Aligned_cols=244 Identities=27% Similarity=0.441 Sum_probs=212.7
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|++.+.||.|+||.||+|... |+.||||.+..... ..+++.+|+.+++.++|+||+++++++.+....++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 568999999999999999999875 89999999865543 46778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+++++|.++++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---D 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---c
Confidence 999999999997654 79999999999999999999999999999999999999999999999999987663221 1
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
...++..|+|||.+... .++.++||||||+++|+|++ |..||...........+........+..++..+.++|.+||
T Consensus 158 ~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 158 SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence 33456679999998765 47889999999999999997 99999888776666555544444455667899999999999
Q ss_pred ccCCCCCcCHHHHHh
Q 014610 249 KKVPAERPSAKELLR 263 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~ 263 (421)
..+|++|||+.++++
T Consensus 237 ~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 237 ELDPAKRPTFKQLRE 251 (256)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999986
No 303
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=2.8e-43 Score=339.62 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=211.0
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC---
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--- 84 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--- 84 (421)
+...++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3456899999999999999999999999999999999865432 223356778999999999999999999887654
Q ss_pred -------EEEEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecc
Q 014610 85 -------KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (421)
Q Consensus 85 -------~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFG 156 (421)
.+++|+||+++ +|...+... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 777777653 479999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc-cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---CCCC--
Q 014610 157 VSAQLTRTIS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPP-- 230 (421)
Q Consensus 157 la~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~~~~-- 230 (421)
++........ ......+++.|+|||++.+...++.++|||||||++|+|++|++||...+.......+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9876544322 112345688899999887655578899999999999999999999987665443322211 0000
Q ss_pred ------------------------CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 231 ------------------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 231 ------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.....++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012357889999999999999999999999999997
No 304
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=7.2e-43 Score=329.73 Aligned_cols=248 Identities=27% Similarity=0.473 Sum_probs=210.2
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|+++++||+|+||.||+|.+.. ++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 45789999999999999999998654 78899999865443 2367889999999999999999999874 56789999
Q ss_pred ecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-cc
Q 014610 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-~~ 167 (421)
||+.+++|.+++.. +..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999999865 3468999999999999999999999999999999999999999999999999987654221 11
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||++... .++.++||||||+++|+|++ |++||.+.+.......+........+..++.++.++|.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2233567789999998765 47899999999999999998 999998887766666555444445556678899999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||..+|++|||+++++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999975
No 305
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=5.4e-43 Score=334.26 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=210.6
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEEEEEe
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIME 91 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~E 91 (421)
|++++.||.|++|.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999997653 233346688999999999999999999999988 89999999
Q ss_pred cCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-ccc
Q 014610 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~ 169 (421)
|++ ++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 5899988764 5899999999999999999999999999999999999999999999999999876654321 123
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC---C------------------
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---N------------------ 228 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~---~------------------ 228 (421)
...++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+... .
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3467889999998876555789999999999999999999999877654433322110 0
Q ss_pred -CCC--------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 229 -PPQ--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 229 -~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
... +...++..+.++|.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000 001127788999999999999999999999999997
No 306
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.6e-44 Score=347.88 Aligned_cols=259 Identities=25% Similarity=0.472 Sum_probs=209.3
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCE
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 85 (421)
+...-+..|++++.||+||.+.||+++..+.+.+++.|+.....+...+.-+..|+..|.+|+ |.+||+++++-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 445567889999999999999999999877555544555555556777899999999999995 8999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
+||||||- ..+|..+|+.+.. ++.-.++.|..|+|.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99999976 5699999987654 33358899999999999999999999999999999995 579999999999766433
Q ss_pred cc--cccccccCccccCcccccCcC----------CCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHhhccCC----
Q 014610 165 IS--RRKTFVGTPFWMAPEVIQNSE----------GYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRE---- 227 (421)
Q Consensus 165 ~~--~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslGvil~ell~g~~pf~~~~-~~~~~~~i~~~---- 227 (421)
.. ...+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||.... ....+..|...
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 21 234579999999999985432 14568999999999999999999998764 23333333222
Q ss_pred CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 228 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
..+.++.. .++.++++.||.+||.+|||+.++|+|||+.-
T Consensus 593 efp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 593 EFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 12222222 23999999999999999999999999999986
No 307
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=7.9e-43 Score=331.11 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=212.5
Q ss_pred CCceeeceEeecCceEEEEEEECCCCc---EEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
++|++.+.||+|+||.||+|.+..+++ .||||++...........+..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 568999999999999999999887665 69999987665566678899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-
Q 014610 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~- 167 (421)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999999999999875 356899999999999999999999999999999999999999999999999998655332111
Q ss_pred -ccccc---cCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHH
Q 014610 168 -RKTFV---GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (421)
Q Consensus 168 -~~~~~---gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 242 (421)
..... ++..|+|||.+.+. .++.++|||||||++|||++ |..||...+.......+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred ccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence 11111 24579999998765 48899999999999999886 99999888777666665444333344567888999
Q ss_pred HHHHHcccCCCCCcCHHHHHh
Q 014610 243 FVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~ 263 (421)
++.+||..+|.+||++.+|+.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
No 308
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=9.4e-43 Score=327.19 Aligned_cols=248 Identities=29% Similarity=0.512 Sum_probs=215.6
Q ss_pred ceeeceEeecCceEEEEEEECCCC----cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g----~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
|++.+.||.|+||.||+|.+...+ ..||+|++...........+..|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998766 8999999976655546788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 91 EYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
||+.+++|.+++..... +++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999976544 9999999999999999999999999999999999999999999999999987654331111
Q ss_pred c-ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 169 K-TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 169 ~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
. ...+++.|+|||.+.+. .++.++||||||+++|+|++ |.+||...+.......+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1 12367899999998654 48899999999999999998 899998877777666666555555566688999999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||..+|++|||+.|+++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999986
No 309
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=1.1e-42 Score=337.45 Aligned_cols=260 Identities=42% Similarity=0.780 Sum_probs=219.4
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccC--CCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
+.....|...+.||+|+||.||+|++..++..||||.+... ........+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence 44566799999999999999999999999999999998643 2334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
++||||+. |+|.+++. ...++++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 99999996 57877664 456799999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccCccccCcccccC--cCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC-CchHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ-LDEHFSRLMKE 242 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~ 242 (421)
.....|++.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.....+. ....++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 234578999999999752 2346789999999999999999999998776655554444333222 34467889999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
||.+||..+|.+||++.+++.|||+......
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 9999999999999999999999999875443
No 310
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-44 Score=331.65 Aligned_cols=262 Identities=28% Similarity=0.490 Sum_probs=229.0
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (421)
...+|+++++||+|+|++|.+++.+.|.+.||+|+++++- ..++++-++.|..+..+- +||.+|-++.+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3479999999999999999999999999999999987653 344456677788877765 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
+|.||++||+|--.+++...++|+.++.+..+|+.||.|||++|||+||||.+||||+..|++||.|+|+++....+...
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999887777778
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCC-------CCCHHHHHhhccCCCCCCCchHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA-------DLHPMRVLFIIPRENPPQLDEHFSRLM 240 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~-------~~~~~~~~~~i~~~~~~~~~~~~s~~l 240 (421)
.+++||||.|.|||++.+.+ |+..+|+|+|||+|+||+.|+.||. +.+..+-+..+.......++..+|-.+
T Consensus 408 tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred cccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 88999999999999998875 9999999999999999999999995 233444444444444445566677778
Q ss_pred HHHHHHHcccCCCCCc------CHHHHHhChhcccccCC
Q 014610 241 KEFVSLCLKKVPAERP------SAKELLRHRFIRNARKS 273 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rp------t~~elL~hp~~~~~~~~ 273 (421)
..+++..|.+||.+|. ...++..|+||+.+.+.
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 8889999999999996 46899999999976543
No 311
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=3.2e-43 Score=335.41 Aligned_cols=252 Identities=30% Similarity=0.505 Sum_probs=213.0
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
|++.+.||.|++|.||+|.+..+|+.+++|.+...... .....+.+|+.++++++||||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999998655422 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 94 AGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 94 ~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
++ +|.+++.. ..++++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||.+..............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 88887765 46899999999999999999999999999999999999999999999999999876654432333457
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-------------------------
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------------- 227 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------------------- 227 (421)
++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 8899999999877645889999999999999999999999877654433222100
Q ss_pred -CC---CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 228 -NP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 228 -~~---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.. ......++..+.+||.+||.+||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 01123467889999999999999999999999999997
No 312
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=9.6e-43 Score=334.31 Aligned_cols=257 Identities=28% Similarity=0.501 Sum_probs=214.7
Q ss_pred CceeeceEeecCceEEEEEEEC---CCCcEEEEEEeccCC---CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~~~~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 86 (421)
+|++.+.||.|+||.||+|.+. .+|+.||+|++.... .....+.+.+|+.+++++ +||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999885 478999999986532 122346678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~- 165 (421)
|+||||+++++|.+++....++++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHhhccCCCCCCCchHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPPQLDEHFSRLM 240 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l 240 (421)
.......|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...+. ......+.... +..+..++..+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSALA 239 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-CCCCccCCHHH
Confidence 122346789999999998653 2367889999999999999999999964322 22222222222 23455678899
Q ss_pred HHHHHHHcccCCCCCc-----CHHHHHhChhccccc
Q 014610 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~~ 271 (421)
.+++.+||..+|++|| ++.+++.||||....
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998775
No 313
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=1.1e-42 Score=328.53 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=209.7
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++++.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++. ....++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 3468999999999999999999876 4677999998654432 356889999999999999999999875 55689999
Q ss_pred ecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-c
Q 014610 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 167 (421)
||+.+++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........ .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999999753 4689999999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||++.+.. ++.++|+||||+++|+|++ |.+||.+.+..+....+........+...+..+.+|+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 12234566899999987654 7899999999999999999 999998887777766666555555566778899999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||.++|.+|||++++++
T Consensus 239 ~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPTFEYLQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999999874
No 314
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=3.3e-43 Score=340.07 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=206.4
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHH-HHHHHHHHHHHHHcCCCCCeeEEEEEEEeC-------
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------- 83 (421)
.++|++.+.||.|+||.||+|.+..+++.||||.+....... ....+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 689999999999999999999999999999999986543221 234567899999999999999999987543
Q ss_pred -CEEEEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 84 -TKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
..+++|+||+.+ +|...+.. ...+++..+..++.||++||+|||++|++||||||+|||++.++.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 357999999965 67776654 457999999999999999999999999999999999999999999999999998755
Q ss_pred ccccc-----------cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC---C
Q 014610 162 TRTIS-----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---E 227 (421)
Q Consensus 162 ~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~---~ 227 (421)
..... ......|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.. .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 33211 112346789999999987655578999999999999999999999987766543332210 0
Q ss_pred -----------------------CCCCC---chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 228 -----------------------NPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 228 -----------------------~~~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.+..+ ...++..+.+||.+||..||.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00000 01234678899999999999999999999999998
No 315
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=1.2e-42 Score=336.39 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=209.9
Q ss_pred hCCCceeeceEeecCceEEEEEEE-----CCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCC
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 84 (421)
..++|.+.+.||+|+||.||+|.+ ..++..||||.+.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 346899999999999999999975 3456689999987665555567889999999999 7999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~ 162 (421)
..|+||||+.+|+|.+++.... .+++.++..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++....
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999997533 38999999999999999999999999999999999999999999999999987554
Q ss_pred cccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhh-ccCCCCCCCchHHHH
Q 014610 163 RTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI-IPRENPPQLDEHFSR 238 (421)
Q Consensus 163 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~s~ 238 (421)
.... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||........... +........+...+.
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence 3211 112234678899999987764 7899999999999999998 9999987665433322 222222233445688
Q ss_pred HHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 239 ~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.+.+|+.+||.++|++|||+.|+++
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999986
No 316
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=3.6e-43 Score=345.92 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=210.9
Q ss_pred chhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC---
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--- 83 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--- 83 (421)
.-....+|.+.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 3345689999999999999999999999999999999986543 222345678999999999999999999998754
Q ss_pred ---CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 84 ---TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 84 ---~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
...|+|+||+. ++|..++ +..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 34699999995 4787775 34689999999999999999999999999999999999999999999999999865
Q ss_pred cccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-------------
Q 014610 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------- 227 (421)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------- 227 (421)
... ......|++.|+|||++.+...++.++|||||||++|||++|+.||...+.......+...
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 432 2234578999999999876445788999999999999999999999877654433221110
Q ss_pred --------------CCCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 228 --------------NPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 228 --------------~~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.... .....+..+.+||.+||+.||.+||+++++|.||||...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 0113467789999999999999999999999999998764
No 317
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=1.6e-42 Score=331.64 Aligned_cols=249 Identities=23% Similarity=0.407 Sum_probs=201.9
Q ss_pred CCc-eeeceEeecCceEEEEEE----ECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCE
Q 014610 13 SRF-SSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTK 85 (421)
Q Consensus 13 ~~y-~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 85 (421)
++| ++++.||+|+||+||++. ...+++.||+|++...........+.+|+.+|++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 466 999999999999998764 3457889999998765544456778899999999999999999998765 346
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+++||||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 8999999999999999976 569999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---------------HHhhccCC
Q 014610 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---------------VLFIIPRE 227 (421)
Q Consensus 166 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~---------------~~~~i~~~ 227 (421)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......- ....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 11 12234667799999987654 7899999999999999999999986432110 00011111
Q ss_pred CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 228 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.....+..++..+.+++.+||..+|++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 112234456789999999999999999999999986
No 318
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=2.8e-44 Score=329.52 Aligned_cols=260 Identities=26% Similarity=0.444 Sum_probs=210.2
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCC----cEEEEEEeccCCCHH-HHHHHHHHHHHHHcCCCCCeeEEEEEEEe-CC
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLH-QT 84 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g----~~vAiK~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 84 (421)
....|+++..||+|+||.||+|..+.++ +.+|||.++.++... .-...-+|+.+++.++||||+.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457999999999999999999766543 379999987664322 23556789999999999999999999988 88
Q ss_pred EEEEEEecCCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC----CCEEEeec
Q 014610 85 KLWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADF 155 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~----g~vkL~DF 155 (421)
.+|+++||.+. +|.++|+- .+.++...+..+++||+.|+.|||++-|+||||||.||||..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999965 99999963 3568999999999999999999999999999999999999988 89999999
Q ss_pred ccccccccccccc---cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---------HHHHhh
Q 014610 156 GVSAQLTRTISRR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---------MRVLFI 223 (421)
Q Consensus 156 Gla~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~---------~~~~~~ 223 (421)
|+++.+..+.... ..++-|.+|.|||++.+...|+.+.|||++|||+.||++-.+.|.+... ...+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887654332 3467899999999999999999999999999999999999988865321 111111
Q ss_pred c---cCCC----------CCCC-----------------ch------HHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 224 I---PREN----------PPQL-----------------DE------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 224 i---~~~~----------~~~~-----------------~~------~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
| ...+ .|.. .. .-++...+|+.+||..||.+|.|+.|+|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 1 1100 0000 00 012347789999999999999999999999999
Q ss_pred cccc
Q 014610 268 RNAR 271 (421)
Q Consensus 268 ~~~~ 271 (421)
....
T Consensus 341 ~~d~ 344 (438)
T KOG0666|consen 341 TEDP 344 (438)
T ss_pred ccCC
Confidence 8654
No 319
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=2e-42 Score=324.57 Aligned_cols=243 Identities=28% Similarity=0.439 Sum_probs=208.3
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
++||+|+||.||+|.+.. ++.||+|.+...........+.+|+.++++++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999988 9999999987766555667899999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc--ccccccCc
Q 014610 99 ADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RKTFVGTP 175 (421)
Q Consensus 99 ~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~ 175 (421)
.+++.. ...+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++......... .....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 999865 457899999999999999999999999999999999999999999999999998755321111 11223456
Q ss_pred cccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCC
Q 014610 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (421)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 254 (421)
.|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+........+..++..+.+++.+||..+|.+
T Consensus 160 ~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 79999998765 48899999999999999998 89999887766655555444334445667889999999999999999
Q ss_pred CcCHHHHHh
Q 014610 255 RPSAKELLR 263 (421)
Q Consensus 255 Rpt~~elL~ 263 (421)
|||+.|+++
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999986
No 320
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.3e-42 Score=340.71 Aligned_cols=252 Identities=22% Similarity=0.437 Sum_probs=212.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCC-------CcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-------g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 83 (421)
..+|++.+.||+|+||.||+|.+... +..||+|++...........+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986532 3379999987655555678899999999999 799999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~ 147 (421)
+.+++|+||+.+|+|.+++.... .++...+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999997532 47788899999999999999999999999999999999999
Q ss_pred CCEEEeeccccccccccccc--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhc
Q 014610 148 GDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (421)
Q Consensus 148 g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i 224 (421)
+.+||+|||++......... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...+..+....+
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999998755332111 1122345679999999775 48899999999999999998 89999988877776666
Q ss_pred cCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 225 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
........+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5554445555678899999999999999999999999975
No 321
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=7.7e-43 Score=343.80 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=205.8
Q ss_pred hCCCceeeceEeecCceEEEEEEE-----CCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEe-C
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-Q 83 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~ 83 (421)
..++|++.+.||+|+||+||+|++ ..+++.||||+++..........+.+|+.+|.++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 357899999999999999999985 3467899999997655555567888999999999 68999999998765 4
Q ss_pred CEEEEEEecCCCCCHHHHHHcC----------------------------------------------------------
Q 014610 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------- 105 (421)
..+++|||||++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5689999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--cccccccC
Q 014610 106 ---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGT 174 (421)
Q Consensus 106 ---------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt 174 (421)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 2367788899999999999999999999999999999999999999999999876532211 11223456
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHH-HHhhccCCCCCCCchHHHHHHHHHHHHHcccCC
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMR-VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP 252 (421)
+.|+|||++.+. .++.++||||||+++|+|++ |..||....... ....+........+..++..+.+++..||..+|
T Consensus 245 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 245 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred cceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 789999998765 48999999999999999996 999997654322 222222233333344467789999999999999
Q ss_pred CCCcCHHHHHhC
Q 014610 253 AERPSAKELLRH 264 (421)
Q Consensus 253 ~~Rpt~~elL~h 264 (421)
.+|||+.+|++|
T Consensus 324 ~~Rps~~eil~~ 335 (343)
T cd05103 324 SQRPTFSELVEH 335 (343)
T ss_pred hhCcCHHHHHHH
Confidence 999999999986
No 322
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=1.5e-42 Score=329.80 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=204.3
Q ss_pred ceEeecCceEEEEEEECCCCc--EEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~--~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|+||.||+|.+.+++. .+|+|.+.........+.+.+|+.+++++ +||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999988876 46888876544455567889999999999 799999999999999999999999999
Q ss_pred CCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 96 GSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 96 g~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997532 47899999999999999999999999999999999999999999999999975
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHH
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSR 238 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 238 (421)
...... .......++.|+|||++... .++.++|||||||++|||++ |..||...+.......+........+..++.
T Consensus 161 ~~~~~~-~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 161 GQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred ccchhh-hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 322111 11122346679999998765 48899999999999999996 9999988777666666655444444556778
Q ss_pred HHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 239 ~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
++.+++.+||..+|.+|||+.+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHH
Confidence 8999999999999999999999986
No 323
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=8.1e-43 Score=326.62 Aligned_cols=245 Identities=32% Similarity=0.572 Sum_probs=215.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
||.|+||.||++.+..+++.||+|++..... ......+..|+.++++++||||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999999999999999866542 33567889999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCcccc
Q 014610 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (421)
Q Consensus 99 ~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~ 178 (421)
.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..............|+..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998877899999999999999999999999999999999999999999999999999876644322334567899999
Q ss_pred CcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCH
Q 014610 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (421)
Q Consensus 179 aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 258 (421)
|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.. ....++..++..+.+||++||..||.+|||+
T Consensus 161 ~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 161 APEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred ChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 999987654 78899999999999999999999988776555555544 3344556678999999999999999999999
Q ss_pred ---HHHHhChhc
Q 014610 259 ---KELLRHRFI 267 (421)
Q Consensus 259 ---~elL~hp~~ 267 (421)
.++++||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999998
No 324
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.9e-42 Score=326.03 Aligned_cols=242 Identities=28% Similarity=0.460 Sum_probs=208.0
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEE-eCCEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLWIIME 91 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E 91 (421)
.+|++.+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|+||+++++++. .+...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 58999999999999999999765 7889999986443 3467889999999999999999999764 4567999999
Q ss_pred cCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
|+++++|.++++..+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc---CC
Confidence 999999999997643 4889999999999999999999999999999999999999999999999998754332 12
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
...++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+.......+........+..++..+.+++.+||
T Consensus 158 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 158 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 34456789999998765 48899999999999999997 99999887776666666555555556678899999999999
Q ss_pred ccCCCCCcCHHHHHh
Q 014610 249 KKVPAERPSAKELLR 263 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~ 263 (421)
..+|++|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999976
No 325
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=2.7e-42 Score=323.51 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=207.6
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
++||+|+||.||+|... ++..||+|++...........+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999865 58899999987665555556788999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc-cccccCcc
Q 014610 99 ADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPF 176 (421)
Q Consensus 99 ~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~gt~~ 176 (421)
.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 999865 3468999999999999999999999999999999999999999999999999986543221111 12244677
Q ss_pred ccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 177 y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
|+|||++.+. .++.++||||||+++|+|++ |..||...........+........+..++..+.+|+.+||..+|++|
T Consensus 160 y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999998765 47889999999999999998 999998887766666555554445556678999999999999999999
Q ss_pred cCHHHHHhC
Q 014610 256 PSAKELLRH 264 (421)
Q Consensus 256 pt~~elL~h 264 (421)
|++.++++.
T Consensus 239 p~~~~l~~~ 247 (250)
T cd05085 239 PKFSELQKE 247 (250)
T ss_pred CCHHHHHHH
Confidence 999999863
No 326
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=1.1e-42 Score=340.83 Aligned_cols=257 Identities=23% Similarity=0.406 Sum_probs=209.1
Q ss_pred CceeeceEeecCceEEEEEEECCC--CcEEEEEEeccCC-CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeC----CE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKEL--NKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ----TK 85 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~--g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----~~ 85 (421)
+|++.+.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999988 9999999986432 222356678899999999 599999999875432 45
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+|+++||+. ++|.+++.....+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999995 6999999888899999999999999999999999999999999999999999999999999987654321
Q ss_pred c----cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc----------------
Q 014610 166 S----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------- 225 (421)
Q Consensus 166 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~---------------- 225 (421)
. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 12335799999999988765568899999999999999999999998765432221110
Q ss_pred -----------CCCCC---CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 226 -----------RENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 226 -----------~~~~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..... ......+..+.+||.+||+.||.+|||+.+++.|||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00001 11123467899999999999999999999999999997543
No 327
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=2e-42 Score=330.31 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=214.6
Q ss_pred hCCCceeeceEeecCceEEEEEEECC----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe-CCE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTK 85 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 85 (421)
-+++|++.+.||+|+||.||+|.+.. ++..|++|.+...........+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999999876 3688999998765566667889999999999999999999998765 567
Q ss_pred EEEEEecCCCCCHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccc
Q 014610 86 LWIIMEYMAGGSVADLIQSG--------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~--------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGl 157 (421)
.++++||+.+++|.+++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998653 4589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCch
Q 014610 158 SAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDE 234 (421)
Q Consensus 158 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 234 (421)
++.+...... .....++..|+|||++.+. .++.++|||||||++|++++ |+.||...+..+....+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 8755322111 1223467789999998765 48999999999999999998 999999887777666555554444455
Q ss_pred HHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 235 ~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.++..+.+++.+||..+|++|||+.++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67889999999999999999999999986
No 328
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=2.4e-42 Score=326.29 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=208.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++.+.||+|++|.||+|.+..+ ..||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 346799999999999999999988764 4699998754332 2356788999999999999999999875 45689999
Q ss_pred ecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-c
Q 014610 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 167 (421)
||+.+++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||++++++.++|+|||++........ .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999999753 3588999999999999999999999999999999999999999999999999876533211 1
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.........+........+..++..+.+++.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 12234677899999987654 7899999999999999999 999999887776666665554444556788999999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||.++|++||+++++++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
No 329
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=2.9e-42 Score=325.39 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=212.3
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
..++|++.+.||+|+||.||+|.+.. ++.||||.+..... ....+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 46789999999999999999999864 57899999875433 2366889999999999999999999999889999999
Q ss_pred ecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-cc
Q 014610 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-~~ 167 (421)
||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999999764 468999999999999999999999999999999999999999999999999987654211 11
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.........+........+...+..+.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1122345789999998765 48899999999999999998 999998887777666665554444455568899999999
Q ss_pred HcccCCCCCcCHHHHHh
Q 014610 247 CLKKVPAERPSAKELLR 263 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~ 263 (421)
||..+|.+||+++++++
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999975
No 330
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=3e-42 Score=329.05 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=214.8
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCc----EEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
...+|++.+.||+|+||+||+|.++.+|. .||+|.+...........+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45789999999999999999999877665 6899998776666667788999999999999999999999887 789
Q ss_pred EEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999999763 569999999999999999999999999999999999999999999999999987654322
Q ss_pred ccc--cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHH
Q 014610 166 SRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (421)
Q Consensus 166 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 242 (421)
... ....++..|+|||.+... .++.++|+|||||++|||++ |..||......+....+........+...+..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 111 112235679999998765 48899999999999999998 99999988877766666555544555567788999
Q ss_pred HHHHHcccCCCCCcCHHHHHh
Q 014610 243 FVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~ 263 (421)
++.+||..+|..|||+.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999976
No 331
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=1.3e-42 Score=331.74 Aligned_cols=251 Identities=27% Similarity=0.479 Sum_probs=208.4
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
|++.+.||.|++|+||+|++..+++.||||.+.............+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999999999999999865433223344567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccccccc
Q 014610 94 AGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (421)
Q Consensus 94 ~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 171 (421)
+|+|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcCCC
Confidence 789999887654 7899999999999999999999999999999999999999999999999998765432 222345
Q ss_pred ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC------------------------
Q 014610 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------------ 227 (421)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------------------ 227 (421)
.|+..|+|||++.....++.++|+||||+++++|++|++||......+....+...
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 78999999998866555789999999999999999999999776654433221100
Q ss_pred --CCCCC---chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 228 --NPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 228 --~~~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
....+ ....+..+.+||.+||..+|++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00000 01125779999999999999999999999999997
No 332
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-42 Score=341.21 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=202.5
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-EEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLW 87 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~ 87 (421)
..++++|.....||+|+||.||+|.... |..||||.+....... ..++..|+.+|.+++|||+|+++|+|.+.+ ..+
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 4577899999999999999999998876 4999999876655432 456999999999999999999999999988 599
Q ss_pred EEEecCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEccCCCEEEeecccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG---KIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~---iiHrDlkp~NILl~~~g~vkL~DFGla~~~~ 162 (421)
||+||+++|+|.+++.... +++|....+|+.++++||+|||... ||||||||+|||||++.++||+|||+|....
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999997654 8999999999999999999999853 9999999999999999999999999996543
Q ss_pred ccccccccc-ccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC------HHHHHh-hccCCC-----C
Q 014610 163 RTISRRKTF-VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH------PMRVLF-IIPREN-----P 229 (421)
Q Consensus 163 ~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~------~~~~~~-~i~~~~-----~ 229 (421)
.......+. .||.+|+|||++... ..+.++|||||||+|.||++|+.+..... ...... .+.... -
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred ccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 311222223 899999999999875 48999999999999999999998876432 111110 111100 0
Q ss_pred CCCc-hH-----HHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 230 PQLD-EH-----FSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 230 ~~~~-~~-----~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
+.+. .. .-..+..+..+|++.+|..||++.|+++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 11 2223667788999999999999999865
No 333
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=2.3e-42 Score=333.00 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=206.1
Q ss_pred hCCCceeeceEeecCceEEEEEEECC----------------CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCee
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKE----------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv 74 (421)
+.++|++.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 35689999999999999999986543 34579999987655555667899999999999999999
Q ss_pred EEEEEEEeCCEEEEEEecCCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 014610 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-----------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANIL 143 (421)
Q Consensus 75 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NIL 143 (421)
++++++..++..++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987532 3667889999999999999999999999999999999
Q ss_pred EccCCCEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh--CCCCCCCCCHHH
Q 014610 144 LTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMR 219 (421)
Q Consensus 144 l~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~--g~~pf~~~~~~~ 219 (421)
++.++.++|+|||++..+..... ......+++.|+|||+..+. .++.++|||||||++|||++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999876533211 11223456789999988765 48999999999999999998 788998766544
Q ss_pred HHhhcc-------CCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 220 VLFIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 220 ~~~~i~-------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
...... .......+..++..+.+|+.+||..||.+|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 433211 11111223346788999999999999999999999975
No 334
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=1.8e-42 Score=331.64 Aligned_cols=251 Identities=21% Similarity=0.399 Sum_probs=204.6
Q ss_pred CCceeeceEeecCceEEEEEEE----CCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFD----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~----~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 86 (421)
.-|++++.||+|+||.||+|.. ..++..||+|.+...........+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3579999999999999999974 4578899999987665555667899999999999999999999998875 568
Q ss_pred EEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999999664 468999999999999999999999999999999999999999999999999987654332
Q ss_pred c---cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---------------HHHHhhccCC
Q 014610 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---------------MRVLFIIPRE 227 (421)
Q Consensus 166 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~---------------~~~~~~i~~~ 227 (421)
. ......|+..|+|||++.+. .++.++|||||||++|+|+++..|+..... ......+...
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 11234577789999998765 488999999999999999998766432110 1111111112
Q ss_pred CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 228 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.....+..++..+.+||.+||+.+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2223344578899999999999999999999999874
No 335
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=2.8e-42 Score=332.39 Aligned_cols=260 Identities=35% Similarity=0.611 Sum_probs=212.6
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 89 (421)
..++|++.+.||+|+||.||+|.+..+++.||||.+...........+.+|+.++.++ .||||+++++++.+....|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4578999999999999999999999999999999997665444556667788777666 499999999999999999999
Q ss_pred EecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
|||+. ++|.+++.. ..++++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++........
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 99994 578877755 4679999999999999999999997 5999999999999999999999999999876543222
Q ss_pred ccccccCccccCcccccCc---CCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHhhccCCCCCCCc--hHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD--EHFSRLMK 241 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~--~~~s~~l~ 241 (421)
.....+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+....+.....+..+ ..++.++.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 2234578899999998654 2367899999999999999999999976433 2233333222222222 24688899
Q ss_pred HHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
+||.+||..||.+|||+.++++||||.....
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 9999999999999999999999999986543
No 336
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=9e-43 Score=332.12 Aligned_cols=252 Identities=31% Similarity=0.508 Sum_probs=212.2
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
|++.+.||+|++|.||+|.+..+++.||+|++.... .......+..|+.++++++||||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999987653 2233466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 94 ~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
. ++|.+++.+. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 7 5999999875 5899999999999999999999999999999999999999999999999999876654433334456
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC--------------------CCCCC-
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------------ENPPQ- 231 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~--------------------~~~~~- 231 (421)
++..|+|||.+.+...++.++|||||||++|+|++|.+||...........+.. ...+.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 788999999987664588999999999999999999999987665443322110 00000
Q ss_pred -------CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 232 -------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 232 -------~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
....++..+.++|.+||..+|++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 011246789999999999999999999999999997
No 337
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=1.8e-42 Score=333.48 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=206.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCC--------------cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELN--------------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g--------------~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 77 (421)
..+|++.+.||+|+||.||+|.+..++ ..||||.+...........+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468999999999999999999876532 358999987655555667899999999999999999999
Q ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 014610 78 GSYLHQTKLWIIMEYMAGGSVADLIQSG------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (421)
Q Consensus 78 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~ 145 (421)
+++...+..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 9999999999999999999999998542 1368889999999999999999999999999999999999
Q ss_pred cCCCEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh--CCCCCCCCCHHHHH
Q 014610 146 ENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRVL 221 (421)
Q Consensus 146 ~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~--g~~pf~~~~~~~~~ 221 (421)
.++.+||+|||++........ ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+.....
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999875432211 112234577899999987664 8999999999999999988 77888877655543
Q ss_pred hhcc-------CCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 222 FIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 222 ~~i~-------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+. .......+..++..+.+|+.+||..+|++|||+++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3221 11111223346789999999999999999999999975
No 338
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=2.9e-42 Score=366.60 Aligned_cols=148 Identities=32% Similarity=0.589 Sum_probs=138.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
.++|++++.||+|+||+||+|.+..+++.||||++.... .......+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999986543 334457788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
|||+.|++|.+++...+.+++..++.++.||+.||+|||.+||+||||||+||||+.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999887889999999999999999999999999999999999999999999999999975
No 339
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=2.6e-42 Score=328.37 Aligned_cols=251 Identities=23% Similarity=0.421 Sum_probs=212.7
Q ss_pred CCceeeceEeecCceEEEEEEECC-----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
++|++++.||+|+||.||+|+++. +.+.||+|.+...........+.+|+.++++++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 689999999999999999999764 356899999876555545678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 88 IIMEYMAGGSVADLIQSGP---------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~---------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999997655 6999999999999999999999999999999999999999999999999998
Q ss_pred cccccc-cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCC-CCCchH
Q 014610 159 AQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP-PQLDEH 235 (421)
Q Consensus 159 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 235 (421)
...... ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+..... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence 644321 11223346778899999987654 7889999999999999998 8899987776665555543222 122345
Q ss_pred HHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 236 ~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
++..+.+++.+||..+|.+|||+.+++.+
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 78899999999999999999999999864
No 340
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1e-42 Score=359.10 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=196.5
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCC-CcEEEEEEe--------------cc--CCCHHHHHHHHHHHHHHHcCCCCC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVI--------------DL--EESEDEIEDIQKEISVLSQCRSPY 72 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-g~~vAiK~~--------------~~--~~~~~~~~~~~~E~~il~~l~hpn 72 (421)
...++|++++.||+|+||+||+|..+.. +..+++|.+ .+ .........+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876543 222222211 00 112234566889999999999999
Q ss_pred eeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 014610 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (421)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~ 147 (421)
|+++++++...+..|+|+|++. ++|.+++... .......++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999994 5787776432 234467788999999999999999999999999999999999
Q ss_pred CCEEEeecccccccccccc-cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCC-CCCCC--HHHHHhh
Q 014610 148 GDVKVADFGVSAQLTRTIS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP-LADLH--PMRVLFI 223 (421)
Q Consensus 148 g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~p-f~~~~--~~~~~~~ 223 (421)
|.+||+|||++..+..... .....+||+.|+|||++.+. .++.++|||||||+||||++|..+ +.... ....+..
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999976644322 22346899999999999876 489999999999999999998754 43221 1111111
Q ss_pred ccC------CCCC--------------------CCc-----hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 224 IPR------ENPP--------------------QLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 224 i~~------~~~~--------------------~~~-----~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
+.. ...+ .++ ..++..+.++|.+||..||.+|||+.|+|.||||....
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 100 0000 000 12345678889999999999999999999999998653
No 341
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=2e-42 Score=347.09 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=209.4
Q ss_pred hCCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCC
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 84 (421)
..++|.+.+.||+|+||.||+|++. .+++.||||++.........+.+.+|+.+|.++. ||||+++++++..++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3457888999999999999999864 3467899999976655555567889999999997 999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCC----------------------------------------------------------
Q 014610 85 KLWIIMEYMAGGSVADLIQSGP---------------------------------------------------------- 106 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~---------------------------------------------------------- 106 (421)
.+++|||||.+|+|.+++.+.+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986431
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc
Q 014610 107 ----------------------------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (421)
Q Consensus 107 ----------------------------------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~ 146 (421)
.+++..+..++.||+.||+|||+++++||||||+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 3567778899999999999999999999999999999999
Q ss_pred CCCEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHH-h
Q 014610 147 NGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-F 222 (421)
Q Consensus 147 ~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~-~ 222 (421)
++.+||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|||++ |..||......+.. .
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 99999999999875432211 12234678899999999765 48899999999999999998 89999776544432 2
Q ss_pred hccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 223 ~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.+.....+..+..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 233333334455678999999999999999999999999874
No 342
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=2.9e-42 Score=337.65 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=211.2
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe-CCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l 88 (421)
.+++|++++.||.|+||.||+|.+..+|+.||||.+.... .......+.+|+.++++++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5789999999999999999999999999999999876433 22345678899999999999999999999876 567899
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
|+||+ +++|.++++. .++++..+..++.||++||+|||++|++||||+|+|||++.++.++|+|||++..... ..
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~ 162 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QM 162 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---Cc
Confidence 99999 6699988865 5789999999999999999999999999999999999999999999999999875432 22
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhh-------------------------
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI------------------------- 223 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~------------------------- 223 (421)
....+++.|+|||++.+...++.++|||||||++|+|++|++||...........
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 3457889999999987645588999999999999999999999977654221110
Q ss_pred --ccCCCCCC---CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 224 --IPRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 224 --i~~~~~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.....+.. ....++..+.++|.+||+.+|++|||+++++.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00001111 112357889999999999999999999999999999644
No 343
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=4.4e-42 Score=324.34 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=202.6
Q ss_pred ceEeecCceEEEEEEECC---CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEE-eCCEEEEEEecCC
Q 014610 19 ELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLWIIMEYMA 94 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~---~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~~~ 94 (421)
+.||+|+||.||+|.+.. .+..||||.+...........+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 478999999999998754 346799999865545556678889999999999999999999765 4566899999999
Q ss_pred CCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc----cccc
Q 014610 95 GGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRK 169 (421)
Q Consensus 95 gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~----~~~~ 169 (421)
+|+|.+++.+. ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999999763 456788889999999999999999999999999999999999999999999987543211 1112
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
...+++.|+|||.+.+. .++.++|||||||++|||++ |.+||...+.......+........+..++..+.+++.+||
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 161 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred cCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence 33467789999998765 48899999999999999999 57788877766666555555444445567889999999999
Q ss_pred ccCCCCCcCHHHHHhC
Q 014610 249 KKVPAERPSAKELLRH 264 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~h 264 (421)
..+|++||++.++++.
T Consensus 240 ~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 240 HPKPEMRPTFSELVSR 255 (262)
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999863
No 344
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=4.9e-42 Score=325.85 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=212.5
Q ss_pred CCCceeeceEeecCceEEEEEEECCC---CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..+|.+.+.||+|+||.||+|.+... ...||||...........+.+.+|+.++++++||||+++++++.+ ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 46799999999999999999987654 457999998766555566789999999999999999999998875 55789
Q ss_pred EEecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999999999999997643 5899999999999999999999999999999999999999999999999998765433111
Q ss_pred -ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHH
Q 014610 168 -RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (421)
Q Consensus 168 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~ 245 (421)
.....+++.|+|||.+... .++.++|||||||++|+|++ |..||...........+........+..++..+.++|.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (270)
T cd05056 164 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 242 (270)
T ss_pred ecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 1122345689999998765 48899999999999999986 99999888776666666555555556678899999999
Q ss_pred HHcccCCCCCcCHHHHHhC
Q 014610 246 LCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~h 264 (421)
+||..+|.+|||+.+++..
T Consensus 243 ~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 243 KCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999863
No 345
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=4.7e-42 Score=323.23 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=205.6
Q ss_pred ceEeecCceEEEEEEECC-CC--cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 19 ELIGRGSFGDVYKAFDKE-LN--KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~-~g--~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
+.||+|++|.||+|.+.. .+ ..||||.+.........+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999999865 33 36999999776654567889999999999999999999999988 889999999999
Q ss_pred CCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc---ccc
Q 014610 96 GSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKT 170 (421)
Q Consensus 96 g~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~---~~~ 170 (421)
++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999997653 6899999999999999999999999999999999999999999999999998766442211 112
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccC-CCCCCCchHHHHHHHHHHHHHc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~~L 248 (421)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.. ......+..++..+.+++.+||
T Consensus 160 ~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 160 LKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 45778899999987654 8899999999999999998 9999988777665554432 2222234456789999999999
Q ss_pred ccCCCCCcCHHHHHh
Q 014610 249 KKVPAERPSAKELLR 263 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~ 263 (421)
..+|++|||+.++++
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999986
No 346
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=6.6e-42 Score=322.02 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=210.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 4589999999999999999998864 778999988644322 3568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc-ccc
Q 014610 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (421)
Q Consensus 92 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~ 169 (421)
|+.+++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999998753 5689999999999999999999999999999999999999999999999999875533211 112
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHc
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 248 (421)
...++..|+|||++.+. .++.++||||||+++|+|++ |..||...........+........+...+..+.+|+.+||
T Consensus 160 ~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 238 (256)
T cd05112 160 GTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238 (256)
T ss_pred CCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 23456789999998765 48889999999999999998 99999887776666655544333334456889999999999
Q ss_pred ccCCCCCcCHHHHHhC
Q 014610 249 KKVPAERPSAKELLRH 264 (421)
Q Consensus 249 ~~dP~~Rpt~~elL~h 264 (421)
..+|++|||+.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 239 KERPEDRPSFSLLLHQ 254 (256)
T ss_pred ccChhhCCCHHHHHHh
Confidence 9999999999999874
No 347
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=2.5e-43 Score=361.28 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=225.1
Q ss_pred chhhCCCceeeceEeecCceEEEEEEEC-----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe
Q 014610 8 QEAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (421)
Q Consensus 8 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 82 (421)
.+-...+-+..+.||+|+||+||+|+.. +..+.||||.++.....+..++|++|+++|..|+|||||+++|++..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445567888999999999999999764 34578999999888777788999999999999999999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHHcC----------C----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 014610 83 QTKLWIIMEYMAGGSVADLIQSG----------P----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~~----------~----~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g 148 (421)
++.+|+|+|||..|||.++++.. . +|+..+...|+.||+.|++||-++.+|||||...|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999642 2 388999999999999999999999999999999999999999
Q ss_pred CEEEeecccccccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhcc
Q 014610 149 DVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIP 225 (421)
Q Consensus 149 ~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~ 225 (421)
.|||+|||+++......- ......-..+||+||.+...+ |+.++||||+||+|||+++ |+-||.+....+++..+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 999999999986543210 011112356899999998875 9999999999999999995 999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHH
Q 014610 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262 (421)
Q Consensus 226 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL 262 (421)
.+.....+.+++.++.+|+..||+.+|.+||++.||-
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9988888999999999999999999999999999984
No 348
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.6e-43 Score=346.93 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=216.8
Q ss_pred CCceeeceEeecCceEEEEEEECCCCc---E-EEEEEecc--CCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNK---D-VAIKVIDL--EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~---~-vAiK~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
++-.+.++||+|+||.||+|..+..+. . ||||.... .........+.+|+++|++++|||||++||+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445566999999999999998775422 3 89999875 23567788999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+||||+|.||+|.+++++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||++.......
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999999999876 49999999999999999999999999999999999999999999999999987654211
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhc-cCCCCCCCchHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII-PRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~l 243 (421)
.......-...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+ ..+.+...+...+.++..+
T Consensus 317 ~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 111111245679999999887 59999999999999999997 89999999999988888 5566666677788999999
Q ss_pred HHHHcccCCCCCcCHHHHHh
Q 014610 244 VSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~ 263 (421)
+.+|+..+|+.|||+.++.+
T Consensus 396 ~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhccCChhhccCHHHHHH
Confidence 99999999999999999975
No 349
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=6.6e-42 Score=327.01 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=205.7
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-HHHHHHHHHHHHHHcC---CCCCeeEEEEEEEeCCE-----
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTK----- 85 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~----- 85 (421)
|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999999999999998754322 2234566788777666 59999999999988776
Q ss_pred EEEEEecCCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~ 163 (421)
++++|||+. ++|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 58999887643 589999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC----------------
Q 014610 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------------- 227 (421)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~---------------- 227 (421)
. .......+++.|+|||++.+.. ++.++|+|||||++|+|++|.+||......+....+...
T Consensus 160 ~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 160 E-MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred C-cccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 3 2223446889999999998764 789999999999999999999999887665443322110
Q ss_pred -------CC---CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 228 -------NP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 228 -------~~---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
.. ......++..+.++|.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00112456788999999999999999999999999997
No 350
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=4.1e-42 Score=325.78 Aligned_cols=244 Identities=27% Similarity=0.500 Sum_probs=206.7
Q ss_pred ceEeecCceEEEEEEECCCC------cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 19 ELIGRGSFGDVYKAFDKELN------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g------~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
+.||+|+||.||+|.+...+ +.||||.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46999999999999886544 789999886554445567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-----CEEEeecccccc
Q 014610 93 MAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-----DVKVADFGVSAQ 160 (421)
Q Consensus 93 ~~gg~L~~~l~~~-------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-----~vkL~DFGla~~ 160 (421)
+++++|.+++... ..+++..+..++.||+.||+|||+++++|+||||+|||++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 3478899999999999999999999999999999999999877 899999999875
Q ss_pred ccccc--ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHH
Q 014610 161 LTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (421)
Q Consensus 161 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 237 (421)
..... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+........+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 53221 1112335678899999998764 8999999999999999998 999998887776666655444445556788
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+.++|.+||..+|.+||++.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999975
No 351
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=5.2e-42 Score=331.85 Aligned_cols=251 Identities=20% Similarity=0.356 Sum_probs=209.3
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCc----EEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~----~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 87 (421)
.++|+.++.||+|+||.||+|.+..+|. .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 5689999999999999999999987776 47889886655555556788999999999999999999988654 467
Q ss_pred EEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+++||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999999998764 3689999999999999999999999999999999999999999999999999976543222
Q ss_pred c--ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 167 R--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
. .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.........+........+..++..+.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243 (303)
T ss_pred ccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1 1223457789999998765 48899999999999999997 999998776555544444444334445567889999
Q ss_pred HHHHcccCCCCCcCHHHHHhC
Q 014610 244 VSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~h 264 (421)
+.+||..+|++||+++++++.
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999874
No 352
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-43 Score=351.36 Aligned_cols=245 Identities=29% Similarity=0.448 Sum_probs=212.7
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 88 (421)
.....|++...||.|+|+.|-.+.+..+++..++|++.... .+..+|+.++... +||||+++++++.++.+.|+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 35788999999999999999999999999999999997662 3345677666655 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-ccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl-~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
|||++.|+.|.+.+...+.+. .++..|++||+.|+.|||++|+|||||||+|||+ +..|+++|+|||++......
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999999999998755555 8888999999999999999999999999999999 58899999999999876543
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHhhccCCCCCCCchHHHHHHHHHHHH
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~li~~ 246 (421)
.-+-|-|..|.|||++... .|+.++||||||++||+||+|..||...... +....+ ..+.+...+|.++++||.+
T Consensus 470 ~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSECVSDEAKDLLQQ 545 (612)
T ss_pred hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccccccCHHHHHHHHH
Confidence 2344678889999999855 6999999999999999999999999876554 333333 2334447899999999999
Q ss_pred HcccCCCCCcCHHHHHhChhc
Q 014610 247 CLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 247 ~L~~dP~~Rpt~~elL~hp~~ 267 (421)
||+.||.+|+++.+++.||||
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 999999999999999999999
No 353
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=1.6e-42 Score=327.34 Aligned_cols=239 Identities=25% Similarity=0.440 Sum_probs=197.4
Q ss_pred ceEeecCceEEEEEEECCCCcE-------EEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 19 ELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~-------vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
+.||+|+||.||+|.+..++.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 4799999999999998765543 8888875432 3345678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC--------EEEeecccccccc
Q 014610 92 YMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--------VKVADFGVSAQLT 162 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~--------vkL~DFGla~~~~ 162 (421)
|+.+|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999997644 5899999999999999999999999999999999999987765 6999999886543
Q ss_pred cccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhC-CCCCCCCCHHHHHhhccCCCCCCCchHHHHHHH
Q 014610 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (421)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 241 (421)
. .....+++.|+|||++.+...++.++|||||||++|+|++| .+||.............. ...++...+..+.
T Consensus 160 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (258)
T cd05078 160 P----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKWTELA 233 (258)
T ss_pred C----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCcHHHH
Confidence 2 23457889999999998655578899999999999999998 577766655443332221 2233444567899
Q ss_pred HHHHHHcccCCCCCcCHHHHHhC
Q 014610 242 EFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~h 264 (421)
++|.+||+.+|++|||++++++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999864
No 354
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.8e-41 Score=320.36 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=210.0
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
...++|++.+.||+|+||.||+|.+.. +..||+|.+... ......+.+|+.++++++|+||+++++.+.. ...++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 457899999999999999999998654 567999987643 2235678899999999999999999999887 778999
Q ss_pred EecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-c
Q 014610 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-S 166 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-~ 166 (421)
|||+++++|.+++.+ ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999999975 3467888999999999999999999999999999999999999999999999987653321 1
Q ss_pred cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~ 245 (421)
......++..|+|||++... .++.++|+|||||++|+|++ |..||...+.......+...........++.++.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 11223456779999999765 47889999999999999998 99999988776666655555444455667889999999
Q ss_pred HHcccCCCCCcCHHHHHh
Q 014610 246 LCLKKVPAERPSAKELLR 263 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~ 263 (421)
+||..+|++||++.++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999875
No 355
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=6.7e-42 Score=328.15 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=212.4
Q ss_pred CceeeceEeecCceEEEEEEEC---CCCcEEEEEEeccCCC---HHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 86 (421)
+|++.+.||+|++|.||+|.+. .+++.||||++..... ......+..|+.++.++ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 4678999999864321 22345678999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
++||||+.+|+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998778899999999999999999999999999999999999999999999999999876543322
Q ss_pred -cccccccCccccCcccccCcC-CCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHhhccCCCCCCCchHHHHHH
Q 014610 167 -RRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPPQLDEHFSRLM 240 (421)
Q Consensus 167 -~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l 240 (421)
......|++.|+|||.+.+.. ..+.++||||||+++|+|++|..||..... ......+.... ...+..++..+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 239 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-PPFPKTMSAEA 239 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-CCCCcccCHHH
Confidence 123456899999999986542 357889999999999999999999964322 11112222222 23445578899
Q ss_pred HHHHHHHcccCCCCCcC---HHHHHhChhcccccC
Q 014610 241 KEFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (421)
Q Consensus 241 ~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~~~ 272 (421)
.++|.+||+.+|++||| +.++|+||||+...+
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 99999999999999998 567899999987653
No 356
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=8.7e-42 Score=323.97 Aligned_cols=244 Identities=24% Similarity=0.418 Sum_probs=197.0
Q ss_pred ceEeecCceEEEEEEECC--CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~--~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999996533 456789998765555555677889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc--cccc
Q 014610 97 SVADLIQSGP-----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRK 169 (421)
Q Consensus 97 ~L~~~l~~~~-----~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~ 169 (421)
+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999997632 24678889999999999999999999999999999999999999999999986432211 1112
Q ss_pred ccccCccccCcccccC------cCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCC-----CCCCchHHH
Q 014610 170 TFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQLDEHFS 237 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~s 237 (421)
...+++.|+|||++.. ...++.++|||||||++|||++ |..||...........+.... .+.....++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3356778999998743 2246789999999999999998 889998877655544332221 223445678
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+.+++..|+ .||++|||+++|++
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHH
Confidence 88999999998 59999999999986
No 357
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=1.2e-41 Score=323.11 Aligned_cols=244 Identities=25% Similarity=0.379 Sum_probs=197.0
Q ss_pred ceEeecCceEEEEEEEC--CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~--~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|.+. .++..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999864 3567899999876655555567889999999999999999999999999999999999999
Q ss_pred CHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc--ccc
Q 014610 97 SVADLIQSG-----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRK 169 (421)
Q Consensus 97 ~L~~~l~~~-----~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~ 169 (421)
+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999998642 2456778889999999999999999999999999999999999999999999865432211 112
Q ss_pred ccccCccccCcccccCcC------CCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCC-----CCCCCchHHH
Q 014610 170 TFVGTPFWMAPEVIQNSE------GYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE-----NPPQLDEHFS 237 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~------~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~s 237 (421)
...|++.|+|||++.+.. .++.++|||||||++|||++ |..||......+........ ..+.+....+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 346788999999986421 25779999999999999996 99999877665543322211 1122233467
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+.+++.+|+ .+|++|||+++|+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 88999999998 68999999999974
No 358
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=6.4e-43 Score=366.88 Aligned_cols=255 Identities=30% Similarity=0.532 Sum_probs=208.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEE---------
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL--------- 81 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--------- 81 (421)
..++|+.++.||+||||.||+++++-+|+.||||.|+..........+.+|+.+|++|+|||||++|..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 34689999999999999999999999999999999988876667889999999999999999999993220
Q ss_pred ---------------------------------------------------------------------e----------
Q 014610 82 ---------------------------------------------------------------------H---------- 82 (421)
Q Consensus 82 ---------------------------------------------------------------------~---------- 82 (421)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------C--------CEEEEEEecCCCCCHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHC
Q 014610 83 -----------------------Q--------TKLWIIMEYMAGGSVADLIQSGPPL-DEMSIACILRDLLHAIEYLHNE 130 (421)
Q Consensus 83 -----------------------~--------~~~~lV~E~~~gg~L~~~l~~~~~l-~e~~~~~i~~qll~aL~yLH~~ 130 (421)
+ ..+||-||||+..+|.+++.++... ....++.+++||++||+|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 2468999999998999999876655 5788999999999999999999
Q ss_pred CccccCCCCCcEEEccCCCEEEeecccccccc------------------cccccccccccCccccCcccccCcC--CCC
Q 014610 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLT------------------RTISRRKTFVGTPFWMAPEVIQNSE--GYN 190 (421)
Q Consensus 131 ~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ 190 (421)
|||||||||.||+|+.+++|||+|||+|+... .+.+..+..+||..|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999997621 0111234578999999999998765 599
Q ss_pred CccccHHHHHHHHHHHhCCCCCCC-CCHHHHHhhccCCCCCCC---chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChh
Q 014610 191 EKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266 (421)
Q Consensus 191 ~~~DvwslGvil~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~ 266 (421)
.|+||||||||++||+. ||.. ......+..+.....|.. ...--+.-..+|..||+.||++||||.|+|++.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 99999999999999984 3543 233344444444433332 2222345667999999999999999999999999
Q ss_pred cc
Q 014610 267 IR 268 (421)
Q Consensus 267 ~~ 268 (421)
|-
T Consensus 874 lp 875 (1351)
T KOG1035|consen 874 LP 875 (1351)
T ss_pred CC
Confidence 96
No 359
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-43 Score=312.26 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=204.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-----EE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KL 86 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (421)
.++|++.+.||+|+|+.||++.+..++..||+|.+.... .++.+...+|++..++++||||+++++....+. ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 579999999999999999999999999999999987665 556788999999999999999999998665433 48
Q ss_pred EEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 87 WIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~--iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
||++.|...|+|.+.+.. +.-++|.++..|+.+|++||++||+.. ++||||||.|||+++.+.++|.|||.++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999998864 346999999999999999999999998 99999999999999999999999998865
Q ss_pred cccccccc---------cccccCccccCcccccCcC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHhhccCC
Q 014610 161 LTRTISRR---------KTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VLFIIPRE 227 (421)
Q Consensus 161 ~~~~~~~~---------~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~ell~g~~pf~~~~~~~--~~~~i~~~ 227 (421)
....-... ..-..|..|.|||++.-.. ..+.++|||||||+||+|+.|..||...-... ....+...
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 43211110 1224688999999986432 35689999999999999999999997432211 11111111
Q ss_pred CCC-CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 228 NPP-QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 228 ~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
... +-...+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 110 1112389999999999999999999999999874
No 360
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.4e-41 Score=322.13 Aligned_cols=239 Identities=23% Similarity=0.378 Sum_probs=194.5
Q ss_pred ceEeecCceEEEEEEECC------------CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 19 ELIGRGSFGDVYKAFDKE------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~------------~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
+.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 23468899875443 33445778899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC-------EEEeecccc
Q 014610 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-------VKVADFGVS 158 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~-------vkL~DFGla 158 (421)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 999999999999998875 457999999999999999999999999999999999999987664 899999998
Q ss_pred cccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHHhhccCCCCCCCchHHH
Q 014610 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (421)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 237 (421)
...... ....|+..|+|||++.....++.++|||||||++|||+ +|..||......+........ . ......+
T Consensus 160 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~-~~~~~~~ 233 (262)
T cd05077 160 ITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ-C-MLVTPSC 233 (262)
T ss_pred ccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC-c-cCCCCCh
Confidence 654322 34568899999999875556889999999999999998 689998776544433222111 1 1222345
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.++.+||.+||..||.+||++.+|+++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 789999999999999999999999875
No 361
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=1e-41 Score=325.17 Aligned_cols=238 Identities=24% Similarity=0.390 Sum_probs=193.3
Q ss_pred eEeecCceEEEEEEECCC------------------------CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeE
Q 014610 20 LIGRGSFGDVYKAFDKEL------------------------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~------------------------g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 75 (421)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999975321 2468889886443 233456788999999999999999
Q ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC------
Q 014610 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG------ 148 (421)
Q Consensus 76 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g------ 148 (421)
+++++..+...++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999999865 46789999999999999999999999999999999999998654
Q ss_pred -CEEEeecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHHhhccC
Q 014610 149 -DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226 (421)
Q Consensus 149 -~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-~g~~pf~~~~~~~~~~~i~~ 226 (421)
.+||+|||++...... ....+++.|+|||.+.+...++.++|||||||++|||+ +|..||..............
T Consensus 161 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 236 (274)
T cd05076 161 PFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK 236 (274)
T ss_pred ceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence 3899999987543221 23467889999999876555889999999999999985 79999987665443332221
Q ss_pred CCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 227 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.. .++...+..+.++|.+||..+|++|||+.++|++
T Consensus 237 ~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 237 KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 11 2223345679999999999999999999999875
No 362
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=1.3e-41 Score=320.11 Aligned_cols=236 Identities=24% Similarity=0.419 Sum_probs=195.1
Q ss_pred ceEeecCceEEEEEEECCCC----------cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 19 ELIGRGSFGDVYKAFDKELN----------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g----------~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 47999999999999998777 35788876544322 5778899999999999999999999888 77899
Q ss_pred EEecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-------CEEEeecccccc
Q 014610 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-------DVKVADFGVSAQ 160 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-------~vkL~DFGla~~ 160 (421)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999998755 799999999999999999999999999999999999999887 799999999876
Q ss_pred cccccccccccccCccccCcccccCc-CCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHH
Q 014610 161 LTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSR 238 (421)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 238 (421)
... .....++..|+|||++... ..++.++|||||||++|+|++ |..||................. .+.....
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (259)
T cd05037 158 VLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPDCA 231 (259)
T ss_pred ccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCCch
Confidence 543 2245677889999998765 357889999999999999998 6888877654333332222211 1111237
Q ss_pred HHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 239 ~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.+.++|.+||..+|.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999986
No 363
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=2.1e-41 Score=318.64 Aligned_cols=241 Identities=25% Similarity=0.441 Sum_probs=205.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++||||+++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 5799999999999999999864 68899999986543 235788999999999999999999998654 47999999
Q ss_pred CCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccc
Q 014610 93 MAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 170 (421)
+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CCC
Confidence 99999999997543 5899999999999999999999999999999999999999999999999998654321 122
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
...+..|+|||.+.+. .++.++|+|||||++|+|++ |.+||...+.......+........+..++..+.+++.+||.
T Consensus 157 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 157 SKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence 3446789999998765 48899999999999999997 999998887766666655554444455678899999999999
Q ss_pred cCCCCCcCHHHHHh
Q 014610 250 KVPAERPSAKELLR 263 (421)
Q Consensus 250 ~dP~~Rpt~~elL~ 263 (421)
.+|.+||++++++.
T Consensus 236 ~~p~~Rp~~~~l~~ 249 (254)
T cd05083 236 TEPKKRPSFHKLRE 249 (254)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
No 364
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=3.6e-41 Score=322.28 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=199.8
Q ss_pred CCceeeceEeecCceEEEEEE----ECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~----~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 86 (421)
.+|++++.||+|+||.||+|. +..+++.||||.+... .....+.+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 589999999999999999997 4567899999998644 34456788999999999999999999998754 3468
Q ss_pred EEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999999753 468999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----------------HHhhccC
Q 014610 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----------------VLFIIPR 226 (421)
Q Consensus 166 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~----------------~~~~i~~ 226 (421)
.. .....++..|+|||++.+. .++.++|||||||++|||++|..|+......- ....+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 11 1112344569999998765 48899999999999999999877654322110 0011111
Q ss_pred CCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 227 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.........++..+.+||.+||..+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1122233456789999999999999999999999986
No 365
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=3e-41 Score=320.06 Aligned_cols=249 Identities=28% Similarity=0.548 Sum_probs=209.9
Q ss_pred CceeeceEeecCceEEEEEEECC-CCcEEEEEEeccCC---------CHHHHHHHHHHHHHHHc-CCCCCeeEEEEEEEe
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE---------SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLH 82 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~~~~~~---------~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 82 (421)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999988 78899999875321 23345667789988875 799999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEeeccc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~DFGl 157 (421)
++..++||||+++++|.+++. ....+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999998873 34579999999999999999999996 6899999999999999999999999999
Q ss_pred ccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC-chHH
Q 014610 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHF 236 (421)
Q Consensus 158 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 236 (421)
+....... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|.+||...+.......+........ ...+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 87654432 334567899999999998754 78999999999999999999999988776655555443332222 2357
Q ss_pred HHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 237 s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
+..+.++|.+||..||++||++.|+..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 8899999999999999999999999764
No 366
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=8.3e-42 Score=318.79 Aligned_cols=229 Identities=20% Similarity=0.306 Sum_probs=193.0
Q ss_pred cCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHH
Q 014610 24 GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ 103 (421)
Q Consensus 24 G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~ 103 (421)
|.+|.||+|++..+|+.||+|.+.... ...+|...+....||||+++++++......++||||++||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999986542 22345555566679999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCccccCcccc
Q 014610 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183 (421)
Q Consensus 104 ~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~ 183 (421)
+..++++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .....++..|+|||.+
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVG 154 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCccc
Confidence 8778999999999999999999999999999999999999999999999999987654332 2234567889999998
Q ss_pred cCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCH-----
Q 014610 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA----- 258 (421)
Q Consensus 184 ~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----- 258 (421)
... .++.++|+||+|+++|+|++|..|+...... +.......++..++..++++|.+||+.||++|+|+
T Consensus 155 ~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 155 GIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred CCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 665 4789999999999999999999887643221 11111123445678899999999999999999986
Q ss_pred HHHHhChhc
Q 014610 259 KELLRHRFI 267 (421)
Q Consensus 259 ~elL~hp~~ 267 (421)
++++.||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
No 367
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=1e-43 Score=319.63 Aligned_cols=257 Identities=34% Similarity=0.571 Sum_probs=220.3
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHH-cCCCCCeeEEEEEEEeCCEEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS-QCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
..++.+-+..||.|+||+|++-.++.+|+..|||.|+.........++..|.+... .-+.||||++||....++..||.
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 34566778899999999999999999999999999988877777788888888654 45789999999999999999999
Q ss_pred EecCCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeeccccccccc
Q 014610 90 MEYMAGGSVADLIQ-----SGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (421)
Q Consensus 90 ~E~~~gg~L~~~l~-----~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~ 163 (421)
||+|+ .+|..+.+ ....++|..+-.|...++.||.||-.. .||||||||+||||+..|.+||||||++..+..
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99994 57766553 246799999999999999999999954 899999999999999999999999999988766
Q ss_pred ccccccccccCccccCcccccCcC-CCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHhhccCCCCCCCc-----hHH
Q 014610 164 TISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD-----EHF 236 (421)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~-----~~~ 236 (421)
.... +.-.|...|||||.+.... +|+.++||||||++|||+.||..||...+. .+.+..+..+.++.+. .++
T Consensus 221 SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 221 SIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 5433 2457899999999997544 489999999999999999999999987754 4566666667666553 257
Q ss_pred HHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 237 s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
+..+..||.-||.+|-+.||...+++++||++.
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 899999999999999999999999999999974
No 368
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-41 Score=359.90 Aligned_cols=256 Identities=27% Similarity=0.485 Sum_probs=223.9
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCC-----cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEE
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g-----~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 81 (421)
|.+.....-++.+.||+|.||.||.|...... ..||||.+...........+.+|..+|+.++|||||+++|++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 34456678899999999999999999876532 2499999988888888999999999999999999999999999
Q ss_pred eCCEEEEEEecCCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEee
Q 014610 82 HQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (421)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~D 154 (421)
+....+|++|||+||+|..+|++. ..++......++.||++|+.||+++++|||||.+.|+||+....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999874 3588999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccc--cccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCC
Q 014610 155 FGVSAQLTRTISRRKT--FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (421)
Q Consensus 155 FGla~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 231 (421)
||+|+.+....--+.. ..-...|||||.+... .++.++|||||||+|||+++ |..||.+.+..++......+....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 9999855432111111 1223579999999876 49999999999999999996 999999999999888666666777
Q ss_pred CchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 232 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.+..++..+.+++..||+.+|++||++..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 77888999999999999999999999999987
No 369
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=7.9e-41 Score=317.68 Aligned_cols=244 Identities=21% Similarity=0.372 Sum_probs=196.4
Q ss_pred ceEeecCceEEEEEEECCC--CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCC
Q 014610 19 ELIGRGSFGDVYKAFDKEL--NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~--g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (421)
+.||+|+||.||+|..... ...+++|.+...........+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 34567787766555555678999999999999999999999999999999999999999
Q ss_pred CHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc--cccccc
Q 014610 97 SVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISRRKT 170 (421)
Q Consensus 97 ~L~~~l~~~----~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~ 170 (421)
+|.+++.+. ..+++..+..++.||+.||+|||+++++||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999999753 34677788899999999999999999999999999999999999999999987543211 112234
Q ss_pred cccCccccCcccccCc------CCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCC-----CCCCchHHHH
Q 014610 171 FVGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQLDEHFSR 238 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~------~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~s~ 238 (421)
.+|++.|+|||++... ..++.++|||||||++|||++ |..||......+....+.... .+.+...++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 5788999999987532 125678999999999999996 678998777665555433222 2233445788
Q ss_pred HHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 239 ~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.+.+++..|| .+|.+||++++|++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 8999999999 67999999999975
No 370
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=1.1e-40 Score=321.48 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=198.0
Q ss_pred cccchhhCCCceeeceEeecCceEEEEEEECCC---CcEEEEEEeccCCCHHHH----------HHHHHHHHHHHcCCCC
Q 014610 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEI----------EDIQKEISVLSQCRSP 71 (421)
Q Consensus 5 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~~~~~~~~~~~----------~~~~~E~~il~~l~hp 71 (421)
..+.+..+.+|++.+.||+|+||+||+|.+..+ +..+|+|+.......... .....+...+..+.|+
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 456677789999999999999999999999887 778888875443321110 1122334456677899
Q ss_pred CeeEEEEEEEeCC----EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 014610 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (421)
Q Consensus 72 nIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~ 147 (421)
||++++++..... ..++++|++ ..++.+.+......++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999999766543 357888988 45788887766667899999999999999999999999999999999999999
Q ss_pred CCEEEeeccccccccccc-------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HH
Q 014610 148 GDVKVADFGVSAQLTRTI-------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MR 219 (421)
Q Consensus 148 g~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~-~~ 219 (421)
+.++|+|||+|..+.... .......||+.|+|||++.+.. ++.++|||||||+||||++|.+||..... ..
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999997653221 1122357999999999988764 89999999999999999999999987632 11
Q ss_pred --------HHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 220 --------VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 220 --------~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
....+..... .....+..+.+++..|+..+|++||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1122222111 12235788999999999999999999999975
No 371
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=6.5e-41 Score=318.27 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=205.1
Q ss_pred ceeeceEeecCceEEEEEEEC---CCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC------
Q 014610 15 FSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------ 84 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~---~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 84 (421)
|++.++||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 357899999986543 3445677889999999999999999999886532
Q ss_pred EEEEEEecCCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 85 KLWIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999999887421 25789999999999999999999999999999999999999999999999998
Q ss_pred cccccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchH
Q 014610 159 AQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (421)
Q Consensus 159 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 235 (421)
........ ......+++.|++||.+... .++.++|||||||++|+|++ |.+||...+.......+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 76533211 11223456789999998765 47889999999999999998 9999988777665555544443344455
Q ss_pred HHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 236 ~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
++..+.+++.+||..+|++|||+.+++++
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999999864
No 372
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=6.2e-41 Score=319.78 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=205.3
Q ss_pred CCCceeeceEeecCceEEEEEEEC----CCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe--CCE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDK----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTK 85 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 85 (421)
...|++++.||+|+||.||+|... .++..||||++...........+.+|+.+++.++||||+++++++.. +..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357889999999999999999865 34889999998766554456789999999999999999999999887 567
Q ss_pred EEEEEecCCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~ 164 (421)
.++||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999999997644 6999999999999999999999999999999999999999999999999998776532
Q ss_pred ccc---ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---------------HHhhccC
Q 014610 165 ISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---------------VLFIIPR 226 (421)
Q Consensus 165 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~---------------~~~~i~~ 226 (421)
... .....++..|+|||.+.+. .++.++||||||+++|||++|..|+....... ....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 111 1123455679999998766 48899999999999999999999986532111 1111222
Q ss_pred CCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 227 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
......+..++..+.+++.+||..+|.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222223456788999999999999999999999986
No 373
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-43 Score=354.19 Aligned_cols=344 Identities=24% Similarity=0.355 Sum_probs=268.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCC---cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g---~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.+..++.++||.|.||.||+|+.+..| ..||||.++....+.+..+|..|+.||-+++||||++|.|+....+.+.|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 356678899999999999999988665 47999999888888889999999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
|+|||++|+|..+|+.+ +.++..++..+++.|+.|++||-+.|+|||||...|||++.+-.+|++|||+++.+.+....
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999999999764 67999999999999999999999999999999999999999999999999999988655433
Q ss_pred -cccccc--CccccCcccccCcCCCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHH
Q 014610 168 -RKTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 168 -~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 243 (421)
..+..| ..+|.|||.+...+ ++.++||||+||+|||.+ .|..||++....+++..|..+...+.+.+++..+..|
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qL 866 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQL 866 (996)
T ss_pred cccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHH
Confidence 333334 35799999998875 899999999999999966 6999999999999999999998888888999999999
Q ss_pred HHHHcccCCCCCcCHHHHHhChhcccccCChhHHHHhhcC---CCCCCCCCCCCCCccccccccCCCceeeccccCcccc
Q 014610 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER---PKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSEET 320 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
+..||++|-.+||.++||+.+ |.+.-..+..++.+... +..+.............+++++...+++.+.+.....
T Consensus 867 MldCWqkdR~~RP~F~qiV~~--lDklIrnP~SLk~~~~~~~r~s~~lld~~~~~~~~f~sv~~WL~aIkm~rY~~~F~~ 944 (996)
T KOG0196|consen 867 MLDCWQKDRNRRPKFAQIVST--LDKLIRNPNSLKTIAPESPRPSQPLLDRSGSDFTPFRSVGDWLEAIKMGRYKEHFAA 944 (996)
T ss_pred HHHHHHHHhhcCCCHHHHHHH--HHHHhcCchhhcccCCCCCCCcccccCCCCCCCcccCCHHHHHHHhhhhHHHHHHHh
Confidence 999999999999999999874 33222222222222211 1111111122223345667777777777777655544
Q ss_pred eeeccCCceeecCCCCcCccCCcCCCccccccCCCCcc
Q 014610 321 VQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVR 358 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (421)
..+.+.....+.+-.++..-..+..|+.+++..++|-.
T Consensus 945 ag~~s~~~V~q~s~eDl~~~Gitl~GhqkkIl~SIq~m 982 (996)
T KOG0196|consen 945 AGYTSFEDVAQMSAEDLLRLGITLAGHQKKILSSIQAM 982 (996)
T ss_pred cCcccHHHHHhhhHHHHHhhceeecchhHHHHHHHHHH
Confidence 44443332222222333334445556666665554433
No 374
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.4e-43 Score=316.68 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=213.0
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe-------
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH------- 82 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 82 (421)
..+.|+-+.+||+|.||.||+|+.+.+|+.||+|++-.+.. ...-....+|+++|..|+|+|++.+++++..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 35789999999999999999999999999999987543221 1122446789999999999999999987753
Q ss_pred -CCEEEEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 83 -QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
...+|+||.+|+. +|.-++... .+++...|..++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 3458999999965 999998654 6899999999999999999999999999999999999999999999999999976
Q ss_pred ccccc----ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC-------CC-
Q 014610 161 LTRTI----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------EN- 228 (421)
Q Consensus 161 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~-------~~- 228 (421)
+.... ......+-|.+|++||.+.+...|+++.|||+.||||.||+++.+.+.+......+..|.. ..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 64321 1233456799999999999998999999999999999999999999988777665544321 00
Q ss_pred -------------CCCCch----H---------HHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 229 -------------PPQLDE----H---------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 229 -------------~~~~~~----~---------~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
.++++. . -.+++.+++.++|..||.+|++++++|.|.||+.-.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 011111 0 134678999999999999999999999999998643
No 375
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-42 Score=323.26 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=210.2
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC--CC----eeEEEEEE
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PY----ITEYYGSY 80 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h--pn----Iv~l~~~~ 80 (421)
+.+...++|+++..+|+|.||+|.++.+.+++..||||+++... .-.+..+-|+.+|.++.+ |+ +|.+.++|
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 45667899999999999999999999999999999999985332 233556779999999942 33 78888899
Q ss_pred EeCCEEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc------------
Q 014610 81 LHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE------------ 146 (421)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~------------ 146 (421)
.-.++.|||+|.+ |-+++++++.+ .+++-.+++.+++||+++++|||+++++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 77999999875 47999999999999999999999999999999999999942
Q ss_pred --------CCCEEEeecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Q 014610 147 --------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM 218 (421)
Q Consensus 147 --------~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~ 218 (421)
.-.++|+|||-|..... ..++.+.|..|.|||++.+- +++..+||||+||||+||++|...|...+..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 22489999998865432 33678899999999999998 5999999999999999999999999876644
Q ss_pred H---HHhhccCCCCCC------------------------------------C------chHHHHHHHHHHHHHcccCCC
Q 014610 219 R---VLFIIPRENPPQ------------------------------------L------DEHFSRLMKEFVSLCLKKVPA 253 (421)
Q Consensus 219 ~---~~~~i~~~~~~~------------------------------------~------~~~~s~~l~~li~~~L~~dP~ 253 (421)
+ +...|....|.. + .+.--.++.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3 222222111100 0 001123588999999999999
Q ss_pred CCcCHHHHHhChhcccc
Q 014610 254 ERPSAKELLRHRFIRNA 270 (421)
Q Consensus 254 ~Rpt~~elL~hp~~~~~ 270 (421)
+|+|+.|+|.||||+..
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999854
No 376
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=7.9e-42 Score=343.04 Aligned_cols=210 Identities=32% Similarity=0.541 Sum_probs=184.6
Q ss_pred cccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC
Q 014610 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (421)
Q Consensus 5 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 84 (421)
+.++......+...+.||+|+||.||+++++++|+.||||.++........+..-+|+++|++|+|||||+++++-....
T Consensus 5 ~~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 5 PVLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred cccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 44666677888889999999999999999999999999999987665556678889999999999999999999766543
Q ss_pred ------EEEEEEecCCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--cCCC--EE
Q 014610 85 ------KLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENGD--VK 151 (421)
Q Consensus 85 ------~~~lV~E~~~gg~L~~~l~~---~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~--~~g~--vk 151 (421)
...+|||||.||+|...+.+ ...|+|.+++.++..+..||.|||++||+||||||+||++- .+|+ .|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence 46899999999999999975 35799999999999999999999999999999999999984 3343 69
Q ss_pred EeecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCC
Q 014610 152 VADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (421)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~ 215 (421)
|+|||.|+.+... +...+..||+.|++||++.....|+..+|.|||||++|+++||..||-..
T Consensus 165 LtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 165 LTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999999887665 35678899999999999986556999999999999999999999999643
No 377
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-42 Score=342.92 Aligned_cols=261 Identities=50% Similarity=0.921 Sum_probs=239.3
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.....+|+++..+|.|+||.||+|+++.+++..|+|++++... +...-+++|+-+++-++|||||.+++.+.....+||
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4677899999999999999999999999999999999987754 346778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
+||||.||+|.+.-.-.++++|.++..+.++.++||+|||++|-+|||||-.|||+++.|.+||+|||.+..+.....++
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 99999999999998888999999999999999999999999999999999999999999999999999999988888888
Q ss_pred cccccCccccCccccc--CcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCC--CCC--chHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQL--DEHFSRLMKE 242 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~--~~~~s~~l~~ 242 (421)
..++|||+|||||+.. ...+|...+|||++|++..||-.-++|-.+..+++.+..+.+..+ +.+ ...++..+-+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 9999999999999853 334689999999999999999999999999999999888766543 333 3478999999
Q ss_pred HHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 243 FVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 243 li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
|++.+|.++|.+|||++.+|.|||....
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999765
No 378
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=9.7e-41 Score=294.67 Aligned_cols=251 Identities=23% Similarity=0.433 Sum_probs=211.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCC--EEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT--KLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~~~l 88 (421)
.++|++++.+|+|.|+.||.|++..+++.++||+++.. ....+.+|+.||..|. ||||++++++..+.. ...|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 47899999999999999999999999999999998654 3477999999999997 999999999998754 5789
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGla~~~~~~~~~ 167 (421)
|+||+++.+...+. +.++...++.+++||++||.|||++||+|||+||.|++||.. -.++|+|+|+|..... ...
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp-~~e 188 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKE 188 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-Cce
Confidence 99999998888875 458999999999999999999999999999999999999976 5699999999977654 355
Q ss_pred ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHhhccC----------------CCCC
Q 014610 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPR----------------ENPP 230 (421)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~-~~~~~~~~~i~~----------------~~~~ 230 (421)
.+..+.+..|-.||++..-..|+..-|+|||||+|..|+..+.||-. .+..+++.+|.+ .-.+
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 66788999999999998888899999999999999999999988753 333333322210 0000
Q ss_pred CC--------------------chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 231 QL--------------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 231 ~~--------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
.+ ....++++.+||.++|..|-.+|+||.|++.||||...
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 00 01236889999999999999999999999999999754
No 379
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1e-39 Score=322.07 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=215.0
Q ss_pred eeceEeecCceEEEEEEECC----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 17 SLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
..+.||.|-||.||+|+... ..-.||||..+.+...+..+.|..|..+|++++|||||+++|++. ....|||||+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEec
Confidence 44689999999999998643 234689999888777778899999999999999999999999986 4678999999
Q ss_pred CCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc-cc
Q 014610 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KT 170 (421)
Q Consensus 93 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~ 170 (421)
+.-|.|..+++.+ ..++......+.+||+.||+|||+.++|||||...|||+....-|||+|||+++.+....--. +.
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 9999999999865 468889999999999999999999999999999999999999999999999998876542111 11
Q ss_pred cccCccccCcccccCcCCCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcc
Q 014610 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (421)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~ 249 (421)
..-...|||||-+.-.. ++.++|||.|||+|||++ .|..||.+....+++..+.++...++++++++.+..++.+||.
T Consensus 552 ~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWa 630 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWA 630 (974)
T ss_pred cccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhc
Confidence 22345699999997664 899999999999999977 6999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCHHHHHh
Q 014610 250 KVPAERPSAKELLR 263 (421)
Q Consensus 250 ~dP~~Rpt~~elL~ 263 (421)
.+|.+||++.+|..
T Consensus 631 yeP~kRPrftei~~ 644 (974)
T KOG4257|consen 631 YEPSKRPRFTEIKA 644 (974)
T ss_pred cCcccCCcHHHHHH
Confidence 99999999988754
No 380
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-40 Score=316.41 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=215.2
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC------CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe-
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE------SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH- 82 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 82 (421)
.+..+|-++..||+|+|+.||+|.+....++||||+-.+.+ ...-....-+|.+|.+.|+||-||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34578999999999999999999999999999999864433 23335667799999999999999999999974
Q ss_pred CCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEcc---CCCEEEeeccc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--GKIHRDIKAANILLTE---NGDVKVADFGV 157 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~--~iiHrDlkp~NILl~~---~g~vkL~DFGl 157 (421)
.+.+|-|+|||+|.+|.-+++.++.++|.+++.|+.||+.||.||.+. .|||-||||.||||-. -|.+||.|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 567899999999999999999999999999999999999999999976 5999999999999953 37899999999
Q ss_pred cccccccc-------ccccccccCccccCcccccCc---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH---hhc
Q 014610 158 SAQLTRTI-------SRRKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FII 224 (421)
Q Consensus 158 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~---~~i 224 (421)
++.+.... .......||.||++||.+.-. +..+.++||||+|||+|.++.|+.||........+ .-|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 98875432 123446899999999987532 33678999999999999999999999765432221 122
Q ss_pred cCCCCCCC--chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 225 PRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 225 ~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
.+..-..+ .+.++.++++||++||+..-++|....++-.||+|..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 22222222 2457899999999999999999999999999999964
No 381
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=3.7e-39 Score=335.47 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=178.4
Q ss_pred hCCCceeeceEeecCceEEEEEEECCC----CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEE------E
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKEL----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS------Y 80 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~----g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~------~ 80 (421)
..++|++.+.||+|+||.||+|.+..+ +..||||.+...... +....| .+++..+.+++.++.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 457999999999999999999999998 999999987543211 111111 1122222223222221 2
Q ss_pred EeCCEEEEEEecCCCCCHHHHHHcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 014610 81 LHQTKLWIIMEYMAGGSVADLIQSGP--------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140 (421)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~ 140 (421)
..+..++||+||+.+++|.+++.... ...+..+..++.||+.||+|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 34667999999999999999986532 1123456789999999999999999999999999
Q ss_pred cEEEcc-CCCEEEeeccccccccccc-ccccccccCccccCcccccCcC---------------------CCCCccccHH
Q 014610 141 NILLTE-NGDVKVADFGVSAQLTRTI-SRRKTFVGTPFWMAPEVIQNSE---------------------GYNEKADIWS 197 (421)
Q Consensus 141 NILl~~-~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Dvws 197 (421)
|||++. ++.+||+|||+|..+.... ......+||+.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 5899999999997653321 1234578999999999764221 1345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHhhcc--------------CCCCCCCc------hHHHHHHHHHHHHHcccCCCCCcC
Q 014610 198 LGITVIEMAKGEPPLADLHPMRVLFIIP--------------RENPPQLD------EHFSRLMKEFVSLCLKKVPAERPS 257 (421)
Q Consensus 198 lGvil~ell~g~~pf~~~~~~~~~~~i~--------------~~~~~~~~------~~~s~~l~~li~~~L~~dP~~Rpt 257 (421)
|||+||||+++..++.... ......+. ....+.+. ........+||.+||++||.+|||
T Consensus 365 lGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 9999999999876654321 11111110 00000000 011234568999999999999999
Q ss_pred HHHHHhChhccccc
Q 014610 258 AKELLRHRFIRNAR 271 (421)
Q Consensus 258 ~~elL~hp~~~~~~ 271 (421)
+.|+|+||||+...
T Consensus 444 a~e~L~Hpff~~~~ 457 (566)
T PLN03225 444 AKAALAHPYFDREG 457 (566)
T ss_pred HHHHhCCcCcCCCC
Confidence 99999999998643
No 382
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=1.2e-38 Score=295.00 Aligned_cols=241 Identities=41% Similarity=0.666 Sum_probs=206.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHc
Q 014610 25 SFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS 104 (421)
Q Consensus 25 ~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~ 104 (421)
+||.||+|.+..+|+.||+|++.........+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999999999999987655433368899999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCccccCccccc
Q 014610 105 GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184 (421)
Q Consensus 105 ~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~ 184 (421)
...+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++....... ......|+..|++||.+.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHc
Confidence 6669999999999999999999999999999999999999999999999999987665432 334567899999999987
Q ss_pred CcCCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHhhccCCCCCCCchH--HHHHHHHHHHHHcccCCCCCcCHHHH
Q 014610 185 NSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKKVPAERPSAKEL 261 (421)
Q Consensus 185 ~~~~~~~~~DvwslGvil~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt~~el 261 (421)
+. .++.++||||||+++++|++|..||.. .+.......+........... ++..+.+++.+||..+|++||++.++
T Consensus 160 ~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 160 GK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred cC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 55 478899999999999999999999987 444444443333332222222 77899999999999999999999999
Q ss_pred HhChhc
Q 014610 262 LRHRFI 267 (421)
Q Consensus 262 L~hp~~ 267 (421)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
No 383
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=7.9e-39 Score=314.03 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=217.3
Q ss_pred ccccchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeC
Q 014610 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (421)
Q Consensus 4 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 83 (421)
..++.+-+.+...+.++||+|-||.|.++.-.. +..||+|.++..........+.+|+++|.+|+|||||+++++|..+
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 345777788899999999999999999997654 7999999998777777778999999999999999999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
+.+++|+||++.|+|.+++.++.. +.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 999999999999999999987632 345567779999999999999999999999999999999999999999999855
Q ss_pred ccccc--cccccccCccccCcccccCcCCCCCccccHHHHHHHHHHH--hCCCCCCCCCHHHHHhhcc---C----CCCC
Q 014610 162 TRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA--KGEPPLADLHPMRVLFIIP---R----ENPP 230 (421)
Q Consensus 162 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell--~g~~pf~~~~~~~~~~~i~---~----~~~~ 230 (421)
..... .....+-...|||||.+...+ ++.++|||+||++|||++ +...||....+.+...... . ...+
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 43211 111234567899999988775 899999999999999965 6899999888766654332 1 1123
Q ss_pred CCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 231 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+..++..+.+++.+||..+-++||+++++..
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 345567888999999999999999999999954
No 384
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.4e-39 Score=319.40 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=223.0
Q ss_pred CCCceeeceEeecCceEEEEEEECCC-C--cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL-N--KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-g--~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
.++.++.+.||+|+||.|++|.++.. | ..||||.+...........|.+|+.+|.+|+|||+++|||+..+ ..+.|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 45677889999999999999998753 3 46899999776655577899999999999999999999999887 78899
Q ss_pred EEecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 89 IMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
|||++++|+|.+.+++ ...|....+..|+.||+.|+.||.++++|||||...||||...-.|||||||+.+-+....+
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999999976 35688899999999999999999999999999999999999888999999999987765433
Q ss_pred ccccc----ccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHH
Q 014610 167 RRKTF----VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (421)
Q Consensus 167 ~~~~~----~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 241 (421)
.+ .+ .-...|+|||.+.... ++.++|||++||++|||++ |..||.+......+..|.......-++.+++.+.
T Consensus 268 ~Y-vm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 268 MY-VMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred ce-EecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 32 22 2234699999998875 8999999999999999996 8999999999999999987777777788999999
Q ss_pred HHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 242 ~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
++++.||..+|.+|||+..|.+.-++..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9999999999999999999976655544
No 385
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=2e-39 Score=314.49 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=212.7
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC------CCeeEEEEEE
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS------PYITEYYGSY 80 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~ 80 (421)
+.+.+.++|.+....|+|-||+|..|.+...|+.||||+|.... .....=.+|+.||++|+. -|+++|+-.|
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 67778899999999999999999999999999999999996443 233445689999999963 5799999999
Q ss_pred EeCCEEEEEEecCCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeecc
Q 014610 81 LHQTKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFG 156 (421)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFG 156 (421)
...+++|||+|-+ ..+|.+++++.+ .|....++.|+.||+.||..|-..||+|.||||+|||+++. ..+||||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999999998 569999998743 58888999999999999999999999999999999999976 568999999
Q ss_pred cccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhc--cCCC------
Q 014610 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--PREN------ 228 (421)
Q Consensus 157 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i--~~~~------ 228 (421)
.|...... ....+.-+.+|.|||++.+.. |++..|+||.||+||||+||+..|++.....++... .++.
T Consensus 583 SA~~~~en--eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASEN--EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc--cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 88665433 234567788999999999985 999999999999999999999999887654443211 0000
Q ss_pred -------------------------------------C-----------CCCc---hHHHHHHHHHHHHHcccCCCCCcC
Q 014610 229 -------------------------------------P-----------PQLD---EHFSRLMKEFVSLCLKKVPAERPS 257 (421)
Q Consensus 229 -------------------------------------~-----------~~~~---~~~s~~l~~li~~~L~~dP~~Rpt 257 (421)
| +.++ ..+-..+++||.+||..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 0 0011 122346889999999999999999
Q ss_pred HHHHHhChhccc
Q 014610 258 AKELLRHRFIRN 269 (421)
Q Consensus 258 ~~elL~hp~~~~ 269 (421)
..|+|.||||..
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999963
No 386
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.9e-37 Score=315.96 Aligned_cols=258 Identities=21% Similarity=0.370 Sum_probs=188.1
Q ss_pred CCCceeeceEeecCceEEEEEEEC----------------CCCcEEEEEEeccCCCHHH-------------HHHHHHHH
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDK----------------ELNKDVAIKVIDLEESEDE-------------IEDIQKEI 62 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~----------------~~g~~vAiK~~~~~~~~~~-------------~~~~~~E~ 62 (421)
.++|++.++||+|+||+||+|.+. ..++.||||.+........ .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 579999999999999999999752 3457899999865432111 12233477
Q ss_pred HHHHcCCCCCe-----eEEEEEEEe--------CCEEEEEEecCCCCCHHHHHHcC------------------------
Q 014610 63 SVLSQCRSPYI-----TEYYGSYLH--------QTKLWIIMEYMAGGSVADLIQSG------------------------ 105 (421)
Q Consensus 63 ~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~------------------------ 105 (421)
.++.+++|.++ ++++++|.. .+..|||+||+++++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788876554 667776643 35689999999999999988631
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc-ccccccCccccCccccc
Q 014610 106 PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTFVGTPFWMAPEVIQ 184 (421)
Q Consensus 106 ~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~~~ 184 (421)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||++.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 12356778899999999999999999999999999999999999999999998654332111 11224589999999875
Q ss_pred CcCC-------------------CC--CccccHHHHHHHHHHHhCCC-CCCCCCHHHH-----------HhhccCCC-CC
Q 014610 185 NSEG-------------------YN--EKADIWSLGITVIEMAKGEP-PLADLHPMRV-----------LFIIPREN-PP 230 (421)
Q Consensus 185 ~~~~-------------------~~--~~~DvwslGvil~ell~g~~-pf~~~~~~~~-----------~~~i~~~~-~~ 230 (421)
.... |+ .+.||||+||++|+|++|.. ||........ ...+.... ..
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 4210 11 24799999999999999986 7754321111 11111111 11
Q ss_pred CCchHHHHHHHHHHHHHcccCC---CCCcCHHHHHhChhccc
Q 014610 231 QLDEHFSRLMKEFVSLCLKKVP---AERPSAKELLRHRFIRN 269 (421)
Q Consensus 231 ~~~~~~s~~l~~li~~~L~~dP---~~Rpt~~elL~hp~~~~ 269 (421)
......+...++|+.+||.++| .+|+|++|+|+||||..
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2234568899999999999876 68999999999999963
No 387
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-39 Score=326.11 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=202.0
Q ss_pred ceeeceEeecCceE-EEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEEec
Q 014610 15 FSSLELIGRGSFGD-VYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 15 y~~~~~LG~G~~g~-Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
|.-.+++|.|+.|+ ||+|... |+.||||.+- ......+.+||..|+.. .|||||++|+.-.++..+||..|+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 34457889999986 7999877 8899999873 23456788999999998 599999999999999999999999
Q ss_pred CCCCCHHHHHHcCCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc---C--CCEEEeeccccccccc
Q 014610 93 MAGGSVADLIQSGPP----LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---N--GDVKVADFGVSAQLTR 163 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~----l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~---~--g~vkL~DFGla~~~~~ 163 (421)
| ..+|.+++..... ......+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 5699999987311 111345788999999999999999999999999999976 3 4689999999988754
Q ss_pred cc---ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhC-CCCCCCCCHHHHHhhccCCCC--CCCchHHH
Q 014610 164 TI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENP--PQLDEHFS 237 (421)
Q Consensus 164 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g-~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s 237 (421)
.. .+..+..||-+|+|||++.... -+.++||+||||++|+.++| ..||.+.-..+. .|..++. ..+...-.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence 32 2345678999999999998765 57789999999999998875 999986543322 2222222 11111112
Q ss_pred HHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCChhHHHHhhc
Q 014610 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282 (421)
Q Consensus 238 ~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~~~ 282 (421)
.++.+||.+||.++|..||+|.++|.||||+...+.-..+.....
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSD 785 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSD 785 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhh
Confidence 289999999999999999999999999999876655544444433
No 388
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-37 Score=306.87 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=217.7
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..+.....+||-|-||.||.|.++.-...||||.++.+. -.++.|.+|+.+|+.++|||+|+++++|..+-.+|||+|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 345566779999999999999999999999999985443 346889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-ccc
Q 014610 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (421)
Q Consensus 92 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-~~~ 168 (421)
||..|+|.+++++. .-++.-.+..++.||..|++||..+++|||||...|+|+.++..||++|||+++.+.... ...
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 99999999999763 347777888899999999999999999999999999999999999999999998875431 111
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~ 247 (421)
........|.|||-+.-. .++.++|||+|||+|||+.| |-.||.+.+...++..+.++..-.-+..+++.+.+|++.|
T Consensus 424 AGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred cCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 122345679999998765 48899999999999999996 8999999999999998888887777888999999999999
Q ss_pred cccCCCCCcCHHHHHh
Q 014610 248 LKKVPAERPSAKELLR 263 (421)
Q Consensus 248 L~~dP~~Rpt~~elL~ 263 (421)
|+++|.+||+++|+-+
T Consensus 503 W~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred hcCCcccCccHHHHHH
Confidence 9999999999999854
No 389
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-39 Score=293.77 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=214.0
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-----EEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 87 (421)
+.+=.+.||.|+||.||.+.|..+|+.||+|.+.... .-.....+.+|+++|..++|.|+...+++.+... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4455689999999999999999999999999874322 3334577889999999999999999999877543 468
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
+|+|++ ..+|..+|-.-++++.+.+.-+++||+.||+|||+.||.||||||.|+|++.+..+||||||+++........
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 999999 5699999988899999999999999999999999999999999999999999999999999999876543332
Q ss_pred c-cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccC--------------------
Q 014610 168 R-KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------------- 226 (421)
Q Consensus 168 ~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~-------------------- 226 (421)
. ..-+-|-+|.|||++.+...|+.++||||.|||+.||+..+..|...++.+.+..|..
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 2 2346788999999999998999999999999999999999999988887766654411
Q ss_pred ---C--CCCCCc--------hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 227 ---E--NPPQLD--------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 227 ---~--~~~~~~--------~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
. .++.++ ..-..+...++.++|..||.+|.+.++++.|+++.+.+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 0 011111 12234677899999999999999999999999997653
No 390
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-38 Score=290.10 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=212.2
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCC-
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT- 84 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 84 (421)
..-+...+|.-+..+|.|+- .|.-|.|.-+++.||+|.+.... .....++..+|..++..++|+||++++.+|...+
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 45567789999999999999 88899999999999999874432 2334577889999999999999999999998654
Q ss_pred -----EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 85 -----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 85 -----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
.+|+|||++. .+|...+. -.+.-..+..+++|++.|++|||+.||+||||||+||+++.++.+||+|||+|.
T Consensus 90 l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 4799999995 59999886 457788999999999999999999999999999999999999999999999997
Q ss_pred ccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC------------
Q 014610 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------ 227 (421)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~------------ 227 (421)
..... -..+.++.|..|.|||++.+.. |...+||||+||++.||++|+..|.+.+..+...++...
T Consensus 167 ~e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 65433 2345678999999999999875 899999999999999999999999887665544333110
Q ss_pred ---------CCCC---------Cc-----------hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 228 ---------NPPQ---------LD-----------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 228 ---------~~~~---------~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
+.++ ++ ..-+..+++++.+||..||++|.+++++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0000 00 01135689999999999999999999999999998
No 391
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-37 Score=270.01 Aligned_cols=221 Identities=33% Similarity=0.585 Sum_probs=189.2
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
.+...-+..||+|++|.|=+-++..+|+..|+|.+...-......++.+|+.+..+. .+|++|.+|+.+.....+||.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345556789999999999999999999999999998776666778888999987776 6999999999999999999999
Q ss_pred ecCCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 91 EYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 91 E~~~gg~L~~~l----~~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
|.|+ .+|..+- ++++.++|..+-+|+..+++||.|||++ .+||||+||+||||+.+|+||+||||++..+.+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 9994 5776544 5678999999999999999999999976 89999999999999999999999999998876653
Q ss_pred ccccccccCccccCcccccC---cCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHhhccCCCCCCCch
Q 014610 166 SRRKTFVGTPFWMAPEVIQN---SEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLDE 234 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~ 234 (421)
.+ +...|.-.|||||.+.. ..+|+.++||||||+++.||.+++.||... .+.+++..+....+|+++.
T Consensus 204 Ak-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 204 AK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred HH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 32 22568888999998853 236899999999999999999999999754 5677777777777777653
No 392
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.3e-36 Score=337.62 Aligned_cols=238 Identities=18% Similarity=0.313 Sum_probs=190.5
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
..|+..++||+|+||.||+|.+..+|..||||.+...... ...|+.++++++|||||++++++.+.+..|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 4577788999999999999999999999999998644321 23568899999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCcEEEccCCCEEEeeccccccccccccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH---NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH---~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 169 (421)
+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..+++ ||....... ..
T Consensus 765 ~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DT 836 (968)
T ss_pred CCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CC
Confidence 999999999964 899999999999999999999 6699999999999999988887775 665433221 12
Q ss_pred ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHHhhcc----------CCC--CCCC
Q 014610 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----MRVLFIIP----------REN--PPQL 232 (421)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~-----~~~~~~i~----------~~~--~~~~ 232 (421)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+...... ... ....
T Consensus 837 ~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 34789999999999876 489999999999999999999999853211 11100000 000 0111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
......++.+++.+||+.+|++|||+.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 22334567889999999999999999999874
No 393
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5e-36 Score=289.44 Aligned_cols=136 Identities=27% Similarity=0.473 Sum_probs=117.5
Q ss_pred cchhhC-CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-----C---CCeeEEE
Q 014610 7 LQEAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----S---PYITEYY 77 (421)
Q Consensus 7 ~~~~~~-~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-----h---pnIv~l~ 77 (421)
+.+... ++|.++++||.|-|++||+|.|..+.+.||+|+.+-. ..-.+....||.+|++++ | .+||+|+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 455565 8999999999999999999999999999999997533 233456778999999884 3 4699999
Q ss_pred EEEEe----CCEEEEEEecCCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEc
Q 014610 78 GSYLH----QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLT 145 (421)
Q Consensus 78 ~~~~~----~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~ 145 (421)
+.|.. +.++|||+|++ |.+|..+|+. .+.++...++.|++|||.||.|||. .||||-||||+|||+.
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99985 56899999999 7788888875 4679999999999999999999995 5999999999999995
No 394
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-35 Score=310.93 Aligned_cols=250 Identities=27% Similarity=0.494 Sum_probs=213.4
Q ss_pred CCceeeceEeecCceEEEEEEEC----C---CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCC
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDK----E---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~----~---~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 84 (421)
++.++.+.||+|.||.|++|.-. . ....||||.++......+.+.+..|+.+|+.+ +||||+.+++++...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34466679999999999999643 1 15679999987766667789999999999999 5999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 014610 85 KLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g 148 (421)
.+++|+|||..|+|.++++..+ .++......+++||+.|++||++.++|||||...||||+.+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999998754 388999999999999999999999999999999999999999
Q ss_pred CEEEeecccccccccccccc-ccccc--CccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCC-HHHHHhh
Q 014610 149 DVKVADFGVSAQLTRTISRR-KTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLH-PMRVLFI 223 (421)
Q Consensus 149 ~vkL~DFGla~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~-~~~~~~~ 223 (421)
.+||+|||+|+......--. ..-.| ...|||||.+... .|+.++|||||||+|||+++ |..||.+.. ..+....
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999998544321111 11122 2349999999875 59999999999999999996 999999865 5555666
Q ss_pred ccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 224 i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
+..+.....+..++.++.++++.||..+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7777777888888999999999999999999999999975
No 395
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-35 Score=300.79 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=218.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCC----cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g----~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
...+..++||.|+||+||+|++.-.| .+||||++........-..+..|+-+|.+++|||++++++++.... +-|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 45667889999999999999986444 4799999876666666788999999999999999999999987655 889
Q ss_pred EEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc
Q 014610 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~ 167 (421)
|++|+++|+|.++++.+ .++-.+....|.+||++|+.|||+++++||||-..|||+..-.++|+.|||++..+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999754 57889999999999999999999999999999999999999999999999999887665444
Q ss_pred cccccc--CccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 168 RKTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 168 ~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
.+...| .+.|||-|.+... .|+.++|||||||++|||+| |..|+.+....+....+..+.....+...+.++.-++
T Consensus 855 y~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 444333 4569999998766 49999999999999999885 9999999988888888877777777788899999999
Q ss_pred HHHcccCCCCCcCHHHHHh
Q 014610 245 SLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~ 263 (421)
.+||..|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999999864
No 396
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=100.00 E-value=2.2e-36 Score=288.32 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=208.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECC---CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 85 (421)
.....|+++.+||.|+|++||+|.+.. ..+.||+|.+.....+ ..+..|+++|..+. +.||+++.+++..++.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 445789999999999999999999887 7899999998776644 55889999999995 8999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeeccccccccc-
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTR- 163 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGla~~~~~- 163 (421)
+.+|+||++..+..++... ++-.++..+++.++.||+++|.+|||||||||+|+|.+.. +.-.|+|||+|.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999999999866 7789999999999999999999999999999999999854 7889999999862100
Q ss_pred ---------------c-c---------------------------ccccccccCccccCcccccCcCCCCCccccHHHHH
Q 014610 164 ---------------T-I---------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200 (421)
Q Consensus 164 ---------------~-~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 200 (421)
+ . .......|||+|.|||++......++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 00113469999999999988777889999999999
Q ss_pred HHHHHHhCCCCCCCCC-HHHHH---------------h----h--ccC-CCC----------------------------
Q 014610 201 TVIEMAKGEPPLADLH-PMRVL---------------F----I--IPR-ENP---------------------------- 229 (421)
Q Consensus 201 il~ell~g~~pf~~~~-~~~~~---------------~----~--i~~-~~~---------------------------- 229 (421)
|+..++++..||.... +...+ . . +.. .+.
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 9999999999985321 10000 0 0 000 000
Q ss_pred CCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccC
Q 014610 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (421)
Q Consensus 230 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 272 (421)
....+.++..+.+|+.+||..||.+|.||+++|+||||..+..
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0001234557899999999999999999999999999986543
No 397
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=100.00 E-value=1.5e-33 Score=254.17 Aligned_cols=213 Identities=46% Similarity=0.771 Sum_probs=190.0
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCHHH
Q 014610 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD 100 (421)
Q Consensus 21 LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~ 100 (421)
||.|++|.||++.+..+++.+++|++...........+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999988999999998766543345789999999999999999999999999999999999999999999
Q ss_pred HHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCEEEeecccccccccccccccccccCcccc
Q 014610 101 LIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (421)
Q Consensus 101 ~l~~~-~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~ 178 (421)
++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+..............+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 99875 47899999999999999999999999999999999999999 89999999999876654322233466889999
Q ss_pred CcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCH
Q 014610 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (421)
Q Consensus 179 aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 258 (421)
+||.+.....++.+.|+|++|+++++| ..+.+++.+||..+|.+||++
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 999987653478899999999999999 678999999999999999999
Q ss_pred HHHHhCh
Q 014610 259 KELLRHR 265 (421)
Q Consensus 259 ~elL~hp 265 (421)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999874
No 398
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.3e-35 Score=281.23 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=191.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHc--CCCCCeeEEEEEEEeCC----EE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQT----KL 86 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~----~~ 86 (421)
....++++||+|.||.||+|... ++.||||+++.. ..+.++.|.+|.+. ++|+||+++++.-..+. .+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45678899999999999999766 699999998644 45778888887765 58999999999776555 79
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEccCCCEEEeeccc
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---------GKIHRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~---------~iiHrDlkp~NILl~~~g~vkL~DFGl 157 (421)
+||+||-+.|+|.++++. ..+++....+++..++.||+|||+. .|+|||||..||||..|++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999987 6789999999999999999999963 599999999999999999999999999
Q ss_pred cccccccc--ccccccccCccccCcccccCcCCCC-----CccccHHHHHHHHHHHhCC------------CCCCC---C
Q 014610 158 SAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYN-----EKADIWSLGITVIEMAKGE------------PPLAD---L 215 (421)
Q Consensus 158 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwslGvil~ell~g~------------~pf~~---~ 215 (421)
|..+.... +.....+||.+|||||++.+.-.+. .+.||||+|.+||||++.- .||.. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98776432 2334478999999999997654444 3589999999999999732 23321 0
Q ss_pred C--HHHHH-hhccCCCCCCCchHH-----HHHHHHHHHHHcccCCCCCcCHHHHH
Q 014610 216 H--PMRVL-FIIPRENPPQLDEHF-----SRLMKEFVSLCLKKVPAERPSAKELL 262 (421)
Q Consensus 216 ~--~~~~~-~~i~~~~~~~~~~~~-----s~~l~~li~~~L~~dP~~Rpt~~elL 262 (421)
+ -.++. ..+.+...|.++..+ -..+.+.+..||..||+.|+|+.=+-
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 0 01111 112223344554433 35688999999999999999986553
No 399
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-35 Score=291.06 Aligned_cols=200 Identities=31% Similarity=0.493 Sum_probs=178.3
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-------HHHHHHHHHHHHHHcCC---CCCeeEEEEEEEe
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------DEIEDIQKEISVLSQCR---SPYITEYYGSYLH 82 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-------~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~ 82 (421)
..|..++.+|.|+||.|++|++++....|+||.|.++..- ..+-.+-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4599999999999999999999999999999999766521 12234557999999997 9999999999999
Q ss_pred CCEEEEEEecC-CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 83 QTKLWIIMEYM-AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 83 ~~~~~lV~E~~-~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
++.+||+||-- +|-+|+++|..+..++|.++..|++|++.|+++||++||||||||-+||.++.+|-+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999974 56799999999999999999999999999999999999999999999999999999999999988655
Q ss_pred ccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCC
Q 014610 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (421)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~ 214 (421)
.. +...++.||..|.|||++.+.+..+..-|||+||++||-+.....||..
T Consensus 721 ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 43 3456789999999999999887677889999999999999988888764
No 400
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-34 Score=273.47 Aligned_cols=250 Identities=24% Similarity=0.446 Sum_probs=194.6
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHc--CCCCCeeEEEEEEEeCC
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQT 84 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~ 84 (421)
+|-+++.+..+.+.||+|-||.||+|.++ |+.||||++.-.+ .+.+.+|.+|.+. |+|+||..+++.-...+
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 56677889999999999999999999998 9999999986443 3567777777654 69999999998654332
Q ss_pred ----EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEccCCCEEE
Q 014610 85 ----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKV 152 (421)
Q Consensus 85 ----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~--------~iiHrDlkp~NILl~~~g~vkL 152 (421)
.+|||++|-+.|+|+|++.+ ..++.+...+++..++.||++||-. .|.|||||..|||+.++|.+-|
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 58999999999999999988 7899999999999999999999953 4999999999999999999999
Q ss_pred eecccccccccc----cccccccccCccccCcccccCcCC---CC--CccccHHHHHHHHHHHh----------CCCCCC
Q 014610 153 ADFGVSAQLTRT----ISRRKTFVGTPFWMAPEVIQNSEG---YN--EKADIWSLGITVIEMAK----------GEPPLA 213 (421)
Q Consensus 153 ~DFGla~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~---~~--~~~DvwslGvil~ell~----------g~~pf~ 213 (421)
+|+|+|...... ....+..+||-+|||||++...-. +. ..+||||||.+|||++. -.+||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999765433 123467899999999999864321 11 35899999999999885 257886
Q ss_pred CCCHH----HHHhhcc--CCCCCCCch-----HHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 214 DLHPM----RVLFIIP--RENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 214 ~~~~~----~~~~~i~--~~~~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
+..+. +....+. ....|.++. ..-..+-.+++-||..||.-|.||--+.+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 54321 1121111 111222222 22345667899999999999999877653
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=100.00 E-value=1.5e-32 Score=251.98 Aligned_cols=214 Identities=37% Similarity=0.630 Sum_probs=184.4
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
|++.+.||.|++|.||+|.+..+++.+|||.+...........+.+|+..+++++|+||+++++.+......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999998999999998765443356788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc-ccccccc
Q 014610 95 GGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRKTFV 172 (421)
Q Consensus 95 gg~L~~~l~~~~~-l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~ 172 (421)
+++|.+++..... +++..+..++.|++.+|.+||+++++|+||+|.||+++.++.++|+|||++....... .......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999987666 8999999999999999999999999999999999999999999999999987765432 1223567
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCC-CCHH-HHHhhccCCC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPM-RVLFIIPREN 228 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~-~~~~-~~~~~i~~~~ 228 (421)
++..|++||.+.....++.++|+|+||+++++|++|+.||.. .+.. .....+..+.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 889999999984334577899999999999999999999977 4444 4445554444
No 402
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.98 E-value=7.3e-33 Score=300.89 Aligned_cols=199 Identities=18% Similarity=0.279 Sum_probs=147.7
Q ss_pred cCCC-CCeeEEEEEE-------EeCCEEEEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 014610 67 QCRS-PYITEYYGSY-------LHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137 (421)
Q Consensus 67 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDl 137 (421)
.+.| +||++++++| .....+++++|++ +++|.+++.. ..++++..+..+++||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5788888877 2335678889988 6699999975 356999999999999999999999999999999
Q ss_pred CCCcEEEccC-------------------CCEEEeeccccccccccc----------------ccccccccCccccCccc
Q 014610 138 KAANILLTEN-------------------GDVKVADFGVSAQLTRTI----------------SRRKTFVGTPFWMAPEV 182 (421)
Q Consensus 138 kp~NILl~~~-------------------g~vkL~DFGla~~~~~~~----------------~~~~~~~gt~~y~aPE~ 182 (421)
||+||||+.. +.+||+|||+++...... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999653 456666666664321100 00112468999999999
Q ss_pred ccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCC-CCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHH
Q 014610 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261 (421)
Q Consensus 183 ~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~el 261 (421)
+.+.. |+.++|||||||+||||++|.+|+..... ....+... .++.... ......+++.+||.++|.+|||+.|+
T Consensus 187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 DNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChHHH
Confidence 98764 89999999999999999999998764322 11111111 1111111 13446688999999999999999999
Q ss_pred HhChhcccc
Q 014610 262 LRHRFIRNA 270 (421)
Q Consensus 262 L~hp~~~~~ 270 (421)
|+||||...
T Consensus 263 l~h~~~~~~ 271 (793)
T PLN00181 263 LQSEFINEP 271 (793)
T ss_pred hhchhhhhh
Confidence 999999753
No 403
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.97 E-value=1.1e-31 Score=253.22 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=215.6
Q ss_pred CCCceeeceEeecCceEEEEEEECCC-----CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe-CCE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTK 85 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 85 (421)
..++++...+-+|.||.||.|++++. .+.|-+|.++...++-++..+..|.-.+..+.|||+..+.++... ...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46789999999999999999988754 345667877766677788889999999999999999999997765 556
Q ss_pred EEEEEecCCCCCHHHHHH-----c---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccc
Q 014610 86 LWIIMEYMAGGSVADLIQ-----S---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~-----~---~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGl 157 (421)
.++++.++.-|+|..++. . .+.++..++..++.|++.|++|||++||||.||...|.+|++.-++||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 788999999999999996 1 24577888899999999999999999999999999999999999999999999
Q ss_pred ccccccccccc--cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCCCCch
Q 014610 158 SAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDE 234 (421)
Q Consensus 158 a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 234 (421)
++.+....-.. ..--....||+||.+.... |+.++|||||||+||||++ |+.||.+.++.++...+..+....-+.
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~ 521 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF 521 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC
Confidence 98765431110 0011245699999998874 9999999999999999996 999999999999999999888888888
Q ss_pred HHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 235 ~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
++++++..++.-||...|++||+++|+..
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99999999999999999999999999864
No 404
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.6e-31 Score=241.66 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=193.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEE-EEEeCCEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYG-SYLHQTKLW 87 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~~~~~ 87 (421)
...+.|.+.+.||+|.||.+.+|.++.++..+++|.+..... ...++.+|..---.| .|.||+.-|+ .|+..+.++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 456789999999999999999999999999999999876543 457888998876556 5899998887 567778889
Q ss_pred EEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--cCCCEEEeeccccccccccc
Q 014610 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~--~~g~vkL~DFGla~~~~~~~ 165 (421)
+++||++-|+|..-+.. ..+-|.....++.|++.|+.|+|++++||||||.+||||- +...+||||||+........
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999998865 5688999999999999999999999999999999999994 23589999999876543221
Q ss_pred ccccccccCccccCcccccCcC----CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----HhhccCCCCCCCc---h
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLD---E 234 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~---~ 234 (421)
...--+..|.+||++.... ...+.+|+|.||+++|.+|+|.+||.....++. .........+.++ .
T Consensus 178 ---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 178 ---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred ---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 1223456789999875432 134678999999999999999999973322111 1111111122233 3
Q ss_pred HHHHHHHHHHHHHcccCCCCCc---CHHHHHhChhc
Q 014610 235 HFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFI 267 (421)
Q Consensus 235 ~~s~~l~~li~~~L~~dP~~Rp---t~~elL~hp~~ 267 (421)
.+++.+..+.++-|..+|++|- +++......|.
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 4678899999999999999993 44444444444
No 405
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.97 E-value=2.3e-30 Score=230.13 Aligned_cols=160 Identities=36% Similarity=0.516 Sum_probs=130.1
Q ss_pred CCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccC
Q 014610 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (421)
Q Consensus 96 g~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 174 (421)
|+|.+++.. ++++++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 689999986 467999999999999999999999998 999999999999999 9998765432 23689
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-Hhhc----cCCCCC--CCchHHHH--HHHHHHH
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFII----PRENPP--QLDEHFSR--LMKEFVS 245 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~-~~~i----~~~~~~--~~~~~~s~--~l~~li~ 245 (421)
+.|||||++.+. .++.++|||||||++|||++|..||........ ...+ ....+. .....++. .+.++|.
T Consensus 68 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 68 PYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred ccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999876 489999999999999999999999976543221 1111 111111 12334555 6999999
Q ss_pred HHcccCCCCCcCHHHHHhChhccc
Q 014610 246 LCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 246 ~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
+||..+|.+|||+.|+++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 999999999999999999999863
No 406
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.96 E-value=8.8e-28 Score=229.64 Aligned_cols=252 Identities=38% Similarity=0.609 Sum_probs=208.7
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHH--HHHHHHHHHHHHHcCCCC-CeeEEEEEEEeCCEEEEEEe
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED--EIEDIQKEISVLSQCRSP-YITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~--~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 91 (421)
|.+.+.||.|+||.||++.+. ..+++|.+....... ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999988 789999987665443 478899999999999988 79999999988888999999
Q ss_pred cCCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-CEEEeecccccccccccc-
Q 014610 92 YMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTIS- 166 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~---~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-~vkL~DFGla~~~~~~~~- 166 (421)
++.+++|.+++.... .+++..+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887754 799999999999999999999999999999999999999988 799999999875544322
Q ss_pred -----cccccccCccccCcccccCc--CCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHhhccCCCCC----C
Q 014610 167 -----RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPP----Q 231 (421)
Q Consensus 167 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~ell~g~~pf~~~~~----~~~~~~i~~~~~~----~ 231 (421)
.....+||+.|+|||.+.+. ..+....|+|++|++++++++|..||..... ......+.....+ .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23567899999999999873 3578899999999999999999999877653 2333333222211 1
Q ss_pred CchH----HHHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 232 LDEH----FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 232 ~~~~----~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
.... ....+.+++..|+..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111 1257899999999999999999999998866653
No 407
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.96 E-value=2.3e-30 Score=269.40 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=206.8
Q ss_pred CCc-eeeceEeecCceEEEEEEECCCCcEEEEEEec----cCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE
Q 014610 13 SRF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVID----LEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 13 ~~y-~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~----~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 86 (421)
..| ....++|.|++|.|+.+........++.|... .... ......+..|+.+-..++||||+..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 56789999999999888877766666666543 1122 22223377888888999999998888877776666
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~ 166 (421)
+-+||||++ +|+.++.+.+.++..++..++.||+.||+|||+.||.||||||+|++++.+|.+||+|||.+..+..+.+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 666999999 9999999877999999999999999999999999999999999999999999999999999887655444
Q ss_pred c----ccccccCccccCcccccCcCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHh-hc-------cCCCCCCCc
Q 014610 167 R----RKTFVGTPFWMAPEVIQNSEGYN-EKADIWSLGITVIEMAKGEPPLADLHPMRVLF-II-------PRENPPQLD 233 (421)
Q Consensus 167 ~----~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwslGvil~ell~g~~pf~~~~~~~~~~-~i-------~~~~~~~~~ 233 (421)
. ....+|+..|+|||++.+.+ |+ ..+||||.|++++.|.+|+.||......+... .. ....+..+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~-ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKE-YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccc-cCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 3 34578999999999998876 55 46899999999999999999997654433221 01 111223344
Q ss_pred hHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhccccc
Q 014610 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (421)
Q Consensus 234 ~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 271 (421)
..++...+.+|.+||+.+|.+|.|+++|++.+||+.+.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 56788899999999999999999999999999998764
No 408
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.96 E-value=3e-28 Score=238.89 Aligned_cols=166 Identities=19% Similarity=0.227 Sum_probs=133.1
Q ss_pred hhCCCceeeceEeecCceEEEEEEECC-CCcEEEEEEeccC----CCHHHHHHHHHHHHHHHcCCCCCeeE-EEEEEEeC
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYITE-YYGSYLHQ 83 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~ 83 (421)
.+.++|++.+.||+|+||+||+|++.. +++.||||++... ........+.+|+.+|++++|+||++ +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 456789999999999999999999876 6888899987533 12334567999999999999999985 443 2
Q ss_pred CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEccCCCEEEeecccccccc
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI-KAANILLTENGDVKVADFGVSAQLT 162 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDl-kp~NILl~~~g~vkL~DFGla~~~~ 162 (421)
+..|||||||+|++|... .. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|..+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 458999999999999732 11 11 1468899999999999999999999 9999999999999999999998664
Q ss_pred ccccc--------ccccccCccccCcccccCc
Q 014610 163 RTISR--------RKTFVGTPFWMAPEVIQNS 186 (421)
Q Consensus 163 ~~~~~--------~~~~~gt~~y~aPE~~~~~ 186 (421)
..... ....++++.|+|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 43211 1346789999999998643
No 409
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.95 E-value=2.6e-27 Score=231.33 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=197.0
Q ss_pred hhCC-CceeeceEeecCceEEEEEEECCCC-cEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC----CCeeEEEEEE-Ee
Q 014610 10 AAGS-RFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS----PYITEYYGSY-LH 82 (421)
Q Consensus 10 ~~~~-~y~~~~~LG~G~~g~Vy~a~~~~~g-~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~~ 82 (421)
.... +|++.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. +++..+++.. ..
T Consensus 14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 3344 8999999999999999999998875 68999987654332222 67889999988862 6899999998 47
Q ss_pred CCEEEEEEecCCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-----CCEEEeec
Q 014610 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-----GDVKVADF 155 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-----g~vkL~DF 155 (421)
+...||||+++ |.+|.++.+.. +.++...+..++.|++.+|++||+.|++||||||+|+++... -.+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 78899999999 88999988653 589999999999999999999999999999999999999765 35999999
Q ss_pred cccc--ccccccc-------c-ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHh---
Q 014610 156 GVSA--QLTRTIS-------R-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--- 222 (421)
Q Consensus 156 Gla~--~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~--- 222 (421)
|+++ ....... . ...+.||..|.++.+..+.+ .+.+.|+||++.++.+|+.|..||..........
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 3222111 1 12356999999999998875 7999999999999999999999997665322221
Q ss_pred hccCCCCCC-CchHHHHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 223 IIPRENPPQ-LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 223 ~i~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
......... .....+.++..+...+-..+...+|....+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 111111111 223345677888777777889999998888653
No 410
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.95 E-value=2.1e-29 Score=251.70 Aligned_cols=242 Identities=25% Similarity=0.454 Sum_probs=207.0
Q ss_pred eEeecCceEEEEEEE---CCCCcEEEEEEeccCCCHH-HHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 20 LIGRGSFGDVYKAFD---KELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~---~~~g~~vAiK~~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
++|+|+||.|++++. .+.|..||+|+..+..... .......|..++..++ ||.+|+++..++.+..+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998643 3558899999986554211 1125667888999887 9999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccccC
Q 014610 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (421)
Q Consensus 95 gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 174 (421)
||+|...+.....+.+.....+...++-|++++|+.+|+|||+|++||+++.+|++++.|||+++...... ..|||
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----IACGT 156 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----hcccc
Confidence 99999999888889999999999999999999999999999999999999999999999999998765442 22999
Q ss_pred ccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCC
Q 014610 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (421)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 254 (421)
..|||||++. +....+|+||||++++||++|..||.. +....|.+.. ..++..++..+++++..++.++|.+
T Consensus 157 ~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 157 YEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred hhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHH
Confidence 9999999997 367889999999999999999999987 4555555433 3556778999999999999999999
Q ss_pred CcC-----HHHHHhChhcccccCC
Q 014610 255 RPS-----AKELLRHRFIRNARKS 273 (421)
Q Consensus 255 Rpt-----~~elL~hp~~~~~~~~ 273 (421)
|.. +.|+++|+||..+.+.
T Consensus 229 rLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 229 RLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HhccCcchhHHHhccchheeeeHh
Confidence 974 5899999999877544
No 411
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=1e-25 Score=209.33 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=198.6
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (421)
-.++-+|++.++||+|+||..+.|.+.-++++||||.-+... ...+++.|.+..+.|. .++|...|.+-..+.+-.
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 367889999999999999999999999999999999854433 3467888999998885 699999999888999999
Q ss_pred EEEecCCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-----CEEEeeccccccc
Q 014610 88 IIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-----DVKVADFGVSAQL 161 (421)
Q Consensus 88 lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g-----~vkL~DFGla~~~ 161 (421)
||+|++ |.+|.|+.. .+.+|+...++-++.|++.-++|+|++.+|+|||||+|+||...| .+.|+|||+|+..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 789998875 467899999999999999999999999999999999999997543 4899999999987
Q ss_pred cccccc-------ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC---HHHHHhhccCCCC--
Q 014610 162 TRTISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENP-- 229 (421)
Q Consensus 162 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~---~~~~~~~i~~~~~-- 229 (421)
.++.++ ..+..||..||+=--..+.+ .+.+.|+=|||-++..+|-|.+||.+.. ..+.+.+|-....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 765443 34567999999988888876 6889999999999999999999998653 3344444433221
Q ss_pred --CCCchHHHHHHHHHHHHHcccCCCCCcCHH
Q 014610 230 --PQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (421)
Q Consensus 230 --~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 259 (421)
..+..+++.++...+.-.=..+-.+-|..+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 223345676766666555444555556543
No 412
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=2.7e-26 Score=204.75 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=195.6
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC-CCeeEEEEEEEeCCEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~l 88 (421)
..+++|++++.||.|+||.+|.|+...+|..||||+-+.. ....++.-|..+.+.|++ ..|..+..+...+.+-.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 4578999999999999999999999999999999985332 233667889999999975 788888888888899999
Q ss_pred EEecCCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC---CCEEEeecccccccccc
Q 014610 89 IMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRT 164 (421)
Q Consensus 89 V~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~---g~vkL~DFGla~~~~~~ 164 (421)
||+++ |.+|.++.. ....++...+.-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+...+.
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999 889999885 34679999999999999999999999999999999999999633 46999999999876543
Q ss_pred ccc-------ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHhhccC----CCCC
Q 014610 165 ISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPR----ENPP 230 (421)
Q Consensus 165 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~---~~~~i~~----~~~~ 230 (421)
.+. .....||..|.+=-...+.+ .+.+.|+-|+|.+|..+.-|..||.+..... ...+|.. ..+.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 222 23467999999877777664 5788999999999999999999998775432 2223322 2233
Q ss_pred CCchHHHHHHHHHHHHHcccCCCCCcCH
Q 014610 231 QLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (421)
Q Consensus 231 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 258 (421)
.+...+|.++.-.+.-|=..--++-|..
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 3455678888888888866665666664
No 413
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.93 E-value=1e-25 Score=203.13 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=112.9
Q ss_pred eeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH--HH-----------------------HHHHHHHHHHHHcCCCC
Q 014610 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DE-----------------------IEDIQKEISVLSQCRSP 71 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~--~~-----------------------~~~~~~E~~il~~l~hp 71 (421)
+.+.||+|+||.||+|.+. +|+.||||+++..... .. .....+|+.+|.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999999997 8999999998654211 00 12234599999999887
Q ss_pred CeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEccCCCE
Q 014610 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL-HNEGKIHRDIKAANILLTENGDV 150 (421)
Q Consensus 72 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yL-H~~~iiHrDlkp~NILl~~~g~v 150 (421)
+|........ .. .+|||||++|+++...+...+++++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.+
T Consensus 80 ~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 80 GIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 7644333222 22 389999999988876644457899999999999999999999 799999999999999998 5789
Q ss_pred EEeecccccccc
Q 014610 151 KVADFGVSAQLT 162 (421)
Q Consensus 151 kL~DFGla~~~~ 162 (421)
+|+|||+|....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999986543
No 414
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.93 E-value=3.7e-26 Score=238.70 Aligned_cols=229 Identities=29% Similarity=0.508 Sum_probs=181.6
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
.-.++|..++.|-.|+||.||.++++.+.+.+|+|+ ++... .+++ |+..-.+|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--ilRn------ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--ILRN------ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--hhhc------cccccCCccee---------------
Confidence 445799999999999999999999999999999954 33221 0111 44444556655
Q ss_pred EecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccccc--
Q 014610 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (421)
Q Consensus 90 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~-- 167 (421)
|+-..+++.-++++.+. +.+++|||+.||+|||+||+|+||+.-|++|+.|||+++........
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 67777777767777665 78999999999999999999999999999999999998653221110
Q ss_pred -------------ccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCC--C
Q 014610 168 -------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--L 232 (421)
Q Consensus 168 -------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~ 232 (421)
...+||||.|.|||++... +|+..+|||++|+|+||.+-|..||.+..+.+++.........+ -
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 1246999999999999876 69999999999999999999999999998888776655443222 2
Q ss_pred chHHHHHHHHHHHHHcccCCCCCc---CHHHHHhChhcccccCChhHH
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKSPRLL 277 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rp---t~~elL~hp~~~~~~~~~~~~ 277 (421)
...++.+++++|.++|+.+|..|. .+-++.+|+||+...+...+.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence 456789999999999999999995 677888999999876664443
No 415
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.92 E-value=6.4e-25 Score=201.26 Aligned_cols=174 Identities=17% Similarity=0.235 Sum_probs=135.7
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHH------HHHHHHHHHcCCCCCeeEEEEEE
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIED------IQKEISVLSQCRSPYITEYYGSY 80 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~------~~~E~~il~~l~hpnIv~l~~~~ 80 (421)
+-..++|+++++||.|+||.||++.. ++..+|||++..... +..... +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 45678999999999999999999654 477899999864432 222233 57999999999999999999987
Q ss_pred EeC--------CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEE
Q 014610 81 LHQ--------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (421)
Q Consensus 81 ~~~--------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL 152 (421)
... +..+|||||++|.+|.++.. +++ ..+.+++.+|..||.+|++||||||+||+++.+| ++|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 654 35799999999999988742 333 2466999999999999999999999999999888 999
Q ss_pred eecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHH
Q 014610 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (421)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 206 (421)
+|||........... ..++... .|+.++|+|+||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~------------d~~vler-~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK------------DRIDLER-HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH------------HHHHHHh-HhcccccccceeEeehHHH
Confidence 999987554221111 0023333 4778999999999987764
No 416
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.92 E-value=2.7e-24 Score=194.10 Aligned_cols=143 Identities=18% Similarity=0.227 Sum_probs=114.8
Q ss_pred eeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH-------------------------HHHHHHHHHHHHHHcCCCC
Q 014610 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------------------DEIEDIQKEISVLSQCRSP 71 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~-------------------------~~~~~~~~E~~il~~l~hp 71 (421)
+.+.||+|+||.||+|.+. +|+.||||+++..... .....+..|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999988 8999999998754210 0012346899999999999
Q ss_pred CeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCE
Q 014610 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150 (421)
Q Consensus 72 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~v 150 (421)
+|.....+.... .||||||++|+++........++++..+..++.|++.+|.+||+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 885544443332 48999999988655443334678899999999999999999999 9999999999999998 8899
Q ss_pred EEeeccccccccc
Q 014610 151 KVADFGVSAQLTR 163 (421)
Q Consensus 151 kL~DFGla~~~~~ 163 (421)
+|+|||+|.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999876543
No 417
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.91 E-value=4.6e-24 Score=201.28 Aligned_cols=235 Identities=20% Similarity=0.299 Sum_probs=153.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC--CHHHHHHHHHHHHHHHcCCC----------CCeeEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS----------PYITEYYGS 79 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~--~~~~~~~~~~E~~il~~l~h----------pnIv~l~~~ 79 (421)
.-.....+.||.|+++.||.+.+.+||+.+|+|++.... .....+++++|.-....+.+ -.++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 345677889999999999999999999999999975443 33456777877765555432 123333332
Q ss_pred EE---------eC---C-----EEEEEEecCCCCCHHHHHHc---CCCC----CHHHHHHHHHHHHHHHHHHHHCCcccc
Q 014610 80 YL---------HQ---T-----KLWIIMEYMAGGSVADLIQS---GPPL----DEMSIACILRDLLHAIEYLHNEGKIHR 135 (421)
Q Consensus 80 ~~---------~~---~-----~~~lV~E~~~gg~L~~~l~~---~~~l----~e~~~~~i~~qll~aL~yLH~~~iiHr 135 (421)
.. .. . +.+++|+-+ .++|.+++.- .... .......+..|+++.+++||+.|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 22 11 1 236778877 5688887642 1211 122223445799999999999999999
Q ss_pred CCCCCcEEEccCCCEEEeecccccccccccccccccccCccccCcccccCc-------CCCCCccccHHHHHHHHHHHhC
Q 014610 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-------EGYNEKADIWSLGITVIEMAKG 208 (421)
Q Consensus 136 Dlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslGvil~ell~g 208 (421)
||+|+|+|++.+|.++|+||+........ ......+..|.+||..... ..++.+.|.|+||+++|.|++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999876544322 1123456789999976442 1367789999999999999999
Q ss_pred CCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCC
Q 014610 209 EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (421)
Q Consensus 209 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 255 (421)
..||........... ....+. ++++.++.||..+|.+||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986543222111 122333 789999999999999999987
No 418
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.91 E-value=1.2e-23 Score=189.11 Aligned_cols=189 Identities=15% Similarity=0.110 Sum_probs=144.1
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC---HHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEE
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 90 (421)
+.+...|++|+||+||.+.. .+..++.+.+....- ......+.+|+++|++|. |++|++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999997755 478888777654432 112235789999999995 5889999885 3469999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEccCCCEEEeeccccccccccccc--
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI-KAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDl-kp~NILl~~~g~vkL~DFGla~~~~~~~~~-- 167 (421)
||+.|.+|...+.. . ...++.|++.+|++||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999999765422 1 2357889999999999999999999 799999999999999999999855433210
Q ss_pred -----------ccccccCccccCcccccCcCCCC-CccccHHHHHHHHHHHhCCCCCCCCC
Q 014610 168 -----------RKTFVGTPFWMAPEVIQNSEGYN-EKADIWSLGITVIEMAKGEPPLADLH 216 (421)
Q Consensus 168 -----------~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwslGvil~ell~g~~pf~~~~ 216 (421)
..-...++.|++|+...-....+ ...++++.|.-+|.++|+..++...+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 01123688899998654332223 45788899999999999998876543
No 419
>PRK10345 hypothetical protein; Provisional
Probab=99.89 E-value=8.5e-23 Score=186.27 Aligned_cols=136 Identities=20% Similarity=0.291 Sum_probs=110.4
Q ss_pred eeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-----CCCCeeEEEEEEEeCC---EEE
Q 014610 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-----RSPYITEYYGSYLHQT---KLW 87 (421)
Q Consensus 16 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~~~ 87 (421)
.-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++++ +||||+++++++.++. .++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4467999999999995 7777766 6999866432 2346789999999999 5799999999999864 434
Q ss_pred -EEEec--CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEEccC----CCEEEeecccc
Q 014610 88 -IIMEY--MAGGSVADLIQSGPPLDEMSIACILRDLLHAI-EYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVS 158 (421)
Q Consensus 88 -lV~E~--~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL-~yLH~~~iiHrDlkp~NILl~~~----g~vkL~DFGla 158 (421)
+|+|| +.+|+|.+++++ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999977 457666 35688888888 99999999999999999999743 37999995544
No 420
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.89 E-value=2.2e-23 Score=197.76 Aligned_cols=189 Identities=26% Similarity=0.386 Sum_probs=146.1
Q ss_pred CCCCeeEEEEEEEe---------------------------CCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHH
Q 014610 69 RSPYITEYYGSYLH---------------------------QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121 (421)
Q Consensus 69 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll 121 (421)
+|||||++...|.+ +..+|+||.... .+|..++.. ...+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHH
Confidence 59999999987643 346899999884 599999976 4466777888999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEc--cCC--CEEEeeccccccccc------ccccccccccCccccCcccccCcCCCC-
Q 014610 122 HAIEYLHNEGKIHRDIKAANILLT--ENG--DVKVADFGVSAQLTR------TISRRKTFVGTPFWMAPEVIQNSEGYN- 190 (421)
Q Consensus 122 ~aL~yLH~~~iiHrDlkp~NILl~--~~g--~vkL~DFGla~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~- 190 (421)
+|+.|||.+||.|||+|.+||||. +|+ .+.|+|||++--... .....-...|.-.-||||+.....+..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 333 589999998642211 011122346888899999987553211
Q ss_pred ----CccccHHHHHHHHHHHhCCCCCCCCCHHHHH-hhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHH
Q 014610 191 ----EKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (421)
Q Consensus 191 ----~~~DvwslGvil~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 259 (421)
.++|.|+.|.+.||+++...||.....+... ........+.++..+++.+++++..+|+.||++|+++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 3789999999999999999999875443322 12333456677888999999999999999999999753
No 421
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.87 E-value=1.3e-23 Score=220.07 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=180.3
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHH---HHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
+|...+.||.+-|=+|.+|++.+ |. |+||++-+...... ..+..+|++ ...++|||++++.-+...++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78899999999999999998875 54 99999865553322 233334445 56678999999998888888899999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccc---ccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT---RTISR 167 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~---~~~~~ 167 (421)
+|+. -+|+|.+.-+.-+...+-+.|+.||+.||..||..||+|||||.+||||+.=..+.|+||.--+... ++...
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 9995 5999999776667777888899999999999999999999999999999998899999997543221 11111
Q ss_pred cccc----ccCccccCcccccCcC---------C-CCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCC---C
Q 014610 168 RKTF----VGTPFWMAPEVIQNSE---------G-YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN---P 229 (421)
Q Consensus 168 ~~~~----~gt~~y~aPE~~~~~~---------~-~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~---~ 229 (421)
..-+ .--.+|.|||.+.... . .+++.||||+||+++||++ |.+||.- ..+.....+. +
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCH
Confidence 1111 2234699999875411 1 4568999999999999885 7988852 1111111111 1
Q ss_pred CCCchHH-HHHHHHHHHHHcccCCCCCcCHHHHHhC
Q 014610 230 PQLDEHF-SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 230 ~~~~~~~-s~~l~~li~~~L~~dP~~Rpt~~elL~h 264 (421)
.+....+ +..++++|..|++.||++|.+|++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 3458999999999999999999999975
No 422
>smart00090 RIO RIO-like kinase.
Probab=99.87 E-value=4.9e-22 Score=185.28 Aligned_cols=145 Identities=21% Similarity=0.231 Sum_probs=117.0
Q ss_pred CCceeeceEeecCceEEEEEE-ECCCCcEEEEEEeccCCCH-----------------------HHHHHHHHHHHHHHcC
Q 014610 13 SRFSSLELIGRGSFGDVYKAF-DKELNKDVAIKVIDLEESE-----------------------DEIEDIQKEISVLSQC 68 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~-~~~~g~~vAiK~~~~~~~~-----------------------~~~~~~~~E~~il~~l 68 (421)
--|++.+.||+|+||.||+|. +..+|+.||||+++..... .....+.+|+.+++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 368999999999999999999 7778999999998654210 0113467899999999
Q ss_pred CCC--CeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEc
Q 014610 69 RSP--YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG-KIHRDIKAANILLT 145 (421)
Q Consensus 69 ~hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~-iiHrDlkp~NILl~ 145 (421)
.+. .+.++++. . ..+|||||++|++|.........+.+..+..++.||+.+|.+||++| ++||||||+||+++
T Consensus 108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 753 34455542 2 34899999999888776544466777788899999999999999999 99999999999999
Q ss_pred cCCCEEEeecccccccc
Q 014610 146 ENGDVKVADFGVSAQLT 162 (421)
Q Consensus 146 ~~g~vkL~DFGla~~~~ 162 (421)
++.++|+|||.|....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999886543
No 423
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.87 E-value=1e-22 Score=184.68 Aligned_cols=240 Identities=22% Similarity=0.384 Sum_probs=194.1
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
...++.+|.+.-.|..|+|++. |..+++|++..... ...-+.+..|.-.|+-+.||||+.+++.+....++.++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3445667888889999999988 66778888765542 22346688888899999999999999999999999999999
Q ss_pred CCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCEEE--eecccccccccccc
Q 014610 93 MAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKV--ADFGVSAQLTRTIS 166 (421)
Q Consensus 93 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qll~aL~yLH~~~--iiHrDlkp~NILl~~~g~vkL--~DFGla~~~~~~~~ 166 (421)
|+-|+|+.++.... -.+..++..++..++.|++|||+.. |.---|....|+||++-+.+| +|--++-+.
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe----- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE----- 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-----
Confidence 99999999998643 3677899999999999999999874 444468889999999876655 454443221
Q ss_pred cccccccCccccCcccccCcCCCC--CccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhcc-CCCCCCCchHHHHHHHHH
Q 014610 167 RRKTFVGTPFWMAPEVIQNSEGYN--EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEF 243 (421)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~--~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~l 243 (421)
...+-.|.||+||.++...... .++|+|||.+++|||.|...||.+..+++.-.++. .+....++..++..+..+
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 1335679999999998654221 46899999999999999999999999988776664 344567788899999999
Q ss_pred HHHHcccCCCCCcCHHHHH
Q 014610 244 VSLCLKKVPAERPSAKELL 262 (421)
Q Consensus 244 i~~~L~~dP~~Rpt~~elL 262 (421)
++-|+..||.+||.++.++
T Consensus 422 m~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhcCCCCcCCCcceeh
Confidence 9999999999999988775
No 424
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.86 E-value=3.5e-21 Score=205.11 Aligned_cols=198 Identities=27% Similarity=0.359 Sum_probs=162.7
Q ss_pred cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC---CCCeeEEEEEEEeC
Q 014610 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQ 83 (421)
Q Consensus 7 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~ 83 (421)
..+..+..|.|.+.||+|+||+||+|.... |+.||+|+-..... ..+.--.+++.+|+ -+.|+.+...+.-.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 455667899999999999999999999888 99999998644331 22222234455555 24566666666777
Q ss_pred CEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-------CCCEEEeecc
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------NGDVKVADFG 156 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-------~g~vkL~DFG 156 (421)
+.-+||+||.+.|+|.+++...+.+++..+..+..|+|.-+++||..+|||+||||+|+||.. .--++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 788999999999999999998899999999999999999999999999999999999999952 2359999999
Q ss_pred ccccccc--ccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCC
Q 014610 157 VSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP 210 (421)
Q Consensus 157 la~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~ 210 (421)
.|..+.- ...+....++|-.+-.+|+..+. .+++.+|.|.|..+++.||.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence 9876532 22345567899999999999887 49999999999999999999974
No 425
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.85 E-value=4.2e-23 Score=215.07 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=214.8
Q ss_pred CCCceeeceEeecCceEEEEEEECC-CCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 88 (421)
...|.+.+.||+|+|+.|-.+.+.. ....+|+|.+.... ......++..|..+-+.+. |+|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 6789999999999999999988754 45567777775553 4555677778999988887 9999999999999999999
Q ss_pred EEecCCCCCHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEccCC-CEEEeeccccccccc-
Q 014610 89 IMEYMAGGSVADLI-QSGP-PLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTR- 163 (421)
Q Consensus 89 V~E~~~gg~L~~~l-~~~~-~l~e~~~~~i~~qll~aL~yLH-~~~iiHrDlkp~NILl~~~g-~vkL~DFGla~~~~~- 163 (421)
++++..|+++++.+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999999 6555 7888899999999999999999 99999999999999999999 999999999988766
Q ss_pred cccc--cccccc-CccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC----CCCCchHH
Q 014610 164 TISR--RKTFVG-TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHF 236 (421)
Q Consensus 164 ~~~~--~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~ 236 (421)
.... ....+| ++.|+|||...+........|+||+|+++.-+++|..|+...........-.... ....+..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2222 234688 9999999999876556788999999999999999999997654433222111111 13345677
Q ss_pred HHHHHHHHHHHcccCCCCCcCHHHHHhChhccc
Q 014610 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (421)
Q Consensus 237 s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 269 (421)
+....+++.++|..+|..|.+.+++..++|+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 888999999999999999999999999999986
No 426
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.84 E-value=1.8e-20 Score=171.65 Aligned_cols=136 Identities=25% Similarity=0.384 Sum_probs=114.9
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCC--H-----HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEE
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--E-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (421)
++.||+|++|.||+|.+ .|..|++|+...... . .....+.+|+.++..+.|++|+....++.+....++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 46899999999999987 578899998643221 1 11345778999999999999887777777788899999
Q ss_pred ecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 91 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
||++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865332 8889999999999999999999999999999999 78999999998753
No 427
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.84 E-value=9.5e-22 Score=193.59 Aligned_cols=176 Identities=27% Similarity=0.463 Sum_probs=136.4
Q ss_pred CEEEEEEecCCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
.++||.|++|...+|.++|.+.. ..+......++.|+..|++| +|.+|||+||.||+...++.+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35899999999999999997543 45677889999999999999 9999999999999999999999999999876
Q ss_pred ccccc------ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHhhccCCCCC-CC
Q 014610 161 LTRTI------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP-QL 232 (421)
Q Consensus 161 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~-g~~pf~~~~~~~~~~~i~~~~~~-~~ 232 (421)
..... .......||.+||+||.+.+. .|+.++||||||++|+||+. =..++. .......+..+..+ .+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHH
Confidence 54332 234567899999999999886 49999999999999999997 222222 22223333333322 12
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhc
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~ 267 (421)
..+. +.-..|+.+||.+.|.+||++.+.-.|.|.
T Consensus 482 ~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2222 334579999999999999988877777664
No 428
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.83 E-value=3.8e-20 Score=168.06 Aligned_cols=139 Identities=23% Similarity=0.248 Sum_probs=111.5
Q ss_pred CceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH---------------------HHHHHHHHHHHHHHcCCCC-
Q 014610 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------DEIEDIQKEISVLSQCRSP- 71 (421)
Q Consensus 14 ~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~---------------------~~~~~~~~E~~il~~l~hp- 71 (421)
.|.+.+.||+|+||.||+|.+. +|+.||||+++..... ........|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4899999999999999999875 7999999987653210 0112366789999999877
Q ss_pred -CeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCE
Q 014610 72 -YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (421)
Q Consensus 72 -nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~v 150 (421)
.++..++ ....++||||++|++|..+... .....++.+++.++.++|+.|++||||||+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 4455543 2445899999999999876431 3466788999999999999999999999999999999999
Q ss_pred EEeeccccccccc
Q 014610 151 KVADFGVSAQLTR 163 (421)
Q Consensus 151 kL~DFGla~~~~~ 163 (421)
+|+|||++.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865543
No 429
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.83 E-value=4.1e-20 Score=167.67 Aligned_cols=131 Identities=24% Similarity=0.358 Sum_probs=107.4
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCC-------HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEec
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (421)
.||+|+||.||+|.. +|..|++|+...... .....++.+|+.+++.+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 478899998543221 11236678899999999988765555555566778999999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
++|++|.+++..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998865321 7899999999999999999999999999999 88999999998765
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.81 E-value=3e-19 Score=185.97 Aligned_cols=137 Identities=23% Similarity=0.332 Sum_probs=112.2
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEe-ccC-CC-----HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLE-ES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~-~~~-~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 85 (421)
..|...+.||+|+||+||+|.+.. ..+++|+. .+. .. ......+.+|+.+++.++|++|+....++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445678899999999999998764 34444432 111 11 1224568899999999999999988877777778
Q ss_pred EEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 86 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
.++||||++|++|.+++. ....++.|++.+|.+||++|++||||||+|||+ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 456789999999999999999999999999999 678999999999854
No 431
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.80 E-value=2e-19 Score=180.19 Aligned_cols=199 Identities=24% Similarity=0.476 Sum_probs=156.3
Q ss_pred HHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCcE
Q 014610 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK-IHRDIKAANI 142 (421)
Q Consensus 65 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qll~aL~yLH~~~i-iHrDlkp~NI 142 (421)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ...++......+++.|++||+|||.-.| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 4678888999999999999999998765 9999999999
Q ss_pred EEccCCCEEEeeccccccccc--ccccccccccCccccCcccccCcCC------CCCccccHHHHHHHHHHHhCCCCCCC
Q 014610 143 LLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEG------YNEKADIWSLGITVIEMAKGEPPLAD 214 (421)
Q Consensus 143 Ll~~~g~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslGvil~ell~g~~pf~~ 214 (421)
+++....+||.|||+...... .........-..-|.|||++..... .+.+.|+||||++++|+++-..||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999765532 1111111223445999999876311 35678999999999999999999976
Q ss_pred CC----HHHHHhhccC-CCC---CCCc--hHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 215 LH----PMRVLFIIPR-ENP---PQLD--EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 215 ~~----~~~~~~~i~~-~~~---~~~~--~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
.. +.+....+.. +.. |.+. ..+.+++..+++.||..+|..||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2234444433 221 1111 134557899999999999999999988753
No 432
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.78 E-value=1.3e-18 Score=156.18 Aligned_cols=138 Identities=21% Similarity=0.315 Sum_probs=100.6
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCH--HHHHH---------------------HHHHHHHHHcCCCC--C
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIED---------------------IQKEISVLSQCRSP--Y 72 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~--~~~~~---------------------~~~E~~il~~l~hp--n 72 (421)
.+.||+|+||+||+|.+. +|+.||||++...... ..... ...|...+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 7999999998653211 11111 13566667666543 3
Q ss_pred eeEEEEEEEeCCEEEEEEecCCCCCHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCE
Q 014610 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150 (421)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~v 150 (421)
+.++++. ...++||||++++.+.. .+.. ... ...+..++.+++.++.++|. +||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhh-hhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 5555543 23589999999854321 1111 011 16788999999999999999 9999999999999999 8899
Q ss_pred EEeeccccccccc
Q 014610 151 KVADFGVSAQLTR 163 (421)
Q Consensus 151 kL~DFGla~~~~~ 163 (421)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999865443
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.76 E-value=1.2e-17 Score=156.02 Aligned_cols=135 Identities=20% Similarity=0.269 Sum_probs=106.4
Q ss_pred ceEe-ecCceEEEEEEECCCCcEEEEEEeccCC------------CHHHHHHHHHHHHHHHcCCCCCe--eEEEEEEEeC
Q 014610 19 ELIG-RGSFGDVYKAFDKELNKDVAIKVIDLEE------------SEDEIEDIQKEISVLSQCRSPYI--TEYYGSYLHQ 83 (421)
Q Consensus 19 ~~LG-~G~~g~Vy~a~~~~~g~~vAiK~~~~~~------------~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~ 83 (421)
.+|| .|+.|+||.+... +..++||.+.... .......+.+|+.++.+|.|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4688 8899999998765 7889999874321 11233567899999999998775 6777764432
Q ss_pred C-E---EEEEEecCCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 84 T-K---LWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 84 ~-~---~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
. . .++|||+++| .+|.+++.. .++++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 3599999997 699999865 4566653 578999999999999999999999999998899999999987
Q ss_pred cc
Q 014610 159 AQ 160 (421)
Q Consensus 159 ~~ 160 (421)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
No 434
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.75 E-value=4.9e-18 Score=145.50 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=113.3
Q ss_pred eeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC--CCeeEEEEEEEeCCEEEEEEecCC
Q 014610 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
+++.||.|.++.||++.+.. ..+++|....... ...+.+|+.+++.+.| +++++++......+..+++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 46789999999999999864 7899999865433 4678899999999976 599999998888888999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 95 gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~---~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
|+.+..+ +......++.+++.+|++||.. +++|+||+|+|||++..+.++|+|||.+..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777654 5567778899999999999985 799999999999999989999999998754
No 435
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.73 E-value=2.9e-18 Score=171.96 Aligned_cols=256 Identities=22% Similarity=0.210 Sum_probs=196.9
Q ss_pred hhCCCceeeceEee--cCceEEEEEEE--CCCCcEEEEEEeccCCC-HHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeC
Q 014610 10 AAGSRFSSLELIGR--GSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ 83 (421)
Q Consensus 10 ~~~~~y~~~~~LG~--G~~g~Vy~a~~--~~~g~~vAiK~~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 83 (421)
.....|-+...+|. |.+|.||.+.+ ..++..+|+|.-+.... ...-..=.+|+...+.++ |+|.++.+..|...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34457788899999 99999999998 88999999998332221 111222345666666664 99999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCcEEEccC-CCEEEeeccc
Q 014610 84 TKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLH----AIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGV 157 (421)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qll~----aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGl 157 (421)
+.+++-+|+| +.+|..+...... +++..++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 9999999999 5788888766544 889999999999999 9999999999999999999999999 8899999999
Q ss_pred cccccccccccc-----ccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCC
Q 014610 158 SAQLTRTISRRK-----TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL 232 (421)
Q Consensus 158 a~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 232 (421)
...+....-... ...|...|++||++.+. ++...|++++|.+..+-.+|..+........+...-....+..+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 887755421111 12678889999998764 78899999999999998887655433211111100000122233
Q ss_pred chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 233 ~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
....+..+...+..|+..+|..|++++.++.|+++.
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 344567777799999999999999999999999986
No 436
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.71 E-value=2e-18 Score=181.31 Aligned_cols=268 Identities=23% Similarity=0.379 Sum_probs=217.0
Q ss_pred hCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC--HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEE
Q 014610 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 11 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 88 (421)
..+.+.+.+-+-+|+++.++.+.-..+|-..++|+..+... ..+.+.+.++-.++-...+|.+++....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45678888999999999999998888887777776543321 1223444555555555567888888877777889999
Q ss_pred EEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccc-cc----
Q 014610 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TR---- 163 (421)
Q Consensus 89 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~-~~---- 163 (421)
|++|..+++|...++..++.+++.++.++..+..+++|||...+.|||++|.|+|+..+|+.++.|||..... ..
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999999998888999999999999999999999999999999999999999999999999842111 00
Q ss_pred -c--------------------c-----ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Q 014610 164 -T--------------------I-----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP 217 (421)
Q Consensus 164 -~--------------------~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~ 217 (421)
. . .......||+.|.+||.+.+.. .+..+|+|++|++++|.++|.+||....+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0 0112356999999999999876 68889999999999999999999999999
Q ss_pred HHHHhhccCCCCCCC--chHHHHHHHHHHHHHcccCCCCCcCHH---HHHhChhcccccCChhHHHH
Q 014610 218 MRVLFIIPRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAK---ELLRHRFIRNARKSPRLLER 279 (421)
Q Consensus 218 ~~~~~~i~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt~~---elL~hp~~~~~~~~~~~~~~ 279 (421)
.+....|.+...++. +...+.++++++..+|..+|.+|.++. ++-.|+||+...+.....+.
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence 998888877665544 346788999999999999999999887 88999999987765544333
No 437
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.63 E-value=4.6e-15 Score=150.49 Aligned_cols=183 Identities=18% Similarity=0.297 Sum_probs=143.3
Q ss_pred ceeeceEeecCceEEE-EEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVY-KAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy-~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (421)
|++ +..+-++.+ +| .|..+.++.+|.|.+.+.... .....+.+-++-|+.++||||+++++.+...+++|||+|.+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence 444 444444444 44 577778899999999876655 55677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEccCCCEEEeecccccccccccccccccc
Q 014610 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (421)
Q Consensus 94 ~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH-~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 172 (421)
..|..+++. +....+...++||+.||.||| +.+++|++|.-+-|+|+..|..||++|.++..............
T Consensus 92 --~Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~ 166 (690)
T KOG1243|consen 92 --RPLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLY 166 (690)
T ss_pred --ccHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccch
Confidence 478888876 447788888999999999998 66899999999999999999999999998755433322112222
Q ss_pred cCccccCcccccCcCCCCCccccHHHHHHHHHHHhC
Q 014610 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG 208 (421)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g 208 (421)
---.|..|+.+... .-..|.|.|||++++++.|
T Consensus 167 ~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 23346777766432 2457999999999999999
No 438
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.60 E-value=4.5e-16 Score=159.68 Aligned_cols=144 Identities=21% Similarity=0.296 Sum_probs=101.1
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCH---------------------------------HHHHH-
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------------------DEIED- 57 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~---------------------------------~~~~~- 57 (421)
-..|+. +.||.|++|+||+|+.+.+|+.||||++...-.. +....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 7999999999999999988999999998633100 11122
Q ss_pred -----HHHHHHHHHcCC----CCCeeEEEEEEEe-CCEEEEEEecCCCCCHHHH--HHcCC----CCCHHHHHHHHHHHH
Q 014610 58 -----IQKEISVLSQCR----SPYITEYYGSYLH-QTKLWIIMEYMAGGSVADL--IQSGP----PLDEMSIACILRDLL 121 (421)
Q Consensus 58 -----~~~E~~il~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--l~~~~----~l~e~~~~~i~~qll 121 (421)
+.+|+..+.++. +.+.+.+-.++.+ ....+||||||+|+.|.++ +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 333444444442 4444444444433 4557899999999999875 33322 355555666666665
Q ss_pred HHHHHHHHCCccccCCCCCcEEEccCC----CEEEeeccccccccc
Q 014610 122 HAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQLTR 163 (421)
Q Consensus 122 ~aL~yLH~~~iiHrDlkp~NILl~~~g----~vkL~DFGla~~~~~ 163 (421)
..|++|+|+||+||+++.+| .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 49999999999999999888 999999999876644
No 439
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.60 E-value=5.7e-15 Score=149.55 Aligned_cols=140 Identities=21% Similarity=0.337 Sum_probs=97.3
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHH---H------------------------------------HHHHH
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED---E------------------------------------IEDIQ 59 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~---~------------------------------------~~~~~ 59 (421)
+.||.|++|.||+|+.+ +|+.||||+....-... + .-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999876 59999999975321100 0 01234
Q ss_pred HHHHHHHcC----C-CCCeeEEEEEE-EeCCEEEEEEecCCCCCHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 014610 60 KEISVLSQC----R-SPYITEYYGSY-LHQTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLH-AIEYLHNEG 131 (421)
Q Consensus 60 ~E~~il~~l----~-hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qll~-aL~yLH~~~ 131 (421)
+|+..+.++ + +++|. +-.++ ......+|||||++|++|.++.... ... ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 455555554 2 34332 22222 2234579999999999999876431 122 23345556655 478899999
Q ss_pred ccccCCCCCcEEEccCCCEEEeeccccccccc
Q 014610 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (421)
Q Consensus 132 iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~ 163 (421)
++|+|+||+||+++.+|.++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999876643
No 440
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.57 E-value=3.5e-16 Score=146.04 Aligned_cols=207 Identities=21% Similarity=0.301 Sum_probs=146.5
Q ss_pred HHHHHcCCCCCeeEEEEEEEeCC-----EEEEEEecCCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 014610 62 ISVLSQCRSPYITEYYGSYLHQT-----KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG- 131 (421)
Q Consensus 62 ~~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qll~aL~yLH~~~- 131 (421)
..-|-++-|-|||+++.+|.+.+ ...+++||++.|+|..++++ ...+....+.+|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34456667999999999987654 47899999999999999975 457889999999999999999999884
Q ss_pred -ccccCCCCCcEEEccCCCEEEeecccccccccc----cccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHH
Q 014610 132 -KIHRDIKAANILLTENGDVKVADFGVSAQLTRT----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (421)
Q Consensus 132 -iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 206 (421)
|+|+++.+.-|++..+|-+|++---........ ........|-++|.|||.=... ..+.++|||+||++..+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHH
Confidence 999999999999999888887532211111000 0011123467889999975443 3567899999999999998
Q ss_pred hCCCCC-CCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCC
Q 014610 207 KGEPPL-ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (421)
Q Consensus 207 ~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 273 (421)
.+..-- ...........+.+... .+ -...-++++.+||+..|..||++..+|.||.+-++...
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~-~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII-GL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee-ec---cCccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 876432 11111111111111100 00 01224578999999999999999999999998766543
No 441
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.56 E-value=5.3e-14 Score=126.43 Aligned_cols=142 Identities=20% Similarity=0.209 Sum_probs=105.2
Q ss_pred eceEeecCceEEEEEEECC------CCcEEEEEEeccCC------------C---------HHHHHHHH----HHHHHHH
Q 014610 18 LELIGRGSFGDVYKAFDKE------LNKDVAIKVIDLEE------------S---------EDEIEDIQ----KEISVLS 66 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~------~g~~vAiK~~~~~~------------~---------~~~~~~~~----~E~~il~ 66 (421)
...||.|--+.||.|.... .+..+|||+.+... . ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998654 35899999864211 0 01122333 8999999
Q ss_pred cCC--CCCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEE
Q 014610 67 QCR--SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL-HNEGKIHRDIKAANIL 143 (421)
Q Consensus 67 ~l~--hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yL-H~~~iiHrDlkp~NIL 143 (421)
++. .-++.+++++ ..-+|||||++++.+....-+...+++..+..++.|++.+|..| |..|+||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 985 3566677764 45689999997654433222234566677888899999999999 8999999999999999
Q ss_pred EccCCCEEEeecccccccccc
Q 014610 144 LTENGDVKVADFGVSAQLTRT 164 (421)
Q Consensus 144 l~~~g~vkL~DFGla~~~~~~ 164 (421)
++ ++.+.|+|||.+.....+
T Consensus 158 ~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred EE-CCcEEEEECCCceeCCCC
Confidence 97 578999999988665443
No 442
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.54 E-value=2.1e-14 Score=126.54 Aligned_cols=127 Identities=17% Similarity=0.212 Sum_probs=96.9
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCe-eEEEEEEEeCCEEEEEEecCCCC
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMAGG 96 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 96 (421)
++.|+.|.++.||++... +..|++|+...... ....+..|+.+++.+.+.++ .+++... ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 467899999999999865 78899999754321 12346789999998865554 4455433 33458999999998
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEEccCCCEEEeeccccc
Q 014610 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK-----IHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 97 ~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~i-----iHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
++... ......++.+++.+|+.||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 87653 11123467899999999999985 9999999999999 6789999999764
No 443
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.54 E-value=5.6e-15 Score=148.49 Aligned_cols=252 Identities=22% Similarity=0.222 Sum_probs=189.9
Q ss_pred hhCCCceeeceEeecCceEEEEEEEC-CCCcEEEEEEeccCC-CHHHHHHHHHHHHHHHcC-CCCCeeEEEEEEEeCCEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDK-ELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~g~~vAiK~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 86 (421)
....+|-.+..||.|.|+.|+..... .++..|++|-+...- .......-..|+-+...+ .|.++++++..|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34578999999999999999998755 678899999764332 111122233566666666 599999999999988888
Q ss_pred EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCEEEeeccccccccccc
Q 014610 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 87 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~-g~vkL~DFGla~~~~~~~ 165 (421)
||=.|||+++++...+.-...+.+...+....|++.++.++|+..++|+|+||+||++..+ +..+++|||+...+.-.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 9999999999998877555678899999999999999999999999999999999999886 78899999987643211
Q ss_pred ccccccccCcccc-CcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWM-APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 166 ~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
.....+.-+++ .+|++.....+..+.|++|||..+++.++|...-..... ...+..+..+-.+. ...+++.+.
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~~-~~~~~q~~~ 494 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLPG-LKLQLQVLL 494 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCCc-hHHhhhhhh
Confidence 11233444455 366665555688899999999999999998765433221 11222232333333 348899999
Q ss_pred HHHcccCCCCCcCHHHHHhChhcc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
+.++..++..|+.+.++..|.-|.
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhcCCccccchhhhhhcccchhh
Confidence 999999999999999998876553
No 444
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.36 E-value=2.4e-12 Score=118.07 Aligned_cols=141 Identities=17% Similarity=0.235 Sum_probs=108.1
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC--CCeeEEEEEEEeC---CEEEEEEec
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQ---TKLWIIMEY 92 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E~ 92 (421)
.+.||.|..+.||++.... |+.|++|+............+.+|+.+++.+.+ ..+.+++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998754 689999997544322234578899999999975 4467777766553 367899999
Q ss_pred CCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014610 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN------------------------------------------- 129 (421)
Q Consensus 93 ~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~------------------------------------------- 129 (421)
++|.++.+.+.. ..+++.....++.+++++|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988876532 456777777788888888888873
Q ss_pred -------------CCccccCCCCCcEEEcc--CCCEEEeecccccc
Q 014610 130 -------------EGKIHRDIKAANILLTE--NGDVKVADFGVSAQ 160 (421)
Q Consensus 130 -------------~~iiHrDlkp~NILl~~--~g~vkL~DFGla~~ 160 (421)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999997653
No 445
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.35 E-value=9e-12 Score=108.83 Aligned_cols=131 Identities=21% Similarity=0.311 Sum_probs=100.8
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEe-ccCCC------HHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEe
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEES------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~-~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (421)
..|++|+-+.+|.+... |..+.+|.- ++.-. .-...+..+|+++|++++--.|...+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46889999999999664 556777752 22211 1123556789999999875555544445567788889999
Q ss_pred cCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 92 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
|++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++..+ .+.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccc
Confidence 99999999998764 25677778888888999999999999999999765 49999999975
No 446
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.31 E-value=3.1e-11 Score=105.06 Aligned_cols=142 Identities=27% Similarity=0.342 Sum_probs=108.8
Q ss_pred eeceEeecCceEEEEEEECCCCcEEEEEEec-cCC------CHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEE
Q 014610 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVID-LEE------SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~-~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (421)
.+..|-+|+-+.|+++.+. |+.+.||.-. +.- ..-...+.++|+++|.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 7889999999999999776 8888888632 211 112246678999999998755555545556777777899
Q ss_pred EecCCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC---CEEEeecccccc
Q 014610 90 MEYMAG-GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQ 160 (421)
Q Consensus 90 ~E~~~g-g~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g---~vkL~DFGla~~ 160 (421)
|||++| -++.+++... ....+.....++++|-+.+.-||.++|||+||..+||+|..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 4788887652 2333444478999999999999999999999999999997665 358999998743
No 447
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.28 E-value=9.1e-11 Score=116.25 Aligned_cols=212 Identities=15% Similarity=0.214 Sum_probs=155.4
Q ss_pred ceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeEEEEEEEe----CCEEEEEEecCCC-CCHHH
Q 014610 26 FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTKLWIIMEYMAG-GSVAD 100 (421)
Q Consensus 26 ~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L~~ 100 (421)
-.+.|+|....+|..|++|.+...... .......-+++++++.|+|||++.++|.. +..+++|++|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 357899999999999999998332211 11123345788999999999999999983 4568999999775 68887
Q ss_pred HHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeeccccccccccc
Q 014610 101 LIQS---------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (421)
Q Consensus 101 ~l~~---------------~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~ 165 (421)
+.-. +...+|..+|.++.||..||.++|+.|+..+-|.|.+||++.+-+++|.-.|+...+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 6521 3357899999999999999999999999999999999999988889988777654443221
Q ss_pred ccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHhhccCCCCCCCchHHHHHHHHHH
Q 014610 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (421)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~s~~l~~li 244 (421)
-|-+.+ -.+-|.=.||.++..|.+|..--...+ .... . ...+...++.+++++|
T Consensus 448 --------------~~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~-----~~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 448 --------------TEPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--H-----LTRITTTYSTDLRNVV 502 (655)
T ss_pred --------------CcchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH--H-----HHHhhhhhhHHHHHHH
Confidence 011221 234688899999999999964321111 1111 0 1123345789999999
Q ss_pred HHHcccCCCCCcCHHHHHhC
Q 014610 245 SLCLKKVPAERPSAKELLRH 264 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~h 264 (421)
.-+...++++ -++.+++.|
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 9999998886 678888765
No 448
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.22 E-value=4.8e-10 Score=106.15 Aligned_cols=131 Identities=15% Similarity=0.087 Sum_probs=94.7
Q ss_pred eEEEEEEECCCCcEEEEEEeccCCCHHHH----------HHHHHHHHHHHcCCC--CCeeEEEEEEEe-----CCEEEEE
Q 014610 27 GDVYKAFDKELNKDVAIKVIDLEESEDEI----------EDIQKEISVLSQCRS--PYITEYYGSYLH-----QTKLWII 89 (421)
Q Consensus 27 g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~----------~~~~~E~~il~~l~h--pnIv~l~~~~~~-----~~~~~lV 89 (421)
..|+++.. .|+.|.||......-.... ..+.+|...+.+|.. -.+++++++... ....+||
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34556543 3788999976332211111 137789998888743 233344444433 2357899
Q ss_pred EecCCCC-CHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-------CCCEEEeeccccc
Q 014610 90 MEYMAGG-SVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------NGDVKVADFGVSA 159 (421)
Q Consensus 90 ~E~~~gg-~L~~~l~~--~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~-------~g~vkL~DFGla~ 159 (421)
||++++. +|.+++.. ..+.++.....++.+++..+.-||.+||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 89999863 345677788899999999999999999999999999999975 4679999999764
No 449
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.13 E-value=4.2e-12 Score=128.28 Aligned_cols=243 Identities=28% Similarity=0.384 Sum_probs=180.9
Q ss_pred CCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCC-eeEEEEEEEeCCEEEEEE
Q 014610 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 90 (421)
+.-|....-+++|++++++|.+...+...+ .+++... ....-++++|.+++||| .+..++.+..+...++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 445666777899999999999888766665 7776543 45667899999999999 888888888888999999
Q ss_pred ecCCCC-CHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEeecccccccccccccc
Q 014610 91 EYMAGG-SVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (421)
Q Consensus 91 E~~~gg-~L~~~l-~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 168 (421)
+++.++ +-...+ ...-.+.+-+...+.+.-+++|++||+.--+||| ||+.++ +..+++||+....+.... ..
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 999887 222111 1112344556666777778899999998888998 888765 689999999988776554 45
Q ss_pred cccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHhhccCCC-CCCCch--HHHHHHH-HHH
Q 014610 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDE--HFSRLMK-EFV 244 (421)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~-~li 244 (421)
++..+|+.++|||+..... +..+.|+|++|+-..+|.-|.+|-.. +......+..+. .+.+.. .++.... ++.
T Consensus 388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~ 464 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP 464 (829)
T ss_pred ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence 6789999999999987764 88999999999988888888888654 333333332222 122211 2222233 488
Q ss_pred HHHcccCCCCCcCHHHHHhChhcccc
Q 014610 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 245 ~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
..|+..-|..|++...++-|.+|...
T Consensus 465 ~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 465 APCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ccccCCCCCCCcchhhHHHHHHhccC
Confidence 89999999999999999999999754
No 450
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.13 E-value=3.3e-10 Score=101.46 Aligned_cols=127 Identities=28% Similarity=0.399 Sum_probs=84.7
Q ss_pred EEEEEEECCCCcEEEEEEeccCC-------------------------CHHHHHHHHHHHHHHHcCCCC--CeeEEEEEE
Q 014610 28 DVYKAFDKELNKDVAIKVIDLEE-------------------------SEDEIEDIQKEISVLSQCRSP--YITEYYGSY 80 (421)
Q Consensus 28 ~Vy~a~~~~~g~~vAiK~~~~~~-------------------------~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~ 80 (421)
.||.|...+ |..+|||+..... ........++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998865 8899999864310 011234567899999999755 566766542
Q ss_pred EeCCEEEEEEecCC--CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEccCCCEEEeeccc
Q 014610 81 LHQTKLWIIMEYMA--GGSVADLIQSGPPLDEMSIACILRDLLHAIEY-LHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 81 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~y-LH~~~iiHrDlkp~NILl~~~g~vkL~DFGl 157 (421)
.-+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 6556554432 22245667788888885555 579999999999999999877 899999998
Q ss_pred ccccc
Q 014610 158 SAQLT 162 (421)
Q Consensus 158 a~~~~ 162 (421)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 76544
No 451
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.12 E-value=1.7e-11 Score=125.31 Aligned_cols=152 Identities=18% Similarity=0.293 Sum_probs=112.1
Q ss_pred HHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeecccccccccccc----cc-----cccccCccccCcccccCcC
Q 014610 118 RDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS----RR-----KTFVGTPFWMAPEVIQNSE 187 (421)
Q Consensus 118 ~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~----~~-----~~~~gt~~y~aPE~~~~~~ 187 (421)
.++..||.|+|.. ++||+.|.|++|.++..|..||+.|+++.....+.. .. ....-...|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~- 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT- 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence 3455999999965 899999999999999999999999998754332111 00 111235569999999874
Q ss_pred CCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHH---hhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHh
Q 014610 188 GYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVL---FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (421)
Q Consensus 188 ~~~~~~DvwslGvil~ell-~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~ 263 (421)
..+.++|++||||++|-+. .|+.-+...+..... ..............++.++++-|.++|..++..||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4788999999999999999 566555443221111 111112222334678899999999999999999999999999
Q ss_pred Chhcccc
Q 014610 264 HRFIRNA 270 (421)
Q Consensus 264 hp~~~~~ 270 (421)
-|||.+.
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999764
No 452
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=99.02 E-value=4.4e-09 Score=96.08 Aligned_cols=106 Identities=24% Similarity=0.280 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHHcCC--CCCeeEEEEEEEeC----CEEEEEEecCCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 014610 55 IEDIQKEISVLSQCR--SPYITEYYGSYLHQ----TKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127 (421)
Q Consensus 55 ~~~~~~E~~il~~l~--hpnIv~l~~~~~~~----~~~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yL 127 (421)
.....+|...+.+|. .-.+++.+++.... ...+||+|++++ .+|.+++.....++......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356778888887774 33345555555442 245899999987 48999998755577888899999999999999
Q ss_pred HHCCccccCCCCCcEEEccCC---CEEEeecccccc
Q 014610 128 HNEGKIHRDIKAANILLTENG---DVKVADFGVSAQ 160 (421)
Q Consensus 128 H~~~iiHrDlkp~NILl~~~g---~vkL~DFGla~~ 160 (421)
|.+||+|+|+++.|||++.++ .+.|+||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999997643
No 453
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.97 E-value=2.3e-08 Score=97.25 Aligned_cols=244 Identities=15% Similarity=0.214 Sum_probs=155.0
Q ss_pred hhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-CCCCeeEEEEEE------E
Q 014610 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY------L 81 (421)
Q Consensus 9 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~------~ 81 (421)
...+.-....+.||+|+-+.+|..-.. +.. +.|+......... .+-+..|... .||-+-.-+.+= -
T Consensus 7 ~~~ge~i~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 7 DVYGEPIPPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred cccCcccCCCccccCCccceeeecchh--hch-hheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 334444556678999999999976221 222 4466544332221 1223344444 566554422211 1
Q ss_pred e-CCEEEEEEecCCCC-CHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEEe
Q 014610 82 H-QTKLWIIMEYMAGG-SVADLIQ------SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (421)
Q Consensus 82 ~-~~~~~lV~E~~~gg-~L~~~l~------~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL~ 153 (421)
+ +..+-++|..+.|. .+..+.. ...-..++.+..+++.|+.+.+.||..|.+-+|++++|+|+++++.|.|.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 2 22367888888764 2333331 12346788999999999999999999999999999999999999999999
Q ss_pred ecccccccccccccccccccCccccCcccccCc----CCCCCccccHHHHHHHHHHHhC-CCCCCCCCH-------HHH-
Q 014610 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKG-EPPLADLHP-------MRV- 220 (421)
Q Consensus 154 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~ell~g-~~pf~~~~~-------~~~- 220 (421)
|-.--.. .........-+|.+.|.+||.-.-. -.-+...|.|.||+++++||.| +.||.+... .+.
T Consensus 160 dsDsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 160 DSDSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cccceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 8653222 2233344556899999999964311 1245678999999999998876 999976421 110
Q ss_pred Hh----h-ccCC------CCC-CCchHHHHHHHHHHHHHccc--CCCCCcCHHH
Q 014610 221 LF----I-IPRE------NPP-QLDEHFSRLMKEFVSLCLKK--VPAERPSAKE 260 (421)
Q Consensus 221 ~~----~-i~~~------~~~-~~~~~~s~~l~~li~~~L~~--dP~~Rpt~~e 260 (421)
+. . .... .|. ....-+++.++.+..+|+.. ++.-|||++.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00 0 0000 011 11234678899999999875 3678999865
No 454
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.96 E-value=4e-09 Score=97.61 Aligned_cols=137 Identities=27% Similarity=0.341 Sum_probs=104.4
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCC-------------------C--HHHHHHHHHHHHHHHcCCCC--
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-------------------S--EDEIEDIQKEISVLSQCRSP-- 71 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-------------------~--~~~~~~~~~E~~il~~l~hp-- 71 (421)
+.+...||-|--|.||.|.+. .|.++|||.=+... + .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456689999999999999987 49999999743211 0 11234567899999999755
Q ss_pred CeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEE
Q 014610 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (421)
Q Consensus 72 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vk 151 (421)
.|.+.+++ +.-.+|||+++|-.|...- +....+..++..|++-+.-+-..|+||+|+.+-||+++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 77777754 4568999999997776542 24455666677777777766689999999999999999999999
Q ss_pred Eeeccccccc
Q 014610 152 VADFGVSAQL 161 (421)
Q Consensus 152 L~DFGla~~~ 161 (421)
++||--+...
T Consensus 243 vIDwPQ~v~~ 252 (304)
T COG0478 243 VIDWPQAVPI 252 (304)
T ss_pred EEeCcccccC
Confidence 9999765443
No 455
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.81 E-value=2.8e-08 Score=101.85 Aligned_cols=141 Identities=25% Similarity=0.336 Sum_probs=94.0
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCC-----------------------------C----HHH------HHHHH
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----------------------------S----EDE------IEDIQ 59 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~-----------------------------~----~~~------~~~~~ 59 (421)
+.|+.++-|.||+|+... |+.||||+....- . .+. .-++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 588999999999999886 9999999974210 0 001 11233
Q ss_pred HHHHHHHcCC-----CCCeeEEEEEEEeCCEEEEEEecCCCCCHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014610 60 KEISVLSQCR-----SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132 (421)
Q Consensus 60 ~E~~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l--~~~~~l~e~~~~~i~~qll~aL~yLH~~~i 132 (421)
+|...+.++. .|+|.-..=++.-.+.-.|+|||++|-.+.+.. +. ..++...+...+.++ -+..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 4555555542 344433333344456678999999999888874 33 445533333322222 1222334899
Q ss_pred cccCCCCCcEEEccCCCEEEeeccccccccc
Q 014610 133 IHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (421)
Q Consensus 133 iHrDlkp~NILl~~~g~vkL~DFGla~~~~~ 163 (421)
+|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999876643
No 456
>PRK09902 hypothetical protein; Provisional
Probab=98.80 E-value=9.6e-08 Score=86.39 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=99.4
Q ss_pred eecCceEEEEEEECCCCcEEEEEEeccC--CC---HHHHHHHHHHHHHHHcCCC--CCeeEEEEEEE--eC--CEEEEEE
Q 014610 22 GRGSFGDVYKAFDKELNKDVAIKVIDLE--ES---EDEIEDIQKEISVLSQCRS--PYITEYYGSYL--HQ--TKLWIIM 90 (421)
Q Consensus 22 G~G~~g~Vy~a~~~~~g~~vAiK~~~~~--~~---~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~--~~--~~~~lV~ 90 (421)
|+||.+.|+..... |+.+=+|.-... .+ +.....+.+|...|.+|.. -.+.++...-. .+ -..+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 66899999997654 446778875311 11 2245778999999988853 22444442211 11 2368999
Q ss_pred ecCCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC--EEEeeccccc
Q 014610 91 EYMAG-GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVSA 159 (421)
Q Consensus 91 E~~~g-g~L~~~l~~~--~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~--vkL~DFGla~ 159 (421)
|-++| .+|.+++... .+.++..-..++.+++.+++-||+.|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 6899988653 35677888899999999999999999999999999999987777 9999998554
No 457
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.74 E-value=1.4e-07 Score=87.46 Aligned_cols=134 Identities=18% Similarity=0.204 Sum_probs=85.0
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCC--CeeEEEEEEEeCCEEEEEEecCCC
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
...||+|..+.||+. .|..+++|...... ....+.+|.++++.+..- -+.+.+++..+.+...+|||+++|
T Consensus 6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred heeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 468999999999984 25567889875433 234578999999988643 357777777778888999999998
Q ss_pred CC-HHHHH--------------H-------cC--CCCCHHH-HHHHHHH----------HHH-HHHHHHH----CCcccc
Q 014610 96 GS-VADLI--------------Q-------SG--PPLDEMS-IACILRD----------LLH-AIEYLHN----EGKIHR 135 (421)
Q Consensus 96 g~-L~~~l--------------~-------~~--~~l~e~~-~~~i~~q----------ll~-aL~yLH~----~~iiHr 135 (421)
.+ +...+ . .- ....... ...+..+ +.. ..++|.. ..++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 21111 0 00 0111110 1111101 111 1222221 247899
Q ss_pred CCCCCcEEEccCCCEEEeeccccc
Q 014610 136 DIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 136 Dlkp~NILl~~~g~vkL~DFGla~ 159 (421)
|++|.||+++.++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999764
No 458
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.74 E-value=2.9e-07 Score=83.67 Aligned_cols=137 Identities=18% Similarity=0.236 Sum_probs=88.7
Q ss_pred hhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHH---------HHHHHHHHHcCC---CCCeeEEE
Q 014610 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED---------IQKEISVLSQCR---SPYITEYY 77 (421)
Q Consensus 10 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~---------~~~E~~il~~l~---hpnIv~l~ 77 (421)
-..++|++++++-......|.+. .-.|+.+.+|........ ..+. ..+++..+.++. --.++.++
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 34578888888888776666555 344789999986433211 1111 122333333332 22333333
Q ss_pred EEEEe-----CCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCEEE
Q 014610 78 GSYLH-----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (421)
Q Consensus 78 ~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~vkL 152 (421)
.+... ....+|||||++|..|.++.. +++ .+...|.+++.-||+.|++|+|.+|+|++++.+ .+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence 32221 234578999999988877642 333 244567788999999999999999999999855 5999
Q ss_pred eecccc
Q 014610 153 ADFGVS 158 (421)
Q Consensus 153 ~DFGla 158 (421)
+||+..
T Consensus 176 ID~~~k 181 (229)
T PF06176_consen 176 IDTQGK 181 (229)
T ss_pred EECccc
Confidence 999854
No 459
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.71 E-value=1.6e-07 Score=86.46 Aligned_cols=137 Identities=20% Similarity=0.356 Sum_probs=83.9
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCC--CeeEEEEEEE---eCCEEEEEEec
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYGSYL---HQTKLWIIMEY 92 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~---~~~~~~lV~E~ 92 (421)
++.|+.|..+.||++.... ..+++|+.... .....+.+|+.+++.+... -+.+++.... .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999998775 48999996543 4557788999998888532 3556666443 23457999999
Q ss_pred CCCCCHHH----------------HHH---cC----CCCCHHH------HHHH---------------HHHHHH-HHHHH
Q 014610 93 MAGGSVAD----------------LIQ---SG----PPLDEMS------IACI---------------LRDLLH-AIEYL 127 (421)
Q Consensus 93 ~~gg~L~~----------------~l~---~~----~~l~e~~------~~~i---------------~~qll~-aL~yL 127 (421)
++|..+.. .+. .. .++.... .... +..+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988877 111 11 1111100 0000 111222 33333
Q ss_pred HH-------CCccccCCCCCcEEEc-cCCCEEEeeccccc
Q 014610 128 HN-------EGKIHRDIKAANILLT-ENGDVKVADFGVSA 159 (421)
Q Consensus 128 H~-------~~iiHrDlkp~NILl~-~~g~vkL~DFGla~ 159 (421)
+. ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 3599999999999999 66677899999764
No 460
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.61 E-value=1.4e-07 Score=101.79 Aligned_cols=206 Identities=22% Similarity=0.293 Sum_probs=149.3
Q ss_pred HHHHHHHHHHHHHHcCCCCCeeEEEEEEEeCCEE----EEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014610 53 DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128 (421)
Q Consensus 53 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH 128 (421)
........|...+.++.|+|++.++.+-...... .+..|+|..-++...+..-+..+...++.+..++++||+|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4456666788889999999999999987654433 345689999999999998899999999999999999999999
Q ss_pred HCCccccCCCCC---cEEEccCCCEEEe--ecccccccccccccccccccCccccCcccccCcCCCCC--ccccHHHHHH
Q 014610 129 NEGKIHRDIKAA---NILLTENGDVKVA--DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGIT 201 (421)
Q Consensus 129 ~~~iiHrDlkp~---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DvwslGvi 201 (421)
+....|.-|-.+ +..++.++.+.+. ||+.+..+.... ......-+..+.+||...... +.. ..|+|.+|..
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-KSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL 381 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcc-cchhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence 996655555444 4444455666666 888776654432 223345566788888876542 333 3699999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccc
Q 014610 202 VIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (421)
Q Consensus 202 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 270 (421)
+..+..|..+-.... .....++........+++.+|+..++++|+++.+++.|+|.+..
T Consensus 382 ~~~~~~~~~i~~~~~----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HhhhhhcCccccccc----------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999998865432110 00111111122267889999999999999999999999999753
No 461
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.60 E-value=5.6e-07 Score=82.74 Aligned_cols=139 Identities=19% Similarity=0.272 Sum_probs=94.8
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCC---------------------HHHH--HHHHHHHHHHHcCC--CCCee
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---------------------EDEI--EDIQKEISVLSQCR--SPYIT 74 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~---------------------~~~~--~~~~~E~~il~~l~--hpnIv 74 (421)
.|..|--+.||+|... ++..||+|+...... ...+ .=..+|+.-|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 5556777789999763 489999999753211 0011 11336888888874 44556
Q ss_pred EEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCEEEe
Q 014610 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVA 153 (421)
Q Consensus 75 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~-~~iiHrDlkp~NILl~~~g~vkL~ 153 (421)
+.+.+. .-.|||||+....+-.-.-+.-++...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.++
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 666543 247999999543111111111234444788888899999998877 8999999999999998 8899999
Q ss_pred ecccccccccc
Q 014610 154 DFGVSAQLTRT 164 (421)
Q Consensus 154 DFGla~~~~~~ 164 (421)
|||-|.....+
T Consensus 209 D~~QaV~~~hp 219 (268)
T COG1718 209 DVSQAVTIDHP 219 (268)
T ss_pred ECccccccCCC
Confidence 99988665544
No 462
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.55 E-value=7.8e-07 Score=83.25 Aligned_cols=134 Identities=17% Similarity=0.168 Sum_probs=83.8
Q ss_pred eEeecCc-eEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCeeEEEEEEEeCCEEEEEEecCCCCC
Q 014610 20 LIGRGSF-GDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (421)
Q Consensus 20 ~LG~G~~-g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 97 (421)
.|-.|.. +.||++... +..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3444444 789999654 4678889865432 345678999988874 3446678887777777899999999987
Q ss_pred HHHHH----------------H---cC----CCCCHH---HHHHH---H----------------HHHHHHHHHHHH---
Q 014610 98 VADLI----------------Q---SG----PPLDEM---SIACI---L----------------RDLLHAIEYLHN--- 129 (421)
Q Consensus 98 L~~~l----------------~---~~----~~l~e~---~~~~i---~----------------~qll~aL~yLH~--- 129 (421)
|.... . .- .++... ..... + ..+...+..|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76432 0 00 011100 00000 0 001112222221
Q ss_pred ----CCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 130 ----EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 130 ----~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 248999999999999987778899999764
No 463
>PLN02876 acyl-CoA dehydrogenase
Probab=98.45 E-value=1.9e-06 Score=94.58 Aligned_cols=145 Identities=16% Similarity=0.265 Sum_probs=93.3
Q ss_pred eeceEeecCceEEEEEEECCCC--cEEEEEEeccCCCHHHHHHHHHHHHHHHcCC-CCCe--eEEEEEEEeC---CEEEE
Q 014610 17 SLELIGRGSFGDVYKAFDKELN--KDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYI--TEYYGSYLHQ---TKLWI 88 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g--~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~~~l 88 (421)
.++.|+.|.+..+|+......+ ..+++|+.+..........+.+|+++|+.+. |++| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4688899999999998765432 4678887654332222356889999999995 6665 7878777654 46789
Q ss_pred EEecCCCCCHHH--------------------HHH---cC-----------CC--CCHHHHHHHHHH-------------
Q 014610 89 IMEYMAGGSVAD--------------------LIQ---SG-----------PP--LDEMSIACILRD------------- 119 (421)
Q Consensus 89 V~E~~~gg~L~~--------------------~l~---~~-----------~~--l~e~~~~~i~~q------------- 119 (421)
||||++|..+.+ .+. .- .+ ....++..|..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998864321 111 10 00 112233332222
Q ss_pred --HHHHHHHHHH-----------CCccccCCCCCcEEEccC-CC-EEEeeccccccc
Q 014610 120 --LLHAIEYLHN-----------EGKIHRDIKAANILLTEN-GD-VKVADFGVSAQL 161 (421)
Q Consensus 120 --ll~aL~yLH~-----------~~iiHrDlkp~NILl~~~-g~-vkL~DFGla~~~ 161 (421)
+...+++|.. ..+||+|+++.|||++.+ +. +-|.||+++...
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2234566743 249999999999999853 33 579999998654
No 464
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.43 E-value=1.1e-06 Score=89.97 Aligned_cols=139 Identities=25% Similarity=0.322 Sum_probs=89.1
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCC------------------------------HHHHHHHH------HHH
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES------------------------------EDEIEDIQ------KEI 62 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~------------------------------~~~~~~~~------~E~ 62 (421)
+.||.-+.|.|++|+.+. |+.||||+-...-. ++....+. +|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 589999999999999887 99999998632110 01112222 233
Q ss_pred HH----HHcCCCCC------eeEEEEEEEeCCEEEEEEecCCCCCHHHH--HHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014610 63 SV----LSQCRSPY------ITEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAIEYLHNE 130 (421)
Q Consensus 63 ~i----l~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~--l~~~~~l~e~~~~~i~~qll~aL~yLH~~ 130 (421)
+- .+.++|-+ |.++|-. .-..-.|+||||+|..+.++ |.+ ..++...+...+.+... +-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence 22 23334544 4444432 23457899999999866654 333 34555544444333222 222347
Q ss_pred CccccCCCCCcEEEcc----CCCEEEeeccccccccc
Q 014610 131 GKIHRDIKAANILLTE----NGDVKVADFGVSAQLTR 163 (421)
Q Consensus 131 ~iiHrDlkp~NILl~~----~g~vkL~DFGla~~~~~ 163 (421)
|++|+|-+|.||++.. ++.+.+.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999983 57899999999876544
No 465
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=98.41 E-value=2.1e-08 Score=110.08 Aligned_cols=212 Identities=14% Similarity=0.082 Sum_probs=152.5
Q ss_pred HHHHHHHHHHHcCCCCCeeEEEEEEEeC--CEEEEEEecCCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH
Q 014610 56 EDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHN 129 (421)
Q Consensus 56 ~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qll~aL~yLH~ 129 (421)
+.+..|...++...|+++...+.-.... ...|.+++||.+|.+++.|-++ .++.+..+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 4445566677778999998888765543 3469999999999999998653 345555565555665777788775
Q ss_pred C-----CccccCCCCCcEEEccCCCEEEeecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHH
Q 014610 130 E-----GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIE 204 (421)
Q Consensus 130 ~-----~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~e 204 (421)
. -.+|+++|+-|.+|..+.++|++++|+.+.............+++.|+.|++....+ ++.++|+|..|+.+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHH
Confidence 4 279999999999999999999999999985555555566788999999999987765 7888999999999999
Q ss_pred HHhCCCCCCCCCHHHHHhhccCCCCCCCchHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcc
Q 014610 205 MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (421)
Q Consensus 205 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~ 268 (421)
+..|..+|-..........+.......++.-.|.++......+|-..-..||.-...+.-+.+.
T Consensus 1433 rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999888754433333333333332223222233333333444444447889888888776664
No 466
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.34 E-value=3.4e-06 Score=73.67 Aligned_cols=130 Identities=23% Similarity=0.269 Sum_probs=92.7
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCeeE-EEEEEEeCCEEEEEEecC
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE-YYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~~lV~E~~ 93 (421)
-++.+.||+|.+|.||++.+. |..+|+|+-..+. ....+..|+++|..+..-++.+ +|.+-. .++.|||+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 356678999999999999887 7799999864433 4578999999999998776654 443322 24559999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCcEEEccCCCEEEeecccccc
Q 014610 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK-AANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 94 ~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlk-p~NILl~~~g~vkL~DFGla~~ 160 (421)
+|-.|.++-... +.. -+..+++..--|-..||-|+.|. |..++|..++.+.|+||.-|..
T Consensus 95 ~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888775431 222 33345566555667799999986 4444444455999999998763
No 467
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.30 E-value=9.5e-06 Score=72.97 Aligned_cols=127 Identities=24% Similarity=0.356 Sum_probs=91.8
Q ss_pred CCCceeeceEeecCc-eEEEEEEECCCCcEEEEEEec---cCCC-------H----------HHHHHHHHHHHHHHcCC-
Q 014610 12 GSRFSSLELIGRGSF-GDVYKAFDKELNKDVAIKVID---LEES-------E----------DEIEDIQKEISVLSQCR- 69 (421)
Q Consensus 12 ~~~y~~~~~LG~G~~-g~Vy~a~~~~~g~~vAiK~~~---~~~~-------~----------~~~~~~~~E~~il~~l~- 69 (421)
+.+++.++.||.|.- |.||++... |+.||+|++. .... . ....-+..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 379999999999999 999999776 8899999932 1110 0 12345677888776664
Q ss_pred --CCCe--eEEEEEEEeCC------------------EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 014610 70 --SPYI--TEYYGSYLHQT------------------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127 (421)
Q Consensus 70 --hpnI--v~l~~~~~~~~------------------~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yL 127 (421)
+.++ |+++|+..-.. ...||.||+.... .+... -+.+|++-+..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 4566 99999874321 1357888876543 23333 345677888889
Q ss_pred HHCCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 128 HNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 128 H~~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
|..||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 3489999854
No 468
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.29 E-value=1.7e-05 Score=71.63 Aligned_cols=129 Identities=21% Similarity=0.351 Sum_probs=93.7
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCC---------------CHHHHHHHHHHHHHHHcCC------CCCeeEE
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---------------SEDEIEDIQKEISVLSQCR------SPYITEY 76 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~---------------~~~~~~~~~~E~~il~~l~------hpnIv~l 76 (421)
...||+|+.=.||.- . .....+||+..... ......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999989865 2 24466899886554 1122455666766655554 7899999
Q ss_pred EEEEEeCCEEEEEEecCCC------CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC--C
Q 014610 77 YGSYLHQTKLWIIMEYMAG------GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--G 148 (421)
Q Consensus 77 ~~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~--g 148 (421)
+|+.+++..+-+|+|.+.. -+|.++++. +.+++ . +...|-+-..||-+++|+.+||+|.||++... |
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998643 478888865 45666 3 33344556678889999999999999999643 2
Q ss_pred --CEEEee
Q 014610 149 --DVKVAD 154 (421)
Q Consensus 149 --~vkL~D 154 (421)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477777
No 469
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=98.25 E-value=4.2e-06 Score=77.92 Aligned_cols=74 Identities=14% Similarity=0.271 Sum_probs=47.0
Q ss_pred eceEeecCce-EEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCC---CeeEEEEEEEeC---CEEEEEE
Q 014610 18 LELIGRGSFG-DVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP---YITEYYGSYLHQ---TKLWIIM 90 (421)
Q Consensus 18 ~~~LG~G~~g-~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~---~~~~lV~ 90 (421)
++.|+.|+.. .||+. +..+++|+..... ....+.+|+.+|+.+... -+.++++..... ...++||
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 3567776666 59986 3457788754322 235788999999887531 344555433322 2358899
Q ss_pred ecCCCCCHH
Q 014610 91 EYMAGGSVA 99 (421)
Q Consensus 91 E~~~gg~L~ 99 (421)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987663
No 470
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.23 E-value=5.3e-06 Score=74.54 Aligned_cols=98 Identities=19% Similarity=0.180 Sum_probs=79.8
Q ss_pred HHHHHHHcCCC-CCeeEEEEEEEeCCEEEEEEecCCCCCHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q 014610 60 KEISVLSQCRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHN---EGK 132 (421)
Q Consensus 60 ~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---l~~~~~l~e~~~~~i~~qll~aL~yLH~---~~i 132 (421)
.|.-+|+.+.+ +++++++|++-. ++|+||...+++... +......++..+.+++.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999976 799999999843 678999987766421 1112346899999999999999999997 458
Q ss_pred cccCCCCCcEEEccCCCEEEeeccccccc
Q 014610 133 IHRDIKAANILLTENGDVKVADFGVSAQL 161 (421)
Q Consensus 133 iHrDlkp~NILl~~~g~vkL~DFGla~~~ 161 (421)
.-.|++|+|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999876544
No 471
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=98.09 E-value=3.6e-05 Score=71.41 Aligned_cols=75 Identities=19% Similarity=0.310 Sum_probs=49.5
Q ss_pred eceEeecCceEEEEEEECC-CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC-CCeeEEEEEEEeCCEEEEEEecCCC
Q 014610 18 LELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWIIMEYMAG 95 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~-~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~g 95 (421)
++.|..|-...+|++.... .++.|++|+..... . ..-...+|+.+++.+.. .-++++++.+. + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-E-LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-c-ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence 5678889999999996553 35788899764322 1 12234578888888853 33445554332 2 479999998
Q ss_pred CCH
Q 014610 96 GSV 98 (421)
Q Consensus 96 g~L 98 (421)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
No 472
>PRK10593 hypothetical protein; Provisional
Probab=98.08 E-value=5.8e-05 Score=72.93 Aligned_cols=92 Identities=20% Similarity=0.241 Sum_probs=63.3
Q ss_pred ccccc-cchhhCCCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC---CCeeEEE
Q 014610 2 ADLAG-LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS---PYITEYY 77 (421)
Q Consensus 2 ~~~~~-~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~ 77 (421)
.+|+. +.+..+..-.-.+.||.|..+.||.....+ + .+.+|+.+... ....+..|+..|+.|.- ..|.+++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~ 76 (297)
T PRK10593 2 EQLRAELSHLLGEKLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVY 76 (297)
T ss_pred hHHHHHHHHHhchhhheeeecCCccceeEEEEEcCC-C-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEE
Confidence 34443 333344466677899999999999985443 3 46778743211 12568899999988853 4678888
Q ss_pred EEEEe---CCEEEEEEecCCCCCH
Q 014610 78 GSYLH---QTKLWIIMEYMAGGSV 98 (421)
Q Consensus 78 ~~~~~---~~~~~lV~E~~~gg~L 98 (421)
+++.+ .+..+||||+++|+++
T Consensus 77 ~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 77 GVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EEeccCCcCCCeEEEEeccCCEec
Confidence 87754 3668999999998765
No 473
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=98.06 E-value=5.7e-05 Score=72.69 Aligned_cols=149 Identities=15% Similarity=0.122 Sum_probs=90.1
Q ss_pred cccchhhC-CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCC--CeeEEEE---
Q 014610 5 AGLQEAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYG--- 78 (421)
Q Consensus 5 ~~~~~~~~-~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~--- 78 (421)
+.+.+..+ ++..-++.|..|....+|+.... +..+++|+... . ....+..|+.++..+.+- .+++++.
T Consensus 5 ~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~ 78 (296)
T cd05153 5 ASFLADYDLGELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADRD 78 (296)
T ss_pred HHHHHHcCCCchhheecccCccccceEEEEeC--CCcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence 34444444 45556788888988999998643 45788898754 2 235577788888877432 2455443
Q ss_pred ---EEEeCCEEEEEEecCCCCCHHH-----------HHHc------C--CC----CCHHHHH------------HHHHHH
Q 014610 79 ---SYLHQTKLWIIMEYMAGGSVAD-----------LIQS------G--PP----LDEMSIA------------CILRDL 120 (421)
Q Consensus 79 ---~~~~~~~~~lV~E~~~gg~L~~-----------~l~~------~--~~----l~e~~~~------------~i~~ql 120 (421)
+...++..++|++|++|..+.. .+.+ . .. ....... .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 1233556789999999866421 1100 0 00 0000000 011123
Q ss_pred HHHHHHHHH-------CCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 121 LHAIEYLHN-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 121 l~aL~yLH~-------~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
..++.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 344455553 369999999999999987777899999753
No 474
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=97.96 E-value=0.00018 Score=71.87 Aligned_cols=78 Identities=21% Similarity=0.207 Sum_probs=56.3
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccC-----CC-HHHHHHHHHHHHHHHcCC---CCCeeEEEEEEEeCCEEEE
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-----ES-EDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLWI 88 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~-----~~-~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 88 (421)
.+.||.|.+..||++.+...++.|+||.-... .. +-..++...|.+.|+.+. -.++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 57899999999999998754468999984311 10 223567778888888763 3467777765 5566789
Q ss_pred EEecCCCCC
Q 014610 89 IMEYMAGGS 97 (421)
Q Consensus 89 V~E~~~gg~ 97 (421)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
No 475
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=97.94 E-value=3.5e-05 Score=72.70 Aligned_cols=133 Identities=17% Similarity=0.272 Sum_probs=78.1
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCe-eEEEEEEEeCCEEEEEEecCCCCCH
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMAGGSV 98 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg~L 98 (421)
.+..|-.+.+|+.. .+++.+++|........-. -+..+|..+++.+..-.+ .+++... . -++|+||++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 45668888999886 3467888997543221110 135789999988864333 3444332 2 3689999998665
Q ss_pred HH--------------HHHc-------CCCCCH-HHHHHHHHHH---------HHHHHHHHHC--------CccccCCCC
Q 014610 99 AD--------------LIQS-------GPPLDE-MSIACILRDL---------LHAIEYLHNE--------GKIHRDIKA 139 (421)
Q Consensus 99 ~~--------------~l~~-------~~~l~e-~~~~~i~~ql---------l~aL~yLH~~--------~iiHrDlkp 139 (421)
.. .+.+ ..+++. ..+..+..++ ...+..+-.. .++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1111 111221 1222322222 1122222222 489999999
Q ss_pred CcEEEccCCCEEEeecccccc
Q 014610 140 ANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 140 ~NILl~~~g~vkL~DFGla~~ 160 (421)
.||+++.++ +.|+||+.|..
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC-CEEEeccccCc
Confidence 999999877 78999997744
No 476
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.87 E-value=0.00018 Score=69.82 Aligned_cols=140 Identities=18% Similarity=0.233 Sum_probs=82.5
Q ss_pred ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCC--CeeEEEEE------EEeCCEE
Q 014610 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYGS------YLHQTKL 86 (421)
Q Consensus 15 y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~------~~~~~~~ 86 (421)
...++.++.|....+|++... +| .+++|+....... ..+..|+.++..|... .+++++.. ...++..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 444677888888899988643 34 5778986543222 3455677777776421 23444431 1224567
Q ss_pred EEEEecCCCCCHH-----------HHHH---c-CCCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 014610 87 WIIMEYMAGGSVA-----------DLIQ---S-GPPL--------DEMSIA---------------CILRDLLHAIEYLH 128 (421)
Q Consensus 87 ~lV~E~~~gg~L~-----------~~l~---~-~~~l--------~e~~~~---------------~i~~qll~aL~yLH 128 (421)
++|+||++|..+. ..+. . ...+ ...... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 1111 0 0000 001000 01112334555554
Q ss_pred H-------CCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 129 N-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 129 ~-------~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 579999999999999988777899999763
No 477
>PRK05231 homoserine kinase; Provisional
Probab=97.86 E-value=0.00041 Score=67.53 Aligned_cols=137 Identities=15% Similarity=0.198 Sum_probs=75.7
Q ss_pred eeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCC--CCeeEEEE------EEEeCCEEEE
Q 014610 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYG------SYLHQTKLWI 88 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~------~~~~~~~~~l 88 (421)
.++.|+.|....+|+.... +..+++|+.. .... ..+..|+.+++.|.. -.+.+++. +....+..++
T Consensus 26 ~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred ccchhccccccceEEEEeC--CCcEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 3566778888899998654 3368899875 2222 334445555555521 11333332 1233567899
Q ss_pred EEecCCCCCHH-----------HHHHc----CCCC--------C--H-HH-HH-----------HHHHH-HHHHHHHHH-
Q 014610 89 IMEYMAGGSVA-----------DLIQS----GPPL--------D--E-MS-IA-----------CILRD-LLHAIEYLH- 128 (421)
Q Consensus 89 V~E~~~gg~L~-----------~~l~~----~~~l--------~--e-~~-~~-----------~i~~q-ll~aL~yLH- 128 (421)
++||++|..+. ..+.+ ...+ . . .. +. ..+.+ +-..++.+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999886431 11110 0000 0 0 01 00 01111 111222332
Q ss_pred ------HCCccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 129 ------NEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 129 ------~~~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
..++||+|++|.|||++.+...-|+||+.+.
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999866556899999764
No 478
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.76 E-value=2e-05 Score=75.18 Aligned_cols=135 Identities=22% Similarity=0.277 Sum_probs=96.1
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCC-----------------HHH----HHHHHHHHHHHHcCC-C
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----------------EDE----IEDIQKEISVLSQCR-S 70 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~-----------------~~~----~~~~~~E~~il~~l~-h 70 (421)
.-+.+...||-|.-+.||.+-+.. |++.++|+-.+... ... .-...+|...|+.|. |
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 356778899999999999998875 89999996432110 000 122446888888885 3
Q ss_pred -CCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 014610 71 -PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (421)
Q Consensus 71 -pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiHrDlkp~NILl~~~g~ 149 (421)
--|.+.++ .+..++|||++.|..|.....- ..+..+...++.-+--|-.+|+||+|..--||+|++++.
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 22444443 4556899999999888776422 122334445555566778899999999999999999999
Q ss_pred EEEeecccc
Q 014610 150 VKVADFGVS 158 (421)
Q Consensus 150 vkL~DFGla 158 (421)
++++||--.
T Consensus 241 i~vIDFPQm 249 (465)
T KOG2268|consen 241 IVVIDFPQM 249 (465)
T ss_pred EEEeechHh
Confidence 999999654
No 479
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.70 E-value=0.00021 Score=69.06 Aligned_cols=76 Identities=18% Similarity=0.273 Sum_probs=50.1
Q ss_pred eceEeecCceEEEEEEECC------CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCC-eeEEEEEEEeCCEEEEEE
Q 014610 18 LELIGRGSFGDVYKAFDKE------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWIIM 90 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~------~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 90 (421)
++.|..|-...||++.... .++.|++|+..... ....+..+|+.+++.+...+ ..++++.+. + .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 4567778888999987543 26789999964432 12345678888888885322 345555543 2 3689
Q ss_pred ecCCCCCHH
Q 014610 91 EYMAGGSVA 99 (421)
Q Consensus 91 E~~~gg~L~ 99 (421)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887664
No 480
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=97.68 E-value=0.00014 Score=73.20 Aligned_cols=168 Identities=21% Similarity=0.299 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHcCCCCCeeEEEEEEEe-CCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 014610 56 EDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134 (421)
Q Consensus 56 ~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~~iiH 134 (421)
.++.-...+++.+.|+|...++++-.. .....+|+|++ +.+|.+++..+. +-..... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 345566788999999999999987654 34588999999 679999987643 2221111 122221
Q ss_pred cCCCCCcEEEccCCCEEEeecccccccccccccccccccCccccCcccccCcCCCCCccccHHHHHHHHHHHhCCCCCCC
Q 014610 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (421)
Q Consensus 135 rDlkp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell~g~~pf~~ 214 (421)
-|| ++.+| -++ . ...+. .++++|||++|.++.+++-|...+..
T Consensus 91 -----~~~-------~~~td-~~~---t----~~~~~-----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFL---T----KYPSP-----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -----ehh-------hhccc-ccc---c----cCCCC-----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 222 22222 010 0 00011 12489999999999999999988877
Q ss_pred CCHHHHHhhccCCCCCCC-----------chHHHHHHHHHHHHHcccCCCCCcCHHHHHhChhcccccCChhH
Q 014610 215 LHPMRVLFIIPRENPPQL-----------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (421)
Q Consensus 215 ~~~~~~~~~i~~~~~~~~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~ 276 (421)
....+....+.+-..... ...++..+..++++|+...|..||...++.+++-|.++-+....
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t~ 206 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLTV 206 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhhH
Confidence 766665555433221111 11235567788899999999999999999999999877544444
No 481
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=97.52 E-value=0.00063 Score=64.96 Aligned_cols=31 Identities=19% Similarity=0.320 Sum_probs=25.5
Q ss_pred CccccCCCCCcEEEccCCC-EEEeeccccccc
Q 014610 131 GKIHRDIKAANILLTENGD-VKVADFGVSAQL 161 (421)
Q Consensus 131 ~iiHrDlkp~NILl~~~g~-vkL~DFGla~~~ 161 (421)
.++|+|++|.|||++.++. +-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997565 469999987543
No 482
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.51 E-value=0.00061 Score=65.94 Aligned_cols=147 Identities=16% Similarity=0.233 Sum_probs=88.7
Q ss_pred CCceeeceEeecCceEEEEEEECCCCcEEEEEEec-cCCCHHHHHHHHHHHHHHHcCCC--CCeeEEEEEEEeCC--EEE
Q 014610 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-LEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQT--KLW 87 (421)
Q Consensus 13 ~~y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~-~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~--~~~ 87 (421)
....+++.+-.|.--.+|..... ++.++++ .+ ............+|+.+|+.+.- .-+...++++.++. ..|
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 34455555544444455665544 8889998 43 23344556778899999998753 23445555555554 669
Q ss_pred EEEecCCCCCHH------------------HHHHc-------CC-------CCCHHHHHHHHHHH--------------H
Q 014610 88 IIMEYMAGGSVA------------------DLIQS-------GP-------PLDEMSIACILRDL--------------L 121 (421)
Q Consensus 88 lV~E~~~gg~L~------------------~~l~~-------~~-------~l~e~~~~~i~~ql--------------l 121 (421)
.||+|++|..+. +.+.. +. .....++..+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 999999883222 12210 00 00111222222222 2
Q ss_pred HHHHHHHHC--------CccccCCCCCcEEEccCCCEEEeecccccccc
Q 014610 122 HAIEYLHNE--------GKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (421)
Q Consensus 122 ~aL~yLH~~--------~iiHrDlkp~NILl~~~g~vkL~DFGla~~~~ 162 (421)
.-..||+.+ .++|+|+++.||+|+.++.+-++||+++....
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 234455543 48999999999999999889999999886543
No 483
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.42 E-value=0.0014 Score=63.94 Aligned_cols=145 Identities=17% Similarity=0.236 Sum_probs=97.3
Q ss_pred eeeceEeecCceEEEEEEECCCCcEEEEEEeccC------------------------CCHHHHHH-HHHHHHHHHcCCC
Q 014610 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE------------------------ESEDEIED-IQKEISVLSQCRS 70 (421)
Q Consensus 16 ~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~------------------------~~~~~~~~-~~~E~~il~~l~h 70 (421)
.+...|..|--+.||.|.... |..+|||+.+.. .....+.- ..+|++-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344567788889999997654 888999986421 00111111 2367888888876
Q ss_pred CCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEccCCC
Q 014610 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGD 149 (421)
Q Consensus 71 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH-~~~iiHrDlkp~NILl~~~g~ 149 (421)
-.|...--... ..-+|||+++.......-.-+.-.++...+..+-.|++.-+.-|- ..++||.||.--|+|+- +|.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 55432222221 224799999964333222223457888888888888888887765 56899999999999995 679
Q ss_pred EEEeecccccccccc
Q 014610 150 VKVADFGVSAQLTRT 164 (421)
Q Consensus 150 vkL~DFGla~~~~~~ 164 (421)
+.++|-+-+.....+
T Consensus 303 lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDHP 317 (520)
T ss_pred EEEEEccccccCCCh
Confidence 999999877554443
No 484
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.41 E-value=0.0013 Score=64.56 Aligned_cols=75 Identities=17% Similarity=0.303 Sum_probs=51.1
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEe----cc--CCCHHHHHHHHHHHHHHHcCC--CC-CeeEEEEEEEeCCEEEEE
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI----DL--EESEDEIEDIQKEISVLSQCR--SP-YITEYYGSYLHQTKLWII 89 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~----~~--~~~~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV 89 (421)
+.||-|....||++.+...++.|+||.- .. ..-+-...+..-|...|+... -| .++++|. .+.....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence 3579999999999998654478999973 21 111333566677888887764 34 4555554 356667799
Q ss_pred EecCCC
Q 014610 90 MEYMAG 95 (421)
Q Consensus 90 ~E~~~g 95 (421)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
No 485
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=97.19 E-value=0.0081 Score=58.06 Aligned_cols=28 Identities=39% Similarity=0.561 Sum_probs=24.8
Q ss_pred CCccccCCCCCcEEEccCCCEEEeecccc
Q 014610 130 EGKIHRDIKAANILLTENGDVKVADFGVS 158 (421)
Q Consensus 130 ~~iiHrDlkp~NILl~~~g~vkL~DFGla 158 (421)
.+++|+|+++.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999965
No 486
>PLN02236 choline kinase
Probab=97.12 E-value=0.0036 Score=61.77 Aligned_cols=137 Identities=16% Similarity=0.237 Sum_probs=80.8
Q ss_pred eeceEeecCceEEEEEEECC----CCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCe-eEEEEEEEeCCEEEEEEe
Q 014610 17 SLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIME 91 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~----~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E 91 (421)
-++.|-.|-.-.+|++.... .++.|++|+..... . ..-+..+|..+++.+..-++ .++++.+..+ .|+|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 34556568888999986532 34789999864332 2 22234678888888854333 3555555332 5799
Q ss_pred cCCCCCHHHH--------------HH---c-C---C--CCCHHHHHHHHHHH-----------------HHHHHHHH---
Q 014610 92 YMAGGSVADL--------------IQ---S-G---P--PLDEMSIACILRDL-----------------LHAIEYLH--- 128 (421)
Q Consensus 92 ~~~gg~L~~~--------------l~---~-~---~--~l~e~~~~~i~~ql-----------------l~aL~yLH--- 128 (421)
|+++.+|... ++ . . . ......+..++.++ ...+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987665421 11 0 0 0 11123333443222 11122222
Q ss_pred -----HCCccccCCCCCcEEEcc-CCCEEEeeccccc
Q 014610 129 -----NEGKIHRDIKAANILLTE-NGDVKVADFGVSA 159 (421)
Q Consensus 129 -----~~~iiHrDlkp~NILl~~-~g~vkL~DFGla~ 159 (421)
...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 125899999999999986 4789999998764
No 487
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.12 E-value=0.0082 Score=60.08 Aligned_cols=82 Identities=18% Similarity=0.121 Sum_probs=54.8
Q ss_pred eeceEeecCceEEEEEEECCCCcEEEEEEeccC----CC--HHHHHHHHHHHHHHHcCC---CCCeeEEEEEEEeCCEEE
Q 014610 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ES--EDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLW 87 (421)
Q Consensus 17 ~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~----~~--~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~ 87 (421)
..+.||.|....||+..+. +..|+||.-... .. +....+...|+..|+.+. ...+.+++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778899999999999874 456899985411 10 113455566677777664 247888887665 4567
Q ss_pred EEEecCCC--CCHHHHH
Q 014610 88 IIMEYMAG--GSVADLI 102 (421)
Q Consensus 88 lV~E~~~g--g~L~~~l 102 (421)
++||++++ ..+.+-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 88999977 2444433
No 488
>PRK12396 5-methylribose kinase; Reviewed
Probab=97.08 E-value=0.0025 Score=63.37 Aligned_cols=76 Identities=21% Similarity=0.336 Sum_probs=53.6
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEe----ccCC-CHHHHHHHHHHHHHHHcCC--CC-CeeEEEEEEEeCCEEEEE
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVI----DLEE-SEDEIEDIQKEISVLSQCR--SP-YITEYYGSYLHQTKLWII 89 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~----~~~~-~~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV 89 (421)
.+.||-|.-.-||++.+...++.|+||.- +... -+-...+..-|..+|+.+. .| .++++|. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 67889999999999998544678999973 2111 1334577788888888764 34 4556664 356677899
Q ss_pred EecCCC
Q 014610 90 MEYMAG 95 (421)
Q Consensus 90 ~E~~~g 95 (421)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
No 489
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=97.00 E-value=0.0027 Score=60.92 Aligned_cols=84 Identities=14% Similarity=0.201 Sum_probs=53.0
Q ss_pred cchhhCCC--ceeeceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC---CCCeeEEEEEEE
Q 014610 7 LQEAAGSR--FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYL 81 (421)
Q Consensus 7 ~~~~~~~~--y~~~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~ 81 (421)
+.+..+.. -+-.+.|+.|....+|+.. .+++.+.||+-... ....+..|+.-|+.|. --.+++++++..
T Consensus 9 ~~~~~~~~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~ 82 (288)
T PF03881_consen 9 ISEQLGADFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGE 82 (288)
T ss_dssp HHHHHTS-----EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE
T ss_pred HHHHhCCCCceeeeEecCCCChhheEEEE--CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 44555555 5566789999999999986 56889999987622 2356778888888873 455778888888
Q ss_pred eCCEEEEEEecCCCC
Q 014610 82 HQTKLWIIMEYMAGG 96 (421)
Q Consensus 82 ~~~~~~lV~E~~~gg 96 (421)
..+.-+|||||++.+
T Consensus 83 ~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 83 YDDDAFLLLEFLEMG 97 (288)
T ss_dssp -SSCCEEEEE-----
T ss_pred ecCCceEEEEeecCC
Confidence 777789999999876
No 490
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=96.97 E-value=0.0039 Score=61.16 Aligned_cols=136 Identities=16% Similarity=0.209 Sum_probs=79.0
Q ss_pred eceEeecCceEEEEEEECCC---CcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCCCe-eEEEEEEEeCCEEEEEEecC
Q 014610 18 LELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~---g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 93 (421)
++.|..|-...+|++..... +..|++|+.-... . ..-+..+|..+++.+..-++ .++++++. ++ +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence 45555588888999875432 3478999864322 1 22334678888888865444 45555553 22 589999
Q ss_pred CCCCHHH--------------HHHc--CCC------C-CHHHHHHHHHHH----------------------HHHHHHHH
Q 014610 94 AGGSVAD--------------LIQS--GPP------L-DEMSIACILRDL----------------------LHAIEYLH 128 (421)
Q Consensus 94 ~gg~L~~--------------~l~~--~~~------l-~e~~~~~i~~ql----------------------l~aL~yLH 128 (421)
+|.+|.. .+++ ..+ . ....+..++.++ ..-+..+.
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 172 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK 172 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence 8765521 1111 011 1 123333333222 11122221
Q ss_pred ----HCC----ccccCCCCCcEEEcc-CCCEEEeeccccc
Q 014610 129 ----NEG----KIHRDIKAANILLTE-NGDVKVADFGVSA 159 (421)
Q Consensus 129 ----~~~----iiHrDlkp~NILl~~-~g~vkL~DFGla~ 159 (421)
..+ ++|.|+.+.|||++. ++.++|+||..|.
T Consensus 173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 112 799999999999975 4789999999764
No 491
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=96.91 E-value=0.027 Score=54.66 Aligned_cols=29 Identities=14% Similarity=0.211 Sum_probs=26.7
Q ss_pred CccccCCCCCcEEEccCCCEEEeeccccc
Q 014610 131 GKIHRDIKAANILLTENGDVKVADFGVSA 159 (421)
Q Consensus 131 ~iiHrDlkp~NILl~~~g~vkL~DFGla~ 159 (421)
+++|+|+.+.|||++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998764
No 492
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=96.32 E-value=0.013 Score=57.13 Aligned_cols=72 Identities=18% Similarity=0.300 Sum_probs=57.1
Q ss_pred CCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCEEEeecccccc
Q 014610 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (421)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~-~iiHrDlkp~NILl~~~g~vkL~DFGla~~ 160 (421)
+.+.|++|++- |++|.-. +.-...++..++++.+..+.-+..+ ..-|||+.-.||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34568888876 5555433 2245678888999988888888765 689999999999999 99999999999873
No 493
>PRK06148 hypothetical protein; Provisional
Probab=96.31 E-value=0.05 Score=61.29 Aligned_cols=137 Identities=18% Similarity=0.278 Sum_probs=76.2
Q ss_pred ceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC-------CCCCeeEEEE-----EEEe-CC-
Q 014610 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-------RSPYITEYYG-----SYLH-QT- 84 (421)
Q Consensus 19 ~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~-----~~~~-~~- 84 (421)
+.|+ |..-.+|+.... +|+.+++|+.+..... ..+..|..+|..| .-|.+++-.+ .... ++
T Consensus 31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~ 105 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGE 105 (1013)
T ss_pred eecC-CcCCceEEEEeC-CCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCc
Confidence 5564 345678888643 4778999998754322 2334445555443 2344443321 1111 22
Q ss_pred -EEEEEEecCCCCCHHHH-------HH--------------c--C----CCCCH-----------------HHHHHHHHH
Q 014610 85 -KLWIIMEYMAGGSVADL-------IQ--------------S--G----PPLDE-----------------MSIACILRD 119 (421)
Q Consensus 85 -~~~lV~E~~~gg~L~~~-------l~--------------~--~----~~l~e-----------------~~~~~i~~q 119 (421)
..+-+++|++|..|.+. +. . . ..+.+ ...+.++.+
T Consensus 106 ~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~ 185 (1013)
T PRK06148 106 PRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVER 185 (1013)
T ss_pred eEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHH
Confidence 46778999999777651 10 0 0 01111 111222333
Q ss_pred HHHHHH-----HHH--HCCccccCCCCCcEEEccCC--CEE-Eeecccccc
Q 014610 120 LLHAIE-----YLH--NEGKIHRDIKAANILLTENG--DVK-VADFGVSAQ 160 (421)
Q Consensus 120 ll~aL~-----yLH--~~~iiHrDlkp~NILl~~~g--~vk-L~DFGla~~ 160 (421)
+++.+. .|. ..++||+|+++.|||++.++ ++. |+|||-+..
T Consensus 186 ~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 186 FLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 333222 121 24799999999999999775 555 999998753
No 494
>PTZ00384 choline kinase; Provisional
Probab=96.06 E-value=0.054 Score=54.18 Aligned_cols=78 Identities=15% Similarity=0.201 Sum_probs=47.1
Q ss_pred eeeceEeecCceEEEEEEECCC-CcE-----EEEEEeccCCCHHHHHHHHHHHHHHHcCCCCC-eeEEEEEEEeCCEEEE
Q 014610 16 SSLELIGRGSFGDVYKAFDKEL-NKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWI 88 (421)
Q Consensus 16 ~~~~~LG~G~~g~Vy~a~~~~~-g~~-----vAiK~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~l 88 (421)
..++.|..|-...+|++..... +.. |.+++.. ......-+-.+|+.+++.+..-+ -.++++.+.. ++
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 3455666688889999975432 222 4444421 11111223467899999996544 4555665532 69
Q ss_pred EEecCCCCCHH
Q 014610 89 IMEYMAGGSVA 99 (421)
Q Consensus 89 V~E~~~gg~L~ 99 (421)
|.||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987654
No 495
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=96.04 E-value=0.11 Score=50.85 Aligned_cols=134 Identities=18% Similarity=0.285 Sum_probs=78.4
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCC---CCC---eeEEEEEE--EeCC--EEEEE
Q 014610 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPY---ITEYYGSY--LHQT--KLWII 89 (421)
Q Consensus 20 ~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~---hpn---Iv~l~~~~--~~~~--~~~lV 89 (421)
.|.+ .-..||+....+ |+. ++|+..... ...++..|...|..|. .+- |..+=|-. .-.. ..+-|
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~~-iLki~~~~~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GRY-ILKIYRPGW---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred cccc-ccCceEEEEecC-CCe-EEEEecCCC---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 3444 445688887664 444 899886652 2355677788877763 222 22222211 1123 77889
Q ss_pred EecCCCCCHHH------------HHH------cCC---------CCCHH----HH---------HHHHHHHHHHHHHHHH
Q 014610 90 MEYMAGGSVAD------------LIQ------SGP---------PLDEM----SI---------ACILRDLLHAIEYLHN 129 (421)
Q Consensus 90 ~E~~~gg~L~~------------~l~------~~~---------~l~e~----~~---------~~i~~qll~aL~yLH~ 129 (421)
++|++|..+.. ++. ++- ...+. .. .....++...++.+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999877762 110 000 11121 00 1123345555555554
Q ss_pred C--------C--ccccCCCCCcEEEccCCC-EEEeeccccc
Q 014610 130 E--------G--KIHRDIKAANILLTENGD-VKVADFGVSA 159 (421)
Q Consensus 130 ~--------~--iiHrDlkp~NILl~~~g~-vkL~DFGla~ 159 (421)
. + +||+|+.|.|||++.+.. +.++|||-+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 3 999999999999998875 8999999753
No 496
>PRK11768 serine/threonine protein kinase; Provisional
Probab=96.00 E-value=0.23 Score=48.54 Aligned_cols=69 Identities=17% Similarity=0.083 Sum_probs=40.9
Q ss_pred ceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcCCCC--CeeEEE---E--EEEeCCEEEEEEecCCCCC
Q 014610 26 FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYY---G--SYLHQTKLWIIMEYMAGGS 97 (421)
Q Consensus 26 ~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~---~--~~~~~~~~~lV~E~~~gg~ 97 (421)
-..||+.... +|..+++|+..... .....+..|+..+..|... .|+... + ....++..+.|+++++|..
T Consensus 38 eN~vy~v~~~-~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 38 ENRVYQFGDE-DGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cceEEEEecC-CCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3468988653 36789999875332 1235567788777766321 122211 1 2233567788999998754
No 497
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=95.81 E-value=0.035 Score=50.74 Aligned_cols=85 Identities=16% Similarity=0.125 Sum_probs=59.7
Q ss_pred HHHHHHHHHHHcCCCCCeeEEEEEEEeCCEEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--Ccc
Q 014610 56 EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--GKI 133 (421)
Q Consensus 56 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~yLH~~--~ii 133 (421)
..+..+.++++++. .|+++..- .+-.+-++.|+|-.... . .. .++.-=+++|.-.|+. +.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~---~~-N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N---FS-NFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c---hh-HHHHHhHHHHHHhhccCCCee
Confidence 44577888888875 47777742 34457799999943111 1 11 1111225678888843 699
Q ss_pred ccCCCCCcEEEccCCCEEEeeccc
Q 014610 134 HRDIKAANILLTENGDVKVADFGV 157 (421)
Q Consensus 134 HrDlkp~NILl~~~g~vkL~DFGl 157 (421)
|+|-.|+||+-|+.|.+||.|-+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999874
No 498
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=95.60 E-value=0.054 Score=49.76 Aligned_cols=76 Identities=12% Similarity=0.248 Sum_probs=53.7
Q ss_pred eceEeecCceEEEEEEECCCCcEEEEEEeccCCCHHHHHHHHHHHHHHHcC---CCCCeeEEEEEEEeCCEEEEEEecCC
Q 014610 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTKLWIIMEYMA 94 (421)
Q Consensus 18 ~~~LG~G~~g~Vy~a~~~~~g~~vAiK~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (421)
.+.+.-|..-..|...+. ..+|-+|+-. ......+..|+.-|+.| +--.|.+++.+-.++.+.|+||||++
T Consensus 21 r~~v~gG~inea~~v~dg--~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 21 REEVSGGDINEAWRLRDG--TDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred ccccCCccccceeEeecC--CcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 345555655566665443 5678888743 23456777888777666 34678889998889999999999998
Q ss_pred CCCHH
Q 014610 95 GGSVA 99 (421)
Q Consensus 95 gg~L~ 99 (421)
.|.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 76554
No 499
>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function. All known members of this group are proteins from drosophila and Caenorhabditis elegans.
Probab=95.57 E-value=0.068 Score=51.24 Aligned_cols=72 Identities=14% Similarity=0.160 Sum_probs=43.3
Q ss_pred eecCceEEEEEEECC----C----CcEEEEEEeccCCC----HHHHHHHHHHHHHHHcCC-------------CCCeeEE
Q 014610 22 GRGSFGDVYKAFDKE----L----NKDVAIKVIDLEES----EDEIEDIQKEISVLSQCR-------------SPYITEY 76 (421)
Q Consensus 22 G~G~~g~Vy~a~~~~----~----g~~vAiK~~~~~~~----~~~~~~~~~E~~il~~l~-------------hpnIv~l 76 (421)
|.|-.|.+|++.-.. + ...+.||....... ......+.+|+.+.+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677788888876532 2 33578888762221 112355667777655431 1345677
Q ss_pred EEEEEeCCEEEEEEecC
Q 014610 77 YGSYLHQTKLWIIMEYM 93 (421)
Q Consensus 77 ~~~~~~~~~~~lV~E~~ 93 (421)
+..-.+....+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 76665555678998855
No 500
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=95.47 E-value=0.052 Score=53.88 Aligned_cols=62 Identities=21% Similarity=0.262 Sum_probs=43.3
Q ss_pred EEEEEEecCCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEccC
Q 014610 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY-LHNEGKIHRDIKAANILLTEN 147 (421)
Q Consensus 85 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qll~aL~y-LH~~~iiHrDlkp~NILl~~~ 147 (421)
...||-+|..|.++..+++. ...+|.....++.--..||-- |--.+++|.|++|.||++...
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 34677789999999999875 444555555555544455432 334589999999999999543
Done!